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1Preface and Outline
 
2Preface and Outline 
PrefaCe and ouTline of This Thesis
Life on earth is generally divided into three domains: Eukarya, Bacteria and Archaea. Organisms from all three domains experience invasions by selfish genetic elements, such as transposons, plasmids and viruses. To defend 
themselves against these selfish elements, they carry a variety of immune systems. 
While the Eukarya are known to contain a large repertoire of immune systems 
with a high degree of sophistication, defense systems found in prokaryotic micro-
organisms appeared to be much more rudimentary. However, in 2006, Bacteria 
and Archaea were predicted to possess a novel immune system of extraordinary 
complexity. This immune system, known as CRISPR-Cas, is unique in being both 
adaptive and inheritable, and it relies on small RNA molecules that guide the 
defense. This thesis describes recently gained insights into the mechanism of this 
newly discovered prokaryotic immune system in Escherichia coli, and presents data 
that indicate how expression of this small RNA based defense system is regulated 
in this model organism.
Chapter 1 – Introduction into small RNAs in bacteria
The first chapter provides an overview of known regulatory functions of small RNA 
(sRNA) molecules in bacteria, ranging from regulation of gene expression by cis or 
trans-encoded sRNA that base pair with complementary mRNA, to RNA structures 
known as aptamers that are involved in sensing concentrations of specific meta- 
bolites or other small molecules. Other examples of regulatory sRNAs are touched 
upon as well, such as sRNAs that regulate enzyme activity, and prokaryotic argo-
nautes that may utilize oligonucleotides to cleave complementary nucleic acids. 
Chapter 2 – How prokaryotes generate adaptive immunity
The second introductory chapter describes the variety of immune systems that 
prokaryotes have: receptor masking, superinfection exclusion mechanisms, restric-
tion/modification systems, abortive infection systems, and CRISPR-Cas. The main 
focus of this chapter is on the Type I-E CRISPR-Cas system that is found in E. coli. 
This chapter also describes various examples of beneficial interactions between 
viruses and their hosts, and the limitations of some immune systems to provide 
full protection are discussed in the light of potential fitness benefits conferred by 
mobile genetic elements.
Chapter 3 – Regulation of CRISPR-based immunity in Escherichia coli 
In the model organism E. coli, CRISPR-Cas has been described to be fully repressed 
by a global transcriptional repressor, known as H-NS. This third chapter describes 
the identification of a transcriptional activator, LeuO, that can relieve the H-NS 
mediated repression of cas gene transcription. A model is proposed that may 
explain how a virus infection can activate LeuO-induced CRISPR-Cas expression.
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Chapter 4 – Structure and function of the Cascade ribonucleoprotein 
complex
One of the key components of the E. coli CRISPR-Cas immune system is the Cascade 
ribonucleoprotein complex. In Chapter 4, the stoichiometry and low resolution 
structure of this multi-subunit complex are presented. Furthermore, some first 
insights into the biological function of Cascade are described. It is demonstrated 
that Cascade loaded with a crRNA molecule can specifically bind double stranded 
DNA containing a complementary sequence, without utilizing ATP. Using a variety 
of techniques, it is shown that the specific DNA binding activity of Cascade relies 
on the formation of an RNA/DNA heteroduplex structure, known as an R-loop. 
Chapter 5 – Molecular basis of DNA topology constrained CRISPR- 
interference
CRISPR-interference in vivo requires both Cascade and the nuclease/helicase Cas3. 
In Chapter 5, the combined activities of Cascade and Cas3 are addressed, using a 
plasmid as a biologically relevant target DNA molecule. It is demonstrated that the 
negatively supercoiled topology of a plasmid contributes half of the energy required 
for local melting of the target DNA to enable Cascade-mediated R-loop formation. 
Single molecule scanning force microscopy shows that Cascade localizes at the apex 
of supercoiled loops when bound to its target sequence. Using a bimolecular fluo-
rescence complementation assay, Cas3 recruitment upon R-loop formation is moni-
tored, and subsequent degradation of the target DNA is shown using in vitro assays.
Chapter 6 – Binding and bending of target DNA by Cascade
Using negatively supercoiled plasmids, the roles of the Cse1 and Cse2 subunits of 
Cascade in DNA binding are addressed in Chapter 6. Data are presented that show 
that Cse1 is crucial for nonspecific binding. Cse2 on the other hand appears to be 
important for specific binding, possibly by stabilizing the R-loop structure. Further-
more, using scanning force microscopy, it is demonstrated that Cascade introduces 
enhanced flexibility in the target DNA, which may well be due to stretches of single 
stranded DNA immediately flanking the R-loop structure.
Chapter 7 – Cascade avoids autoimmunity by discriminating targets from 
non-targets
Chapter 7 describes the mechanism by which Type I-E CRISPR-Cas systems avoid 
autoimmunity. We demonstrate that the E. coli Type I-E system, unlike the Type 
III-A system of Staphylococcus epidermidis, cannot specifically recognize self DNA 
(e.g., the CRISPR loci on the genome). Instead, Cascade specificially recognizes 
targets using a mechanism that relies on sensing a conserved motif that is located 
adjacent to target sequences but is absent in CRISPR loci. Hence, in contrast to 
the Type III-A self vs. non-self discrimination, Type I-E systems utilize a target vs. 
non-target discrimination mechanism.
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Chapter 8 – Plasmid targeting by Type I-E CRISPR systems 
Besides providing immunity against phage infections, CRISPR-Cas also plays a role 
in plasmid curing. In Chapter 8 bioinformatics analyses are presented that show 
that target sequences on conjugative plasmids are non-randomly distributed over 
these plasmids. Conjugative plasmids belonging to the MOBF family are predomi-
nantly targeted within the leading region of the plasmid. We present experimental 
data showing that spacers targeting this region provide similar levels of resistance 
during CRISPR-interference as spacers targeting other regions of the plasmid. 
Future experiments are required to understand the biological basis of the observed 
bias in conjugative plasmid-derived spacer sequences.
Chapter 9 – Summary, ongoing research and general discussion
The final chapter contains a summary of the work described in this thesis. This 
chapter contains unpublished data that provide some further structural and kinetic 
insights, both from ensemble and single molecule measurements, into Cascade-me-
diated DNA recognition. Finally, the mechanism of action of the E. coli CRISPR 
-Cas system is reviewed. Recent developments in the field are highlighted, and 
the implications of CRISPR-Cas for for bacterial evolution and the potential to use 
CRISPR sequences as a tool to investigate microbial biodiversity are discussed.
5
6
7Chapter 1
Introduction into small RNAs in prokaryotes
Adapted from:
Edze R. Westra, Matthijs M. Jore, Sinan Al-Attar, Stan J.J. Brouns, John van der Oost, 2013. Small 
RNAs in Bacteria. Encyclopedia of Biological Chemistry 2nd Edition.
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absTraCT 
Small RNA (sRNA) molecules in bacteria play key roles in the regulation of gene expression, in controlling protein functionality and in guiding defense against invading DNA. sRNAs involved in transcription regulation are divided 
in a cis- and a trans-encoded class. Cis-encoded sRNAs are encoded by the same 
genomic locus as their target mRNA, residing either on the transcript they regulate 
(riboswitches), or derived from the opposite strand (antisense sRNAs). Trans- 
encoded sRNAs are encoded elsewhere on the genome and require the RNA 
chaperone Hfq for exerting their function. Other sRNAs regulate nucleic 
acid-binding proteins by mimicking the nucleic acid sequence and structure, 
leading to sequestration of the protein. CRISPR RNAs (crRNAs) represent yet 
another class of sRNA that serve as a guide in defense against invading nucleic 
acids, such as viruses and conjugative plasmids. In addition, prokaryotic Argonaute 
has recently been proposed to function in antiviral or anti-plasmid defense that 
is guided by small nucleic acids. In this chapter, the function and molecular 
mechanism of the different classes of sRNAs are reviewed. 
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1inTroduCTionLike all living cells, bacteria rely on a myriad of metabolic pathways for the generation of energy and biomass to support maintenance and growth. Bacteria that thrive in ecosystems with fluctuating physical and chemical 
conditions have evolved control mechanisms that allow them to efficiently 
adjust their metabolic infrastructure by switching on appropriate biochemical 
pathways, while switching off others. The regulatory mechanisms responsible for 
fine-tuning these pathways are of major importance for optimal fitness. Control 
can be executed at all possible levels: DNA transcription, mRNA translation, 
enzyme activity, protein-protein interactions or protein localization. Often, 
the regulation acts on more than one level of a pathway. A classical example 
is the regulation of the tryptophan (Trp) biosynthesis pathway (See box 1). 
Although the analysis of regulation of cellular processes has often focused on 
control by proteins, it has become clear during the last decades that small RNA 
(sRNA) molecules also exert many regulatory functions. During the 30 years since 
the first discovery that bacterial sRNA molecules regulate plasmid replication (70; 
337), the insight in sRNA pathways has increased exponentially (reviewed in (386)). 
Most sRNAs act at the level of transcription and translation of mRNA. These 
sRNAs can be divided in (i) cis-encoded RNA elements that are either part 
Box 1 Regulation of the tryptophan biosynthesis pathway
To avoid unnecessary energy consumption, activation of the tryptophan (Trp) biosynthesis pathway only occurs when intracellular tryptophan levels are low. Several regulatory mechanisms controlling this pathway 
have been described. (1) Tryptophan activates a repressor (TrpR) that negatively 
regulates expression of the trp operon of Escherichia coli (negative feedback 
regulation). (2) In Pseudomonas aeruginosa, indoleglycerol phosphate, a Trp 
biosynthetic pathway intermediate, positively activates TrpI, a positive regulator 
of transcription of tryptophan biosynthesis genes. Indoleglycerol phosphate 
levels increase during Trp biosynthesis, giving rise to feed-forward control. (3) 
When tryptophan levels are low, uncharged tRNAtrp accumulate. In E. coli, the 
presence of tandem tryptophan codons in the leader peptide of the trp operon 
causes stalling of ribosomes when uncharged tRNAtrp are relatively abundant. 
This attenuation permits the formation of an anti-terminator loop, instead of the 
terminator loop that is present otherwise, thereby allowing for transcription (and 
translation) of the remainder of the operon to proceed. (4) In E. coli, the end 
product of the pathway (Trp) inhibits the activity of the first enzyme in the biosyn-
thetic pathway (anthranilate synthase), giving rise to negative feedback regulation.
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of the transcript they target (riboswitches, usually encoded in the 5’ UTR), or 
derived from the opposite strand (antisense sRNA, with perfect complemen-
tarity to the target mRNA) and (ii) trans-encoded sRNAs that are encoded by 
distinct genomic loci, acting on mRNA through direct base pairing with imper-
fect complementarity. Cis-acting riboswitches undergo a conformational change 
upon temperature increase or substrate binding that affects transcription/
translation of the downstream ORF. Both cis- and trans-encoded antisense 
sRNAs modulate either mRNA transcription, translation or mRNA stability. Many 
sRNAs of these classes mediate down-regulation of gene expression, but some can 
also activate genes (reviewed in (121)).
Other classes of sRNAs specifically bind to proteins (enzymes) and as such affect their 
functionality (activity). In addition, new classes of sRNAs have recently been dis- 
covered that make use of dedicated protein components for exerting their specialized 
functions. One of these new classes of small RNAs are crRNA, which are the topic of 
this thesis and are introduced in detail in Chapter 2. crRNA are small RNAs derived 
from CRISPR (clustered regularly interspaced short palindromic repeats) loci and 
function in protecting the cell against invading viral and plasmid DNA. Although 
the eukaryotic RNAi system functions in defense as well, the protein components 
involved in CRISPR-based defense differ substantially from their eukaryotic coun-
terparts. The core enzyme Argonaute is the only protein component of the RNAi 
pathway that is conserved in prokaryotes. It has recently been hypothesized that 
prokaryotic Argonaute (pAgo) is also involved in small RNA (or DNA) mediated 
antiviral defense (232). Altogether, prokaryotic sRNA molecules are involved in 
a wide range of regulatory processes that will be outlined in more detail below.
Cis-aCTing small rnas - riboswiTChes
A relatively simple means of regulating gene expression relies on the formation 
of secondary structures within the mRNA through internal base pairing. These 
secondary structures may be influenced (switched on/off) by physical or chemical 
signals as described below, and either interfere with transcription/translation of 
the mRNA itself or affect the stability of the transcript. Often the secondary struc-
ture occludes the Shine-Dalgarno (SD) sequence, hence interfering with ribosome 
binding and translation initiation.
RNA Thermosensors
In the case of RNA thermosensors, the SD masking structure is usually a regular 
hairpin that is stable only at lower temperatures. At elevated temperatures, the helical 
structure melts, making the SD sequence accessible for translation initiation (Fig. 
1A)(reviewed in (270)). This type of regulation often controls genes that are involved 
11
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1in response to a sudden temperature increase, such as heat-shock genes (257), and virulence gene expression after entry in a warm-blooded (mammalian) host (189). The s32 (RpoH) containing RNA polymerase holoenzyme plays an important role 
in the E. coli heat shock response. Translation of the rpoH mRNA is regulated 
by a well-studied thermosensor, that only allows efficient translation at elevated 
temperatures. This thermosensor contains 4 hairpin structures that encompass 
the entire SD sequence as well as 
the start codon. The imperfect 
complementarity in the stems 
causes enough destabilization 
for immediate melting of the 
structure at slightly elevated 
temperatures, while favoring 
the hairpin structure at lower 
temperatures (184; 257). Intro-
ducing stabilizing point muta-
tions in the s32 thermosensor 
sequence strongly decreases 
translation rates of the mRNA 
during heat-shock, since it has 
become unresponsive to tempe- 
rature change (257).
Other well-studied examples 
of thermosensors include the 
5’-UTR of the phage l cIII gene 
that is involved in deciding 
whether the lytic or lysogenic 
pathway of the viral lifecycle will 
be entered (8-10; 280). Another 
example is the ROSE (Repression 
Of heat-Shock gene Expression) 
element that is found upstream 
of several Bradyrhizobium 
japonicum genes (68; 262; 269). 
Analogous elements probably 
exist in other organisms as well 
(273). Like the rpoH thermosen-
sors, these structures comprise a 
set of stem-loop structures that 
include the SD sequence and 
the AUG start codon. Also here, 
Figure 1 Schematic of Riboswitches. 
Riboswitches are cis-acting regulatory elements that are 
usually located in the 5’ UTR of the mRNA they regulate. 
Upon elevated temperature (temperature-dependent 
riboswitch) or ligand binding (ligand-dependent ri-
boswitch), their conformation changes, resulting in  
alterations in mRNA transcription or translation. Ri-
boswitches serve as on/off switches, and ligand binding/
elevated temperature can either cause inhibition (off-
state) or relieve of inhibition of mRNA transcription/
translation (on-state). In the off-state, either the SD 
sequence is masked (interference with translation), or a 
transcriptional terminator stem-loop is formed (inter-
ference with transcription). In the examples depicted 
here, temperature-dependent and ligand-dependent 
riboswitches that control translation by masking the 
SD sequence are shown. The secondary structure of a 
temperature-dependent riboswitches is very sensitive to 
small increases in temperature, due to the mismatches 
present in the stem-loop. The melting of the secondary 
structure allows translation (or transcription when the 
stem-loop is a transcription terminator) of the down-
stream gene, since the SD sequence is no longer masked. 
Ligand-dependent riboswitches contain an aptamer 
region that specifically binds a ligand, which leads to 
structural rearrangements in both the aptamer region, as 
well as the downstream gene expression region. In this 
example, the structural rearrangements lead to masking 
of the SD, but examples are known where the structural 
rearrangements lead to exposure of the SD sequence, or 
where transcriptional terminators are formed or lost. 
12
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a certain number of mismatches is required for melting in response to a small 
increase in temperature (reviewed in (270)).
RNA ligand sensors
The majority of the riboswitches require the binding of a ligand, rather than 
elevated temperature, to induce structural rearrangements. The high number of 
ligand dependent riboswitches that has been identified illustrates their impor-
tance (reviewed in (166)). These riboswitches consist of a ligand-binding domain 
and a gene expression domain. The ligand-binding domain, also known as the 
aptamer region (50 up to several hundreds of nucleotides in size), functions as a 
highly specific receptor for metabolites present in the cell. Binding of the meta- 
bolite causes the formation of alternative secondary structures encompassing 
the aptamer region and part of the downstream sequence. Generally the struc-
tural rearrangements upon ligand binding result in interference with translation 
(masking of the SD sequence) of the transcript (Fig 1B) or with transcription (e.g. 
formation of a hairpin structure (terminator) that aborts further transcription by 
RNA polymerase) (reviewed in (166)). However, some examples of riboswitches 
that promote gene expression upon metabolite binding are also known (233). In 
these cases the structural rearrangements lead to the exposure of the SD sequence 
or the formation of anti-terminator structures (alternative secondary structures 
that prohibit the formation of the transcription terminator).
A riboswitch makes the mRNA responsive to the availability of nutrients or meta- 
bolites inside the cell. This type of regulation is often found in mRNAs that encode 
proteins involved in the uptake or biosynthesis of the metabolite that it binds. The 
ligands for a riboswitch can be as simple as a metal ion, or as complex as amino 
acids and complex cofactors (166). In some cases several genes are controlled by the 
same 5’ riboswitch. For example, the SAM riboswitch, which recognizes S-adenosyl 
methionine (SAM) (important for methylation reactions), is found upstream of a 
number of Bacillus subtilis genes that are involved in methionine and SAM biosyn-
thesis and uptake (145). Although the aptamers are identical, and thus have equal 
affinities for SAM, translation of these gene transcripts is not equally responsive to 
SAM due to differences in the downstream gene expression domain, which takes 
part in the secondary structure rearrangements upon ligand binding. The mRNAs of 
the anabolic pathway components are highly sensitive to SAM, so that they are not 
translated until SAM levels become almost depleted. In contrast, the mRNAs of the 
components involved in SAM uptake are much less sensitive to SAM, and repression 
of these genes is relieved while relatively high levels of SAM are still present. This 
additional layer of regulation causes that SAM uptake systems are switched on first 
when SAM levels drop. If this has no effect, SAM levels further drop to a level that 
relieves repression on the mRNA for SAM biosynthesis genes (reviewed in (166)).
13
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1A decreased sensitivity can also be accomplished by multiple copies of the same riboswitch, since ligand binding to each aptamer is needed (127). An example of this is the riboswitch that binds uncharged tRNAThr to control the thrZ gene 
(threonyl-tRNA synthetase) in Bacillus subtilis. Some mRNAs also contain several 
different 5’ riboswitches to allow integration of multiple signals. For example, 
the mRNA of metE (encoding vitamin B12-independent methionine synthase) 
contains 2 riboswitches, one of which binds SAM, which is the end product of 
MetE (feedback control), and the other binds vitamin B12. The presence of vitamin 
B12 signifies that a more efficient pathway for SAM biosynthesis can be utilized, 
which makes use of the vitamin B12-dependent methionine synthase encoded by 
metH (340).
The generation of transcripts containing a riboswitch that blocks translation may 
seem as a waste of resources compared to regulation at the level of transcription. 
However, it enables a more rapid response to temperature shock or changes in 
metabolite levels, which may be worth the expense. To avoid further spoilage of 
resources due to partial translation of the sequence, the riboswitch is almost always 
located at the 5’-UTR of the transcript.
Cis-enCoded small rnas – anTisense
Apart from elements in the mRNA itself that regulate transcription or translation 
through secondary structure formation, gene expression can also be regulated 
by small antisense RNA molecules that act through base pairing with the target 
mRNA (Fig 2A). The complementarity between the target mRNA and the sRNA 
is perfect in the case of cis-encoded sRNAs, since they are transcribed from the 
opposite strand of the same locus as the target mRNA. In most cases cis-encoded 
sRNAs inhibit transcription or translation of their target transcript. Some func-
tion as anti-toxin by repressing the translation of a toxic protein. These toxin/anti-
toxin systems are often encoded on large conjugative plasmids and ensure that the 
plasmid is retained in the cell and its progeny, since loss of the short-living anti-
toxin causes cell death due to the long-living toxin (130). These toxin/anti-toxin 
pairs are sometimes found on the chromosome of bacterial species as well, where 
they carry out functions that are not yet well understood (118), possibly being bene-
ficial for the host by inducing slow growth under stress conditions, or providing 
defense against plasmids with the same toxin/anti-toxin system.
Other cis-encoded sRNAs bind polycistronic mRNA transcripts to modulate 
expression levels of individual genes within the operon. An example of this type 
of regulation is the base pairing of the antisense sRNA GadY with the gadXW 
mRNA, encoding GadX and GadW, which respectively activate and repress the 
glutamate-dependent acid response in E. coli. The base pairing between GadY and 
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gadXW mRNA leads to cleavage between the gadX and gadW coding sequences 
and increased gadX transcript levels (279; 355). Other examples, such as the anti-
sense sRNA induced transcription termination after fatA in the fatDCBAangRT 
operon in Vibrio anguillarum, and sRNA induced cleavage between the isiA and 
isiB coding sequences in the isiAB transcript in Synechocystis, are described else-
where (386). 
Trans-enCoded small rnas 
Similar to cis-encoded sRNAs, trans-encoded sRNAs regulate mRNA translation 
and stability (reviewed in (336)). They differ from cis-encoded sRNA in that they 
are derived from other loci than their targets. Consequently, the base pairing 
region between the sRNA and the target mRNA contains only partial complemen-
tarity. In most cases the sRNA binds the mRNA sequence at its 5’ end to mask 
the SD sequence and/or start codon (Fig 2B). However, trans-encoded sRNAs that 
enhance translation or transcription of the mRNA transcript through an anti-anti-
sense mechanism have been described as well (reviewed in (121)). In this case base 
pairing of the sRNA leads to structural rearrangements in the mRNA that result 
in exposure of the SD sequence or in anti-termination. The best studied example 
is the regulation of RpoS, an alternative s-factor, by the sRNAs DsrA, ArcZ and 
RprA in E. coli (328). These sRNAs activate RpoS translation through base pairing 
with an inhibitory stem of a hairpin present at the 5’ untranslated region (UTR) of 
the RpoS transcript. The genes that are transcribed in an RpoS dependent manner 
are important for entry in the stationary phase. The sRNA RprA is transcribed in 
response to envelope stress, whereas DsrA is transcribed especially at low tempe- 
ratures.
A key player in regulation by trans-encoded sRNA in Gram-negative bacteria is 
the protein Hfq, which functions as an RNA chaperone (reviewed in (378)). The 
hexameric Hfq binds sRNA and improves the formation of low-complementarity 
duplexes between the trans-encoded sRNA and the target mRNA (328). In hfq 
mutant strains trans-encoded sRNAs fail to exert their regulatory effect ((50; 258; 
356)). Hfq might also be involved in melting secondary structures of the target 
mRNA (258; 314), although this remains a matter of debate (46). By rapid cycling 
of sRNA under in vivo conditions, Hfq serves as a platform for the sRNA mRNA 
interactions (111). 
Since full complementarity is not required, a single trans-encoded sRNA can have 
multiple targets ((11), reviewed in (283; 378)). In some cases a single sRNA targets 
multiple genes involved in the same pathway. For example, in E. coli the sRNA 
RyhB is transcribed in response to iron limitation (reviewed in (240)). RyhB targets 
the mRNA of different operons encoding iron binding proteins, amongst others 
15
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1
bfr (bacterioferritin), sdh (succinate dehydrogenase) and sodB (superoxide dismu-
tase) (239; 241). The Hfq-dependent base pairing between these mRNAs and RyhB 
leads to RNaseE dependent degradation of both the mRNA and RyhB (239). By 
down regulating the levels of these iron-binding proteins, the availability of iron 
for essential cellular processes increases.
small rnas ThaT bind ProTein To modulaTe 
Their aCTiviTy
Few examples are known of sRNAs that bind proteins to modulate their activity 
(reviewed in (386)). These sRNA molecules contain a motif or structure that causes 
high affinity binding by a specific nucleic acid binding protein, leading to seques-
tration of the latter (Fig 2C). For example, the s70-containing RNA polymerase 
Figure 2 Small non-coding RNA molecules can regulate mRNA stability or transla-
tion (antisense RNA), or protein functionality (sequestration). 
A) The complementarity between the target mRNA and the sRNA is perfect in the case of cis-en-
coded sRNAs, since they are transcribed from the opposite strand of the same locus as the target 
mRNA. The outcome of base pairing between the target mRNA and cis-encoded sRNA is usually 
inhibition of translation or degradation of the mRNA, or modulation of the expression of genes in 
an operon, resulting from sRNA induced cleavage between ORFs in a polycistronic transcript.  
B) Trans-encoded sRNAs show only limited complementarity with their target and need the 
hexameric Hfq to exert their regulatory function. Hfq facilitates binding of trans-encoded sRNA 
to target mRNA. Binding of the sRNA  to the target mRNA sequence usually occurs at the 5’ end to 
mask the SD sequence and/or start codon of the mRNA. Although trans-encoded sRNAs usually 
inhibit translation or cause degradation of the mRNA, examples that cause enhanced translation of 
the mRNA transcript have been described as well. In these cases the trans-encoded sRNAs bind a 
stem-loop that functions as a transcription terminator (anti-termination), or base pairing induces 
structural rearrangements in the mRNA that result in exposure of the SD sequence.  
C) Some sRNAs are known that modulate the functionality of a nucleic acid binding protein 
(NABP). These sRNA molecules function by sequestering the NABP, due to the presence of a motif 
or structure to which the NABP binds with high affinity.
16
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(RNAP) has high affinity for the 6S sRNA due to its conserved secondary structure 
that is highly reminiscent of the DNA conformation in an open promoter (reviewed 
in (384)). During exponential growth, the majority of transcription is carried out 
by RNAP containing s70. However, when cells enter the stationary phase upon 
nutrient depletion, alternative sigma factors associate with the core RNAP leading 
to transcription switching. The 6S sRNA facilitates transcription by alternative 
sigma factors, since the high affinity binding of s70 to 6S leads to sequestration of 
the former. As a result, transcription from certain s70 promoters is inhibited, and 
instead, transcription mainly takes place from ss promoters.
In E. coli two sRNAs, CsrB and CsrC, regulate CsrA protein activity in an ana- 
logous manner. Dimers of CsrA act as global post-transcriptional regulators of 
carbon metabolism. These dimers exert their regulatory function by binding target 
mRNA sequences with GGA motifs in their 5’-UTR. As CsrB and CsrC each contain 
multiple GGA motifs, an increase in their levels leads to sequestration of CsrA (20; 
386). 
ProkaryoTiC argonauTe
In RNAi in eukaryotes, three major forms of small regulatory RNAs can be distin-
guished: microRNAs (miRNAs), small interfering RNAs (siRNAs) and piwi-in-
teracting RNAs (piRNAs). miRNAs are endogenously encoded non-coding RNAs 
that regulate cellular processes through sequence-specific transcriptional or post 
transcriptional gene silencing. Initially it was thought that siRNAs are exclusively 
derived from extrachromosomal elements such as viruses and sequence-specifically 
suppress these elements. However, the recent discovery of endogenously encoded 
siRNAs has made the boundaries between miRNAs and siRNAs less well-de-
fined. Despite their distinct roles and origins, miRNAs and siRNAs share common 
themes in their mechanistic pathways. Two core proteins involved in both RNAi 
pathways are Dicer and Argonaute (note that it can be distinct paralogous proteins 
in one organism that are involved in either pathway). Dicer contains two RNaseIII 
domains that each cleave one strand of a dsRNA precursor molecule, generating 
short dsRNA. One of these strands (the guide) is then transferred to Argonaute, 
which facilitates base pairing with complementary RNA target sequences. miRNAs 
generally display imperfect base pairing while siRNAs generally display perfect 
base pairing with the target transcript. The PIWI-domain of Argonaute, which 
shares structural homology to RNaseH family proteins, can cleave the complemen-
tary target RNA in case of perfect base pairing. Subsequent recycling of the small 
RNA-protein complex enhances the silencing effect. 
Argonaute is the only protein component of RNAi of which homologs can be found 
in prokaryotes. Prokaryotic argonaute genes have been identified in ~80 sequenced 
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1genomes. Interestingly, crystal structures and in vitro activity assays of these prokaryotic Argonaute proteins provided the RNAi field with a wealth of insight in the mechanism of target binding and cleavage. However, their role in prokary-
otes remains elusive. It has recently been hypothesized that they are involved in 
antiviral (and anti-plasmid) defense (232), which is supported by several observa-
tions: (i) in eukaryotes many homologous Argonaute proteins are involved in anti-
viral defense, (ii) phylogenetic analysis of prokaryotic argonaute gene sequences 
suggests extensive horizontal gene transfer (HGT), which is typically observed 
for virus defense systems, (iii) comparative gene neighborhood analysis revealed 
enriched association of argonaute genes with known phage-defense genes such as 
restriction endonucleases, (iv) in virus-infected T. thermophilus cultures, expres-
sion of the argonaute gene, as well as the cas genes is enhanced, (v) Argonaute 
proteins from Aquifex aeolicus and T. thermophilus display DNA-guided nuclease 
activity in vitro. 
Despite its putative role in antiviral defense, the exact mechanism of virus defense 
remains to be elucidated. Small guide RNAs could direct base pairing and target 
cleavage analogously to RNAi in eukaryotes. However, prokaryotic Argonaute 
shows a higher affinity for guide-DNA than for guide-RNA and contains both DNA 
and RNA guided nuclease activity. Despite in vitro RNA degradation, the associ-
ation of Argonaute with putative dsDNA nucleases suggests that DNA is being 
targeted directly. More insight in this exciting supposed small nucleic acid-based 
antiviral defense system is to be expected in the near future.
CrisPr-based defense againsT infeCTion
A more recently discovered class of prokaryotic small RNA molecules is involved in 
defense against invaders, such as viruses and conjugative plasmids. The hallmark of 
this defense system are loci of Clustered Regularly Interspaced Short Palindromic 
Repeats (CRISPR) with often adjacently located CRISPR associated (cas) genes. 
CRISPRs are the main topic of this thesis and are introduced, together with other 
antiviral defense systems, in Chapter 2. 
ConClusions
Altogether small RNA molecules have diverse functions in prokaryotes (both 
bacteria and archaea), ranging from regulation of gene expression, mRNA trans-
lation and protein functionality, to guiding target recognition in the recently 
discovered CRISPR-based defense system. The presence of Argonaute homologs 
in prokaryotes suggests the existence of additional host defense pathways utilizing 
small nucleic acids.
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absTraCT 
Organisms need to continuously adapt to changes in their environment. Through horizontal gene transfer, bacteria and archaea can rapidly acquire new traits that may contribute to their survival. However, because new 
DNA may also cause damage, removal of imported DNA and protection against 
selfish invading DNA elements are also important. Hence, there should be a 
delicate balance between DNA uptake and DNA degradation. Here, we describe 
prokaryotic antiviral defense systems, such as receptor masking or mutagenesis, 
blocking of phage DNA injection, restriction/modification, and abortive infection. 
The main focus of this review is on CRISPR (clustered regularly interspaced short 
palindromic repeats)/Cas (CRISPR-associated), a prokaryotic adaptive immune 
system. Since its recent discovery, our biochemical understanding of this defense 
system has made a major leap forward. Three highly diverse CRISPR-Cas types exist 
that display major structural and functional differences in their mode of generating 
resistance against invading nucleic acids. Because several excellent recent reviews 
cover all CRISPR subtypes, we mainly focus on a detailed description of the Type 
I-E CRISPR-Cas system of the model bacterium Escherichia coli K12.
23
Chapter 2 How Prokaryotes Generate Adaptive Immunity
2
inTroduCTion
All viruses live in intimate association with their host cell, which they require for propagation. The symbiosis between a virus and its host is often thought of as a parasitic interaction. In this view, viruses exploit host resources for 
their own benefit at the expense of the host. For example, after intracellular pro- 
liferation, the new generation of viruses spread through the population, leaving 
behind a heavily damaged or dead host cell. It is important to bear in mind, 
however, that despite their bad reputation, some viruses can have a conditionally 
beneficial effect on their host (308). Examples from the eukaryotic literature include 
virus-host relationships in which endogenous (para)retroviruses have advanced 
host evolution through the acquisition of viral genes (155) or in which they function 
in host defense against exogenic variants of the same virus or closely related viruses 
(347). Another more complex example of virus-host mutualism is the interaction 
between polydnaviruses and endoparasitoid wasps, where viral genes are required 
for successful development of the wasp egg in the lepidopteran insect host (105). 
Likewise, bacteria and phages can have a mutualistic relationship. In the case of 
some pathogenic bacteria, phages encode virulence factors required for bacterial 
invasion (reviewed in (44; 52)). Intriguingly, a mutualistic aphid-bacterium inter-
action has been described that relies on a phage that is integrated in the bacterial 
genome; a toxin encoded by this prophage specifically kills invading parasites of the 
aphid host (277). Moreover, lysogenic phages encoding superinfection exclusion 
(Sie) systems can benefit a bacterial population because their rare excision from the 
host genome results in the release of phage particles that infect competing bacteria 
that do not contain a similar prophage, whereas the lysogen-carrying bacterial 
population is protected by Sie (see below) (41; 51; 210). In view of these examples of 
viruses conferring (conditional) advantages, the combination of host defense and 
recombination systems should be considered as a compromise between resistance 
against harmful DNA on the one hand and admission of useful DNA on the other.
To protect themselves against parasitic invaders, many species have developed 
multilayered antiviral defense systems. Mammals combat viruses by apoptosis of 
infected cells, clearance of infected cells by natural killer cells, antibody production 
by the cell-based adaptive immune system (reviewed in (7)), and probably also by 
RNA interference (RNAi) (311). In plants and insects, infection by RNA viruses is 
mainly controlled by RNAi (reviewed in (217; 372)). Plants also employ programmed 
cell death through the hypersensitive response (reviewed in (410)), whereas insects 
use intracellular protein-mediated antiviral defense (57; 401). Archaea and bacteria 
also contain numerous lines of defense against their viruses or phages, respectively 
(reviewed in (179; 202)), such as receptor masking, blocking DNA injection (Sie), 
restriction/modification (R-M) and R-M-like systems, abortive infection (Abi), and 
the recently identified CRISPR/Cas system, which is the main focus of this review.
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baCTerial and arChaeal defense sysTems
Antiviral defense systems in prokaryotes are multilayered, acting at virtually all 
stages of the viral life cycle (Figure 1). The different types of prokaryotic defense 
systems evolve rapidly because of antagonistic coevolution between virus and host, 
which is best described as a combination of an arms race of defense and coun-
ter-defense and fluctuating selection on rare host and parasite genotypes (135; 153).
Preventing Viral Attachment
An effective and simple means of acquiring phage resistance is the blocking of 
phage adsorption to the host cell, either by masking the receptor (e.g., through 
expression of polysaccharides on the cell surface) or by downregulating or 
mutating receptor molecules (reviewed in (179)). Examples of phage resistance by 
receptor masking have been described for Aeromonas salmonicida (181), Staphy-
lococcus aureus (274; 275), Escherichia coli (303), and Lactococcus spp. (reviewed 
in (116)). Some phages counteract receptor masking by carrying carbohydrate-de-
grading enzymes (312; 342). More direct alterations to phage receptors (muta- 
genesis, downregulation, and loss) usually come with (conditional) fitness costs, 
or can make the host more susceptible to infection by other viruses (17). Nonethe-
less, this is a commonly encountered mechanism to escape phage predation, which 
phages can counter by mutations leading to recognition of the altered receptor or 
another receptor (reviewed in (164)). This is nicely exemplified by a recent phage 
l and E. coli coevolution experiment where, after E. coli evolved to downregu-
late the natural receptor (LamB), the phage evolved through several point muta-
tions in its receptor binding protein (J) to bind a new receptor (OmpF) (248).
Blocking DNA Injection
Obstruction of the entry of the viral genome in the host’s cytoplasm makes up a 
second line of defense. The proteins blocking DNA injection are usually localized 
in association with or in close proximity to the membrane/cell wall and can be 
encoded by a plasmid (125) or by a prophage (244; 385), reviewed in (116; 221). In the 
latter case, the process is referred to as Sie. Sie was originally described for T-even 
phages and their E. coli hosts (100; 120) but has since also been found in other 
phages, such as those infecting lactic acid bacteria (116). 
Although Sie is often considered to be important at the level of phage-phage inter-
actions, this system can in fact provide a selective advantage to the part of the 
bacterial population carrying the prophage (51). The bacteria can multiply for many 
generations while carrying the prophage. At some stage, upon specific (stress) 
stimuli, some prophages excise, multiply, and proliferate (killing the host cell). As 
such, the prophage is used as a weapon to infect and kill competing (prophage- 
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free) bacteria, whereas the prophage-carrying fraction of the population remains 
intact because of Sie. Under these conditions, the host bacterium and Sie-encoding 
prophage have a mutualistic relationship (reviewed in (308)).
Figure 1 Schematic overview of prokaryotic defense systems. 
Bacterial cells contain several independent mechanisms to defend themselves against phage infec-
tion (or other invading DNA, such as conjugative plasmids). Defense mechanisms include blocking 
of phage adsorption or DNA injection. Other systems act directly on the invader DNA, such as 
restriction/modification and CRISPR (clustered regularly interspaced short palindromic repeats)/
Cas (CRISPR-associated). Abortive infection systems are a form of altruistic defense, causing cell 
death upon infection as a sacrifice to protect the rest of the population. These defense systems can 
act independently of each other, but crosstalk between different systems may be possible. Note 
that the infecting “blue phage” contains a DNA fragment that has a sequence identical to the blue 
fragment in the CRISPR locus of the host cell. This coloring is to distinguish it from the grey phages 
that are destroyed by other mechanisms. The abbreviations C, M and R used in the figure stand for 
Cas protein, Methyltransferase and Restriction endonuclease, respectively.
26
Chapter 2 How Prokaryotes Generate Adaptive Immunity
Digestion of Nonself DNA
If phage adsorption and DNA injection are not prevented, intracellular defense 
systems may act directly on the viral DNA to neutralize the invader. The R-M 
system is a broad-range prokaryotic immune system that targets DNA. A typical 
R-M system consists of a DNA methyltransferase, which modifies specific DNA 
sequences, and a restriction endonuclease, which cleaves the same sequences 
when unmodified. The general principle of these systems is that the host’s genomic 
DNA is methylated and hence protected against cleavage, whereas exogenic DNA 
is unmodified and restricted. Three major R-M types have been identified that 
follow this classical scheme. In addition, a fourth type has been identified that 
consists of restriction enzymes cleaving modified DNA only (reviewed in (306)). 
More recently, an R-M-like system, known as phage growth limitation (Pgl), has 
been found in Streptomyces coelicolor. Pgl somehow modifies offspring phage 
DNA, which targets it for destruction when these phages infect cells that also carry 
the Pgl system (341). The Pgl system is made up of at least four genes, one of which 
resembles a methyltransferase (175). The molecular mechanism of this interesting 
new system remains to be determined.
Type I R-M systems require S-adenosylmethionine (AdoMet) for DNA methyla-
tion and Mg2+ and ATP for endonuclease activity. These systems encode a nuclease 
(hsdR), a DNA methyltransferase (hsdM), and a recognition sequence-binding 
specificity subunit (hsdS) that together form a 400-500 kDa multiprotein complex 
with a hsdR2hsdM2hsdS1 stoichiometry. Type I restriction sites are asymmetric and 
bipartite, with a separation into two fragments of 3-4 bp and 4-5 bp interspaced 
by 6-8 bp nonspecific sequence (reviewed in (263)). Although hemimethylated 
sequences trigger methyltransferase activity by the hsdM subunits (380), unmethy-
lated sequences induce ATP-dependent DNA translocation by the hsdR subunits, 
whereas the hsdS subunit remains bound to the restriction site, leading to loop 
formation in the DNA. Subsequent cleavage is catalyzed by the hsdR subunits at 
sites remote from the restriction site when the R-M complex collides with a second 
R-M complex, or when another collision block occurs ((339) reviewed in (263)).
Type II R-M systems are the best-known restriction modification systems because 
they have revolutionized molecular cloning and are presently utilized in virtually 
all laboratories employing recombinant DNA techniques. In contrast to type I and 
type III R-M systems, type II R-M systems are ATP-independent and cleave DNA 
at a well-defined position, most often within or very near to the restriction site 
(reviewed in (290)). Restriction sites are usually 4-8 bp palindromic sequences. 
Often Mg2+-dependent cleavage requires restriction endonucleases to form homo- 
dimers or homotetramers to generate symmetrical cleavage products with either 
blunt or sticky ends. Again, sequences are protected by DNA modification by a 
(generally) separately encoded DNA methyltransferase. In contrast to the other 
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types, type II methyltransferases and restriction endonucleases work completely 
independently (reviewed in (290)), therewith sharing certain properties with 
selfish addiction modules, such as toxin-antitoxin systems (265).
Type III R-M sytems consist of a mod gene encoding a DNA methyltransferase and 
a res gene encoding a restriction endonuclease. Complexes with a Mod2Res2 stoi-
chiometry are stimulated by AdoMet and cleavage activity requires ATP, Mg2+, and 
two inversely oriented unmethylated nonpalindromic recognition sequences (5-6 
bp). The methyltransferase provides protection by catalyzing methylation of one 
strand of the recognition sequence (22; 45; 180). During DNA replication some 
sites become unmodified but remain protected, as these unmodified sites are never 
inversely oriented (246). Type III endonucleases cleave 25-27 bp downstream of 
the recognition site. Interestingly, expression of mod genes is phase variable in 
some organisms, which might be a way of downregulating host defense to allow 
for (potentially beneficial) DNA uptake (14; 98). Alternatively, these phase variable 
type III R-M systems may have evolved into regulatory systems that control expres-
sion of target genes through their methylation status (reviewed in (117; 331)).
Phages can escape R-M systems in several ways: (a) by mutagenesis of target 
sequences; (b) by carrying inhibitors of restriction endonucleases, (c) by carrying 
enzymes that hydrolyze R-M cofactors (e.g., AdoMet), (d) by incorporating modified 
nucleotides in their DNA (reviewed in (383)), or (e) by encoding their own (multispe-
cific) methyltransferases (reviewed in (35; 198)). Possibly type IV R-M systems, 
which specifically recognize methylated DNA or modified nucleotide-containing 
DNA (25; 306), evolved as a counter defense against these escape mechanisms. As 
type IV systems cleave modified DNA, they do not encode a modification enzyme.
Abortive Infection
Similar to the apoptosis mechanism in eukaryotic cells, the widespread Abi systems 
in prokaryotes induce cell death upon viral infection as a sacrifice to protect other 
cells of the same species. In E. coli several Abi systems have been described, either 
consisting of a single protein (e.g., LitA, PrrC, PifA), or, in the case of Rex, consisting 
of a two-component system (reviewed in (202; 255)). Lactic acid bacteria also 
contain many Abi systems, with Lactococcus lactis alone containing as many as 20 
Abi systems (AbiA to AbiU), most of which consist of single proteins (reviewed in 
(67)). In general, the toxic effect of an Abi system is conferred by their cleavage of 
essential cellular components, therefore necessitating a tight regulation of these 
Abi systems. Interestingly, Fineran and coworkers recently discovered a new class 
of toxin/antitoxin (TA) systems [protein toxin (ToxN)/RNA antitoxin (ToxI); type 
III TA systems] that functions as an Abi system (112). It has been proposed that the 
phage triggers disruption of ToxIN transcription or affects stability of the ToxIN 
complex, causing mobilization of the toxin, which allows it to exert its effect (38).
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Adaptive Immunity
CRISPR-Cas, the latest addition to the list of known prokaryotic anti-invader 
systems, appears to be the most complex of these systems. The CRISPR-Cas system 
is unique in being the only adaptive and inheritable prokaryotic immune system 
known to date. Below, we briefly describe its discovery and summarize our current 
understanding of the system (for extensive reviews, see (6; 34; 173; 192; 236; 349; 
366)) before we elaborate in detail on the Type I-E CRISPR-Cas system.
CrisPr-Cas disCovery
In 1987, Ishino and coworkers (182) discovered an unusual structure of repetitive 
DNA downstream from the E. coli iap gene consisting of invariant direct repeats 
(29 nt) and variable spacing sequences (32 nt). Although similar repeat clusters 
were subsequently identified in Haloferax mediterranei, Streptococcus pyogenes, 
Anabaena, and Mycobacterium tuberculosis (143; 170; 238; 252; 368), their func-
tion remained unknown (251). Jansen and coworkers coined the term CRISPR 
and reported that CRISPRs colocalize with specific cas genes (187). CRISPR-Cas 
systems are exclusively found in prokaryotes (186) - in approximately half of the 
bacteria and almost all archaea (142). Although different systems were proposed 
to classify the typical combinations of cas genes (148; 230), a recent classification 
defines three main types, each with two or more subtypes (231). The emergence of 
bacterial and archaeal genome sequences on the one hand and viral and plasmid 
sequences on the other resulted in the key discovery that CRISPR spacers resemble 
fragments of foreign genetic elements, suggesting that the spacers were derived 
from invading genomes (39; 250; 294). These observations, together with the 
detection of CRISPR locus transcripts with defined lengths of one or more spacer 
repeat units (213; 345; 346) and predicted nucleic acid-related activities for many of 
the cas genes, led Makarova and coworkers to propose that CRISPR-Cas neutralizes 
invaders via a mechanism reminiscent of RNAi (230). Soon thereafter, Barrangou 
and coworkers (28) provided the first experimental evidence that the CRISPR-Cas 
system of the lactic acid bacterium Streptococcus thermophilus functions as an 
inheritable, adaptive prokaryotic immune system.
Given the long history of the study of phage biology, it may appear puzzling that 
the CRISPR-Cas immune system was not discovered earlier. To some extent, this is 
due to the rather tight regulation of CRISPR-Cas systems in model organisms, such 
as E. coli and Salmonella enterica, causing their expression to be silenced under 
normal laboratory growth conditions. Genomics research starting from 1995 has 
resulted in the elucidation of the ubiquitous repetitive CRISPR loci and the associ-
ated gene clusters. Hence, the only adaptive and inheritable prokaryotic immune 
system known to date has remained hidden long enough to grant present-day 
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researchers the opportunity to explore this exciting field. Indeed, during the last 
six years, CRISPR research has been flourishing, resulting in a rapid gain of insight 
in the molecular mechanisms of this highly diverse defense system.
CrisPr arrays
A CRISPR array consists of host-derived repeating sequences of typically around 
30 bp that are interspaced by similar-sized acquired spacer sequences. A CRISPR 
locus may vary in length from just a few to several hundred repeat-spacer units. 
The repeat sequences have been classified in 12 different clusters, some of which 
are predicted to form a hairpin secondary structure, whereas others are predicted 
to be unstructured (201). Usually a CRISPR-Cas subtype associates with a single 
repeat cluster, although exceptions to this have been reported (see below). CRISPR 
loci are generally flanked by an adenine/thymine (AT) -rich leader sequence  (187), 
which have been shown to contain promoter elements (150; 214; 293; 297) and 
binding sites for regulatory proteins (293; 297). Moreover, the observed polarized 
acquisition of new spacer sequences at the leader end of the CRISPR array gave rise 
to the speculation that leader sequences may contain binding sites for Cas proteins 
involved in CRISPR adaptation (6).
TyPe i, TyPe ii, and TyPe iii CrisPr-Cas syTems
Careful re-evaluation of the various sets of cas genes has revealed that CRISPR-Cas 
systems cluster into three basic types (Type I, Type II, and Type III) (Figure 2), 
which are further divided into at least ten subtypes (Type IA-F, Type IIA-B, and 
Type IIIA-B). The genes that are present in each CRISPR-Cas variant are cas1 and 
cas2 (231). The mechanism of all CRISPR-Cas systems is divided into three stages: 
adaptation, expression, and interference. During the adaptation stage, resistance 
is acquired by integration of a new spacer sequence in a CRISPR array. During the 
expression stage, cas genes are transcribed and translated; in addition, CRISPRs 
are transcribed into precursor CRISPR RNAs (pre-crRNAs) that are subsequently 
cleaved by a Cas6 homolog in Type I and Type III systems (49; 60; 156; 157; 296), and 
by an RNase III in Type II systems (90). Mature crRNA contains (part of) a single 
spacer sequence, and hence can only recognize a single target. During the interfer-
ence stage, the crRNA guides one or more Cas proteins to cleave complementary 
nucleic acids.
Type I systems are characterized by the presence of Cas3, comprising a histidine/
aspartate (HD) -nuclease domain and a DExH helicase domain, which can also be 
encoded in separate open reading frames or can be fused to other Cas proteins (230; 
231) (see below). All Type I systems are thought to form a crRNA-guided surveillance 
ribonucleoprotein complex, similar to the Cascade complex identified in Type I-E 
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of E. coli K12 (49). For Type I-A (archaeal Cascade, here referred to as IA-Cascade) 
and Type I-F (Csy complex, here referred to as IF-Cascade) Cascade-like complexes 
have been recently described (215; 396). Type I-A CRISPR-Cas systems have been 
studied in the hyperthermophilic crenarchaeon Sulfolobus solfataricus (146; 213; 
214; 317). Although CRISPR transcript levels appear to be modulated by a repeat 
Figure 2 Schematic overview of the Type I, II, and III CRISPR expression and inter-
ference stages.
Three main types of CRISPR-Cas (CRISPR-associated) systems are now known, and these display 
major mechanistic differences. In this schematic overview, the expression and interference stages 
are depicted for the three different types. Transcription of the CRISPR gives rise to a pre-crRNA 
molecule, which is subsequently cleaved in the repeat sequence by a Cas6 homolog in Type I (often 
a subunit of Cascade-like complexes) and Type III systems, and by RNase III and Cas9 in Type II 
systems. The generated crRNA molecules undergo a further processing event in Type II and Type 
III systems. Mature crRNA molecules are bound to a Cas protein or protein complex. In the case 
of Type III-B, the CRISPR RAMP Module (Cmr) complex binds and cleaves complementary RNA, 
whereas the other types bind and cleave dsDNA (double-stranded DNA). Targets contain a proto-
spacer-adjacent motif (PAM) either downstream (Type I) or upstream (Type II) of the protospacer.
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binding protein, Cbp1 (91; 286), the system is constitutively expressed under labo-
ratory growth conditions and protects against virus infection, probably by targeting 
DNA (234). Reverse transcripts of the CRISPR have also been detected, but their 
functional significance remains to be determined (214; 413). Lintner and colleagues 
reported on a Sulfolobus IA-Cascade complex, consisting of at least four different 
Cas protein subunits (Csa5, Cas7, Cas5, and Cas6) loaded with crRNA of 60-70 nt 
derived from CRISPR loci belongingto any of three different CRISPR repeat clus-
ters present in S. solfataricus. As in E. coli IE-Cascade,which has a Cas7 backbone 
of six copies (see below), the Cas7 subunit is most abundant in IA-Cascade. The 
Cas6 subunit cleaves pre-crRNA at a single position, yielding spacer sequences 
flanked by a repeat-derived 5’-handle of 8 nt and 3’-handle of 16-17 nt [identical to 
Cas6-mediated pre-crRNA cleavage in Pyrococcus furiosus (60)]. The Sulfolobus 
IA-Cascade binds ssDNA (single-stranded DNA) targets with a sequence comple-
mentary to the crRNA guide (215), but dsDNA (double-stranded DNA) binding 
remains to be determined. Recently, a IC-Cascade complex has been isolated from 
Bacillus halodurans (268). A Cas5d subunit of this complex serves as an endoribo- 
nuclease that cleaves the pre-crRNA (268). So far, hardly any literature exists on 
Type I-B, I-C and I-D systems. The Type I-E system has been extensively studied, 
mostly using E. coli K12 as a model organism (see below). 
The Type I-F system has been studied in Pseudomonas aeruginosa; a CRISPR and
cas gene-dependent effect on prophage mediated inhibition of swarming and 
biofilm formation was reported (see section, Other Functions of CRISPR-Cas) (55; 
Box 1 A modified definition of protospacer sequences 
Protospacer sequences were initially defined as the sequences identical to the spacer sequences (93). We here refine this initial definition by proposing that the protospacer is the sequence complementary to the crRNA (CRISPR 
RNA) spacer (the reverse complement of the initially defined protospacer). This 
definition takes into account the direction of transcription of the CRISPR and 
thereby eliminates ambiguities of orientation and strand of the spacers. In addition, 
it has been demonstrated for several subtypes that CRISPR-Cas target recognition 
takes place by base pairing between the crRNA spacer and the complementary 
nucleic acid sequence of a target (151; 191; 394). In the case of Type III-B systems, 
single-stranded nucleic acids (RNA) appear to be targeted (150; 151; 413). However, 
the established targeting of single-stranded nucleic acids imposes the need to 
define protospacer sequences as the sequence complementary to a crRNA spacer. 
Moreover, protospacer-adjacent motif (PAM) recognition in Type I-E systems 
takes place specifically in the base pairing/target strand (393). This implies that 
the main interactions with target DNA involve the strand base pairing with the 
crRNA, arguing for using the term protospacer to refer to this strand of the DNA.
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409). More recently, CRISPR-based immunity of Pseudomonas aeruginosa against 
phage infection was also demonstrated (54). Type I-F Cas proteins have been 
studied biochemically and structurally. Co-crystal structures of crRNA and Cas6f, 
a metal-independent pre-crRNA endoribonuclease (157; 296), revealed specific 
protein-RNA interactions between Cas6f and the hairpin-forming crRNA repeat 
(157) and provided insight in the mechanism of pre-crRNA cleavage by Cas6f (158). 
In addition, a Pseudomonas IF-Cascade was recently isolated that consisted of four 
different proteins (Csy11, Csy21, Csy36, and Cas6f1) with a low resolution structure 
and dsDNA-binding properties somewhat resembling E. coli IE-Cascade (396).
Type II systems are the most compact, encoding Cas1, Cas2, Cas9, and either Csn2 
(Type II-A) or Cas4 (Type II-B) (Figure 2). The first evidence for CRISPR-dependent 
immunity came from the Type II-A system of S. thermophilus, where both Csn2-de-
pendent CRISPR adaptation and Cas9-dependent interference were observed upon 
phage infection (28). The recently resolved structure of Csn2 shows that it forms a 
tetrameric ring-like structure that is 26 Å wide and that contains conserved lysine 
residues involved in binding dsDNA (106). Until recently, the expression stage in 
Type II systems was poorly understood owing to the lack of a Cas6-like pre-crRNA 
endoribonuclease. A recent paper by Deltcheva and coworkers (36) resolved this 
issue, revealing an unexpected crRNA maturation pathway that requires an 89 
or 171-nt trans-acting CRISPR-associated RNA (named tracrRNA) that base pairs 
with the pre-crRNA repeat sequences. Subsequent recruitment of a housekeeping 
RNase III catalyzes, together with Cas9, cleavage of the pre-crRNA in the repeat; 
this yields 66-nt crRNA molecules that are further trimmed at the 5’ end to produce 
39-42-nt mature crRNA containing a 20-nt spacer sequence (90). During Type II 
CRISPR interference, target DNA is cleaved in the protospacer sequence (124). A 
recent study on the Type II system of Streptococcus pyogenes demonstrated that 
this cleavage is carried out by a ribonucleoprotein complex consisting of Cas9, 
the mature crRNA and the tracrRNA (188). It was shown that the HNH-nuclease 
domain of Cas9 cleaves the base pairing strand, while the RuvC nuclease domain 
cleaves the displaced strand, resulting in a blunt-end cleavage product (188). 
Two Type III systems exist, Type III-A and Type III-B, which differ most notably in 
the nature of their target nucleic acid. Although Marraffini and coworkers demon-
strated that the Type III-A system of Staphylococcus epidermidis targets DNA (235), 
the Type III-B system of P. furiosus was shown to cleave RNA both in vitro (151) and 
in vivo (150), which is the first example of a prokaryotic immune system targeting 
RNA. The ribonucleoprotein effector complex consists of six different Cas proteins 
(Cmr1, Cas10, Cmr3, Cmr4, Cmr5, and Cmr6) and mature crRNA of either 39 nt or 
45 nt (151). Recently, an analogous crRNA-loaded Cmr (CRISPR RAMP Module) 
complex, containing seven Cmr proteins (Cmr1-7), with manganese-dependent 
endoribonuclease activity on complementary RNA, was isolated from S. solfataricus 
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(413). Detailed studies of the expression stage of Type III-B demonstrated that Cas6 
binds crRNA at the 5’ end of the unstructured repeat sequence (59) and wraps the 
crRNA around its surface to position the well-defined cleavage site in the Cas6 cata-
lytic center (382), yielding 67-nt crRNAs through metal-independent endoribo- 
nuclease activity (60). These are further trimmed at the 3’ end through unknown 
mechanisms to 39-nt and 45-nt mature crRNA species that are complexed with Cas 
proteins (149). In the S. epidermidis Type III-A systems pre-crRNA maturation also 
comprises a primary Cas6-mediated sequence-specific processing step at the base of 
a putative stem-loop structure in the pre-crRNA repeat (156; 235), followed by a ruler-
based sequence-unspecific crRNA maturation step that involves crRNA trimming 
at the 3’ end, yielding mature crRNA of two defined lengths (37 nt and 43 nt) (156).
self/non-self disCriminaTion
Examination of protospacer-flanking sequences targeted by Type I and Type II 
CRISPR-Cas systems led to the identification of conserved sequence motifs, coined 
protospacer-adjacent motifs (PAMs) (39; 174; 253), that are essential for CRISPR 
interference (93). In contrast, Type III CRISPR interference appears to lack such 
a PAM requirement (231). Further analysis revealed a correlation between PAM 
sequences and specific repeat clusters (253) and hence with CRISPR-Cas subtypes 
(201) (Table 1).
Although Type I systems require PAM sequences of 2 or 3 nt at the 3’ end of the 
protospacer on the target DNA strand (see box 1, A modified definition of proto-
spacer sequences) (253). Type II systems require a PAM sequence of 4 or 5 nt at 
the 5’ end of the protospacer on the target DNA strand (39; 93; 124; 174). Some 
recent studies indicate that in the Type I-B and I-E systems, some variation in PAM 
motifs is allowed (115; 124; 343; 393). For most CRISPR-Cas systems the sequence 
requirements, function, and recognition of PAMs are poorly understood. For Type 
I-E systems it was shown that PAM recognition takes place only in the base-pairing 
strand (310; 393) through a Cascade subunit (Cse1) that specifically interacts with 
the PAM (310). Type II systems on the other hand recognize the PAM in the displaced 
strand (188). PAMs could serve a dual role in selecting appropriate protospacers 
during CRISPR adaptation, as well as in distinguishing CRISPR spacers from their 
respective protospacers during CRISPR interference (190; 366).
The absence of a PAM requirement for the RNA-targeting Type III-B CRISPR-Cas 
system may be explained by the fact that self-targeting of mRNA is less delete-
rious or may even serve a regulatory purpose (150). Type III-A systems on the other 
hand have a fundamentallydifferent mechanism to discriminate self (the CRISPR 
DNA) from nonself (any other DNA) (237) that relies on base pairing between the 
crRNA repeat sequence and the sequence flanking the protospacer. When three 
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positions of the repeat fragment in the 5’ handle of the crRNA molecule base pair 
with a target nucleotide sequence, CRISPR interference is prohibited; mismatches 
at these positions trigger CRISPR interference (237).
Table 1 Protospacer-adjacent motif (PAM) sequences identified for CRISPR-Cas 
subtypes 
Type Species Ref PAM (5’-3’)a Typical repeat CRISPR 
cluster
I-A Sulfolobus solfa-
taricus P2
(146; 
214; 
253)
Protospacer-NGG
(PS-NGG)
GATAATCTCTTAT-
AGAATTGAAAGb
7
PAM
down-
stream 
of
proto-
spacer
Metallosphaera 
sedula DSM5348
(253) PS-NGG GTTAATCTTCTAT-
AGAGTTGAAAG
7
Unknown 11
I-B Methanother- 
mobacter therm- 
autotrophicus 
DH
(253) PS-NGG GTTAAAATCAGAC-
CAAAATGGGATT-
GAAAT
1
Listeria monocy-
togenes
(253) PS-NGG GTTTTAAC-
TACTTATTAT-
GAAATCTAAAT
1
Unknown 6,9
I-C Streptococcus 
pyogenes
(253) PS-GAA GTCTCACCCT-
TCATGGGTGAGTG-
GATTGAAAT
3
Xanthomonas 
oryzae 
(253) PS-GAA GTCGCGTCCT-
CACGGGCGCGTG-
GATTGAAAC
3
I-D Unknown Unknown
I-E Escherichia coli 
K12
(253; 
315; 
343; 
393)
PS-CTT
PS-CAT
PS-CCT
PS-CTC
GWGTTCCCCG-
CGCCAGCGGGGA-
TAAACCGb
2
Pseudomonas 
aeruginosa 2192
(253) PS-CTT GTGTTCCCCA-
CATGCGTGGGGAT-
GAACCG
2
I-F P. aeruginosa 
PA14
(54; 
253)
PS-GG GTTCACTGCCGT-
GTAGGCAGCTAA-
GAAAb
4
Shewanella spp. (253) PS-GG GTTCACCGCCG-
CACAGGCGGCT-
TAGAAA
4
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Type Species Ref PAM (5’-3’)a Typical repeat CRISPR 
cluster
II-A S. thermophilus 
DGCC7710
(CRISPR1)
(174, 
93)
WTTCTNN-PS GTTTTTGTACTCT-
CAAGATTTAAG-
TAACTGTACAAC
10
PAM 
up- 
stream  
of 
proto- 
spacer
S. thermophilus
CNRZ1066
(39) TTTYRNNN-PS GTTTTTGTACTCT-
CAAGATTTAAG-
TAACTGTACAAC
10
S. thermophilus
DGCC7710 
(CRISPR3)
(174) CNCCN-PS GTTTTAGAGCTGT-
GTTGTTTCGAATG-
GTTCCAAAAC
10
II-B S. pyogenes (253) CCN-PS GTTTTAGAGC-
TATGCTGT-
TTTGAATG-
GTCCCAAAACb
10
L. monocy-
togenes
(253) CCN-PS GTTTTAGAGC-
TATGTTATTTT-
GAATGCTAC-
CAAAAC
10
III-A Staphylococcus 
epidermidis
(237) No PAM GATCGAT-
ACCCACCCCGAA-
GAAAAGGGGAC-
GAGAACb
8
No PAMIII-B Pyrococcus 
furiosus
(150) No PAM GTTCCAATAA-
GACTAAAATA-
GAATTGAAAGb
6
S. solfataricus (413) No PAM GATTAATCCC- 
AAAAGGAATT-
GAAAGb
7
aPAM and protospacer correspond to sequence on target strand (i.e., strand that base pairs with crRNA).
bDirection of CRISPR transcription verified.
The III-A system therefore targets almost all randomly provided DNA sequences 
with a complementary protospacer, whereas PAM-dependent systems only target 
those protospacers having the PAM motif.
The TyPe i-e CrisPr-Cas sysTem
Type I-E systems can be found in some actinobacteria, firmicutes, and methano-
genic archaea as well as in many proteobacteria, including E. coli K12. All three 
stages of CRISPR defense have been studied for the Type I-E system, placing it 
among the best understood CRISPR-Cas systems to date.
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Adaptation
CRISPR adaptation under laboratory conditions was first observed in the Type II 
system of S. thermophilus (28; 124; 174). Comparative genomics has revealed a vari-
able spacer content in two CRISPR loci of E. coli strains (96; 354), suggesting that E. 
coli acquires new spacers over time. Indeed, very recently three groups have inde-
pendently demonstrated CRISPR adaptation in the Type I-E system of E. coli (79; 
343; 405).
Although CRISPR adaptation is dormant in wildtype E. coli K12 because of repres-
sion of cas gene expression (see below), spacer acquisition could be observed in 
cells in which cas1 and cas2 expression levels are elevated (79; 343). In addition, 
spacer acquisition was observed in E. coli BL21-AI cells in which cas1 and cas2 were 
overexpressed (405). In contrast, E. coli BL21-AI cells in which only cas1 or only cas2 
was overexpressed were deficient in spacer integration, indicating that Cas1 and 
Cas2 together are responsible for CRISPR adaptation (405). Consistent with their 
role in CRISPR adaptation, cas1 and cas2 are invariably associated with CRISPR 
loci (231) and are not required for crRNA processing or CRISPR interference (49). 
Sometimes Cas1 and Cas2 are fused to each other or to other proteins (231; 291). In 
the Thermoproteus tenax Type I-A system a complex consisting of the Cas1-Cas2 
fusion protein, Cas4 and Csa1 has been reported that was denoted Cascis [CRISPR 
associated complex for spacer integration] (291). 
So far, E. coli CRISPR-adaptation studies have been reported only for nonlytic 
bacteriophages and plasmids (79; 343; 405). Abedon (1) suggested that, in the case 
of a lytic phage infection, CRISPR adaptation may be preceded by a facilitation 
step. This step supports bacterial survival upon first time exposure to a new phage 
followed by degradation of the phage DNA, providing the cell with a DNA substrate 
from which new spacer sequences can be acquired.
 
As in S. thermophilus (28; 124; 174), new spacers are integrated in a polar fashion 
at the leader end of the CRISPR locus (79; 96; 343; 354; 405), suggesting that the 
integration machinery directly interacts with this region (6). Indeed, the first 
repeat and 60 bp of the leader sequence immediately upstream the first repeat 
are essential for integration of new spacers (405). Moreover, it has been demon-
strated that the first repeat is duplicated during spacer integration (79; 405).
Integrated spacers were acquired from protospacers located on plasmid DNA (79; 
343; 405) and phage DNA (79). Pre-spacers (6) of at least 33-34bp are selected 
in a nonrandom process to target protospacers flanked by a CTT PAM, whereas 
the selection of the strand, locus, and nucleotide content of the protospacer 
appears to be random (79; 343; 405). Spacers are integrated in both CRISPR loci 
of E. coli K12 that have a leader sequence upstream, and spacers from both loci 
actively contribute to CRISPR interference (79; 343); in the case of E. coli BL21-AI 
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new spacers were integrated in only one of the two CRISPR loci (405), which is 
explained by the fact that the other CRISPR locus does not have an upstream leader 
sequence. The adaptation machinery appears to lack an intrinsic ability to distin-
guish between invading DNA and genomic DNA: Self-targeting spacers are readily 
acquired during phage infection, which causes autoimmunity and eventually cell 
death (333), hence imposing a need for a tight regulation of CRISPR adaptation.
Often multiple spacers against the same target are integrated in a single clone (79; 
343). Interestingly, the presence of the first targeting spacer has been found to 
accelerate acquisition of subsequent spacers from this target: a positive feedback 
loop mechanism referred to as priming (79; 343). Priming has also been observed 
in response to escape mutagenesis of phages (79). The observation that all E. coli 
Cas proteins (Cas1, Cas2, Cascade and Cas3) are required for priming (79), is in- 
dicative of crosstalk between the CRISPR interference and CRISPR adaptation 
pathways. Based on the priming phenomenon, it has been suggested that degrada-
tion of the invader DNA, mediated by the first integrated spacer, yields degraded 
DNA fragments suitable for acquisition of secondary spacers (343). Moreover, 
secondary acquired spacers always target the same DNA strand as the primary inte-
grated spacer, indicating that spacer acquisition after priming is a strand-specific 
process (79; 343). The acquisition of multiple spacers provides enhanced resistance 
and lowers the chance of invader escape by point mutations (49; 79; 343), hence 
providing an evolutionary benefit to the host.
Interestingly, the complement of the protospacer-flanking nucleotide of the PAM 
is always conserved in the spacer-flanking nucleotide of the repeat (343). For 
example, integration of a spacer containing the prevalent CTT PAM co-occurs 
with a repeat with a CCG 3’-end, whereas deviations from this dominant PAM (e.g., 
ATT or TTT) co-occur with corresponding mutations in the last nucleotide of the 
proximal repeat (CCT or CCA, respectively). This observation indicates that the 
last nucleotide of the repeat is derived from the PAM of the invading DNA during 
spacer acquisition rather than being copied during repeat duplication (Figure 3). 
Polymorphisms at this last position of the repeat are not duplicated into newly 
synthesized repeats (79; 343), in contrast to polymorphisms in the before-last 
nucleotide of the repeat, which are duplicated (79). This provides further evidence 
that during spacer acquisition, only 28 bases of the repeat are copied and that 
32-33bp of the protospacer plus the protospacer adjacent nucleotide of the PAM 
are integrated between the copied repeats. This is likely to be of functional impor-
tance as it ensures that new spacer sequences are integrated in the correct orienta-
tion. Indeed, spacer integration in S. solfataricus, which appears not to employ this 
mechanism, has been reported to sporadically and erroneously occur in inverted 
orientation (108)
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The studies described above show that, apart from potentially involved host 
factors, Cas1 and Cas2 together are sufficient and essential for integration of new 
spacers (405), but the molecular mechanism of action remains enigmatic. E. coli 
Cas1, as with P. aeruginosa Cas1 (397), is a homodimeric endonuclease with in vitro 
metal-dependent nuclease activity on ssDNA, ssRNA, short dsDNA, and branched 
DNA (e.g., Holiday Junctions) (21). The DNase activity of Cas1 is essential for spacer 
acquisition (405) and might be required for opening of the first repeat of a CRISPR 
locus during spacer integration or for pre-spacer processing. Cas1 was shown 
to be recruited to dsDNA breaks and to bind several housekeeping DNA repair 
Figure 3 Hypothetical mechanism of CRISPR adaptation. 
A) Spacer selection. DNA fragments containing a protospacer-adjacent motif (PAM) sequence 
are recognized. Cas1 and Cas2 are potentially involved in DNA cleavage or trimming, generating a 
pre-spacer containing at least the protospacer proximal nucleotide of the PAM and the full pro-
tospacer sequence. The pre-spacer can either be single stranded or double stranded. B) Spacer 
incorporation. The integration machinery (probably including Cas1 and/or Cas2) recognizes the 
leader strand and integrates the pre-spacer, most likely by end joining of either the 3’ or the 5’ ends 
of the repeat to the 5’ or 3’ ends of the pre-spacer, respectively, depending on which strand of the 
CRISPR is opened. One nucleotide of the PAM forms the last nucleotide of the repeat. This hypo-
thetical scheme does not apply if pre-spacers are single stranded. C) Repeat synthesis. After repeat 
unwinding, DNA polymerase synthesizes the complementary strand of the repeat, resulting in a 
newly incorporated spacer and a copied repeat, and a ligase completes the adaptation stage (D) by 
covalently linking the strands.
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proteins as well as the Cascade subunits Cas7 and Cas6e  (21). Specific inhibition of 
Cas1-mediated Holiday Junction cleavage by Cas6e suggests that Cas1 and Cascade 
sometimes interact (21). 
It was shown that Cas2 proteins from different organisms act as homodimeric 
endoribonucleases with specificity for U-rich regions (32). However, involvement 
of such an activity in CRISPR adaptation is not obvious. Only very recently it was 
shown that Cas2 proteins from T. thermophilus and Bacillus halodurans possess 
pH-dependent endonucleolytic dsDNase activity, generating dsDNA fragments of 
approximately 120bp (267). It is possible that this activity is important for either 
pre-spacer processing or CRISPR-locus opening.
PROPOSED MECHANISM OF CRISPR ADAPTATION
With the recently gained insights in Type I-E CRISPR adaptation, it is tempting to 
speculate about a potential mechanism for primary spacer integration (Figure 3). 
We propose that the integration machinery, consisting of at least Cas1 and Cas2, 
and possibly other housekeeping proteins (but not Cascade or Cas3), recognizes 
and processes pre-spacers with a CTT PAM. The pre-spacer contains at least the 
protospacer proximal nucleotide of the PAM (in most cases a C) and 32-33 bases 
which cover the entire protospacer. The integration machinery likely carries the 
pre-spacer and recognizes the leader strand. Integration of the pre-spacer takes 
place between the leader-proximal repeat and a newly synthesized repeat. Although 
the precise mechanism of repeat duplication and pre-spacer insertion remains 
subject of speculation, the last nucleotide of the repeat is pre-spacer derived (343). 
It is possible that the mechanism of spacer integration is reminiscent of recom-
bination by the HIV1 integrase homodimer (109), which binds and processes the 
ends of linear, to-be-integrated, dsDNA (reviewed in (72)). Next, HIV1 integrase 
end joins the 3’ end viral DNA strands to 5’ end host DNA, after which the gaps are 
filled by host DNA polymerase. 
Expression – Regulation
The expression stage involves regulation of the cas gene and CRISPR expression, 
Cas complex formation, and pre-crRNA maturation (34; 366). The promoters of the 
two CRISPR loci in E. coli K12 are both located in their respective leader sequences 
(293; 297) and contain binding sites for regulatory proteins (297). Although the 
cas3 gene is transcribed from its own constitutive promoter, transcription of the 
other cas genes initiates from a promoter (pcas) upstream of cse1, giving rise to a 
polycistronic transcript encoding Cascade, Cas1 and Cas2 (Figure 4) (297; 391). The 
CRISPR-Cas system in E. coli K12 is tightly regulated with restricted transcription 
from the pcas promoter (293; 297; 391). The heat-stable nucleoid-structuring protein 
H-NS was identified as a key regulator of the CRISPR-Cas system of E. coli K12. 
Although H-NS binds both the pcas and the CRISPR promoter, repression of pcas is 
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strongest, leading to complete blocking of transcription of the Cascade encoding 
genes (297). Interestingly, phage-encoded H-NS and conjugative plasmid-encoded 
H-NS paralogs have been reported (99; 324), possibly counteracting induction of 
the CRISPR-Cas system (324).
CRISPR interference in E. coli has been observed when overexpressing cas genes 
and CRISPRs (49; 104), in H-NS deletion strains (293; 391; 404), and in cells overex-
pressing LeuO (391). LeuO is a LysR-type transcriptional activator that often serves 
as an H-NS antagonist (65; 85; 318; 319; 335). LeuO is a positive regulator of the E. 
coli CRISPR-Cas system that binds the cse1 upstream region at positions flanking 
the H-NS binding sites, thereby blocking cooperative spreading of H-NS along 
the DNA (391). In Salmonella enterica serovar Typhi, the Type I-E CRISPR-Cas 
system was shown to be repressed by H-NS and LRP (leucine-responsive regula-
tory protein), and activated by LeuO (167; 245). Regulation of CRISPR-Cas in E. coli 
is complex because in addition to LeuO, envelope stress can also activate CRISPR 
defense through the two component BaeSR pathway (27; 287). In Thermus thermo-
philus, expression of Type I-E cas genes was reported to be regulated by cyclic-AMP 
receptor protein (CRP) (320) and to be induced upon phage infection (3).
From a host-defense point of view, silencing of CRISPR-Cas seems puzzling. At 
least three possible explanations can be imagined. Firstly, expressing host-de-
fense systems is energy consuming and therefore disadvantageous when the cell is 
already well protected by other defense systems or when phage threats are absent. 
For this reason, CRISPR-Cas regulation by H-NS and LeuO could be tuned such 
that host defense is induced only when required. Under standard growth condi-
tions, LeuO levels in E. coli are low because of H-NS-mediated repression of the 
leuO promoter (196; 227). H-NS is well known to bind AT-rich DNA (272), which 
may lead to H-NS titration from its own genome upon arrival of a mobile genetic 
element with AT-rich DNA. This releases repression of both the LeuO promoter 
(which is positively regulated by LeuO itself) and the pcas promoter, hence insti-
gating a CRISPR-based immune response. In fact, such an H-NS titration effect 
has been reported for an AT-rich plasmid in S. typhimurium (97). This regulatory 
mechanism may be particularly advantageous when a replicating nonlytic element, 
such as a high copy plasmid, has invaded the cell. However, because pre-existing 
Cascade surveillance complexes are absent, cells appear to be ill protected against 
aggressive invaders such as lytic phages. Innate defense systems could provide a 
fist line of defense, potentially providing the cell with sufficient time to activate 
CRISPR-Cas while the infection is ongoing. Although speculative, it is also possible 
that under specific conditions (e.g., phage infection), bacterial cells commu-
nicate (e.g., through quorum sensing) to induce expression of defense systems. 
This is supported by the finding that spacer integration in E. coli took place 
simultaneously in many different cells in a culture (343).
41
Chapter 2 How Prokaryotes Generate Adaptive Immunity
2
A second possible reason to silence CRISPR-Cas is related to the fact that incoming 
DNA may be (conditionally) beneficial for the host; this is in agreement with the 
fact that some organisms evolved sophisticated DNA uptake systems. Although 
cells may be well protected against selfish DNA by constitutively expressing 
CRISPR-Cas and other defense systems, these systems will also block (condition-
ally) beneficial DNA (e.g., plasmids encoding antibiotic resistance or lysogenic 
phage encoding virulence factors). Elevated defense may be disadvantageous when 
harmless DNA enters the cell, and modest defense may be disadvantageous upon 
infection by a lytic phage. Presumably, fitness within a population of a bacterial 
species is increased by heterogeneity in expression of DNA uptake and DNA-restric-
tion systems. Interestingly, the aforementioned transcriptional regulators LeuO/
LRP/CRP are associated to nutrient deprivation (47; 227; 330) when cells may tend 
to remove excess extrachromosomal genomic material. Moreover, under starvation 
conditions cells may depend on the uptake of foreign genetic material to acquire 
new (metabolic) traits. To control the resulting alien DNA accumulation, elevated 
expression levels of cellular defense systems may be required under these conditions.
A third reason to silence CRISPR-Cas could be to avoid autoimmunity problems. 
Approximately one in five CRISPR-Cas-containing organisms contains self- 
targeting spacers (5; 333). On the basis of a lack of conservation of these spacers 
across species and their co-occurrence with inactivating CRISPR or cas gene muta-
tions, it could be ruled out that these spacers have regulatory functions (333). 
Their abundance indicates that self targeting may be a major threat imposed by 
CRISPR-Cas, necessitating a tight regulation of this system to avoid cell death 
through erroneous incorporation of self DNA in CRISPR loci.
Figure 4 Cas operon organization with adjacent CRISPR (clusters of regularly in-
terspaced short palindromic repeats) in E. coli K12. 
The Type I-E system of E. coli K12 comprises eight cas genes and an immediately adjacent CRISPR 
locus with type 2 repeats. Promoters driving expression of the cas genes and the CRISPR are indica- 
ted by black arrows. Several regulatory proteins have been identified that directly act on the CRISPR 
and/or cas gene promoters in E. coli K12. Negative regulators (depicted in red) and positive regula-
tors (depicted in green) are shown in proximity of the promoter they regulate.
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Expression – crRNA Maturation
In E. coli K12, five Cas proteins (Cse1, Cse2, Cas7, Cas5, and Cas6e) form a multipro-
tein complex called Cascade (49). The endoribonuclease Cas6e catalyzes metal- 
independent cleavage in the repeat sequence of the pre-crRNA, yielding mature 
61-nt crRNA with an 8-nt repeat-derived 5’ handle and a 21-nt 3’ handle (49; 191). 
The crRNA remains Cascade bound, giving rise to a ribonucleoprotein complex with 
an unusual stoichiometry of Cse11Cse22Cas76Cas51Cas6e1crRNA1 and an asymmet-
rical seahorse-like shape (Figure 5) (191). Recently, an 8-Å resolution cryo-electron 
microscopy structure of the Cascade complex revealed the position of the subunits 
in the complex (394). The six Cas7 subunits form a backbone on which the other 
subunits assemble, with the crRNA running over the Cas7 subunits, spanning the 
entire complex. Although the structure of a Cas7 homolog from S. solfataricus 
was shown to contain an RNA recognition motif (RRM), it is unclear whether 
these motifs are functional in crRNA binding, as they lack some of the conserved 
sequence motifs generally involved in nucleic acid binding (215). The 5’ end of 
the crRNA is bound by Cse1 and/or Cas7 and/or Cas5, and the hairpin-forming 3’ 
end is bound by Cas6e (394). For Cas6f this binding was shown to be a very high 
affinity protein RNA interaction, with a KD of 50 pM (334). The crystal structure 
of Cse2 from T. thermophilus reveals positively charged surface patches (4), which 
in the dimeric configuration of Cse2 in the complex might provide an interaction 
site for nucleic acids, such as the displaced strand after binding a target dsDNA. 
A high-resolution structure of Cas6e from T. thermophilus reveals a two domain 
RAMP protein, with both domains adopting an RNA recognition motif (RRM) 
fold (a subclass of the ferredoxin fold)(103), structurally similar to P. furiosus Cas6 
((60) reviewed in (366)). More recently, high resolution structures of Cas6e from 
T. thermophilus bound to part of the crRNA repeat reveal that the predicted crRNA 
hairpin structure (albeit with a stem of six instead of seven base pairs) runs over a 
basic groove on the Cas6e surface (131; 309). Most sequence-specific Cas6e-crRNA 
interactions occur between a Cas6e b-hairpin structure and the major groove of 
the crRNA, mainly at the 3’ end of the repeat sequence (131; 309). Although the 
positioning of the base of the crRNA hairpin relative to the N-terminal domain 
is similar in P. aeruginosa Cas6f (157), the overall structure of RNA-bound Cas6f 
is rather different from the tandem RRM-fold Cas6e-crRNA structure; Cas6f 
contains a single N-terminal ferredoxin fold domain that is connected to an a-helix 
containing C-terminal domain through an extended linker, which is involved in 
sequence-specific interactions with the major groove of the crRNA repeat (157). 
P. furiosus Cas6 also has a tandem RRM-fold architecture but binds an unfolded 
repeat through wrapping of the crRNA around the protein, anchoring the 5’ end of 
the repeat in a groove between the RRM domains (382). Interestingly, despite the 
differences in structure and crRNA binding, pre-crRNA cleavage catalyzed by all 
Cas6-homologs yields mature crRNA with an 8-nt 5’ handle (49; 60; 157; 215; 235; 
413).
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Figure 5 Schematic representation of Cascade and Cascade-mediated R-loop for-
mation.
A) Cascade consists of five different Cas proteins that are present in an uneven stoichiometry. 
The Cas7 subunit forms the backbone of the complex. The 3’ end of the crRNA is bound by the 
Cas6e subunit,whereas binding of the 5’ end appears to involve a Cas7 subunit and/or Cas5 and/
or Cse1. Spacer and repeat sequences of the crRNA are indicated in green and orange, respectively. 
B) Schematic of the R-loop formed by Cascade upon dsDNA binding. The protospacer-adjacent 
motif (PAM) sequence is indicated in purple. The seed sequence corresponds to a noncontiguous 
sequence of 7 nt at the 5’ end of the spacer sequence.
Interference
The crRNA loaded Cascade serves as a surveillance complex that functions in 
recognition of invader DNA but requires Cas3 for conferring CRISPR interference 
as a final step of the defense mechanism. The E. coli CRISPR-Cas system has been 
demonstrated to be functional in neutralizing distinct types of invasive DNA: phage 
infection (lvir, M13) (49; 315), plasmid transformation (49; 315), lysogenization, and 
prophage induction (l) (104) as well as high copy number plasmid curing (343; 
393). In addition to Cascade and Cas3, CRISPR interference requires the chaperone 
high temperature protein G (HtpG) for Cas3 folding (404). The CRISPR-inter- 
ference dsDNA target requires a PAM sequence, which is recognized by a loop 
structure of the Cse1 subunit of Cascade (310), and a fully complementary seed 
region (a noncontiguous 7-nt sequence at the 3’ end of the complementary DNA 
strand) (Figure 5), whereas up to five mismatches outside the seed region of the 
protospacer are tolerated (315). CRISPR interference is a multistep process, presu-
mably starting with (a) Cascade scanning for PAM and protospacer seed regions on 
a dsDNA target, followed by (b) binding of the target sequence through base pairing 
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between the crRNA and the complementary DNA (initially limited to the seed, 
eventually resulting in R-loop formation over the entire crRNA spacer sequence) 
(Figure 5), (c) Cas3 recruitment by Cascade, (d) Cas3-mediated target DNA nicking, 
(e) reduced affinity of Cascade for the protospacer, presumably facilitating Cascade 
dissociation, and (f) full degradation of the dsDNA target by Cas3. During the first 
step, the Cascade surveillance complex scans dsDNA for target sites. Although the 
scanning mechanism is poorly understood, PAM sites may function in this process 
by recruiting Cascade to potential target sites (310). Cascade may bind PAM sites 
and check for complementarity to the crRNA seed sequence. If the target DNA 
seed region is fully complementary to the crRNA seed sequence, base pairing over 
the entire spacer/protospacer sequence follows (315). Upon DNA binding, both 
the protein complex (191; 394) and the target DNA (393) undergo conformational 
changes. Cascade does not require ATP for strand separation (191) but instead utilizes 
the energy stored in the negative supercoiled (nSC) DNA topology of the target 
(393). Because all circular DNA molecules in mesophiles have an nSC topology in 
vivo, it was initially suggested that this could be a general property of all mesophilic 
CRISPR-Cas systems that target dsDNA. However, recently Cas9-mediated R-loop 
formation was shown not to require negative supercoiling of the target DNA (188). 
Cas3 recruitment takes place after Cascade has specifically bound its target (R-loop 
state), which is most likely triggered by the conformational changes of Cascade 
and/or the bending of the target DNA (393). In E. coli K12, the Cas3 protein consists 
of two domains: an N-terminal HD-nuclease domain and a C-terminal superfamily 
2 DExD/H-box helicase domain (230). A number of recent structural and bioche-
mical studies demonstrate that Cas3 has metal-dependent nuclease activities (33; 
154; 260; 323). The HD domain of Cas3 from the Type I-E system of S. thermo-
philus displays magnesium-dependent endonuclease activity on ssDNA, and its 
helicase domain has ATP- and magnesium-dependent DNA/DNA and DNA/RNA 
unwinding activity in the 3’ to 5’ direction (323). In line with this, the Type I-A Metha- 
nocaldococcus jannaschii Cas3 HD domain has magnesium-dependent endonu-
clease and 3’-5’ exonuclease activity on ssDNA and ssRNA that is stimulated in the 
presence of ATP by the M. jannaschii Cas3 helicase domain (33). In accordance 
with these biochemical activities, it was recently demonstrated that the E. coli Cas3 
HD-nuclease domain of a Cascade-Cas3 effector complex specifically nicks target 
DNA and subsequently degrades the target in the 3’ to 5’ direction through the 
combined action of the HD nuclease and DExD/H-box helicase domains (393). 
The generated cleavage products may be used for integration of new spacers, which 
would explain the aforementioned priming effect during CRISPR adaptation (343).
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Cas3 in TyPe i CrisPr-Cas sysTems
All Type I systems contain Cas3 but not necessarily encoded as a single two-domain 
protein, as is the case in E. coli K12. So far, five variants of cas3 gene arrangements 
have been recognized. The HD-nuclease and DExD/H helicase domains can be 
encoded as separate proteins, as a fusion protein with either N-terminal HD and 
C-terminal helicase domains, or in inverted orientation with N-terminal helicase 
and C-terminal HD-nuclease domains (16). This indicates some degree of flexibility 
with respect to the positioning of these domains relative to each other. Moreover, 
two examples of Cas3 fused to other Cas proteins have been described. In the P. 
aeruginosa I-F system, N-terminal cas2 is fused to the cas3 HD-nuclease domain, 
followed by the C-terminal helicase domain (230). In Streptomyces griseus, N-ter-
minal cas3 (with an N-terminal HD and C-terminal helicase domain) is fused 
to a C-terminal cse1 gene. This Cas3-Cse1 fusion suggested that the separately 
encoded Cas3 and Cse1 directly interact in vivo, which was demonstrated to occur 
upon Cascade protospacer recognition (393). The observed truncation of HD-nu-
clease and helicase domains suggests that these single domain proteins are either 
recruited separately to Cascade or a Cascade-like complex, or they preassemble to 
form a Cas3 nuclease/helicase two-protein complex that functions similar to E. coli 
Cas3. The fusion of Cas2 to Cas3 provides another indication for crosstalk between 
the interference stage and the adaptation stage because Cas2 is involved in CRISPR 
adaptation (393), whereas Cas3 is known to be involved in target DNA cleavage.
oTher funCTions of CrisPr-Cas
Many proteins have more than one function, such as methyltransferases of the 
type III R-M system that, besides their role in bacterial defense, have also been 
implicated in phase variation (reviewed in (331)). Another example concerns the 
eukaryotic RNAi system that functions both in host defense, and in gene regula-
tion (reviewed in (61)). Several studies have recently suggested that CRISPR-Cas 
has additional functions other than host defense. In P. aeruginosa, the Type I-F 
CRISPR-Cas system has been implicated in affecting phage-mediated inhibition of 
swarming and biofilm formation (55; 409). It was reported that this effect is caused 
by a spacer with partial complementarity to the phage genome. It should be noted, 
however, that despite the five mismatches with the phage target, all mismatches 
are at positions in the spacer that, analogous to the Type I-E system, would still 
allow for functional spacer/protospacer interaction (315; 394). Also in Type I-E a 
CRISPR-mediated effect based on partial complementarity between spacer and 
protospacer was reported (287). Type III-B systems may well have a regulatory role 
by cleaving complementary mRNAs (150). The possibility that CRISPR-Cas can 
exert gene regulatory functions is an interesting hypothesis that awaits further 
mechanistic analysis.
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Another study has recently suggested a link between Cas1 and DNA repair (21), in 
line with the initial hypothesis of CRISPR-Cas being a DNA repair system (229). 
The authors describe interactions of Cas1 with DNA repair components and reveal 
defects in chromosome segregation and DNA repair in DCas1 strains. Further 
support for a role in DNA repair comes from a study on P. furiosus, which describes 
that cas gene expression is upregulated in response to gamma irradiation (398).
general issues, ConClusions, and ouTlook
Biochemical insights in the CRISPR-Cas system have increased tremendously 
over the past few years, yet many mechanistic details remain to be determined. 
In particular, little is known about the I-B, I-C, and I-D systems. Another issue 
that has already received some attention from a number of studies is how phages 
escape CRISPR-based immunity. Phages have evolved a number of strategies to 
escape R-M systems (see Introduction), ranging from removal of restriction sites 
by mutagenesis to protein-mediated inhibition of R-M enzymes. Similarly, eukary-
otic RNA plant viruses all carry inhibitors of RNAi (reviewed in (379)). Mecha-
nisms to evade CRISPR interference include mutagenesis of the protospacer and/
or PAM (93; 315; 316) and possibly phage encoded H-NS (324), although the latter 
remains to be verified. Other strategies to overcome CRISPR-Cas can be imagined, 
including protein-mediated or RNA-mediated inhibition of essential CRISPR-Cas 
components (e.g., binding of surveillance/effector complexes, or binding of 
crRNA). Furthermore, modification of phage DNA may potentially affect CRISPR 
interference through inhibition of R-loop formation or inhibition of Cas3 medi-
ated cleavage.
It will also be highly interesting to see whether synergistic effects of multiple 
immune systems exist. As outlined in the introduction, bacteria can contain 
various defense systems, yet their interactions are unknown. For example, DNA 
fragments generated by R-M systems could serve as spacer precursors to instigate a 
CRISPR-based response against an invader before it has escaped the R-M system. 
Also, many bacteria and in particular archaea contain multiple CRISPR-Cas systems 
belonging to different (sub)types. Whether crosstalk between these systems occurs 
remains unknown. These and other open questions will undoubtedly receive more 
attention over the coming years.
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absTraCT 
The recently discovered prokaryotic CRISPR-Cas defense system provides immunity against viral infections and plasmid conjugation. It has been demonstrated that in Escherichia coli transcription of the Cascade genes 
(cse1, cse2, cas7, cas5, cas6e) and to some extent the CRISPR array, is repressed 
by heat-stable nucleoid-structuring (H-NS) protein, a global transcriptional 
repressor. Here we elaborate on the control of the E. coli CRISPR-Cas system, and 
study the effect on CRISPR-based anti-viral immunity. Transformation of wild-type 
E. coli K12 with CRISPR spacers that are complementary to phage Lambda, does 
not lead to detectable protection against Lambda infection. However, when an 
H-NS mutant of E. coli K12 is transformed with the same anti-Lambda CRISPR, 
this does result in reduced sensitivity to phage infection. In addition, it is demon-
strated that LeuO, a LysR-type transcription factor, binds to two sites flanking the 
cse1 promoter and the H-NS nucleation site, resulting in derepression of cse1, cse2, 
cas7, cas5, cas6e, cas1, cas2 transcription. Over-expression of LeuO in E. coli K12 
containing an anti-Lambda CRISPR leads to an enhanced protection against phage 
infection. This study demonstrates that in E. coli H-NS and LeuO are antagonistic 
regulators of CRISPR-based immunity.
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inTroduCTion
Invasions by viruses and conjugative plasmids pose a threat to microbial cells. To neutralize selfish DNA elements, bacteria and archaea have developed several defense strategies, such as receptor masking, restriction/modification and 
abortive infection (179; 202). Recently it was discovered that Clustered Regularly 
Interspaced Short Palindromic Repeats (CRISPR) (182) and CRISPR associated 
(cas) genes (187) form a sophisticated immune system that uses small RNAs to 
target mobile genetic elements, reviewed by (173; 192; 236; 366). CRISPRs consist 
of repeating sequences of approximately 30 nucleotides that are separated by 
unique sequences of similar size, called spacers (251). The spacer sequences are 
commonly derived from phages and plasmids (39; 250; 294), and new spacers can 
be added to the existing CRISPR array, expanding the invader repertoire (28), in a 
process known as CRISPR adaptation. The presence of a spacer matching a viral or 
plasmid sequence confers resistance to invasion by these elements (28; 49; 235). 
The biochemical pathways underlying CRISPR defense are partially known and 
involve transcription of the array into a long precursor CRISPR RNA. This precursor 
is cleaved in the repeat sequences by a Cas endonuclease (Cas6e in E. coli (49), 
Cas6 in Pyrococcus furiosus (60)), releasing small crRNAs that serve to guide the 
defense.
The cas genes encode the protein machinery that carries out the various steps of 
CRISPR defense. Approximately 45 families of cas genes have been identified (148). 
CRISPR-Cas systems are classified based on their cas genes into three main types 
that can be further subdivided into ten subtypes (148); (231).
The Type I-E CRISPR-Cas immune system in E. coli K12 is composed of 8 cas genes 
(cas1, cas2, cas3, cse1, cse2, cas7, cas5 and cas6e) and a downstream CRISPR locus 
with type 2 repeats (201) containing 12 spacer-repeat units (CRISPR I) (Fig. 1A). An 
additional 6 spacer-containing CRISPR (CRISPR II) and a 2 spacer CRISPR (CRISPR 
III) with type 2 repeats, as well as a CRISPR with type 4 repeats (201) containing 1 
spacer repeat unit (CRISPR IV) are located elsewhere on the genome (96). In addi-
tion to a CRISPR containing an anti-invader sequence, only Cas3 and the proteins 
Cse1, Cse2, Cas7, Cas5 and Cas6e that form the Cascade complex (CRISPR-asso-
ciated complex for antiviral defense), are required for CRISPR interference (49). 
A recent study has demonstrated that in E. coli K12 transcription from the cse1 
and CRISPR I promoters is repressed by heat-stable nucleoid-structuring protein 
(H-NS) (297), a global repressor of transcription in many Gram-negative bacteria. 
A microarray study indicates that transcription of cse1, cse2, cas7 and cas2 is 
elevated in an E. coli K12Dhns strain compared to wild-type (wt) E. coli K12 (172). In 
addition, H-NS was shown to possess high binding affinity for the intergenic region 
between cas3 and cse1 (281; 297). H-NS has a preference for binding AT-rich DNA 
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sequences (272). After initial binding of H-NS to high affinity nucleation sites (42; 
204) repression of transcription is mediated by cooperative spreading along the 
DNA (defined as DNA stiffening (216)) and by creating looped structures through 
formation of DNA-protein-DNA bridges (75). Moreover, H-NS acts as a DNA struc-
turing protein (216; 335).
Overcoming H-NS mediated repression of cas gene transcription may be a key 
requirement for CRISPR-Cas functionality. Generally, H-NS repression can be 
relieved by a number of proteins, such as SlyA, VirB and others (335). One of these 
proteins is the regulator LeuO (65; 85), which belongs to the LysR family of trans- 
cription factors (335) and is found in all proteobacteria, except the d subdivision 
(225). The leuO gene maps next to the leuABCD operon (63; 65; 168), whose gene 
products are required for leucine synthesis (375). Recent data indicate that LeuO 
is involved in regulating transcription of many genes, often as an H-NS antagonist 
(319; 335). However, since under laboratory growth conditions the genomic leuO 
gene itself is repressed by H-NS (196; 227) all LeuO regulation studies make use 
of plasmid encoded leuO under control of constitutive or inducible promoters. In 
the host environment leuO is likely to be induced under certain conditions as for 
example virulence of Salmonella enterica leuO mutants is attenuated (206).
Figure 1 LeuO and H-NS 
regulate cas gene expres-
sion. 
A) Schematic illustration of 
the CRISPR-Cas locus in E. 
coli K12 that consists of 8 cas 
genes (cas3 (ygcB), cse1 (ygcL or 
casA), cse2 (ygcK), cas7 (ygcJ), 
cas5 (ygcI), cas6e (ygcH), cas1 
(ygbT) and cas2 (ygbF)) and 
a downstream CRISPR locus 
containing 12 spacers and 13 
repeats (CRISPR I). The cas3, 
anti-cas3 (anti-pcas), cse1 (pcas) 
and CRISPR I promo- 
ter are indicated with an arrow 
(297). B) qPCR analysis of cas 
gene transcript abundance in E. 
coli Δhns and E. coli W3110 expressing leuO (induced or non-uninduced). Fold changes are given as 
compared to wt E. coli W3110 expression levels. Error bars indicate one standard deviation.
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A genomic screen for LeuO-binding DNA fragments in E. coli K12 revealed 12 gene 
clusters, including the cse1-cas2 operon (ygcL, ygcK, ygcJ, ygcI, ygcH, ygbT, ygbF) 
(319). When LeuO was over-expressed, increased expression of cse1 and cas2 was 
observed in E. coli (319), and of cse1 (STY3070) in Salmonella enterica serovar Typhi 
(167). We therefore investigated whether LeuO can mediate H-NS derepression 
of cas gene and CRISPR transcription. In this study we demonstrate that LeuO 
counteracts H-NS-dependent repression of the cse1 promoter by reorganizing the 
DNA protein contacts within the transcription initiation region. The consequen-
tial change results in increased transcription of the Cascade genes, the limiting 
factor for CRISPR-based defense against phage infection in E. coli K12.
resulTs
LeuO activates cas gene expression
To study the effect of LeuO on cas gene expression, transcript levels of the E. 
coli K12 cas genes in mid-exponential growth phase were examined using a DNA 
microarray approach. RNA samples isolated from a wt E. coli K12 strain containing 
a leuO encoding plasmid were compared to RNA isolated from a strain containing 
the empty vector. In addition, RNA isolated from a ΔleuO mutant carrying the 
empty vector was analyzed. Comparison of cas gene transcription levels between 
the LeuO-expressing strain and the control strain revealed a significant upregu-
lation of transcription of cse1, cse2, cas7, cas5, cas6e and cas1 and cas2 transcrip-
tion, showing a gradual decrease from cse1 (65-fold) to cas2 (5-fold) (Table 1). No 
change in the transcription level of cas3 was detected. These results are consistent 
with a polycistronic transcription of cse1, cse2, cas7, cas5, cas6e (the Cascade-en-
coding genes) and possibly the cas1, cas2 genes, with polar effects for the trans- 
cription of the more downstream genes. However, we did not observe significant 
differences in cas gene transcription in the ΔleuO 
mutant compared to the wt strain (Table 1), 
indicating that leuO is not expressed under the 
growth conditions used here. 
Figure 2 Antagonistic regulation of transcription 
from the cse1 promoter (pcas) by H-NS and LeuO. 
The transcriptional activity of the cse1 promoter (pcas) was 
tested by primer extension analysis using 25 μg total RNA 
isolated from wt or Dhns cells transformed with the control 
vector pKESK22 or the LeuO expression plasmid pKEDR13. 
RNA was isolated 2h after IPTG induction. In lane 5 a 
G+A-sequencing ladder was separated as size marker. The 
position of the resulting cDNA product and the primer are 
indicated on the left.
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Table 1 Microarray analysis of activation of cas genes by LeuO
pLeuO / wt ΔleuO / wt
gene fold-changea p valueb fold-changea p valueb
cas3 1.0 n. s. 0.93 1.1 n. s. 0.76
cse1 65.4 < 0.05 -1.2 n. s. 0.08
cse2 30.0 < 0.05 -1.1 n. s. 0.20
cas7 24.8 < 0.05 1.0 n. s. 0.81
cas5 17.5 < 0.05 1.1 n. s. 0.68
cas6e 15.4 < 0.05 -1.2 n. s. 0.31
cas1 8.8 < 0.05 1.2 < 0.05
cas2 5.4 < 0.05 1.1 n. s. 0.34
a The fold change of cas genes expression was determined by microarray analysis. pLeuO / wt indicates 
the ratio of cas transcripts detected upon overexpression of LeuO (using plasmid pKEDR13) as com-
pared to wildtype E. coli K12 (transformed with the empty vector plasmid pKESK22). ΔleuO / wt indicates 
the ratio of cas transcripts detected in a DleuO mutant as compared to wildtype.
b n.s. is not significant
To verify the observed increase in cas gene expression levels, quantitative PCR 
(qPCR) was performed on total RNA isolated from 3 strains during mid-exponen-
tial phase: wt E. coli, a Dhns strain and a wt strain expressing leuO from a plasmid. 
This analysis showed that the Cascade-encoding genes displayed increased trans- 
cription in both hns knockout and leuO expressing strains (Fig. 1B). While the 
increase in cse1, cse2, cas7, cas5, cas6e transcripts was modest in hns knockout 
strains, on average 5-fold, the effect of introducing leuO was more dramatic, with 
an average increase of 236-fold after induction of leuO expression. An increase in 
the Cascade-encoding gene transcripts was also observed when leuO expression 
was not induced, due to leakage from the pT5/lac promoter. The cas1 and cas2 genes 
also displayed increased transcript abundance in leuO expressing strains, although 
at lower levels than cse1, cse2, cas7, cas5, cas6e. Consistent with the microarray 
data, a trend of transcript fold change was observed, with polar effects downstream 
of cse1, again suggesting a polycistronic mRNA of the cse1-cas2 operon. Compared 
to the effect on the other cas genes, only a small increase of cas3 transcription was 
observed in leuO expressing strains.
To further evaluate the effects of H-NS and LeuO on transcription from the cse1 
promoter (known as pcas (297)), RNA samples from wt strains expressing leuO from 
a plasmid and strains lacking hns were compared by primer extension analysis. No 
cas transcripts were detected in wt cells containing an empty expression vector. 
Transcripts directed from pcas were only detected in cells expressing leuO from a 
plasmid or in hns knockout strains (Fig. 2), indicating that transcription of the 
cse1-cas2 operon is tightly controlled by H-NS and LeuO. 
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Figure 3 Formation of mature crRNA. 
A) Northern analysis of total RNA from wt E. coli K12 and wt E. coli K12 + Cascade-encoding genes 
(pNH6) using the single stranded spacer sequence NH30 (Table S2) as a probe. B) Northern analysis 
as in (A) of total RNA from E. coli K12 Dhns and C) wt E. coli K12 expressing leuO from a plasmid 
(pNH41) with an OD600 of 0.5, 1 and 3.0. M, size marker (pUC19/MspI ladder). E. coli K12 Dcse1 
(JW2730) serves as a control and marker for mature crRNA.
LeuO causes increased crRNA abundance
The CRISPR I locus is transcribed in E. coli K12 and the transcript is cleaved by 
the Cas6e subunit of Cascade into small crRNAs that subsequently remain bound 
by Cascade (49; 297). In K12 small crRNAs were virtually undetectable by North-
ern blot analysis (49) and (Fig. 3A). To investigate whether this was due to too 
low transcription levels of cse1, cse2, cas7, cas5, cas6e, the wt strain was trans-
formed with a plasmid encoding the Cascade protein components under control 
of an arabinose-inducible promoter. In the wt strain expressing cse1, cse2, cas7, 
cas5, cas6e from a plasmid, crRNAs with a length of about 61 nt could be detected. 
The requirement for plasmid-encoded synthesis of Cascade for detection of small 
crRNAs indicates that the level of Cascade in wt E. coli is insufficient for gener-
ating and stabilizing mature crRNAs. Furthermore we analyzed the levels of 
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Figure 4 H-NS and LeuO binding to the DNA region upstream of cse1 (the IGLB 
fragment). 
A) Electrophoretic Mobility Shift Assay (EMSA) of the IGLB fragment with LeuO and H-NS, either 
alone (lanes 5-7) or with pre-bound LeuO and subsequent addition of H-NS (lanes 8-11) or pre-
bound H-NS and subsequent addition of LeuO (lanes 12-15). B) DNase I footprint of IGLB in the 
presence of either H-NS or LeuO or both. LeuO was pre-incubated with the reaction mixture. The 
2 main regions protected by LeuO are indicated. The ladder indicates the IGLB coordinates relative 
to the cse1 start codon, indicated in C) the sequence and coordinates of IGLB, with the H-NS and 
LeuO binding sites indicated with boxes. See also Fig. 5A for footprints showing the LeuO binding 
region I.
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crRNAs in an hns knockout strain and in the wt strain expressing leuO constitutively 
from a plasmid. Both deletion of hns and over-expression of leuO caused significant 
crRNA accumulation, due to enhanced expression of Cascade in these two strains 
(Fig. 3B and 3C). The Cse1 knockout strain (JW2730) serves as a control and marker 
for the mature crRNA. It was previously shown that a Cse1 knockout strain gene-
rates elevated levels of mature crRNA (49), due to read-through of the downstream 
cas genes from the kanamycin resistance marker containing recombination cas-
sette by which the cse1 gene is replaced (293).
Binding of LeuO and H-NS to the DNA sequence upstream of cse1
The cse1-cas3 intergenic region (here denoted IGLB) contains pcas, for which 
H-NS has strong binding affinity, as well as the divergently oriented anti-cas3 
(known as anti-pcas) promoter, that is located 80 bp upstream of pcas and gives 
rise to an antisense transcript of unknown function (Fig. 1A and Fig. 4C) (297).
Both LeuO and H-NS bind the IGLB fragment, as determined by Electrophoretic 
Mobility Shift Assay (EMSA) (Fig. 4A, lanes 2-4 and 5-7). Pre-bound LeuO impedes 
cooperative binding of H-NS to the IGLB fragment (Fig. 4A, lanes 9-11). In line with 
this, pre-bound H-NS is partly released from the DNA when LeuO is added to the 
complex (Fig. 4A lanes 12-15). In order to map the binding region of LeuO within 
the IGLB fragment DNase I footprint analysis was performed. Upon limited DNase 
I hydrolysis of the IGLB DNA fragment, H-NS causes an extended footprint (Fig. 
4B), as shown before (297). In addition, LeuO protects two sites (site 1 and site 2) 
within the IGLB fragment that flank the high affinity H-NS nucleation site (Fig. 
4B and 4C). LeuO site 1 is located 20 bp downstream of pcas and LeuO site 2 spans 
the divergent anti-pcas (Fig. 4B and 4C). Interestingly, in the presence of LeuO the 
extended protection by H-NS is no longer visible (Fig. 4B, compare lanes 2 and 4), 
indicating that due to LeuO binding the DNA region containing the H-NS high- 
affinity binding site is no longer protected from DNase I cleavage, in agreement 
with decreased cooperative binding (Fig. 4A). 
In order to analyze the effect of LeuO on RNA polymerase (RNAP) binding to the 
promoter sites, DNase I footprints were performed in the presence of RNAP and 
LeuO. Moreover, the effect on transcription initiation and RNAP open complex 
formation was analyzed by KMnO4 footprints of stable initiation complexes. RNAP 
binds to the two promoters (pcas and anti-pcas) (Fig. 5A, lanes 3 and 3’, indicated I 
(pcas) and II (anti-pcas)) (297). Addition of the DNA binding proteins LeuO or H-NS 
alone does not cause changes in the KMnO4 reactivity (Fig. 5A, lanes 2’, 4’ and 5’). 
Binding of LeuO abolishes the spreading of H-NS along the DNA, resulting in a 
lack of protection by H-NS in the region between positions -160 to -240 (Fig. 5A, 
compare lanes 2 and 5), as observed before (Fig. 4B). When RNAP binding was 
studied in the presence of both transcription factors it turned out that the order of 
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addition to the DNA is crucial for the resulting footprint. RNAP binding was only 
affected when H-NS and/or LeuO were added to the DNA prior to RNAP. While 
prior binding of H-NS to the IGLB DNA fragment completely abolished RNAP-pro-
moter interaction and open complex formation (Fig. 5A and 5B, compare lanes 3’ 
and 6’), prior binding of LeuO had a repressive effect only on RNAP binding at 
anti-pcas (Fig. 5A and 5B, compare lanes 3’ and 7’; Fig. 4E, lane 5’). This can also be 
seen on the retardation gels (Fig. 5C and 5D), where the DNA/RNAP complex II is 
lost in the presence of LeuO (Fig. 5C, lane 7). This complex remains stable when 
H-NS is added last (Fig. 5C, lane 9), in contrast to a sample with only H-NS or 
where H-NS is added before LeuO (Fig. 5C, lanes 6 or 8, respectively). Moreover, 
the change in nucleotide reactivities indicates that LeuO binding alters the archi-
tecture of the transcription initiation complex at the pcas promoter (compare Fig. 
5B, lanes 7’ with Fig. 5A, line 3’ and Fig. 5E, lane 3’ with lane 5’). Altogether these 
data indicate that LeuO plays an important role in the regulation of expression of 
the cse1-cas2 operon by antagonizing H-NS-dependent repression of pcas.
H-NS and LeuO regulate CRISPR-based immunity against phage 
infection 
The effect of H-NS on CRISPR-based defense against phage infection was analyzed 
in wt and Dhns E. coli strains, grown in Luria Bertani broth. Since none of the 
spacers of E. coli K12 target known bacteriophages, an artificial seven spacer CRISPR 
(J3) with the native promoter was designed containing one spacer that targets the 
template strand of the gene encoding the phage Lambda tail protein (J). A non- 
targeting (N) CRISPR (49) served as a negative control. Introducing the J3 CRISPR 
reduced the sensitivity to virulent phage Lambda (lvir) infection 4-fold in the Dhns 
but not in the wt strain (Fig. 6A). Complementation of the Dhns strain reversed 
the reduction in phage sensitivity, demonstrating that CRISPR-based defense is 
Figure 5 Effects of LeuO and H-NS on RNA polymerase open complex formation at 
the IGLB fragment. 
A) and B) show either DNase I (lanes 1-14) or KMnO4 (lanes 1’-14’) footprint analyses of the 
non-template strand of IGLB after binding of RNA polymerase, H-NS or LeuO, either individually 
or in combination. The numbers above the lanes indicate the order of addition of the respective 
proteins. The cse1 promoter (pcas) (I) and the anti-cas3 promoter (anti-pcas) (II) are indicated. The 
arrowheads indicate the nucleotides within open complexes at the promoter sites. C) and D) show 
the binding of RNA polymerase, H-NS or LeuO, either individually or in combination. C) shows 
Electrophoretic Mobility Shift Assays of the samples in (A) and (B). The numbers above the lanes 
indicate the order of addition of the respective proteins. D) shows Electrophoretic Mobility Shift 
Assays of the samples in (E). The positions of the free DNA and complexed DNA are given on the 
left. The retardation gels (C) and (D) are not standard retardation gels but controls for the foot-
print complexes to see if no major decomposition has occurred. Because complexes are kept at 30°C 
for some time under RNAP binding conditions these gels are sometimes different from standard 
retardation experiments (e.g. Fig. 4A). E) Shows a similar analysis as in (A) and (B) for the template 
strand of IGLB (DNase I footprint lanes 1-8; KMnO4 footprint lanes 1’-8’). The protein concentra-
tions used are H-NS (1 mM), LeuO (1 mM) and RNA polymerase (50 nM).
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negatively regulated by H-NS (Fig. 6A). When cells were grown in richer media 
(2YT) until stationary growth phase, higher resistance levels were observed, up to 
a 10-fold reduced sensitivity compared to a non-targeting strain (data not shown). 
Moreover, plaques were much smaller in the hns knockout strains equipped with 
the J3 CRISPR when using 2YT.
Further evidence that H-NS controls CRISPR-based immunity was obtained using 
Figure 6 Effect of 
H-NS and LeuO on 
CRISPR-based re-
sistance in vivo. 
A) A synthetic CRISPR 
with one spacer (J3) tar-
geting phage Lambda on 
a plasmid (pWUR564) 
is introduced in E. coli 
K12Dhns, E. coli K12, 
and complemented E. 
coli K12Dhns expressing 
hns from the pHOP11 
plasmid. Phage re-
sistance is monitored 
by determining the 
efficiency of plaquing 
(EOP) after challenge 
with virulent Lambda 
phage. B) The effects 
of leuO (pKEDR13) and 
cas3 (pWUR608) expres-
sion on phage resistance 
is monitored in E. coli 
K12DCRISPRI::CRISPRJ3 
(indicated as J3) C) The 
effect of introducing 
the cse1-cas2 operon 
(pWUR607), cas3 or a 
CRISPR on phage resist-
ance is monitored in E. 
coli K12DCRISPRI::CRIS-
PRJ3 (indicated as J3).
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3genetically engineered strains in which the genomic CRISPR I locus was replaced by the J3 or a non-targeting CRISPR. E. coli K12DCRISPRI::CRISPRJ3 (E. coli J3) was fully sensitive to infection by phage Lambda, despite the presence of a genomic 
J3 spacer (Fig. 7). However, when the dominant negative hnsG113D mutant was 
expressed from a plasmid, the sensitivity of E. coli J3 to phage lvir infection was 
reduced 3.6 fold (Fig. 7). This mutant still forms heterodimers with wt H-NS, but 
does not bind DNA and therefore interferes with H-NS mediated transcriptional 
repression resulting from the formation of higher-order DNA-protein complexes 
(362). This observation is consistent with the reported finding that expression of 
hns mutant G113D induces transcription from pcas in wt E. coli (297).
When plaque assays were performed in E. coli J3 over-expressing leuO from 
a plasmid, a ~6 fold reduced sensitivity to phage lvir infection was observed 
(Fig. 6B), demonstrating that LeuO activates CRISPR-based defense in E. 
coli. A 3-fold reduced sensitivity was observed when leuO expression was not 
induced, probably due to leakage from the ptac promoter. When E. coli J3 cells 
were grown to stationary phase in rich 2YT medium, an increased resistance 
level was observed with turbid and very small plaques in leuO over-expressing 
strains containing a targeting CRISPR (data not shown), whereas plaques in 
the same strain containing a non-targeting CRISPR were clear and of normal 
size. Although cas3 gene expression was not strongly induced when LeuO was 
expressed from a plasmid (Table 1 and Fig. 1B), the expression of cas3 was not 
a limiting factor for resistance, since introduction of a cas3 expression plasmid 
into E. coli J3 expressing leuO did not lead to elevated resistance levels (Fig. 6B).
When a plasmid expressing cse1, cse2, cas7, cas5, cas6e, cas1, cas2 was introduced 
in E. coli J3, a 2.5-fold reduced sensitivity to phage infection was observed (Fig. 6C), 
which was not observed when a CRISPR expression vector containing spacer J3 or a 
plasmid encoding cas3 was introduced (Fig. 6C), indicating that expression of the 
genes encoding Cascade (cse1, cse2, cas7, cas5, cas6e) is limiting for CRISPR-based 
defense in wt E. coli.
Figure 7 Effect of H-NS G113D 
on CRISPR-based resistance 
in vivo. 
Expression of the dominant 
negative hns mutant G113D causes 
reduced sensitivity of E. coli 
K12DCRISPRI::CRISPRJ3 to phage 
l infection as measured by plaque 
assay. 
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disCussion
The Type I-E CRISPR-Cas system is present in many Proteobacteria and in some 
Actinobacteria, Firmicutes and methanogenic Archaea. A recent analysis of 
a collection of natural isolates shows that this CRISPR-Cas subtype occurs in 
approximately 60% of the E. coli strains (96). The study presented here provides 
experimental evidence for regulation of the Type I-E CRISPR-Cas system in E. coli 
K12 by the antagonists H-NS and LeuO. These antagonistic DNA-binding proteins 
regulate the expression of several genes in E. coli, such as the bgl operon (utili-
zation of b-glucosides) (361), the yjjQ-bglJ operon (virulence factor and activator 
of bgl, respectively) (338) and the Salmonella enterica Serovar Typhi ompS1 gene 
(outer membrane protein and pathogenicity determinant) (85).
We demonstrate that relieving H-NS-mediated repression of cas gene transcrip-
tion is required for CRISPR-based immunity and that derepression is mediated 
by LeuO through direct binding of DNA sequences upstream of cse1. The EMSA 
and footprint results (Fig. 4) support the finding that elevated amounts of LeuO 
counteract H-NS-mediated repression of the cse1-cas2 operon in vivo. Moreover, 
these data indicate that LeuO-induced activation of transcription from the cse1 
promoter (pcas) does not simply result from a displacement of bound H-NS, since 
LeuO cannot facilitate the binding of RNA polymerase when H-NS is pre-bound. 
Instead, LeuO abrogates the cooperative spreading of H-NS upon binding to the 
cse1 promoter region.
Interestingly, the transcript levels of the cse1-cas2 operon were higher in cells 
expressing leuO than in hns knockout strains (Fig. 1B), suggesting that either LeuO 
functions as an enhancer of transcription of the cse1-cas2 operon, or that derepres-
sion in K12Dhns is incomplete. The latter could be due to additional repressors 
involved in silencing the cse1-cas2 operon, or due to functional redundancy between 
suppressors of gene transcription. In particular, StpA has been reported to possess 
high binding affinity for pcas (297). Although a K12DstpA strain showed similar cas 
gene transcript levels as a wt K12 strain (297) it cannot be excluded that StpA-me-
diated repression of cas gene transcription takes place in the absence of H-NS.
Cells expressing leuO showed higher resistance levels compared to hns knockout 
strains, due to the higher expression of the cas genes and higher abundance of 
mature crRNA (Fig. 1B and Fig. 3BC). Compared to the CRISPR-based resistance 
levels to phage infection observed in Streptococcus thermophilus (28) or E. coli 
BL21-AI over-expressing the cas genes and the CRISPR (49), the resistance levels of 
wt E. coli over-expressing leuO are relatively low. However, at present it is unknown 
whether a similar level of CRISPR-based immunity can be reached by wt E. coli, 
and if it can, under what conditions.
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Although we were able to show that CRISPR-based immunity is activated by over-
producing LeuO, the natural growth conditions that induce CRISPR-based defense 
are still unknown. Our experiments show that a genomic anti-Lambda spacer alone 
does not provide resistance to phage infection in wt E. coli due to the absence of 
Cascade. We speculate that leuO expression levels under laboratory growth condi-
tions are too low to induce derepression pcas, and that phage l exposure itself does 
not activate CRISPR-defense. Unaltered expression of leuO and the cas genes was 
also observed during infection with bacteriophage PRD1 (292).
Since H-NS is known to bind DNA of incoming phage or plasmid directly (271; 
272) this might result in redistribution of H-NS (97; 99), allowing expression of 
the Cascade genes due to decreased local concentrations of the repressor. As leuO 
expression is negatively regulated by H-NS and positively by LeuO itself (65; 172), 
this would further amplify the activating signal for cas gene transcription.
Interestingly, leuO expression levels are induced by the alarmone guanosine 
tetraphosphate (ppGpp) (64; 110; 227). ppGpp is involved in stress signaling 
cascades leading to the stringent response under nutrient limiting conditions. 
Since these conditions slow down phage proliferation dramatically (313), bacte-
rial cells may then stand a better chance of surviving phage encounters, hence 
inducing CRISPR-based defense may be more beneficial. However, induction of 
the stringent response by amino-acid starvation, e.g. by serine hydroxamate (352) 
neither increased the transcription from pcas nor the formation of mature crRNA 
(data not shown). Although under laboratory conditions CRISPR-based defense 
is suppressed, the diversity in spacer content in natural isolates of E. coli strongly 
suggests that the CRISPR-Cas system as a whole is active and functional in natural 
ecosystems (96).
In an independent parallel study, it has been shown that an E. coli hns knockout 
strain containing an anti-Lambda spacer is less sensitive to phage infection (293), 
in agreement with the data presented here. It seems that the Dhns strain containing 
the T3 spacer used in (293), shows higher levels of resistance than the Dhns strain 
containing the J3 spacer that was used in this study. The T3 spacer has originally 
been described (49) as the spacer that confers the highest level of immunity of 8 
different spacers tested. 
Although a number of studies involving H-NS and LeuO have been carried out in E. 
coli and S. enterica (167; 172; 222; 272; 319), the outcome of these studies has never 
been interpreted in the light of CRISPR-based defense. Based on these genome-
wide analyses we propose that the expression of the Type I-E cas genes from Salmo-
nella enterica are likely to be regulated by H-NS and LeuO as well. For instance, 
in S. enterica Serovar Typhi transcription of cse1 (STY3070) appears to be affected 
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by H-NS and LeuO (167), despite the poor conservation of the intergenic region 
between the divergently oriented cas3 and cse1 genes in this strain. In S. enterica 
Serovar Typhimurium strain LT2 H-NS binding sites were found encompassing 
the translation start site of the cas3 gene (222). Another study showed that in this 
strain the transcription of cas3, cse2, cas7 and cas5 is elevated in the absence of 
H-NS (272). Perhaps the cas genes are controlled by a single promoter in this strain, 
since the intergenic region between cas3 and cse1 is only 12 nucleotides in length.
Altogether, this study provides evidence that the Type I-E CRISPR-Cas system in E. 
coli is regulated by the antagonists H-NS and LeuO, and we propose that this regu-
latory mechanism is conserved in S. enterica as well. The upcoming challenge will 
be to identify conditions that activate this sophisticated defense system to allow 
defense against invasion by foreign DNA.
exPerimenTal ProCedures
Strains
The wildtype E. coli K12 W3110 (BW25113) strain and the E. coli K12 W3110 derivative 
Dhns (JW1225) and Dcse1 (JW2730) from the KEIO collection (19), supplied by the 
American Type Culture Collection (ATCC), and E. coli K12 MC4100 (288) derivative 
Dhns (PD32) (92) were used throughout the study.
Gene cloning and recombination 
A synthetic recombination cassette was designed corresponding to 400 bp flanking 
regions on each side of the CRISPR I locus separated by a kanamycin resistance 
gene flanked by FRT-sites (GAAGTTCCTATACTTTCTAGAGAATAGGAACTTC). 
The construct contained a PstI site followed by 400 nt of the CRISPR I upstream 
region of the E. coli K12 W3110 genome (2875875-2876274), followed by a NcoI site, 
then the sequence AAACAAAGAATT, a KpnI site, followed by an FRT-site, a SphI 
site, a kanamycin resistance gene with a sequence corresponding to pJJDuet30 
(2186-1276), a XhoI site, an FRT site, a NotI site, and 395 nt of the CRISPR I down-
stream region of the E. coli K12 W3110 genome (2877225-2877619) (GeneArt AG, 
Regensburg, Germany). A synthetic CRISPR sequence including leader sequence 
containing 7 spacers and 8 repeats was used (Table S1, ref. (391)) (Geneart AG, 
Regensburg, Germany). This synthetic CRISPR was cloned between the flanking 
regions using the NcoI and KpnI sites (see online supporting information Fig. S3 
of ref. (391)). The NcoI and EcoRI sites in the leader and second spacer were used 
to exchange the first spacer sequence of the CRISPR; the constructs created were 
named J3 and R44 (Table S1). The other spacers in the CRISPR were sequences 
with no homology to phage Lambda. These constructs were used as recombi-
nation cassettes to replace the existing CRISPR I locus in the E. coli K12 W3110 
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genome, following a protocol described elsewhere (80), with minor modifications. 
For recombination, the sequences were PCR-amplified using primers BG3017 and 
BG3019 (Table S2) with high fidelity pfu-turbo polymerase and transformed by 
electroporation into E. coli K12 W3110 containing pKD46, kindly provided by the 
ATCC. Transformants were grown at 30°C and plated on LB-Agar + kanamycin (50 
mg ml-1). The pKD46 plasmid has a temperature sensitive origin of replication, and 
was removed through growth at 37°C (80). Recombination was validated by PCR 
and sequencing. The antibiotic resistance cassette was removed using Flp recom-
binase encoded on plasmid pCP20, and subsequent growth at 37°C, as described 
(80). The DleuO mutant was constructed with the l red-gam system using oligo-
nucleotides T209 and T210 (Table S2), as described (80). After deletion of leuO the 
resistance cassette used for selection was removed using Flp recombinase encoded 
on plasmid pCP20 (80).
Plasmids and Vectors
Plasmid pWUR607 (TetR) contains the cse1-cas2 operon, which was PCR-amplified 
from E. coli K12 MG1655 genomic DNA using primers BG2173 and BG2174 (Table 
S2), and cloned into vector pACYC184 using the restriction sites EcoRI and NcoI. 
Plasmid pWUR608 (CamR) was constructed by cloning a cas3 amplicon generated 
with primers BG2171 and BG2172 (Table S2) into pACYC184 using the restriction 
enzymes BamHI and SphI. In the experiments where a CRISPR was introduced on 
a plasmid, the pACYCduet-1 vector (CamR) (Novagen) was used, using the NcoI 
and Acc65I restriction sites. pWUR477 containing the non-targeting CRISPR (N) 
was described previously (49). Expression of the CRISPR from this plasmid in K12 
was under control of the leader sequence that contains the CRISPR I promoter 
(297). pWUR564 is a derivative of pWUR477 that has the NcoI-EcoRI fragment 
(containing the leader sequence up to half of the second spacer) replaced with the 
NcoI-EcoRI fragment of construct J3 (Table S1). For expression of wt hns and hnsG113D 
the previously described pHOP11 and pHM52 plasmids were used, respectively 
(297). The pCA24N plasmid from ASKA(-) clone JW0075 encodes leuO behind 
an PT5/lac promoter (IPTG inducible). pKEDR13, encoding leuO behind a ptac 
promoter (IPTG inducible), and the control vector pKESK22 were described earlier 
(226; 338). The IPTG inducible leuO expression plasmid pNH41 was constructed 
by cloning the leuO amplicon, generated using primers NH329 and NH330 (Table 
S2), into the 2.2 kb XbaI fragment of pZE12-luc, following a previously published 
protocol (364). Plasmid pNH6 contains the cse1-cas6e operon (PCR amplified 
with pre-phosphorylated primer NH193 and primer NH194 (Table S2)) inserted by 
blunt end and EcoRI cloning into vector pCU01 (pBAD-TOPO vector derivative), as 
described (363). Plasmid pUC18-IGLB was described before (297). 
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Microarray
E. coli K12 MG1655 was transformed with plasmid pKEDR13 (KanR lacIq ptac leuO) 
(338) for expression of leuO or with control vector pKESK22 (KanR lacIq ptac). 
Exponential cultures were inoculated from fresh overnight cultures to an OD600 of 
0.1 in LB supplemented with 25 mg ml-1 kanamycin. IPTG was added after 30 min of 
growth to a final concentration of 1 mM. After additional 60 minutes the bacteria 
were harvested using Qiagen RNAprotect and used for RNA isolation using the 
Qiagen RNeasy MiniKit system. In brief, 1 ml of each culture (OD600 between 0.5 
and 0.6) was used and processed according to the manufacturer’s instructions 
including DNase I on-column treatment. RNA quality was assayed by denaturing 
urea-PAGE and by measuring the ratio of absorption at 260/280 nm in a Gene-
Quant II spectrophotometer (Amersham). RNA concentration was determined by 
measuring UV light absorption at 260 nm. The procedure was carried out four 
times with independent clones.
Synthesis of cDNA (and cRNA) and hybridization of Affymetrix GeneChip® E. coli 
Genome 2.0 microarrays was carried out according to the manufacturer’s instruc-
tions. In total, four independent RNA samples of each group (wt, leuO expressing 
and leuO deficient strains) were used. Data analysis was performed using Affy-
metrix Software. Fluorescence values were normalized to the GeneChip standard 
reference probes. Differential expression values were calculated as fold-change of 
leuO expressing samples compared to samples of LeuO-deficient control strains.
qPCR analysis of gene expression
qPCR analysis of cas gene transcript abundance was performed on cDNA synthe-
sized using High Capacity Reverse Transcription Kit (Applied Biosystems) from 
RNA extracted by the hot-phenol method (37) and DNase-treated using Turbo 
DNA-free kit (Ambion). 10 ml samples for RNA extraction were taken at OD600 
~0.5 from E. coli W3110, E. coli W3110 carrying pCA24N (leuO) and E. coli Δhns 
(JW1225-2). When LeuO expression was induced, samples were taken 30 min after 
addition of 0.5 mM IPTG. The qPCR reactions were performed using Power SYBR 
green PCR master mix (Applied Biosystems) according to manufacturer’s instruc-
tions, and primers were designed using Primer Express 3.0 (Applied Biosystems). 
For the complete list of primers used see Table S3. Two primer pairs were designed 
against cse1 as internal control. The PCR reactions were performed on a 7300 Real 
Time PCR System (Applied Biosystems) and analyzed using 7300 System SDS Soft-
ware 1.3 (Applied Biosystems). Fold change of cas gene transcription was calcu-
lated using the relative quantification method with tmRNA as endogenous control 
and E. coli W3110 cas gene transcript abundance as calibrators. All PCR reactions 
were performed in six replicates. Control PCRs without template or without cDNA 
(produced by standard cDNA synthesis but excluding reverse transcriptase) were 
67
Chapter 3 Regulation of CRISPR-based Immunity in Escherichia coli
3
performed to monitor general contamination levels and genomic DNA contamina-
tion of RNA extracts, respectively.
Northern Blotting
Total RNA was extracted at the OD600 indicated using TRIZOL reagent (Invitrogen) 
according to the manufacturer’s protocol. Expression of the Cascade-encoding 
genes from pNH6 was induced at an OD600 of 0.5 by adding 0.2% of arabinose 
for 15 min. 10 mg of total RNA was denatured at 95°C with an equal volume of 
formamide loading dye, FD (90% formamide, 15 mM EDTA, 0.05% bromophenol 
blue and 0.05% xylene cyanol), and subsequently separated on an 8% denaturing 
polyacrylamide gel. A 32P-labeled pUC19 DNA/MspI ladder (Fermentas) was used 
as size marker. The RNA was electrotransferred to Nylon N+ membranes (GE 
Healthcare) at 10 V for 15h. Transfer was performed in a BIORAD blotting chamber 
in 1xTBE buffer at 4°C followed by drying of the membrane and UV-crosslinking. 
Prehybridization was carried out for 2–4 h at 42°C in 15 ml prehybridization buffer 
(5x SSC, 5x Dernhardt, 0.05 M sodium phosphate pH 6.7, 1% dextran sulphate, 
0.1% SDS) together with 75 ml herring sperm DNA (20 mg ml-1). Hybridization was 
carried out overnight at 42°C in the same buffer lacking herring sperm DNA but 
containing [g-32P]-ATP-labeled oligonucleotide probe NH30 (Table S2) specific for 
spacer 2 of the CRISPR1 locus. The probe was labeled with [g-32P]-ATP (40 pmol 
DNA, 10x kinase buffer, T4 polynucleotide kinase (PNK, Ambion), [g-32P]-ATP) by 
incubation at 37°C for 45 min. Prior to hybridization, the probe was purified over 
a G-50 column (GE Healthcare). Membranes were washed once for 20 min at 60°C 
in 2xSSC, 0.5% SDS and once for 20 min in 0.5x SSC, 0.5% SDS. Signals were quan-
tified in a Molecular Dynamics PhosphorImager model 400S with ImageQuant 
software version 4.2a (Molecular Dynamics).
Electrophoretic Mobility Shift Assay
E. coli RNAP, LeuO and H-NS were purified according to published procedures 
(297; 338). The IGLB fragment (position -1 to -414, relative to the first nucleotide of 
the cse1 (ygcL) start codon) was obtained by EcoRI/HincII or BamHI/SacI diges-
tion of plasmid pUC18-IGLB. Purified DNA fragments were end-labelled by Klenow 
(Promega) and [a-32P]-dATP. Binding reactions with the indicated amounts of 
protein were performed in 50 mM Tris-HCl, pH 7.4, 70 mM KCl, 15 mM NaCl, 1 
mM EDTA, 10 mM b-mercaptoethanol at a final heparin concentration of 20 ng 
ml-1. Complexes were separated on native 5% (w/v) polyacrylamide gels and visua-
lized by autoradiography as described (297).
Footprint analyses
DNase I footprinting of free DNA and DNA-protein complexes was performed 
as described (297). Formation of open RNAP-promoter complexes was analyzed 
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by KMnO4 modification of single-stranded nucleotides within the transcription 
bubble. 40 ml RNAP-DNA complexes were treated with 160 mM KMnO4 for 2 min 
at 30°C. The reaction was stopped by addition of 5.3 ml b-mercaptoethanol and 5.3 
ml 500 mM EDTA and the samples were ethanol precipitated after phenol/chloro-
form extraction. Pellets were dissolved in 10% piperidine and incubated at 90°C for 
30 min. After two rounds of washing with distilled water followed by lyophilizing, 
the pellets were dissolved in 50 ml distilled water and precipitated with ethanol. 
Cleavage products were separated on 10% denaturing polyacrylamid gels and 
visualized by autoradiography. The following protocol was used in footprint 
experiments with more than one protein: LeuO or the protein-free buffer, and 
H-NS or the respective buffer, were incubated with the template DNA for 5 min at 
30°C. Next RNAP or the RNAP dilution buffer was added and incubated for another 
10 min. Finally heparin was added to a final concentration of 200 ng ml-1 with a 
further incubation at 30°C for 5 min. An aliquot of this solution was loaded on a 
native gel to verify complex formation and the remaining solution was used for the 
different footprint experiments. 
Primer extension analysis
Primer extension reactions with 25 mg total RNA hybridized to a radiolabeled 
specific cas primer oligonucleotide (5’-ATACAATTAATCTATACATATATTAA-
GATG-3’) were performed with AMV reverse transcriptase (Promega) as described 
(2).
Phage Lambda infection studies
Host sensitivity to phage infection was tested using a virulent phage Lambda 
(lvir), as before (49). The host strains for infection were either wt E. coli K12 W3110, 
E. coli K12 W3110 Dhns, or the engineered E. coli K12 W3110 strains (E. coli K12D 
CRISPRI::CRISPRJ3 and E. coli K12DCRISPRI::CRISPRR44) (Table S4). The sensi-
tivity of the host to infection was calculated as the efficiency of plaquing (the 
plaque count ratio of a strain containing an anti-Lambda CRISPR to that of the 
strain containing an non-targeting CRISPR) (49). 
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absTraCT 
The CRISPR immune system in prokaryotes utilizes small guide RNAs to neutralize invading viruses and plasmids. In Escherichia coli, immunity is dependent on a ribonucleoprotein complex called Cascade. Here we 
present the composition and low-resolution structure of Cascade and show 
how it recognizes double-stranded DNA targets in a sequence specific manner. 
Cascade is a 405 kDa complex comprising five functionally essential Cas proteins 
(Cse11Cse22Cas76Cas51Cas6e1) and a 61 nucleotide crRNA with 5’-hydroxyl and 
2’,3’-cyclic phosphate termini. The crRNA guides Cascade to dsDNA target 
sequences by basepairing with the complementary DNA strand while displacing 
the non-complementary strand to form an R-loop. Target DNA recognition by 
Cascade takes place without ATP consumption, suggesting that continuous 
invader DNA surveillance takes place without energy investments. The structure 
of Cascade reveals an unusual seahorse-shape that undergoes conforma-
tional changes upon target DNA binding. A structural model of Cascade is 
presented that provides insight into the architecture of Cas protein complexes.
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inTroduCTion
The constant pressure of invading viruses and conjugative plasmids has shaped the evolution of host defense systems in prokaryotes. The widely distributed CRISPR (Clustered Regularly Interspaced Short Palindromic 
Repeats) immune system represents the most recently discovered prokaryotic 
defense strategy (reviewed by (94; 173; 192; 236; 366)). The system consists of 
repeats that are interspaced by unique sequences called spacers, which are derived 
from viral and plasmid DNA (39; 250; 294). CRISPR-based immunity is adaptive 
and inheritable because it can both memorize invaders by storing fragments of 
their DNA, and pass that information on to subsequent generations following a 
Lamarckian type of evolution (197; 366).
The CRISPR-associated (Cas) protein machinery is encoded by gene clusters that 
are located in close proximity of the CRISPR locus (187), which has allowed for the 
extensive horizontal transfer of complete CRISPR-Cas systems (133). Multiple types 
of cas-gene sets have been recognized (148; 230) that correlate with specific fami-
lies of repeat sequences (201).
The mechanism of CRISPR-Cas-induced immunity has been divided into three 
stages. In the first stage, CRISPR adaptation, the host encounters an invader and 
integrates a fragment of foreign DNA into the CRISPR as a new spacer, resulting 
in resistance to foreign genetic elements carrying this sequence (28; 174; 367). 
Although the molecular determinants of foreign DNA recognition have not been 
elucidated, the crystal structure and metal-dependent DNase activity of Cas1 indi-
cated that this enzyme may be involved in generating small DNA fragments that 
are used as precursors for CRISPR adaptation (397). Newly acquired spacers from 
both the coding and template strand of the viral genome have been shown to confer 
immunity (28).
The second stage, CRISPR expression, involves transcription and translation of 
the cas genes and transcription of the CRISPR, yielding a precursor CRISPR RNA 
(pre-crRNA). In E. coli K12 expression of the cse1-cas2 operon is tightly regulated 
by the antagonistic transcription regulators H-NS (293; 297) and LeuO (391). Upon 
expression of the cas genes, the pre-crRNA is cleaved within the repeat regions 
(149; 214; 345) by a specific Cas endoribonuclease. Three pre-crRNA processing 
endonucleases have been described: Cas6e from Escherichia coli (49), Cas6 from 
Pyrococcus furiosus (60) and Cas6f from Pseudomonas aeruginosa (157). In E. 
coli, Cas6e is an essential component of the Cascade complex (CRISPR-associa- 
ted complex for antiviral defense), which consists of five Cas proteins (Cse1, Cse2, 
Cas7, Cas5, Cas6e) (Fig.1A). Cas6e-generated mature crRNAs remain bound to 
Cascade to guide host defense. This is distinct from the situation in P. furiosus in 
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which Cas6-generated crRNAs (also called psiRNAs) end up in the Cmr-complex 
encoded by the RAMP module of Cas proteins, where they are further trimmed at 
the 3’-end from ~67 to 39 or 45 nucleotides. The guide RNA-loaded Cmr-complex 
cleaves single stranded target RNA sequence-specifically (151). In E. coli, the third 
stage, CRISPR interference, not only requires Cascade loaded with anti-invader 
crRNA, but also the participation of the predicted nuclease/helicase Cas3. Because 
crRNAs complementary to the either strand of the phage DNA provided resistance, 
it was proposed that Cascade is a crRNA-guided complex that targets DNA rather 
than mRNA (49). A series of genetic experiments in Staphylococcus epidermidis 
involving a conjugative plasmid showed that the Csm-type CRISPR-Cas system 
targets DNA as well (235). Although DNA is the prime candidate for the target 
molecule in the E. coli and S. epidermidis model systems, direct molecular evidence 
of Cas proteins interacting with their target DNA has been lacking. In this study 
we show how Cascade recognizes target DNA and present a structural model of 
Cascade that provides insight into the mechanism of crRNA-guided recognition 
of DNA targets.
Figure 1 Core complexes of Cascade retain crRNA. 
A) Schematic diagram of the CRISPR-Cas locus in E. coli K12 containing cas3 (ygcB), cse1 (casA, 
ygcL), cse2 (casB, ygcK), cas7 (casC, ygcJ), cas5 (casD, ygcI), cas6e (casE, ygcH), cas1 (ygbT), cas2 
(ygbF) (148; 187). B) Coomassie blue-stained SDS-polyacrylamide gel showing StrepTactin purified 
Cascade, CascadeDCse1 and CascadeDCse1Cse2. Protein marker sizes in kDa. The asterisk marks 
the Strep-tagged subunit. C) Ethidium bromide-stained denaturing PAA-gel showing nucleic acids 
isolated from purified Cascade (sub-)complexes. RNA marker sizes in nucleotides. D) RNase A or 
DNase I treatment of Cascade bound nucleic acids from Cascade. E) Size exclusion elution profiles 
of CascadeDCse1Cse2, CascadeDCse1 and Cascade before and after DNase I treatment.
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Core sub-complexes of Cascade
The E. coli K12 Type I-E CRISPR-Cas system consists of a gene cluster encoding 
eight cas genes (cas3, cse1, cse2, cas7, cas5, cas6e, cas1 and cas2) and a downstream 
CRISPR locus (Fig. 1A). Five Cas proteins (Cse1, Cse2, Cas7, Cas5, Cas6e) form the 
Cascade complex, which cleaves a long precursor transcript of the CRISPR region 
(pre-crRNA) into small crRNA molecules that remain bound to the complex (49). 
To investigate the role of the individual subunits, we first tested whether each 
subunit is required for antiviral defence. Viral plaque assays with Cas3 and Cascade 
lacking one type of protein subunit showed that all protein components of Cascade 
are indispensible for the virus resistant phenotype of E. coli (Fig. 2).
We then systematically overproduced and affinity purified different combinations 
of Cascade subunits and checked for the presence of mature crRNA. This analy- 
sis showed that Cse1 or both Cse1 and Cse2 could be omitted without affecting 
the apparent stoichiometry of the remaining complex (CascadeDCse1 and Cascade 
DCse1Cse2, respectively) or the mature crRNA (Figs. 1B and 1C). We noticed that 
Cascade, unlike CascadeDCse1 and CascadeDCse1Cse2, always co-purified with 
large nucleic acid molecules (>300 nt) (Fig. 1C). Removal of the Cas proteins 
followed by nuclease treatments showed that RNase A only hydrolyzed the crRNA, 
while DNase I removed the long nucleic acids, thereby identifying the co-purified 
nucleic acid as DNA (Fig. 1D). Size exclusion chromatography of the three types of 
complexes revealed that the vast majority of CascadeDCse1 and CascadeDCse1Cse2 
were present in a single form, whereas Cascade displayed a substantial void peak in 
addition to a discrete peak at ~11 ml (Fig. 1E). DNase I treatment prior to gel filtra-
tion eliminates the void peak without disruption of the discrete Cascade peak, again 
indicating the presence of Cascade-bound DNA (Fig. 1E).
Figure 2 All Cascade 
subunits are required 
for immunity. 
The efficiency of plaquing 
(EOP) was determined in 
E. coli BL21-AI contai- 
ning complete Cascade, 
phage λ-targetting T1-4 
CRISPR (described in 
(42)) and Cas3, and for 
strains expressing Cascade 
sub-complexes lacking 
one of the Cas proteins. 
Host strain E. coli BL21-AI 
does not contain cas-
genes. Error bars indicate 
one standard deviation.
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Architecture of crRNA
The characteristics of the mature crRNA species were accurately determined by 
subjecting mature crRNAs isolated from Cascade to denaturing RNA chromato- 
graphy (95; 381) and electrospray ionization mass spectrometry (ESI-MS). To 
simplify the analysis, a uniform crRNA preparation was obtained by co-expressing 
Cascade with a designed CRISPR containing eight repeats and seven identical 
spacers (denoted CRISPR R44). This setup resulted in a Cascade preparation in 
which each molecule was loaded with the same crRNA. Chromatography demon-
strated the purity and homogeneity of the crRNA in Cascade (Fig. 3A). Furthermore, 
the observed retention time was consistent with an approximate length of 60 nt. 
The ESI-MS spectra indicated that the crRNA had a molecular weight of 19,660.80 
Da (Fig. 3B), which corresponds well to an expected molecular weight of 19,660.82 
Da for a 61 nt crRNA resulting from a single Cas6e endoribonuclease cleavage event 
in each repeat. The purified mature crRNA was also analyzed using ESI-MS/MS 
analysis following RNase T1 and RNase A digestion. A number of oligoribonu-
cleotide digests were assigned to the mature crRNA sequence (Fig. 4) and were 
consistent with the previously determined Cas6e cleavage site, 5’ of the terminal 
base of the hairpin (49). The molecular weight analysis of the crRNA indicated a 
Figure 3 Architecture of crRNA. 
A) Ion-pair reversed-phase HPLC purification of mature R44 crRNA at 75°C. B) Multiple-charged 
ESI-MS spectra of the purified mature crRNA. C) Enhanced view of the 18- charged species before 
(upper graph) and after acid treatment (lower graph) indicating the hydrolysis of the 2’,3’-cyclic 
phosphate. D) diagram of mature crRNA derived from the R44 CRISPR showing the 5’ hydroxyl 
group and 2’,3’-cyclic phosphate.
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Figure 4 RNase digests of the crRNA. 
A) Sequence of mature crRNA with the R44 spacer sequence shaded, and the hairpin underlined.  
B) Base peak chromatogram of the RNaseT1 digest of mature crRNA. The predominant oligoribonu-
cleotide peaks assigned to the mature crRNA are highlighted. C) Summary of the identified oligo- 
ribonucleotides assigned to mature crRNA from the RNaseT1 digest. D) Base peak chromatogram 
of the RNaseA digest of mature crRNA. The predominant oligoribonucleotide peaks assigned to the 
mature crRNA are highlighted. E) Summary of the identified oligoribonucleotides assigned to ma-
ture crRNA from the RNaseA digest. ^ indicates cyclic 2’,3’-phosphate. It is worth mentioning that 
the cyclic phosphate 3’-end is not a substrate for E. coli poly(A) RNA polymerase, and this explains 
why only shorter, apparently partly degraded crRNAs were cloned and sequenced previously (42).
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Figure 5 Target rec-
ognition by Cascade. 
A-B) Effect of the type of 
crRNA bound. Cascade 
was loaded with either 
targeting crRNA (derived 
from the R44 CRISPR, 
Supplementary Fig.2) 
or non-targeting crRNA 
(derived from the K12 
CRISPR). The binding 
of these two types of 
Cascade complexes to 
one type of probe is 
shown. DNA probes are 
86 nucleotide ssDNA or 
dsDNA sequences con-
taining the R44 proto-
spacer (32 nucleotides), 
flanked by 27 nucleotides 
on either end C-H) Effect 
of uniform crRNA- 
loaded complexes (R44 
CRISPR) on the binding 
of DNA probes with and 
without protospa- 
cer (denoted target and 
non-target, respectively). 
The binding of Cas-
cade, CascadeDCse1 and 
CascadeDCse1Cse2 to an 
86 nucleotide target or 
non-target ss/dsDNA is 
shown. Non-target DNA 
probes contain a scram-
bled R44 protospacer 
sequence. I-J) Effect of 
uniform crRNA-loaded Cascade (R44 CRISPR) on the binding of target and non-target ssRNA and 
dsRNA. A-H) Labeled probe concentration 1 nM. DNA competitor concentration is 2500, 500, 50, 5 
and 0.5 ng/µl (n.b. the highest concentration was not used for CascadeDCse1Cse2), protein concen-
tration is 200-300 nM except in I-J where the Cascade concentration range is 200, 100, 50, 25 and 
12.5 nM.
5’-hydroxyl group and a 2’,3’-cyclic phosphate terminus. The presence of a cyclic 
phosphate terminus was confirmed by acid treatment of the crRNA, which showed 
a mass shift of 18 Da, corresponding to the hydrolysis of the 2’,3’-cyclic phosphate 
to a 2’ or 3’ phosphate (Fig. 3C). Mature crRNA is 61 nucleotides long and contains 
the 32 nucleotide spacer sequence, flanked by repeat-derived sequences on either 
end: 8 bases at the 5’ terminus (5’-handle) and 21 bases forming a hairpin with a 
tetra-nucleotide loop at the 3’ terminus (3’-handle) (Fig. 3D).
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Target DNA recognition
The observation that DNA co-pu-
rified with Cascade (Figs. 1C 
and 1D) prompted us to analyze 
the DNA binding behaviour of 
Cascade in detail. Electrophoretic 
mobility shift assays (EMSAs) 
demonstrated that Cascade was 
able to bind single-stranded 
(ss) DNA containing a sequence 
complementary to the spacer 
sequence of the crRNA (Figs. 5A, 
5C and Fig. 6). Double-stranded 
(ds) target DNA was also bound 
(Figs. 5B and 5D), without the 
need for, or enhancement by, 
additional co-factors such as 
divalent metal-ions or ATP (data 
not shown). The dissociation 
constant (KD) of Cascade for 
single- and double-stranded 
target DNA was 8 and 790 nM, 
respectively. In addition to target 
DNA, Cascade also displayed 
weak non-target DNA binding 
(Figs. 5C and 5D). Competitor 
DNA blocked Cascade from 
binding non-target DNA, and 
very high competitor concen-
trations also blocked binding 
to target DNA (Figs. 5A-D). The 
competitor had little effect on 
preformed Cascade-target DNA 
complexes, indicating a stable 
interaction between Cascade and 
complementary DNA substrates, 
while non-target interaction was 
transient (not shown). At high 
competitor concentrations the binding of target DNA by a proportion of Cascade 
lacking Cse1 was observed, as was evident from the faster migration rate of the 
CascadeDCse1-DNA complex (Figs. 5A, 5C and Fig. 6).
Figure 6 Native PAGE of Cascade-target DNA 
complexes. 
Coomassie-blue stained native PAGE analysis of Cas-
cade and sub-complexes binding ssDNA oligonucleo-
tides complementary to the R44 crRNA. The gel shows 
the increased migration rates of Cascade complexes 
loaded with uniform R44 crRNA in the presence their 
complementary target ssDNA due to the additional 
charge negative charge of the ssDNA. By contrast, the 
migration rate of Cascade loaded with different crRNAs 
derived from the E. coli K12 CRISPR I array that does 
not contain the R44 spacer is not affected. In addition, 
differences in migration rates of the various complexes 
(Cascade, CascadeDCse1 and CascadeDCse1Cse2) are 
visible.
Figure 7 Cse1 
complementa-
tion of non- 
specific DNA  
binding. 
Binding ability of 
uniform crRNA- 
loaded (R44) Cas-
cade, CascadeDCse1 
+ Cse1, Cascade 
DCse1 and Cse1 to 
non-target ssDNA is 
shown. While Cse1 
does not exhibit 
detectable non-spe-
cific DNA binding 
by itself, it is able to 
restore the non-spe-
cific DNA binding of 
CascadeDCse1.
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Figure 8 R-loop formation by Cascade. 
A) Competition assay between R44 crRNA-loaded Cascade and CascadeDCse1 for R44 ssDNA target. 
Total protein concentration is 500 nM in each reaction, and the Cascade: CascadeDCse1 ratio is 1:0, 
100:1, 10:1, 1:1, 1:10, 1:100 and 0:1. When used, DNA competitor concentration is 1 mg/µl. B) Effect of 
labelling the complementary or non-complementary strand of a long dsDNA target containing the 
R44 protospacer with 27 bp flanks. C) as B) but with a short dsDNA target encompassing only the 
R44 protospacer. B-C) Cascade concentration range is 1500, 300, 60 and 12.5 nM. D-E) Mapping of 
single stranded DNA regions in the Cascade-target DNA complex using Nuclease P1 and KMnO4. 
Probes were labelled at the 5´-end of the non-target or target strand, respectively. Sensitive regions 
are indicated by dashed lines, and the protospacer by a solid line according to the G+A sequencing 
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CascadeDCse1 and CascadeDCse1Cse2 displayed only sequence-specific binding to 
ss- and dsDNA targets, and did not bind non-target DNA (Figs. 5E-H). Consistent 
with that observation, the target DNA binding behaviour of these sub-complexes 
was not affected by the addition of competitor DNA. The addition of purified Cse1 
to CascadeDCse1 preparations restored Cascade-like non-specific DNA binding 
ability, but Cse1 alone did not display non-specific DNA binding (Fig. 7). Because the 
mobility shift caused by Cascade or CascadeDCse1 binding could be distinguished 
(Figs. 5A, 5C and Fig. 6), competition assays were performed between the two 
types of complexes. This showed that addition of target to a mix of equal amounts 
of Cascade and CascadeDCse1 resulted in substantially more target ssDNA being 
bound by Cascade; a CascadeDCse1:Cascade ratio of 25:1 was required to distribute 
the target equally between the types of complexes (Fig. 8A). This difference was more 
pronounced when dsDNA target probes were used (data not shown). Furthermore, 
less dsDNA target was shifted by CascadeDCse1 than Cascade at equivalent condi-
tions (Figs. 5D and 5F), indicating again that Cse1 enhances target DNA localization.
It appears that Cascade recognizes 32-nucleotide target sequences (referred to 
as protospacers) within dsDNA molecules by base pairing of the crRNA spacer 
sequence with the complementary DNA strand. Analysis of long dsDNA targets 
(protospacer with 27 bp flanks) showed that both strands shifted (Fig. 8B) pro- 
bably due to base pairing of the flanking regions. Only the complementary strand 
shifted when short dsDNA targets (corresponding to the protospacer) were used, 
suggesting that crRNA base pairing with the complementary strand caused 
displacement of the non-complementary strand (Fig. 8C).
Displacement of the non-complementary strand was shown by performing enzy-
matic and chemical footprint analyses specific for single-stranded DNA (299) 
using Cascade loaded with targeting (R44) and non-targeting (K12) crRNA. Endo-
nuclease P1 footprints showed that an 18-base region (G27-C44) of the non-tar-
geted strand corresponding to the first half of the protospacer was susceptible to 
cleavage after binding by Cascade (Figs. 8D and 8H). In line with this observation, 
six thymines and one adenine in the same region of the non-targeted strand were 
also sensitive to permanganate modification and subsequent piperidine cleavage 
lanes of each strand. Cascade loaded with K12 derived crRNA was used as a control. F) Exonuclease 
III mapping of accessible double stranded DNA regions upstream and downstream of the Cas-
cade-DNA-complex. The positions of the borders of the Cascade protected regions are indicated 
by dashed arrows. G) Detection of the R-loop formed between the crRNA-spacer sequence and a 
supercoiled plasmid containing the protospacer sequence. A 0.8% agarose gel is shown indicating 
the mobility of the different plasmid forms (SC: supercoiled, L: linear, OC: open circular) and the 
mobility shifts caused by R44-Cascade, and R44-crRNA binding. H) Schematic diagram of the 
R-loop formed in crRNA-guided double-stranded DNA recognition by Cascade. The crRNA is base 
paired to the complementary strand of the protospacer DNA, locally displacing the non-comple-
mentary strand. Regions sensitive to nuclease P1 and KMnO4 are indicated by hash (#) and asterisk 
(*) signs, respectively.
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(Figs. 8E, and 8H). These results suggest that only the first half of the non-targeted 
strand of the protospacer is exposed in the Cascade-DNA complex and the second 
half of the protospacer shielded. The targeted strand showed P1 sensitivity in a 
region proximal to the protospacer region (Figs. 8D and 8H), which may indicate 
a distortion in DNA conformation due to Cascade-induced strand opening further 
downstream. Permanganate assays also indicated that a single base of the targeted 
strand of the protospacer (T33) was sensitive to modification (Figs. 8E and 8H), 
suggesting that this base is unpaired in the hybrid crRNA:DNA duplex. Exonu-
clease III footprints showed that the sequences flanking the protospacer are of a 
double-stranded nature and that Cascade protects a region of approximately nine 
bases including the protospacer adjacent motif (PAM) (253) on the protospacer 
proximal flank, and approximately fourteen bases on the protospacer distal flank 
(Fig. 7F and 7H).
To demonstrate crRNA:DNA basepairing we made use of a 3 kb plasmid containing 
the target sequence. Specific binding of R44-Cascade to supercoiled plasmid 
results in a clear mobility shift of the plasmid (Fig. 8G). The retardation of the 
plasmid is partially relieved by proteolytic removal of the Cascade protein sub- 
units leaving only the crRNA bound to the target DNA (Fig. 8G). These nucleic acid 
complexes are known to produce a slight shift in gel electrophoretic mobility of the 
plasmid (400). Subsequent RNaseH treatment restores the original gel mobility of 
the plasmid, indicating that Watson-Crick basepairing occurs between the crRNA 
and one strand of the plasmid DNA (Fig. 8G). The specific binding of Cascade thus 
leads to the formation of an R-loop (Fig. 8H): a structure where the spacer-part of 
the crRNA is base paired with one DNA strand of a duplex, leaving the displaced 
strand single stranded (351).
Cascade-mediated cleavage of target DNA was not observed under the conditions 
tested. Binding to complementary ssRNA could be demonstrated (Fig. 5I), but this 
did not result in target RNA cleavage. In contrast to dsDNA, no binding to dsRNA 
was observed (Fig. 5J). In addition, very little non-specific interaction occurred 
between Cascade and ss- or dsRNA (Figs. 5I and 5J).
Subunit stoichiometry
To understand the structural basis of the interaction between Cascade and target 
DNA, the composition of the Cascade protein assembly was determined using 
an array of mass spectrometric analyses. Denaturing and tandem mass spec-
trometry analyses resulted in accurate mass measurements for each compo-
nent of Cascade (see online Supplementary Table 1 in ref. 165). The measured 
masses Cse1, Cse2 and Cas5 were in agreement with the expected values and 
the mass of Cas7 and Cas6e with the primary amino acid sequence lacking the 
N-terminal methionine. A complex composed of one copy of each Cascade 
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component (Cse11Cse21Cas71Cas51Cas6e1/crRNA1) would have a mass of 184 kDa. 
Analysis of the intact assembly by native mass spectrometry (160) showed two 
major charge state distributions, corresponding to masses of 405,365 ± 135 
Da and 349,399 ± 84 Da (Fig. 9A). A third low intensity charge state distribu-
tion around 2,200 m/z was observed with a mass of 42,524 ± 8 Da, close to the 
theoretical molecular weight of a Cse2 dimer (42,521 Da). Proteolytic removal 
of the affinity tag on Cse2 confirmed the presence of two Cse2 copies (Fig. 10A).
The two major complexes of 405 and 349 kDa likely resemble the intact Cascade 
and a Cascade sub-complex lacking Cse1, in agreement with the mass difference 
of 55,966 Da. The presence of this sub-complex suggests that at least one Cse1 
copy is located at the periphery of Cascade with a rather low affinity. Tandem mass 
spectrometry experiments on intact Cascade ions revealed that Cse1 was the first 
subunit to be expelled from the complex under collisional activation conditions, 
again indicative of a peripheral position of Cse1 within the complex (Fig. 10B). In 
addition to the elimination of Cse1, also the loss of Cas7 was observed by tandem 
mass spectrometry. Similarly, selection and activation of the 349 kDa Cascade 
Figure 9 Subunit composition of Cascade. 
A) Native nano-ESI mass spectrum of Cascade. Two charge state distributions are present at high 
m/z values, corresponding to complexes of 405 kDa (purple) and 349 kDa (pink). The charge state 
distribution indicated in red indicates the Cse2 dimer. B) Cascade (sub)complexes analyzed by 
native mass spectrometry. The sub-complexes were formed in solution after adding 5% 2-propanol 
to the buffer solution containing Cascade.
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Figure 10. Native 
mass spectra of 
Cascade
A) Native mass 
spectrum of Cas-
cade after treatment 
with HRV3C pro-
tease. A dominant 
species with a mass 
of 401,279 Da (blue 
triangle) was ob-
served, confirming 
the presence of two 
copies of Cse2 in 
the intact assembly. 
Indicated by the 
green triangles is 
the complex lacking 
Cse1. B) Tandem 
mass spectrum of 
the 42+ ion of Cas-
cade. Besides the 
dissociation of Cse1 
(green) also Cas7 
(orange) dissociated 
from the complex. 
The complex lack-
ing Cse1 further ex-
pels a Cas7 subunit 
to form a 310 kDa 
Cascade sub-com-
plex (blue). The low 
m/z region of the 
spectrum shows the 
dissociated Cse1, Cas7 and Cas5 proteins. Overlapping peaks of two different complexes are indicat-
ed by two colors. C) Native mass spectrum of Cascade bound to the ssDNA-probe. The mass of the 
complex increased by 10,201 Da, indicating the presence of one crRNA per Cascade. The inset shows 
the same spectrum after energetically activating the Cascade-ssDNA probe complex. The charge 
state distribution for the ssDNA probe is centered around 2,000 m/z.
sub-complex showed the loss of one Cas5 and up to two Cas7 subunits. Unfor-
tunately, Cascade could not be further disrupted by tandem mass spectrometry, 
hampering the full assignment of its stoichiometry. Therefore a number of alterna-
tive strategies were devised.
Since Cascade was loaded with a single type of crRNA (R44 crRNA), the number of 
bound crRNA molecules could be determined by adding a complementary ssDNA 
probe. The total molecular weight of Cascade increased by the mass of a single 
ssDNA-probe, indicating the presence of one accessible crRNA (Fig. 10C).
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For further characterization we used a combined approach of in solution and 
in gas-phase dissociation of Cascade (220; 416). By adding a low percentage of 
2-propanol, Cascade was partially disrupted, resulting in a variety of Cascade 
sub-complexes (Fig. 9B, and see online Supplementary Table 2 in ref. 165). In addi-
tion to the intact Cascade (405 kDa), we also detected Cascade lacking Cse1 (349 
kDa), and seven additional sub-complexes, the largest of which is a 307 kDa species. 
The difference between the 349 kDa and 307 kDa sub-complexes is 42,442 Da and 
likely reflects the loss of the Cse2 dimer, which was previously observed (Fig. 9A).
The apparent consecutive loss of five times a mass of around 40 kDa (from 307 kDa 
down to 107 kDa) is directly evident from this catalogue of sub-complexes (Fig. 
9B). This implies that at least five Cas7 subunits are present in intact Cascade. This 
hypothesis was confirmed by subjecting each of these sub-complexes to tandem 
mass spectrometry (online Supplementary Table 2 in ref. 165). In addition to 
Cas5, Cas6e and one crRNA molecule, this analysis revealed the presence of even 
a sixth Cas7 subunit in the 107 kDa sub-complex (Fig. 9B). Combining all mass 
spectrometry data resulted in a Cascade stoichiometry of Cse11Cse22Cas76Cas51- 
Cas6e1/crRNA1. The theoretical mass of this complex is in excellent agreement with the 
experimental mass (405,095 Da versus 405,365 ± 135 Da), band intensities on protein 
gels (Fig. 1B), and elution profiles on a calibrated size exclusion column (Fig. 1E). 
Similar analyses of the purified sub-complexes revealed masses and compositions 
consistent with Cascade: 349 kDa for Cse22Cas76Cas51Cas6e1/crRNA1 and 324 kDa 
for Cas76Cas51Cas6e1/crRNA1 (data not shown). The constituency of the complexes 
and the elimination of specific subunits in solution and under tandem mass spec-
trometry conditions reinforced the assignments of subunits in the structural model 
presented below.
Structure of Cascade
Insights into the structural organization of Cascade were obtained by single 
particle electron microscopy (EM) and small angle X-ray scattering (SAXS). The 
Cascade complex is an elongated particle with no discernible symmetry, and with 
no apparent structural resemblance to known protein complexes. The particle has 
approximate dimensions of 10 x 20 nm, and resembles a seahorse with a curled-up 
tail (Figs. 11A-C, S). The particle displays a striking indentation on one side which 
gives rise to the head and neck features of the seahorse. While only three very similar 
types of projection maps were obtained for Cascade (Figs. 11A-C), a total of six more 
diverse groups of projections were observed for Cascade with target ssDNA bound 
(Figs. 11D-I). The apparent loss of adsorption orientation bias upon target DNA 
binding could be due to altered surface properties of the complex resulting from 
DNA binding or reflect some conformational heterogeneity. Some projections, 
however, showed clear similarity to Cascade projections in the DNA-free form 
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(e.g. Fig. 11F and 11A), allowing for the comparison between the DNA-bound and 
DNA-free states of Cascade. Difference map analysis reveals relatively small changes 
Figure 11 Electron  
Microscopic structure of 
Cascade. 
A-C, S) Three Cascade projec-
tions showing an elongated, 
seahorse-shaped particle with 
20 x 10 nm dimensions. A typ-
ical indentation that contrib-
utes to the head feature of the 
seahorse is indicated with a 
hash (#) sign. D-I) Six Cascade projections bound to target ssDNA. The arrow indicates an antici-
pated rotation along the vertical axis. The six regularly arranged Cas7 subunits are indica- 
ted with an asterisk (*) sign. J-L) Difference map indicating the morphological changes in mainly 
the head and back areas of Cascade resulting from target DNA binding (L). The difference map 
was generated from Cascade (J) and Cascade with target ssDNA bound (K). M-O) Difference map 
showing the location of the Cse1 subunit (O). The difference map was generated from Cascade (M) 
and CascadeDCse1 (N) projection maps with target ssDNA bound. P-R) Difference map showing 
the location of the Cse2 subunits (R). The difference map was generated from CascadeDCse1 (P) and 
CascadeDCse1Cse2 (Q). S) Enlargement of A) defining the seahorse-like morphological features 
of Cascade. The number of particle projections to create the average shown is depicted on the 
bottom-right corner of each image. The section (§) sign indicates that the depicted particle is a mir-
rored view of the original to match the predominant orientation of the Cascade projection shown 
in panel A. Raw electron micrographs and an overview of the particle analysis method is given in 
Supplementary Fig. 7 and 8 of ref. 191, respectively. The scale bar equals 10 nm. T) Structural model 
of Cascade. The position of Cas5, Cas6e and the crRNA could not be assigned with confidence.
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Figure 12 Interactions be-
tween individual Cascade 
subunits. 
Composite of Coomassie blue-
stained SDS-polyacryl- 
amide gels and Western blots 
of affinity purified tagged 
Cascade subunits (underlined) 
co-expressed with untagged 
Cascade subunits and pre- 
crRNA. All subunits co-purify 
with Cas7 except Cse1, which 
does copurify with Cas6e. 
Western blots were probed 
with anti-Cascade antibodies.  
Note that the N-terminal 
Strep-tagged Cascade subunits 
migrate slower through the gel 
than the untagged proteins.
throughout the Cascade particle, and more pronounced changes occurring in the 
head and back of the seahorse-shaped morphology of Cascade comprising Cse2 
and Cas7 subunits (as described below, Figs. 11J-L). The observed change suggests 
that Cascade undergoes conformational changes upon target DNA binding.
Structural model
Given the availability of stable sub-complexes of Cascade and knowing their 
subunit compositions allowed for the investigation of subunit localization within 
the Cascade structure. Some of the projections of Cascade with target ssDNA show a 
regularly shaped and evenly spaced feature with sharp edges that spans the torso 
of the complex (Fig. 11I). This repeated feature traverses the spine of this struc-
ture and is consistent with the six copies of Cas7 that are present in the complex 
and comprise the backbone of Cascade. The position of the target DNA recogni-
tion-enhancing subunit Cse1 was determined from difference maps between target 
DNA-bound forms of Cascade and one of three classes of the CascadeDCse1 particle 
(Figs. 11M-O). The analysis revealed that Cse1 is located in the curled-up tail of 
the seahorse (Fig. 11O). The position of Cse2 was identified using difference maps 
between of CascadeDCse1 and CascadeDCse1Cse2 complexes (Figs. 11P-R). Both 
of these subcomplexes yielded only one particle class average with strong resem-
blance to each other. Apart from the six better resolved Cas7 subunits in these 
projections of CascadeDCse1 and CascadeDCse1Cse2 (Figs. 11P and 11Q), the diffe- 
rence map showed one region compatible with two Cse2 copies (Fig. 11R), consistent 
with the Cse2 homodimer observed with mass spectrometry (Fig. 9A). The Cse2 
dimer is contributing the nose to the seahorse-shaped morphology of Cascade 
(Figs. 11R and 11S). 
In addition to the position of some of the subunits in 
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Figure 13 Solution scattering model of Cascade obtained with Small-Angle X-ray 
Scattering. 
Scattering data for Cascade were collected at 10 keV (λ = 1.24 Å) from two protein concentrations, 
and include scattering vectors (q), ranging from A) 0.015 Å -1 to 0.127 Å -1 for Cascade and  
B) 0.015 Å -1 to 0.133 Å -1 for Cascade bound to target DNA. Guinier approximations of each curve 
estimates the radius of gyration (R(g)) for Cascade and for Cascade bound to target DNA at 5.6 nm. 
The pair-distribution function (insert) indicates that the radius of gyration for both particles is ~5.6 
nm. C) Ab initio reconstructions of Cascade reveal a seahorse shaped complex, consistent with EM 
imaging. D) DNA binding induces a conformational change in Cascade. E) Superposition of the 
solution structures of Cascade without (yellow) and with target DNA (mesh). Images have been 
rendered using Chimera.
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the Cascade structure, we also investigated the topological constraints of Cascade. 
Protein pulldown experiments between Cas7 and one of the remaining Cascade 
components showed that Cse2, Cas5 and Cas6e form stable two-component 
complexes with Cas7, whereas Cse1 does not copurify with Cas7 (Fig. 12). Pulldown 
assays suggest that the association of this subunit with the Cas7 backbone may 
either be relatively weak, or may be mediated by Cas6e (Fig. 12).
The combined observations result in a structural model in which the position of 
Cse1, Cse2 and Cas7 can be assigned with confidence, contributing the curled-up 
tail, nose and torso of the seahorse, respectively (Fig. 11T). The model predicts that 
Cas5, Cas6e and at least part of the crRNA are located in the main body of Cascade 
at the tail-end of the Cas7 spine, in the proximity of Cse1. Alternatively, the crRNA 
could also be bound along the spine of the Cas7 backbone and in this way define 
the rather unusual number and arrangement of Cas7 subunits by the length of the 
crRNA.
Solution structure
Ab initio small-angle x-ray scattering (SAXS)-based reconstruction of Cascade and 
Cascade bound to target DNA result in models (Fig. 13) that have a shape and size 
similar to the particle observed by EM (Fig. 11). The SAXS model of Cascade reveals 
an asymmetric seahorse-shaped particle with a relatively narrow head compared 
to its main body. Upon target DNA binding the volume of Cascade increases from 
1024 to 1235 nm3 and the morphology of the particle changes into a shape with 
fewer prominent features. The changes include the loss of the indentation on one 
side which gives rise to the nose, head and neck features of the seahorse (Fig. 13C 
and 13D). These structural changes in Cascade involve regions of the complex 
assigned to Cse2 and Cas7 subunits. In addition to the loss of the nose-shape 
feature consisting of Cse2, which is prominent in a DNA-free complex (Fig 11A and 
Fig. 13C) indistinguishable in the DNA-bound state, the Cse1 tail appears to be 
more extended in the DNA-bound form. Although both EM and SAXS reveal that 
Cascade undergoes a conformational change upon target DNA binding, the degree 
of the observed conformational change appears to be different, possibly due to in 
solution versus adsorbed particle effects. It should be mentioned that the changes 
in the shape of Cascade are not a consequence of DNA-induced changes to the 
subunit stoichiometry of the complex (Fig. 10C), but are indicative of a ligand-in-
duced conformational change.
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disCussion 
Composition of Cascade
Cascade is a ribonucleoprotein complex in E. coli that plays a central role in 
CRISPR-based defense against mobile genetic elements, such as phages and conju-
gative plasmids. Despite its central role, very little is known about how the host 
counterattack is accomplished. Cascade has a mass of 405 kDa and consists of five 
proteins (Cse1, Cse2, Cas7, Cas5 and Cas6e) and one guide RNA (49). The core 
of the protein complex consists of six Cas7 (previously known as CasC) subunits, 
presumably to provide a structural backbone for the other subunits and the crRNA. 
Given the presence of Cas7-homologs (COG1857) in the majority of Cas subtypes 
(230), these proteins could be components of Cascade-like protein complexes from 
other microbes. The next most frequently found subunit of the complex is Cas5 
(previously known as CasD), which belongs to the RAMP protein class (Repeat- 
Associated Mysterious Proteins). This protein co-occurs with Cas7-homologs in 
five subtypes (230). Cas5 is present in a single copy in Cascade and together with six 
Cas7 subunits and one Cas6e (previously known as CasE) subunit part of a minimal 
Cascade core that accommodates a single mature crRNA. This minimal core is 
expanded by a dimer of Cse2 (previously known as CasB), a positively charged 
protein (pI 9.2). A crystal structure of the Cse2 from Thermus thermophilus HB8 
shows a strictly α-helical protein with a conserved basic surface patch that suggests 
a role in nucleic acid interactions (4). Cascade is completed by one copy of Cse1 
(previously known as CasA), the largest and most loosely attached subunit of the 
five. Gene synteny analysis of the various Cas gene clusters shows that Cse1 and 
Cse2 only occur in the I-E-subtype (366).
The crRNA is remarkably stable when bound by Cascade or the CascadeDCse1 and 
CascadeDCse1Cse2 sub-complexes, indicating that it is tightly associated with the 
CascadeDCse1Cse2 core of the protein complex and well shielded from cellular 
ribonuclease activities. Yet it is sufficiently exposed to allow for base pairing 
with complementary nucleic acids. Interestingly, the length of the 5’ handle is 
conserved among crRNAs from E. coli, S. epidermidis and P. furiosus (49; 60; 235), 
suggesting a general mechanism of binding. A recent study in S. epidermidis (Type 
III-A) showed that differential complementarity of the 5’-handle of the crRNA with 
the downstream protospacer flank allows discrimination between self DNA (the 
CRISPR) and non-self DNA (the target) (237). While non-complementarity of the 
5’-handle results in a sequence that is targeted, base pairing of at least nucleotide 
5, 6 and 7 of the 5’-handle provides self protection (237). In other CRISPR-Cas 
systems the regions flanking the protospacer (i.e. opposite of the 5’ or 3’-handle 
of the crRNA) often harbour short sequence motifs that are known as CRISPR 
motifs (93; 174) or protospacer adjacent motifs (PAM) (253). The relevance of these 
short nucleotide sequences was originally shown in S. thermophilus by sequencing 
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phages that had overcome host immunity by mutating a single nucleotide of the 
motif (93). The crRNA is further characterized by the presence of a 5’-hydroxyl 
group, as was observed for Cas6e-generated crRNA (60). Eukaryotic small inter-
fering RNA (siRNA) and microRNA (miRNA) by contrast need to be 5’-phospho-
rylated in order to bind to Argonaute and serve as a guide for the RNA-induced 
silencing complex (RISC) (224). E. coli crRNAs are unmodified, unlike plant siRNAs 
and miRNAs as well as vertebrate piwi-interacting RNAs for example, which are 
methylated at the 2’-hydroxyl group of the 3’-terminal ribonucleotide to prevent 
uridylation and associated destabilization (176; 212). The cyclic 2’,3’-phosphate of 
crRNA results from a metal ion-independent endonuclease activity on the 3’-side of 
the phosphodiester bond of pre-crRNA, as suggested previously (60). These initial 
pre-crRNA endonuclease cleavage products are the mature form of the crRNA in E. 
coli, in contrast to crRNAs from P. furiosus, S. solfataricus and S. epidermidis which 
are trimmed at the 3’-end (151; 214; 237). It is worth mentioning that the cyclic 
phosphate 3’-end is not a substrate for E. coli poly(A) RNA polymerase (408), and 
this explains why only shorter, apparently partly degraded crRNAs were cloned and 
sequenced previously (49).
Target DNA recognition by R-loop formation
Multiple lines of evidence suggest that crRNAs directly target invader DNA in the 
E. coli (I-E), S. epidermidis (III-A) and likely also S. thermophilus (II-A) model 
systems (28; 49; 235). However, biochemical evidence of Cas-protein complexes 
recognizing their target DNA has been lacking, limiting our understanding of how 
specificity of the CRISPR immune system is accomplished. Compositional analysis 
indicates that each Cascade molecule contains one crRNA molecule, programming 
the protein complex to locate a single invader DNA sequence. Binding studies 
showed that Cascade enables stable crRNA basepairing with the complementary 
strand of double stranded protospacer DNA without supplemented co-factors 
such as ATP. This surprising characteristic of Cascade is physiologically impor-
tant, since most cellular and invader DNA is of double-stranded nature. The ATP- 
independence of this scanning process is in line with the absence of homology 
between the Cascade subunits and classical ATP-consuming helicases (322). It 
allows cells to continuously scan nucleic acids for crRNA matches without major 
energy investments, contributing to the efficiency of the CRISPR-Cas system. 
Given the conservation of the Cas7 and Cas5 core among the several CRISPR-Cas 
systems, ATP-independent recognition of target DNA may be an inherent feature 
of CRISPR-Cas systems targeting DNA. In addition to sequence-specific DNA 
recognition, Cascade also interacts non-specifically with DNA. Cascade sub-com-
plexes lacking Cse1, however, display only sequence-specific DNA recognition. 
Direct competition assays between Cascade and CascadeDCse1Cse2 demonstrate 
the superiority of Cascade in locating the single- and double-stranded protospacer 
DNA, suggesting a role for Cse1 as an enhancer. Cascade thus appears to interact 
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with DNA in two different modes, initially non-specifically via Cse1, and in a second 
stage sequence-specifically via Watson-Crick base pairing of the crRNA. The 
sequence-specific mode gives rise to the formation of an R-loop (351): a structure 
that is known to prime replication of bacterial plasmids (183), bacterial chromo-
somes (26) and mitochondrial DNA (209). Moreover, R-loop formation has been 
associated with recombination events at immunoglobulin class switch sequences 
(407). A sliding eight basepair R-loop occurs in elongating RNA polymerase 
complexes during transcription (132). We propose that the formation of such an 
R-loop by Cascade marks the DNA for subsequent interference processes catalyzed 
by other Cas proteins, such as Cas3. The non-specific affinity of Cascade for DNA 
may enable the scanning process which allows Cascade to associate fast enough 
with incoming foreign DNA to neutralize a rapidly proliferating phage or conjuga-
tive plasmid in a cell. Further analysis showed that although Cascade exhibits little 
non-specific affinity for RNA, it binds complementary ssRNA as well. Base pairing 
of the crRNA with mRNA occurs when the coding strand of an invading nucleic 
acid is targeted. This could titrate out unpaired Cascade-bound crRNAs, reducing 
the effectiveness of the immune response when the coding strand is targeted (49). 
Cascade does not recognize a protospacer within a dsRNA molecule, indicating 
that the ability to locate protospacers in a nucleic acid duplex is restricted to 
dsDNA. Recently, a distinct Cas protein complex of the Type III-B (Cmr) subtype 
from P. furiosus was shown to cleave ssRNA complementary to the bound guide 
RNA (151), akin to RISC in eukaryotes. Target RNA hydrolysis takes place 14 bases 
from the 3’-end of the guide RNA, suggesting that target RNA cleavage occurs by 
a ruler mechanism. The difference in target nucleic acid – RNA or DNA - between 
Type III-B and Type I-E subtypes may illustrate the remarkable diversity present 
among CRISPR-Cas systems.
Structural basis for target DNA recognition
Cascade displays an unusual seahorse-shaped architecture. The backbone of this 
structure is composed of six Cas7 subunits that are arranged in an arch, representing 
the torso of the Cascade particle. Cas7 only assembles into this stable hexameric 
arrangement in the presence of Cas5, Cas6e and crRNA. Although the location 
of these latter three components in the structure could not be determined by 
direct methods, mass spectrometry showed the existence of a 107 kDa 2-propanol- 
induced sub-complex containing single copies of Cas7, Cas5, Cas6e and crRNA 
(Fig. 9B). This subassembly of Cascade implies that these four components are 
in close proximity of each other, or that they remain associated by stable binding 
to the crRNA. Further disassembly of Cascade reveals a Cas6e-crRNA particle, 
suggesting that Cas6e holds on tightly to the crRNA after pre-crRNA cleavage. 
Despite the fact that the location of the crRNA remains unclear, we expect that the 
61 nucleotide molecule is bound by a substantial part of Cascade. The length of the 
32 nucleotide spacer sequence base paired to its target ssDNA is approximately 8.2 
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nm. Together with the 5’ and 3’ handles, the crRNA could be up to 10 nm in length. 
In an unpaired state, the crRNA likely experiences some conformational flexibility, 
whereas in a DNA base-paired state, the conformation of the spacer sequence is 
constrained by the formation of the RNA:DNA hybrid helix, which in contrast 
to the B-type dsDNA helix is close to A-type (276). This constraint might induce 
the conformational change observed in the EM and SAXS structures of Cascade, 
and may trigger recruitment of Cas3. This large Cas protein is required for inter- 
ference, but is not a constituent of Cascade (49). It is tempting to speculate that 
the HD-nuclease domain of Cas3, which has been reported to carry out DNase 
activity on single and double-stranded DNA molecules in Sulfolobus solfataricus 
(154), cleaves the invading DNA interacting with Cascade.
In conclusion, Cascade is a widespread and highly unusual ribonucleoprotein 
complex capable of sequence specific recognition of double stranded invader DNA 
archived in the CRISPR blacklist. The direct attack on invader DNA rather than its 
derived RNA transcripts may be the reason that allows prokaryotes to neutralize 
invasive selfish DNA elements effectively.
exPerimenTal ProCedures
Protein production and purification
Cascade complexes were produced and purified as described previously (49), 
using the expression plasmids listed in the online Supplementary Table 3 
of ref. 165. Cascade was routinely purified with an N-terminal Strep-tag 
II fused to Cse2 (or Cas7 in CascadeDCse1Cse2). Size exclusion chromato 
graphy (Superdex 200 HR 10/30 (GE)) was performed using 20 mM Tris-HCl 
(pH 8.0), 0.1 M NaCl, 1 mM dithiotreitol. Cascade preparations (~0.3 mg) were 
incubated with DNase I (Invitrogen) in the presence of 2.5 mM MgCl2 for 15 
min at 37 °C prior to size exclusion analysis. Co-purified nucleic acids were 
isolated by extraction using an equal volume of phenol:chloroform:isoamyl 
alcohol (25:24:1) pH 8.0 (Fluka), and incubated with either DNase I (Invitrogen) 
supplemented with 2.5 mM MgCl2 or RNase A (Fermentas) for 10 min at 37°C.
Lambda phage infection
Plaque assays were performed using bacteriophage Lambda and the efficiency of 
plaquing (EOP) was calculated as described previously (49).
HPLC purification of crRNA
All samples were analyzed by ion-pair reversed-phased-HPLC on an Agilent 1100 
HPLC with UV260 nm detector (Agilent) using a DNAsep column 50 mm × 4.6 mm 
I. D. (Transgenomic, San Jose, CA). The chromatographic analysis was performed 
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using the following buffer conditions: A) 0.1 M triethylammonium acetate (TEAA) 
(pH 7.0) (Fluka); B) buffer A with 25% LC MS grade acetonitrile (v/v) (Fisher). 
The crRNA was obtained by injecting purified intact Cascade at 75°C using a linear 
gradient starting at 15% buffer B and extending to 60% B in 12.5 min, followed by a 
linear extension to 100% B over 2 min at a flow rate of 1.0 ml/min. Hydrolysis of the 
cyclic phosphate terminus was performed by incubating the HPLC-purified crRNA 
in a final concentration of 0.1 M HCl at 4°C for 1 hour. The samples were concen-
trated to 5-10 µl on a vacuum concentrator (Eppendorf) prior to ESI-MS analysis.
ESI-MS analysis of crRNA
Electrospray Ionization Mass spectrometry was performed in negative mode 
using an UHR-TOF mass spectrometer (maXis) or an HCT Ultra PTM Discovery 
instrument (both Bruker Daltonics), coupled to an online capillary liquid chroma- 
tography system (Ultimate 3000, Dionex, UK). RNA separations were performed 
using a monolithic (PS-DVB) capillary column (200 mm x 50 mm I.D., Dionex, UK). 
The chromatography was performed using the following buffer conditions: C) 0.4 
M 1,1,1,3,3,3,-Hexafluoro-2-propanol (HFIP, Sigma-Aldrich) adjusted with triethyl-
amine (TEA) to pH 7.0 and 0.1 mM TEAA, and D) buffer C with 50% methanol 
(v/v) (Fisher). RNA analysis was performed at 50°C with 20% buffer D, extending 
to 40% D in 5 min followed by a linear extension to 60% D over 8 min at a flow rate 
of 2 ml/min.
Protein and Native Mass spectrometry
Cascade was analyzed in 0.15 M ammonium acetate (pH 8.0) at a protein concen-
tration of 5 mM. This protein preparation was obtained by five sequential concen-
tration and dilution steps at 4°C using a centrifugal filter with a cut-off of 10 kDa 
(Millipore). Proteins were sprayed from borosilicate glass capillaries and analyzed 
on a LCT electrospray time-of-flight or modified quadrupole time-of-flight instru-
ments (both Waters, UK) adjusted for optimal performance in high mass detec-
tion (344; 365). Exact mass measurements of the individual Cas proteins were 
acquired under denaturing conditions (50% acetonitrile, 50% MQ, 0.1% formic 
acid). Sub-complexes in solution were generated by the addition of 2-propanol to 
the spray solution to a final concentration of 5% (v/v). Instrument settings were as 
follows; needle voltage ~1.2 kV, cone voltage ~175 V, source pressure 9 mbar. Xenon 
was used as the collision gas for tandem mass spectrometric analysis at a pressure 
of 1.5 10-2 mbar. The collision voltage varied between 10-200 V.
Electrophoretic mobility shift assays (EMSA)
EMSA was performed by incubating Cascade, CascadeDCse1 or CascadeDCse1Cse2 
with 1 nM labelled nucleic acid in 50 mM Tris-Cl pH 7.5, 100 mM NaCl. Salmon 
sperm DNA (Invitrogen) was used as competitor. The EMSA reactions were incu-
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bated at 37 °C for 20-30 min prior to electrophoresis on 5% polyacrylamide gels. 
The gels were dried and analyzed using phosphor storage screens and a PMI phos-
phor imager (Bio-Rad). Target DNA binding and cleavage activity of Cascade was 
tested in the presence of 1-10 mM Ca, Mg or Mn-ions.
DNA targets were gel-purified long oligonucleotides (Isogen Life Sciences or 
Biolegio), listed in Supplementary Table 3. The oligonucleotides were end-labeled 
using g32P-ATP (PerkinElmer) and T4 kinase (Fermentas). Double-stranded DNA 
targets were prepared by annealing complementary oligonucleotides and digesting 
remaining ssDNA with Exonuclease I (Fermentas). Labelled RNA targets were in 
vitro transcribed using T7 Maxiscript or T7 Mega Shortscript kits (Ambion) with 
a32P-CTP (PerkinElmer) and removing template by DNase I (Fermentas) diges-
tion. Double stranded RNA targets were prepared by annealing complementary 
RNAs and digesting surplus ssRNA with RNase T1 (Fermentas), followed by phenol 
extraction.
Plasmid mobility shift assays were performed using plasmid pWUR613 containing 
the R44 protospacer. The fragment containing the protospacer was PCR-amplified 
from bacteriophage P7 genomic DNA using primers BG3297 and BG 3298 (Supple-
mentary Table 3). Plasmid (0.4 mg) and Cascade were mixed in a 1:10 molar ratio 
in a buffer containing 5 mM Tris-HCl (pH 7.5) and 20 mM NaCl and incubated at 
37°C for 30 minutes. Cascade proteins were then removed by proteinase K treat-
ment (Fluka) (0.15 U, 15 min, 37°C) followed by phenol/chloroform extraction. 
RNA-DNA complexes were then treated with RNaseH (Promega) (2 U, 1 h, 37°C).
Chemical and enzymatic probing analyses
Chemical and enzymatic probing assays were performed using dsDNA probes 
prepared by annealing of the complementary oligonucleotides BG3009 and BG3010 
(Supplementary Table 3). 2.5 pmol of 5´-end labelled oligonucleotide was annealed 
to 6 pmol of its unlabeled complementary oligonucleotide to ensure saturation of 
the labelled oligonucleotide.
Chemical probing with KMnO4 was performed by incubating 0.01 nM DNA with 
3 mM R44-Cascade or K12-Cascade in 50 mM Tris-Cl pH 7.5, 100 mM NaCl in a 
total volume of 30 ml, followed by incubation at 30°C for 30 min. The samples were 
diluted by adding equal amounts of Aqua dest prior to addition of 4 ml of 160 mM 
KMnO4. Permanganate modification was allowed for 2 min at 30°C. The reaction 
was stopped by the addition of 4.8 ml b-mercaptoethanol and 5.3 ml 0.5 M EDTA, 
followed by phenol/chloroform extraction and precipitation with ethanol. The 
pellets were dissolved in 50 ml of 10 % piperidine and incubated at 90°C for 30 
min. After lyophylization the pellets were washed twice with 30 µl Aqua dest and 
lyophylized. Finally, the pellets were dissolved in 50 ml of 0.3 M Na-Acetate and 
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precipitated with ethanol. The cleavage products were separated on a denaturing 
10% polyacrylamide gel together with G/A-sequencing of oligonucleotides (242) 
and visualized by autoradiography.
For probing with P1 nuclease (Sigma) 30 ml of the Cascade-DNA complexes was 
diluted by addition of 30 ml 60 mM Na-Acetate, pH 5.3, followed by incubation 
with 0.09 units of P1 nuclease at 37°C for 30 min. After phenol/chloroform extrac-
tion and precipitation with ethanol, the cleavage products were separated on a 
10% denaturing gel and visualized by autoradiography. For ExoIII footprinting of 
Cascade-bound DNA complexes the binding reactions were diluted with equal 
amounts Aqua dest and incubated with 60 U of ExoIII (Promega) at 37°C for 20 
min. The cleavage reactions were stopped by addition of EDTA to a final concentra-
tion of 20 mM, followed by phenol/chloroform extraction and precipitation with 
ethanol.
Electron microscopy
Purified protein samples were negatively stained with 2% uranyl acetate on 
glow-discharged carbon-coated copper grids. R44 target ssDNA (BG3028, Online 
Supplementary Table 3 of ref. 191) was added to Cascade sub-complexes loaded with 
R44 crRNA in a two-fold excess at least 5 min prior to sample preparation. Electron 
microscopy was performed on a Philips CM120 equipped with a LaB6 tip operating 
at 120 kV. Images were recorded with a Gatan 4000 SP 4K slow-scan CCD camera at 
130,000× magnification at a pixel size (after binning the images) of 0.23 nm at the 
specimen level with GRACE software for semi-automated specimen selection and 
data acquisition (278). Single particle projections were selected from micrographs 
mainly by reference-based automated particle selection procedure incorporated 
into GRIP (GRoningen Image Processing) software (369). Approximately 400,000 
single particles were selected and extracted from 17,000 electron micrographs. 
Single particle data sets were analyzed with the GRIP software using multi-refer-
ence alignments and no-reference alignments, multivariate statistical analysis, and 
hierarchical ascendant classification. The final two-dimensional projection maps 
were calculated from the best resolved classes by summing the best 5–20% of the 
projections based on the correlation coefficient determined in the alignment step.
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absTraCT 
The prokaryotic CRISPR-Cas immune system is based on genomic loci that contain incorporated sequence tags from viruses and plasmids. Using small guide RNA molecules, these sequences act as a memory to reject 
returning invaders. Both the Cascade ribonucleoprotein complex and the Cas3 
nuclease/helicase are required for CRISPR-interference in Escherichia coli, but it 
is unknown how natural target DNA molecules are recognized and neutralized 
by their combined action. Here we show that Cascade efficiently locates target 
sequences in negatively supercoiled DNA, but only if these are flanked by a Proto-
spacer Adjacent Motif (PAM). PAM recognition by Cascade exclusively involves the 
crRNA-complementary DNA strand. After Cascade-mediated R-loop formation, 
the Cse1 subunit recruits Cas3, which catalyzes nicking of target DNA through its 
HD-nuclease domain. The target is then progressively unwound and cleaved by the 
joint ATP-dependent helicase activity and Mg2+-dependent HD-nuclease activity 
of Cas3, leading to complete target DNA degradation and invader neutralization.
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inTroduCTion
Bacteria and archaea have a variety of defense systems against invasive DNA elements (reviewed by (202)). CRISPR-Cas defense systems provide adaptive immunity by integrating plasmid and viral DNA fragments in loci 
of clustered regularly interspaced short palindromic repeats (CRISPR) on the host 
chromosome (28). The viral- and plasmid-derived sequences, known as spacers, 
are separated by short host-derived repeat sequences. A re-evaluation of the 
diversity of CRISPR-Cas systems has resulted in a classification into three distinct 
types that vary in CRISPR-associated (cas) gene content, and display major differ-
ences throughout the CRISPR defense pathway (231). RNA transcripts of CRISPR 
loci (pre-crRNA) are cleaved specifically in the repeat sequences by Cas endoribo-
nucleases in Type I and Type III systems (49; 60; 157; 296) or by RNase III in Type 
II systems (90). The generated crRNAs are bound by a Cas protein complex and 
utilized as guides to detect complementary DNA or RNA sequences (49; 151; 191; 215; 
394). Cleavage of target nucleic acids has been demonstrated in vitro and in vivo for 
the Pyrococcus furiosus Type III-B system (150; 151; 413), in vitro for the Sulfolobus 
solfataricus Type III-B system (Zhang et al., 2012) and in vivo for the Streptococcus 
thermophilus Type II system (124). For Type I systems the mechanism of invader 
rejection is anticipated to involve DNA cleavage, but, in contrast to Type II and 
Type III systems, direct evidence for sequence specific recognition and degradation 
of invader nucleic acids is still lacking.
Escherichia coli strain K12 encodes a CRISPR-Cas Type I-E system containing eight 
cas genes (cas1, cas2, cas3 and cse1, cse2, cas7, cas5, cas6e) and a downstream 
CRISPR locus with type-2 repeats (201). Five proteins, Cse1, Cse2, Cas7, Cas5 and 
Cas6e (previously referred to as CasA, CasB, CasC, CasD and CasE, respectively) 
form a ribonucleoprotein complex named Cascade (CRISPR associated complex 
for anti-viral defense) (49). After cleavage of the pre-crRNA by Cas6e, the mature 61 
nt crRNA is retained by the complex (49; 191). The crRNA guides sequence specific 
binding of Cascade to double stranded (ds) DNA molecules through base pairing 
between the crRNA spacer and the complementary protospacer (191), forming an 
R-loop. Although target DNA recognition by Cascade involves strand separation, 
this process is ATP-independent (191).
Phage resistance in Type I-E systems not only requires Cascade, but also Cas3 
(49). Cas3 has an N-terminal HD-nuclease domain and a C-terminal Super-
family 2 (SF2; DExD/H) helicase domain (230). Recently, structural and biochem-
ical analyses of the Type I-E Cas3 HD-domain from Thermus thermophilus HB8 
(TthCas3HDdom) have revealed manganese or nickel-dependent endonuclease 
activity on ssDNA (260). The Type I-A Methanocaldococcus jannaschii Cas3 
HD-domain (MjaCas3’’) has magnesium-dependent endo- and 3’-5’ exonuclease 
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activity on ssDNA and ssRNA, which is stimulated by the M. jannaschii Cas3 heli-
case domain (MjaCas3’) in the presence of ATP (33). Likewise, the Type I-E HD- 
domain of S. thermophilus Cas3 (SthCas3) displays magnesium-dependent endo-
nuclease activity on ssDNA, while its DExD/H-box helicase domain has ATP- and 
magnesium-dependent DNA/DNA and DNA/RNA unwinding activity in the 3’ to 
5’ direction (323). In addition, Cas3 from E. coli was recently reported to unwind 
DNA/RNA heteroduplexes (177). Based on these biochemical activities it has been 
speculated that the Cas3 HD-domain may play a role in target DNA cleavage (191; 
323), and that the helicase domain may be involved in either protospacer scan-
ning or Cascade recycling (323). However, the mechanism of CRISPR-interference 
through the combined action of Cascade and Cas3 has yet to be demonstrated.
Here we show that Cas3-independent target DNA recognition by Cascade marks 
DNA for cleavage and ATP-dependent degradation by Cas3. DNA binding by 
Cascade is constrained by strict topological requirements of the target DNA. 
Furthermore, efficient target binding requires that the target sequence is flanked 
by a Protospacer Adjacent Motif (PAM), with PAM recognition taking place exclu-
sively in the targeted strand of the DNA. Upon binding a protospacer sequence, 
Cascade recruits Cas3, allowing Cas3 to degrade the target DNA.
resulTs
Cascade exclusively binds negatively supercoiled target DNA
Recently, the Cascade complex of E. coli K12 was reported to bind unnatural, short 
dsDNA molecules of 65 or 86 bp sequence-specifically by R-loop formation (191; 
315). It has remained unclear, however, whether Cascade is sufficient to recognize 
natural dsDNA targets with relevant topologies, or if it requires Cas3 helicase 
activity to accomplish this.
The 3 kb pUC19-derived plasmid used in this study, denoted pUC-l, contains a 350 
bp DNA fragment corresponding to part of the J gene of phage l, which is targeted 
by J3-Cascade (Cascade loaded with crRNA containing spacer J3 (391)). Using elec-
trophoretic mobility shift assays we could show that Cascade has high affinity for a 
nSC target plasmid. At a molar ratio of pUC-l to J3-Cascade of 1:8 all nSC plasmid 
containing a CAT PAM was bound by Cascade (Fig. 1A), while a plasmid carrying an 
escape mutation in the PAM (CGT) (315) was fully bound only at a molar ratio of 1:64 
(Fig. 1B). Cascade carrying the non-targeting crRNA R44 (R44-Cascade) displayed 
nonspecific binding at a molar ratio of 1:128 (Fig. 1C). The dissociation constant 
(KD) of nSC pUC-l was determined to be 13 ± 1.4 nM for J3-Cascade (Fig. 2A), 
 while the KD of nSC pUC-l with the mutated CGT PAM was 55 ± 12 nM (Fig. 2B). 
The KD of nonspecific pUC-l binding was determined to be 429  ± 152 nM for 
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Figure 1 Cascade only binds nSC plasmid DNA with high affinity. 
A) Gel-shift of nSC plasmid DNA with J3-Cascade, containing a targeting (J3) crRNA. pUC-l was 
mixed with 2-fold increasing amounts of J3-Cascade, from a pUC-l : Cascade molar ratio of 1 : 0.5 
up to a 1 : 256 molar ratio. The first and last lane contain only pUC-l. B) Gel-shift as in (A) with an 
escape mutant of pUC-l containing a single point mutation in the PAM (CAT to CGT). C) Gel-shift 
as in (A) with R44-Cascade containing a non-targeting (R44) crRNA. D) Gel-shift as in (A) with 
Nt.BspQI nicked pUC-l. E) Gel-shift as in (A) with PdmI linearized pUC-l. F) Specific binding of 
Cascade to the protospacer monitored by BsmI footprinting at a pUC-l : Cascade molar ratio of 
10:1. Lane 1 and 5 contain only pUC-l. Lane 2 and 6 contain pUC-l mixed with Cascade. Lane 3 and 
7  contain pUC-l mixed with Cascade and subsequent BsmI addition. Lane 4 and 8 contain pUC-l 
mixed with BsmI. G) BsmI footprint as in (F) with Nt.BspQI cleavage of one strand of the plasmid 
subsequent to Cascade binding. Lane 1 and 6 contain only pUC-l. Lane 2 and 7 contain pUC-l 
mixed with Cascade. Lane 3 and 8 contain pUC-l mixed with Cascade and a subsequent BsmI 
footprint. Lane 4 and 9 contain pUC-l mixed with Cascade, followed by nicking with  Nt.BspQI 
and a BsmI footprint. Lane 5 and 10 contain pUC-l nicked with Nt.BspQI. H) BsmI footprint as in 
(F) with EcoRI cleavage of both strands of the plasmid subsequent to Cascade binding. Lane 1 and 6 
contain only pUC-l. Lane 2 and 7 contain pUC-l mixed with Cascade. Lane 3 and 8 contain pUC-l 
mixed with Cascade and a subsequent BsmI footprint. Lane 4 and 9 contain pUC-l mixed with Cas-
cade, followed by cleavage with  EcoRI and a BsmI footprint (combined cleavage of BsmI and EcoRI 
produces a 2.8 kb fragment and a ~200 nt fragment; the latter is not visible on this gel). Lane 5 and 
10 contain pUC-l cleaved with EcoRI.
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R44-Cascade (Fig. 2C). Interestingly, J3-Cascade was unable to bind relaxed target 
DNA with measurable affinity, such as nicked open circular (OC) (Fig. 1D) or linear 
pUC-l (Fig. 1E), showing that Cascade only has high affinity for natural dsDNA 
substrates that have a nSC topology.
To distinguish nonspecific binding from specific binding, we made use of the BsmI 
restriction site that is located within the protospacer to perform a BsmI footprint 
analysis. While R44-Cascade does not protect the BsmI site from cleavage (Fig. 1F, 
lane 3), pUC-l is protected from BsmI cleavage in the presence of J3-Cascade 
(Fig. 1F, lane 7). This shows that Cascade is able to locate and bind a protospacer 
sequence in a physiologically relevant target DNA molecule in the absence of Cas3.
Figure 2 Cas-
cade DNA 
affinities for 
dsDNA
A) Fit of 
the fraction 
pUC-l bound 
to J3-Cascade 
plotted against 
the concen-
tration of free 
J3-Cascade 
gives the disso-
ciation constant 
(KD) for specific 
binding. B) Fit 
of the fraction 
pUC-l with 
mutant PAM 
(CGT) bound 
to J3-Cascade 
plotted against 
the concentra-
tion of free J3-Cascade gives the dissociation constant (KD) for specific binding to a PAM mutant 
plasmid C) Fit of the fraction pUC-l bound to R44-Cascade plotted against the concentration of 
free R44-Cascade gives the dissociation constant (KD) for non-specific binding. D) Gel-shift of 
pUC-l bound to Cascade with subsequent Nt.BspQI cleavage of one strand of the plasmid. Lane 1 
and 6 contain only pUC-l. Lane 2 and 7 contain pUC-l mixed with Cascade. Lane 3 and 8 contain 
pUC-l mixed with Cascade and subsequent Nt.BspQI nicking. Lane 4 and 9 contain pUC-l mixed 
with Cascade, followed by addition of a ssDNA probe complementary to the displaced strand in the 
R-loop and subsequent nicking with  Nt.BspQI. Lane 5 and 10 contain pUC-l nicked with Nt.BspQI. 
E) Gel-shift of pUC-l bound to Cascade with subsequent EcoRI cleavage of both strands of the plas-
mid. Lane 1 and 6 contain only pUC-l. Lane 2 and 7 contain pUC-l mixed with Cascade. Lane 3 and 
8 contain pUC-l mixed with Cascade and subsequent EcoRI cleavage. Lane 4 and 9 contain pUC-l 
mixed with Cascade, followed by addition of a ssDNA probe complementary to the displaced strand 
in the R-loop and subsequent cleavage with EcoRI. Lane 5 and 10 contain pUC-l cleaved with EcoRI.
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Based on the observed helicase activity of Cas3 on RNA/DNA heteroduplexes, Cas3 
has been hypothesized to play a role in recycling Cascade, presumably after ssDNA 
cleavage by its HD-domain (323). Since Cascade alone cannot bind a nicked plasmid 
with measurable affinity, we investigated whether Cascade bound to nSC plasmid 
remains associated after relaxation of the DNA. To this end, Cascade bound nSC 
pUC-l was nicked with Nt.BspQI, followed by a BsmI footprint to monitor Cascade 
dissociation. Nt.BspQI cleaves pUC-l ~400 bp downstream of the protospacer, 
generating pUC-l with an OC topology. Interestingly, Cascade remains plasmid 
bound after single strand nicking, as can be seen from the protection of the BsmI 
site (Fig. 1G, compare lanes 4 and 9). However, in a gel-shift assay, Cascade dissoci-
ates from the DNA, indicating that the Cascade-DNA interaction is weakened by 
the change in topology (Fig. 2D, compare lanes 8 and 10). Similar observations are 
made when both DNA strands of pUC-l are cleaved after Cascade binding, both in 
a BsmI footprint (Fig. 1H, compare lanes 4 and 9) and in a gel-shift assay (Fig. 2E, 
compare lanes 8 and 10). This shows that, although the Cascade-DNA interaction is 
weakened upon relaxation of the DNA, Cascade remains bound to the protospacer 
sequence after introducing a single or double strand break in the nSC target DNA.
Cascade induces bending of bound target DNA
In order to corroborate the binding of Cascade to nSC plasmids, and to investigate 
the topological consequences of Cascade induced R-loop formation, we employed 
scanning force microscopy. Using this approach we visualized complexes formed 
between purified Cascade and pUC-l. Specific complexes containing a single 
bound J3-Cascade complex were formed, while unspecific R44-Cascade yielded no 
DNA-bound complexes in this assay under identical conditions (data not shown). 
Out of 81 DNA molecules observed, 66 (81%) were found to have J3-Cascade bound 
(Fig. 3A-P). In most cases (86%) Cascade was found at the apex of a loop, whereas 
in only a small fraction (14%) Cascade was found at non-apical positions. These 
data show that Cascade binding causes bending and possibly wrapping of the 
DNA, probably to facilitate local melting of the DNA duplex.
Negative supercoils provide energy for Cascade-mediated R-loop  
formation
The preferential binding of plasmids with a nSC topology as compared to OC and 
linear DNA prompted us to investigate whether this is related to differences in the 
Gibbs free energy of strand separation associated with these topologies. At 37°C, the 
Gibbs free energy for separating strands over the length of a spacer sequence (32 bp) 
in a long dsDNA molecule is calculated to be approximately 190 kJ/mol (Supplemen-
tary Material S1 of ref. 393). For DNA binding and strand separation to occur spon-
taneously, the total change in the Gibbs free energy should be negative. A major part 
of the approximately 190 kJ/mol will be balanced by the (partial) re-establishement 
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of base pairs between 
the protospacer DNA 
and the crRNA. An 
important contribu-
tion in balancing the 
remainder is the Gibbs 
free energy stored in 
the negative supercoils. 
It can be calculated 
(Supplementary Mate-
rial S2 and S3 of ref. 
393) that the change in 
the Gibbs free energy 
of supercoiling associ-
ated with unwinding 
plasmid dsDNA over 
32 base pairs contrib-
utes approximately -90 
kJ/mol, nearly half of 
the total Gibbs energy 
required.
Previous Cascade-DNA 
binding studies were 
performed with linear 
dsDNA fragments of 
65 and 86 bp (315; 191), 
raising the question why short DNA molecules are bound by Cascade while a linear 
3 kb DNA molecule is not bound. This can be explained by the lower melting 
temperature of short DNA as compared to long DNA, which implies that sepa-
rating strands in shorter DNA fragments requires less energy input. The estimated 
decrease in the Gibbs free energy of strand separation over 32 bp in 86 bp dsDNA, 
as compared to long (e.g., 3 kb) dsDNA, is -20 kJ/mol (Supplementary Material S4 
of ref. 393). Since this effect is much smaller than the described supercoiling effect, 
other factors may also play a role in causing the observed differences between 
Cascade binding and strand separation in these targets of different length.
Cascade tolerates four distinct PAMs that are recognized in the base 
pairing strand
Previously, it has been demonstrated that the presence of a PAM flanking the proto-
spacer is important for Cascade target DNA binding (315). To monitor the plasticity 
of PAM recognition, we generated mutants of a PAM flanking a previously described 
Figure 3 Cascade induces bending of target DNA upon 
protospacer binding. 
A-P) Scanning force microscopy images of nSC plasmid DNA with 
J3-Cascade containing a targeting (J3) crRNA. pUC-l was mixed 
with J3-Cascade at a pUC-l : Cascade ratio of 1 : 7. Each image shows 
a 500 x 500 nm surface area. White dots correspond to Cascade.
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phage M13 protospacer (315), and tested CRISPR-interference against these PAM 
mutants in a phage M13 infection experiment. Although most PAM mutants escape 
interference, this analysis reveals that Cascade tolerates at least four different 
PAMs (Fig. 4A). Cascade displays high affinity binding to dsDNA containing the 
M13 protospacer flanked by either one of these four tolerated PAMs (Fig. 4BCDE). 
In contrast, dsDNA containing the M13 protospacer flanked by an escape PAM 
is bound with decreased affinity (Fig. 4F), in good agreement with previous 
DNA binding studies (315). The distinct binding behavior of Cascade to targets 
containing a PAM versus those lacking a PAM allowed us to investigate whether 
PAM recognition takes place in one or in both strands of the target DNA. To this 
end, we performed gel-shift assays with dsDNA targets containing hybrid PAMs, in 
which one strand contains a tolerated PAM and the other strand contains an escape 
PAM (Fig. 4I and Fig. 4J). Comparing Cascade binding to these targets containing 
hybrid PAMs with Cascade binding to targets either containing or lacking a PAM 
on both strands demonstrates that PAM recognition takes place exclusively in the 
crRNA-base pairing strand. Cascade binding to a dsDNA containing the PAM in 
the target strand (at the 3’ end of the strand that base pairs with the crRNA) (Fig. 
4J), is comparable to Cascade binding to a dsDNA substrate containing the PAM in 
both strands (Fig. 4H). On the other hand, Cascade binding to a dsDNA containing 
the PAM in the non-target strand (at the 5’ end of the displaced strand) (Fig. 4J), 
is reminiscent of Cascade binding to a dsDNA substrate lacking a PAM in both 
strands (Fig. 4G). This demonstrates that PAM recognition exclusively takes place 
in the target strand.
Cascade interacts with Cas3 upon protospacer recognition
Although Cascade alone is sufficient for binding to nSC DNA targets, CRISPR-inter- 
ference also requires Cas3 (49). Sequence analysis of cas3 genes from organisms 
containing the Type I-E CRISPR-Cas system reveals that Cas3 and Cse1 occur as 
fusion proteins in Streptomyces sp. SPB78 (Accession Number: ZP_07272643.1), 
in Streptomyces griseus (Accession Number YP_001825054), and in Catenulispora 
acidiphila DSM 44928 (Accession Number YP_003114638). The existence of these 
fusion proteins suggests that stand-alone Cas3 also directly interacts with Cascade 
in vivo, and that the Cse1 subunit may provide a docking site for such an association.
To investigate this, we designed bimolecular fluorescence complementation (BiFC) 
experiments to monitor interactions between Cas3 and Cascade in vivo before and 
after phage l infection. BiFC experiments rely on the capacity of the non-fluores-
cent halves of a fluorescent protein (e.g., YFP) to refold and to form a functional 
fluorescent molecule when the two halves occur in close proximity (reviewed in 
(194)). As such, it provides a tool to reveal protein-protein interactions, since the 
efficiency of refolding is greatly enhanced if the local concentrations are high, e.g., 
when the two halves of the fluorescent protein are fused to interaction partners. 
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Figure 4 Cascade tolerates 4 distinct PAMs that are recognized on the target 
strand. 
A) Mutagenesis of the PAM flanking the previously described M13 protospacer on the phage M13 
genome gives rise to either mutants that escape CRISPR-interference (sequences shown in red) or 
to mutants that are still subject to CRISPR-interference (sequences shown in black). B-F) Gel-shift 
assays to monitor M13-Cascade binding to 65 nt dsDNA probes containing the M13 protospacer 
flanked by the PAM sequences indicated by an asterisk in (A), corresponding to four PAMs (B-E)  
that are tolerated and a single escape PAM mutant (F). G) Gel-shift assays using 65 nt dsDNA 
probes containing the M13 protospacer flanked by an escape PAM sequence (GGG/CCC) on both the 
target and the displaced strand. H) Gel-shift as in (G) with the M13 protospacer being flanked by a 
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For our experiments we fused Cse1 C-terminally with the N-terminal 155 amino 
acids of Venus (Cse1-N155Venus), an improved version of YFP (264). Cas3 was 
C-terminally fused to the C-terminal 85 amino acids of Venus (Cas3-C85Venus).
The BiFC analysis reveals that Cascade does not interact with Cas3 in the absence 
of invading DNA (Fig. 5ABC, Fig. 5J and supplemental information Fig. S2 of ref. 
393). Upon infection with phage l however, cells expressing CascadeDCse1, Cse1-
N155Venus and Cas3-C85Venus are fluorescent if they co-express the anti-l CRISPR 
7Tm (Fig. 5DEF, Fig. 5J and Fig. S2 of ref. 346). When co-expressing a non-targeting 
CRISPR R44 (Fig. 5GHI, Fig. 5J and Fig. S2 of ref. 346), the cells remain non-fluores-
cent. This shows that Cascade and Cas3 specifically interact during infection upon 
protospacer recognition and that Cse1 and Cas3 are in close proximity of each other 
in the Cascade-Cas3 binary effector complex.
Nuclease and helicase activities of Cas3 are essential for CRISPR- 
interference
To address the fate of the invading DNA upon formation of the Cascade-Cas3 
effector complex, and to examine the role of the Cas3 nuclease and helicase activi- 
ties during CRISPR-interference, we made three HD-domain and three heli-
case domain mutants. Some of these mutants have been shown to abolish 
MjaCas3’ and TthCas3HDdom nuclease and SthCas3 nuclease and helicase activity 
in vitro (33; 260; 323). The HD-domain mutants that were tested include two 
conserved residues that are involved in metal ion coordination, Cas3 H74A and 
Cas3 D75A (corresponding to TthCas3HDdom H69A and D70A, MjaCas3’ H66A 
and D67A), and a conserved residue Cas3 K78A (TthCas3HDdom K73A, MjaCas3’ 
K70A) that may be involved in substrate positioning (260). The helicase domain 
mutants that were generated are motif I mutant Cas3 K320N (corresponding 
to the SthCas3 K316A mutant (323)), motif II mutant Cas3 D452N (SthCas3 
D452A (323)) and motif III double mutant Cas3 S483A/T485A. While motifs 
I and II are thought to be involved in ATP binding and hydrolysis, motif III is 
thought to be involved in coupling ATP hydrolysis to unwinding activity (359).
To test whether these mutants are still functional in vivo, resistance against pUC-l 
transformation was determined in E. coli BL21-AI strains expressing J3-Cascade 
and a Cas3 mutant. Upon transformation with a target plasmid, cells expressing 
J3-Cascade and any one of the three HD-domain mutants of Cas3 have transfor-
mation efficiencies that are least 104-fold higher than cells expressing wt Cas3; the 
tolerated PAM sequence (CTT/AAG) on both the target and the displaced strand. I) Gel-shift assays 
as in (G) with the M13 protospacer being flanked by an escape PAM sequence (GGG) on the target 
strand and a tolerated PAM (AAG) on the displaced strand. J) Gel-shift assays as in (G) with the M13 
protospacer being flanked by a tolerated PAM sequence (CTT) on the target strand and an escape 
PAM (CCC) on the displaced strand.
110
Chapter 5 Molecular Basis of DNA Topology Constrained CRISPR-interference 
obtained efficiencies of the mutants are only slightly below the value observed for 
cells expressing the non-targeting R44-Cascade and wt Cas3 (Fig. 6A). The helicase 
domain mutants were also severely compromised in exerting their function, with 
the exception of the Cas3 S483A/T485A double mutant (Fig. 6A). The finding that 
Cas3 nuclease and helicase mutants are impaired in CRISPR-interference strongly 
suggests that both activities are essential for effective invader neutralization.
Additionally, we analyzed curing of pUC-l from E. coli BL21-AI strains upon 
induction of expression of the cas genes and CRISPR. Cells were examined 
over time for loss of pUC-l. Five hours after induction, 90% of cells expressing 
wt Cas3 or the Cas3 S483A/T485A double mutant lost pUC-l as measured by 
selective plating (Fig. 6B). Sequencing of pUC-l from cells that were unable to 
cure this plasmid (carrying either wt Cas3 or the Cas3 S483A/T485A double 
mutant) revealed four escape mutants containing either mutations in the 
seed region or (partial) deletions of the protospacer (Fig. 7) in agreement with 
Figure 5 BiFC analysis reveals that Cascade and Cas3 interact upon target recogni-
tion. 
A) Venus fluorescence of cells expressing CascadeDCse1 and CRISPR 7Tm, which targets 7 proto-
spacers on the phage l genome, and Cse1-N155Venus and Cas3-C85Venus fusion proteins. B) Bright-
field image of the cells in (A). C) Overlay of (A) and (B). D) Venus fluorescence of phage l infected 
cells expressing CascadeDCse1 and CRISPR 7Tm, and Cse1-N155Venus and Cas3-C85Venus fusion 
proteins. E) Brightfield image of the cells in (D). F) Overlay of (D) and (E). G) Venus fluorescence of 
phage l infected cells expressing CascadeDCse1 and non-targeting CRISPR R44, and N155Venus and 
C85Venus proteins. H) Brightfield image of the cells in (G). I) Overlay of (G) and (H). J) Average of 
the fluorescence intensity of 4-7 individual cells of each strain, as determined using the profile tool 
of LSM viewer (Carl Zeiss). Error bars represent the standard deviation of the mean.
111
Chapter 5 Molecular Basis of DNA Topology Constrained CRISPR-interference 
5
previously described escape mutants (315). Cells expressing any of the other 
Cas3 mutants or cells expressing a non-targeting CRISPR did retain the original 
pUC-l plasmid (Fig. 6B). This illustrates that although some mutants still show 
partial resistance against transformation of a single DNA molecule into the cell 
(Fig. 6A), they are deficient in curing a high copy number plasmid (Fig. 6B).
Figure 6 The role of Cas3 nuclease and helicase activities during CRISPR-interference. 
A) Competent BL21-AI cells expressing Cascade, a Cas3 mutant and CRISPR J3 were transformed 
with pUC-l. Colony forming units per microgram pUC-l (cfu/mg DNA) are depicted for each of 
the strains expressing a Cas3 mutant. Cells expressing wt Cas3 and CRISPR J3 or CRISPR R44 serve 
as positive and negative controls, respectively. Experiments were performed in triplicate. Error bars 
represent the standard deviation of the mean. B) BL21-AI cells carrying Cascade, Cas3 mutant, and 
CRISPR encoding plasmids as well as pUC-l are grown under conditions that suppress expression of 
the cas genes and CRISPR. At t=0 expression of the CRISPR and cas genes is induced. The fraction 
of cells that retain pUC-l over time is shown, as determined by the ratio of ampicillin resistant and 
total cell counts. 
Figure 7 pUC-l escape mutants
pUC-l sequences of 4 clones encoding CRISPR J3, Cascade and Cas3 (wt or S483AT485A) indicate 
that these are escape mutants carrying (partial) deletions of the protospacer or carrying a single 
point mutation in the seed region, which explains the inability to cure these plasmids.
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The HD-domain of Cas3 in the Cascade-Cas3 effector complex cleaves 
target DNA
An in vitro characterization of the catalytic features of Cas3 requires its production 
and purification in an active state. Despite various solubilization strategies, Cas3 
overproduced in E. coli BL21 (DE3) was found to be mainly present in inactive aggre-
gates and inclusion bodies (data not shown, and (177)). This issue was resolved by 
producing Cas3 as a Cas3-Cse1 fusion protein, containing a linker identical to that 
of the aforementioned Cas3-Cse1 fusion protein of S. griseus (Fig. 8). When co- 
expressed with CascadeDCse1 and CRISPR J3, a soluble fusion-complex was 
produced that could be purified to apparent homogeneity with the same apparent 
stoichiometry as Cascade (Fig. 9A). To address the functionality of this complex we 
first tested whether it provides resistance against phage l infection. The efficiency 
of plaquing (eop) of phage l on host cells expressing the fusion-complex J3-Cas-
cade-Cas3 was identical to the eop on cells expressing the separate proteins (Fig. 9B).
Since the J3-Cascade-Cas3 fusion-complex was functional in vivo, we proceeded 
with in vitro DNA cleavage assays using this complex. When J3-Cascade-Cas3 was 
incubated with pUC-l in the absence of divalent metals, plasmid binding was 
observed at molar ratios similar to those observed for Cascade (Fig. 9C), while 
nonspecific binding to a non-target plasmid (pUC-P7, a pUC19-derived plasmid 
of the same size as pUC-l, but lacking the J3 protospacer) occurred only at high 
molar ratios (Fig. 9D), indicating that the nonspecific DNA binding properties of 
the complex are also similar to that of Cascade alone.
Figure 9 Cascade-Cas3 fusion complex provides in vivo resistance and has in vitro 
nuclease activity. 
A) Coomassie Blue-stained SDS-PAGE of purified Cascade and Cascade-Cas3 fusion complex.  
B) Efficiency of plaquing of phage l on cells expressing Cascade-Cas3 fusion complex and a tar-
geting (J3) or non-targeting (R44) CRISPR. Cells expressing non-fused Cascade and Cas3 with a 
targeting (J3) CRISPR is given as a control. C) Gel-shift (in the absence of divalent metal ions) of 
nSC target plasmid with J3-Cascade-Cas3 fusion complex. pUC-l was mixed with 2-fold increasing 
amounts of J3-Cascade-Cas3, from a pUC-l : J3-Cascade-Cas3 molar ratio of 1 : 0.5 up to 1 : 128. The 
first and last lanes contain only pUC-l. D) Gel-shift (in the absence of divalent metal ions) of nSC 
non-target plasmid with J3-Cascade-Cas3 fusion complex. pUC-P7 was mixed with 2-fold increasing 
amounts of J3-Cascade-Cas3, from a pUC-P7 : J3-Cascade-Cas3 molar ratio of 1 : 0.5 up to 1 : 128. 
The first and last lanes contain only pUC-P7. E) Incubation of nSC target plasmid (pUC-l, left) or 
nSC non-target plasmid (pUC-P7, right) with J3-Cascade-Cas3 in the presence of 10 mM MgCl2. 
Lane 1 and 7 contain only plasmid. F) Assay as in (E) in the presence of 2 mM ATP. G) Assay as in 
(E) with the mutant J3-Cascade-Cas3K320N complex. H) Assay as in (G) in the presence of 2 mM 
ATP. I) Schematic overview of the three DNA substrates used in the in vitro nuclease assay shown in 
panel (J). The substrates are 89 nt and contain a 39 nt double stranded region at a variable position. 
Asterisks at the 5’ end indicate the presence of the 32P label. J) Incubation of Cascade-Cas3 with the 
5’ labelled substrates shown in (I) in the presence of 10 mM MgCl2. The endonuclease products that 
run low in the gel are better visible in the overexposed version shown in Figure S5 of ref. 393. 
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Interestingly, the J3-Cascade-Cas3 complex displays magnesium-dependent endo-
nuclease activity on nSC target plasmids. In the presence of 10 mM Mg2+, J3-Cas-
cade-Cas3 was found to nick nSC pUC-l (Fig. 9E, lane 2-6), but this increase in 
plasmid nicking over time is not observed for substrates that do not contain the 
target sequence (Fig. 9E, lane 8-12). When both magnesium and ATP are added 
to the reaction, the nSC target plasmid was found to be entirely degraded (Fig. 
9F, lane 2-6), in contrast to a non-target plasmid that remains intact (Fig. 9F, lane 
8-12). In agreement with the observation that Cascade cannot bind relaxed target 
plasmids, linear or nicked OC pUC-l was not degraded by J3-Cascade-Cas3 (data 
not shown). To test whether the Cas3 helicase domain is required for the exo- 
nucleolytic plasmid degradation, we generated a mutant Cascade-Cas3 complex, 
carrying the Cas3 K320N mutation. As expected, the J3-Cascade-Cas3 K320N 
complex still shows nicking activity (Fig. 9G), but, despite the presence of ATP, 
it can no longer degrade target plasmids (Fig. 9H). To determine the direction of 
Cas3-mediated target degradation, we performed an in vitro exonuclease assay 
similar to that described for MjaCas3’’ (33). Incubation of Cascade-Cas3 with any 
of three different substrates consisting of an 89 nt ssDNA (lacking a protospacer 
sequence) annealed at a variable position to a 39 nt probe (Fig. 9I) reveals that Cas3 
has endonuclease and 3’ to 5’ exonuclease activity on the single stranded region 
of the DNA substrate (Fig. 9J). While in this assay the products high up in the 
gel are due to the 3’ to 5’ exonuclease activity of Cas3, the smaller products are 
due to a combination of single stranded endonuclease activity and exonuclease 
activity (Fig. 9J and supplemental information Fig. S5 of ref. 393). Altogether, these 
data demonstrate that during Type I CRISPR-interference in E. coli target DNA 
recognition by Cascade is followed by Cas3-mediated DNA nicking and progressive 
ATP-dependent degradation of target DNA in the 3’ to 5’ direction.
disCussion
In this study we analyzed the molecular mechanism of the CRISPR-interference 
pathway of CRISPR-Cas Type I-E, from target recognition to target degradation. 
As depicted in the model presented (Fig. 10), initial binding of a dsDNA target 
by Cascade leads to DNA bending and recruitment of the nuclease/helicase Cas3. 
Upon formation of a Cascade-Cas3 binary complex, the HD-domain of Cas3 cleaves 
the target DNA, which is followed by progressive ATP-dependent unwinding and 
degradation of the target in the 3’ to 5’ direction (Fig. 10). As Cas3 and Cascade-
like complexes are present in all Type I CRISPR-Cas systems (231), the model is 
anticipated to be applicable for all these systems.
Strikingly, Cascade alone is unable to bind protospacers on relaxed dsDNA. In 
contrast, it binds with high affinity to DNA with a nSC topology. In mesophiles, 
all circular dsDNA molecules have a nSC topology in vivo, which is essential for 
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compaction of chromosomal DNA into the nucleoid, and for key cellular processes 
such as transcription, replication and recombination (reviewed in (30)). The 
higher affinity of Cascade for nSC targets is related to the energy required for 
Figure 10 Model of the CRISPR-interference Type I pathway in E. coli. 
Steps that are not well-understood are depicted with dashed arrows. (1) Cascade (blue) carrying a 
crRNA (orange). (2) Cascade associates non-specifically with the nSC plasmid DNA and scans for a 
protospacer (red), with protospacer adjacent motif (PAM) (yellow). (3) Sequence specific binding to 
a protospacer is achieved through base pairing between the crRNA and the complementary strand 
of the DNA, forming an R-loop. Upon binding, Cascade induces bending of the DNA, and Cascade 
itself undergoes conformational changes (191; 394). (4) The Cse1 subunit of Cascade recruits the 
nuclease/helicase Cas3 (brown). This may be triggered by the conformational changes of Cascade 
and the target DNA. (5) The HD-domain (dark brown) of Cas3 catalyzes Mg2+-dependent nicking of 
the target DNA at an unknown position, possibly within or near to the R-loop. (6) Plasmid nick-
ing alters the topology of the target plasmid from nSC to relaxed OC, causing a reduced affinity of 
Cascade for the target. Dissociation of Cascade from the target may involve Cas3 helicase activity. 
Cascade may then remain associated with Cas3 or may be remobilized to locate new targets (7) Cas3 
degrades the entire plasmid in an ATP-dependent manner as it progressively moves (in the 3’ to 5’ 
direction) along, unwinds and cleaves the target dsDNA. Exonucleolytic degradation takes place in 
the 3’-5’ direction, as was also reported for the combined activities of the helicase MjaCas3’ and the 
nuclease MjaCas3’’ (33).
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opening the dsDNA duplex, which is DNA topology dependent. Negative super-
coiling is considered a high energy DNA conformation and processes that require 
strand separation are generally supported by an nSC topology. A good example 
is RecA-mediated base pairing of ssDNA with the complementary strand in a 
dsDNA duplex during homologous recombination (reviewed in (31; 171)), forming 
a so-called D-loop (193). Although relaxed dsDNA can also serve as a substrate for 
a RecA-ssDNA filament during ATP-independent strand exchange, the efficiency 
of strand exchange is greatly enhanced when the DNA duplex has a negative super-
coiled topology (56).
Type III-B CRISPR-Cas systems have been demonstrated to target single stranded 
nucleic acids (RNA) (150; 151; 413). It is possible that Type I and Type II CRISPR-Cas 
systems can also target ssDNA, such as phage M13 or conjugative plasmid DNA 
as it enters the cell. While systems that target single stranded nucleic acids can 
readily access protospacers, systems that require strand opening of dsDNA require 
an energy source. For denaturing a stretch of 32 bp in a 3 kb plasmid, approxi-
mately half of the energy needed (-90 kJ/mol) is supplied by the free energy of 
supercoiling. The preference for nSC target DNA is therefore likely to be a general 
characteristic for all mesophilic CRISPR-Cas systems that target double stranded 
DNA in an ATP-independent manner.
The remaining ~100 kJ/mol of Gibbs free energy that is required for denaturing a 
stretch of 32 bp may be derived from destabilizing interactions between Cascade 
and the dsDNA duplex, from stabilizing interactions between Cascade and the 
displaced strand, and from base pairing between the crRNA and the target strand. 
Moreover, the recently identified seed sequence in the crRNA (315) may also 
decrease the energetic barrier, because the duplex first needs to be opened over a 
shorter stretch of only 8 nucleotides to pair with the crRNA seed.
Upon binding to the protospacer, conformational changes of Cascade (191; 394) 
and bending of the bound DNA take place. Protein-induced or intrinsic DNA 
bends tend to localize at the apex of supercoiled DNA loops, as this corresponds 
to the energetically most favorable conformation (205; 348)). Similar deformations 
have also been observed with enzymes that wrap DNA, such as RNA polymerase 
(78; 304; 305) and UvrB (256; 377), to facilitate DNA melting. 
The conformational changes of Cascade and the target DNA may expose an inter-
action surface for Cas3 at or near the Cse1 subunit. After recruitment, the Cas3 
HD-domain nicks the target DNA, resulting in a decreased affinity of Cascade 
for the target DNA. The Cas3 helicase domain has previously been reported to 
unwind R-loops in vitro ((33; 323), indicating that the Cas3 helicase domain may 
be involved in recycling of Cascade after relaxation of the nSC target. Moreover, 
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the Cas3 helicase domain has been shown to unwind dsDNA in the 3’ to 5’ direc-
tion (33; 323). This dsDNA unwinding activity is essential for progressive 3’ to 5’ 
exonucleolytic degradation of target DNA by the HD-nuclease domain of Cas3 
(33). In accordance with this, both the nuclease and the helicase activities of Cas3 
are essential for CRISPR-interference. The double mutant of motif III (S483A/
T485A), which is thought to couple ATP hydrolysis to unwinding activity, was 
still functional. Although many SF2 helicases lose their activity when this motif is 
mutated (e.g. translation initiation factor eIF-4A (285)), other studies have shown 
that helicase activity is retained (e.g. the mitochondrial intron splicing helicase 
Mss116p (88)). This indicates that motif III mutants may display a phenotype that 
is not as pronounced as that of motif I and II mutants. The latter interfere with 
CRISPR-interference in vivo and with Cas3 exonuclease activity in vitro. The exonu-
cleolytic degradation of target DNA by Cas3 in the 3’ to 5’ direction is in line with 
the reported activities of the helicase MjaCas3’ and the nuclease MjaCas3’’ (33).
Research over the recent years revealed a huge diversity of CRISPR-Cas defense 
systems: 10 subtypes (148; 230) that are grouped into 3 major types (231). 
CRISPR-dependent invader nucleic acid cleavage has been reported for Type II and 
Type III CRISPR-Cas systems. In the S. thermophilus Type II system target DNA is 
cleaved (124). In contrast, the Type III-B system of P. furiosus and S. solfataricus 
cleaves target RNA in vitro and in vivo (150; 151; 413), while the Type III-A system 
of Staphylococcus epidermidis targets DNA (235), although cleavage has not yet 
been demonstrated. Cascade and Cas3 are the key players in the Type I CRISPR- 
interference pathway. This study demonstrates that Cascade carries out ATP- 
independent DNA surveillance by exploiting the energy stored in nSC target DNA 
while Cas3 carries out complete ATP-dependent destruction of Cascade-marked 
invader DNA.
exPerimenTal ProCedures
Strains, Gene cloning, Plasmids and Vectors
E. coli BL21-AI and BL21 (DE3) strains were used throughout the study. A descrip-
tion of the plasmids used in this study can be found in the Supplementary 
Information (S5) of ref. 393.
Protein production and purification
Cascade and the Cascade-Cas3 fusion complex were expressed and purified as 
described (191). Throughout purification a buffer containing 20 mM HEPES pH 
7.5, 75 mM NaCl, 1 mM DTT, 2 mM EDTA was used for lysis and washing. Protein 
elution was performed in the same buffer containing 4 mM desthiobiotin.
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Electrophoretic Mobility Shift Assay
Purified Cascade was mixed with target DNA (for a list of the oligo’s and plasmids 
used see Table S2 and S3, respectively of ref. 393) in a buffer containing 20 mM 
HEPES pH 7.5, 75 mM NaCl, 1 mM DTT, 2 mM EDTA, and incubated at 37°C for 
15 minutes. Samples containing Cascade-plasmid DNA complexes were run over-
night at 10 mA on a 0.8 % TAE Agarose gel and post-stained with SybR safe (Invitro- 
gen) 1:10000 dilution in TAE for 30 minutes. Cleavage with BsmI (Fermentas) or 
Nt.BspQI (New England Biolabs) was performed in the HEPES reaction buffer 
supplemented with 5 mM MgCl2. Samples containing Cascade bound to short 
double stranded oligo’s were separated on a polyacrylamide gel as before (315).
Scanning Force Microscopy
Purified Cascade was mixed with pUC-l (at a ratio of 7:1, 250 nM Cascade, 35 nM 
DNA) in a buffer containing 20 mM HEPES pH 7.5, 75 mM NaCl, 0.2 mM DTT, 0.3 
mM EDTA and incubated at 37°C for 15 minutes. Subsequently, for AFM sample 
preparation, the incubation mixture was diluted 10x in double distilled water and 
MgCl2 was added at a final concentration of 1.2 mM. Deposition of the protein-DNA 
complexes and imaging was carried out as described before (77).
Fluorescence Microscopy
Overnight culture of BL21-AI cells carrying CRISPR and cas gene encoding plas-
mids, was diluted 1:100 in fresh antibiotic-containing LB, and grown for 1 hour at 37 
°C. Expression of cas genes and CRISPR was induced for 1 hour by adding L-arabi- 
nose (0.2%) and IPTG (1 mM). Phage Lambda infection was done at a Multiplicity 
of Infection (MOI) of 4. Cells were applied to poly-L-lysine covered microscope 
slides, and analyzed using a Zeiss LSM510 confocal laser scanning microscope 
(excitation at 514 nm and detection at 530-600 nm). For detailed materials see S5 
of ref. 393.
Plasmid transformation studies
Transformation of competent cells expressing CRISPR and cas genes with pUC-l 
was analyzed by selective plating. Plasmid curing was analyzed by transforming 
cas gene and CRISPR-containing cells with pUC-l while suppressing T7-poly- 
merase expression by the addition of 0.5% glucose. Expression of cas genes 
and CRISPR was induced and cells were plated on non-selective and on pUC-l- 
selective LB-agar. After overnight growth the percentage of plasmid loss was calcu-
lated from the ratio of colony forming units on the selective and non-selective 
plates. For detailed materials see S5 of ref. 393.
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Phage infection studies
Phage Lambda (lvir), and M13 assays were performed as described (49; 315). M13 
mutants were generated as described previously (315). For detailed methods see S5 
of ref. 393.
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absTraCT 
Prokaryotes possess various defense mechanisms against invading DNA. Adaptive defense by CRISPR-Cas relies on incorporation of invader DNA sequences in the host genome. In Escherichia coli, processed transcripts of 
these incorporated sequences (crRNAs) guide Cascade-mediated invader DNA 
recognition (49; 191; 315; 393). Cascade is a multisubunit ribonucleoprotein complex, 
consisting of one crRNA and five proteins: Cse1, Cse2, Cas7, Cas5 and Cas6e (49; 
191). Cascade-mediated DNA recognition requires a conserved sequence adjacent 
to the target (protospacer adjacent motif, PAM) and a negatively supercoiled DNA 
topology (315; 393). While Cse1 carries out PAM recognition (310), the Cascade 
structure suggests that Cse2 may interact with target DNA in the PAM-distal end 
of the protospacer (394). Using Electrophoretic Mobility Shift Assays, we here 
describe the function of the Cse1 and Cse2 subunits in the context of protospacer 
recognition on negatively supercoiled DNA. While Cse1 is required for nonspe-
cific DNA binding, Cse2 appears to be important for specific binding, presumably 
by mediating stabilizing interactions with the displaced strand, the R-loop, or 
both. Furthermore, we performed Scanning Force Microscopy using linearized 
DNA molecules, which facilitates accurate and reliable measurements of Cascade- 
mediated bending. This analysis reveals that Cascade binding induces flexibility 
in the DNA target, most likely due to single stranded DNA regions flanking the 
R-loop.
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inTroduCTion
Bacteria and archaea defend themselves with the recently discovered CRISPR-Cas system against invading DNA such as phages and conju-gative plasmids (reviewed in (6; 34; 94; 173; 190; 192; 202; 236; 349; 366; 
395)). Nowadays ten different subtypes of CRISPR-Cas systems are recognized, 
that belong to three main types (231). The E. coli K12 Type I-E is one of the most 
extensively studied systems and consists of a CRISPR locus (Clustered Regularly 
Interspaced Short Palindromic Repeats) with type 2 repeat sequences (201) and 8 
CRISPR-associated (cas) genes (cas3, cse1, cse2, cas7, cas5, cas6e, cas1, cas2). The 
CRISPR locus is characterized by repetitive sequences of 29 nt, that are separated 
by 32 nt of invader-derived sequences, known as spacers. During the adaptation 
stage, new spacer sequences can be incorporated in the existing array through as 
yet unknown mechanisms (343; 405). During the subsequent expression stage, the 
CRISPR locus is transcribed into a precursor CRISPR RNA (pre-crRNA) molecule, 
which is then cleaved by a dedicated Cas protein (49). This protein, Cas6e, cleaves 
the pre-crRNA in the repeat sequence to generate 61 nt mature crRNA (191). These 
mature crRNA molecules form a key component of Cascade, a ribonucleoprotein 
complex consisting of crRNA and 5 different Cas proteins: Cse1, Cse2, Cas7, Cas5 
and Cas6e (49; 191). During the interference stage, invader DNA with a sequence 
complementary to the crRNA is recognized by the Cascade complex through base 
pairing between the crRNA and the target DNA sequence (protospacer) (191; 393). 
Following recognition, Cascade as well as the target DNA undergo conformational 
changes (393; 394). Most notably, the positions and orientations of the Cse1, Cse2 
and Cas6e subunits alter upon nucleic acid binding (394), and the target DNA is 
strongly bent at the site of Cascade binding (393). Finally, Cas3 is recruited and the 
invader DNA is degraded by the joint nuclease and helicase activities of the Cas3 
HD-nuclease domain and the Cas3 SF2 helicase domain (393). 
Interestingly, research over the last few years has revealed that Cascade DNA 
recognition is constrained by several features of the target DNA. Firstly, the proto-
spacer needs to be flanked by a conserved motif, known as the protospacer adja-
cent motif (PAM) (253; 315). At least four different PAM sequences are allowed, 
which are being recognized by a loop structure of the Cse1 subunit of the Cascade 
complex (310; 393). Secondly, although mismatches between the crRNA and the 
target DNA are allowed at some positions, the 3’ end of the protospacer needs to 
be fully complementary at the so-called seed region, corresponding to positions 1 
to 5 and positions 7 to 8 of the protospacer (315). Thirdly, the target DNA needs to 
be negatively supercoiled (nSC) (393). The nSC topology contributes half of the 
energy required for strand separation of the double stranded target DNA during 
base pairing between the crRNA, contained by Cascade, and the protospacer (393). 
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The prime task of the Cascade surveillance complex is to locate protospacer 
sequences in alien DNA and to form an R-loop at this target site through base 
pairing between the crRNA and the target DNA strand. The complex architecture 
of Cascade, which has recently been resolved by cryo-EM (394), reflects well the 
complexity of this task (see Fig. 1A for a schematic model of Cascade). Each of the 
subunits plays a crucial role in this process, as seen from the lack of in vivo resis-
tance when any single Cascade subunit is absent (191). The function of some of the 
5 different protein subunits has been (partially) revealed during recent studies. The 
Cas6e subunit cleaves the pre-crRNA and binds the 3’ end of crRNA to incorporate 
it in the Cascade complex (49; 131; 309). The Cas7 subunit plays a structural role 
(191), forming the backbone of the complex (394). Interestingly, Cas7 appears to 
make very close contacts with the crRNA and causes disruption of the R-loop to 
yield 5 helical  segments instead of a continuous crRNA-DNA heteroduplex (394). 
The Cse1 subunit has been shown to be involved in PAM recognition (310). Despite 
the well-characterized function of these subunits, the function of some other 
subunits, such as Cse2 and Cas5, remains enigmatic.
 
Here we elaborate, in the context of negatively supercoiled DNA, on the function 
of Cse1 in nonspecific DNA binding of Cascade and we demonstrate that Cse2 
functions in specific DNA binding of Cascade to target sequences complementary 
to the crRNA. Furthermore, we analyze the previously described DNA bending 
by Cascade using linearized DNA, which facilitates accurate measurements of 
bending. We demonstrate that Cascade induces flexibility in the target DNA at the 
binding site, presumably due to single stranded DNA regions flanking the R-loop.
resulTs and disCussion
Although DNA binding through R-loop formation by Cascade has been studied in 
considerable detail, the function of individual subunits in this process is not full 
understood. Previously, Cascade subcomplexes lacking either Cse1 or both Cse1 
and Cse2 have been described, which enable the effects of the absence of these 
proteins to be assessed (191). Electrophoretic Mobility Shift Assays using short 
linear dsDNA of 85 bp show that CascadeDCse1 loses its nonspecific DNA binding 
activity (191), in agreement with a role for Cse1 in PAM recognition (310). Here, 
we further corroborate this result in the context of negatively supercoiled DNA, 
by the finding that J3-CascadeDCse1 (CascadeDCse1 loaded with the previously 
described J3 crRNA (391)) does not bind to pUC-l, a 3kb negatively supercoiled 
plasmid containing the J3 protospacer sequence (Fig. 1B). Moreover, CascadeDCse1 
loaded with an unrelated non-targeting R44-crRNA (R44-CascadeDCse1) also does 
not show any nonspecific interaction with pUC-l (Fig. 1C). 
The Cse2 subunit has basic patches and may be involved in Cascade nucleic acid 
127
Chapter 6 Binding and Bending of Target DNA by Cascade
6
Figure 1 Cse1 and Cse2 subunits of Cascade are involved in non-specific and  
specific binding to nSC plasmid DNA, respectively. 
A) Schematic model of Cascade, indicating the relative position of each of the 11 different Cas-
cade subunits. B) Gel-shift of nSC plasmid DNA with J3-CascadeDCse1, containing a targeting 
(J3) crRNA. pUC-l was mixed with 2-fold increasing amounts of J3-CascadeDCse1, from a pUC-l 
: Cascade molar ratio of 1 : 0.5 up to a 1 : 256. The first lane contains only pUC-l. C) Gel-shift as in 
(B) with R44-CascadeDCse1 containing a non-targeting (R44) crRNA. D) SDS PAGE of J3-Cascade 
(lane 1) and J3-CascadeDCse2 (lane 2). Asterisks indicate proteins containing an N-terminal StrepII 
purification tag. E) Gel-shift as in (B) with J3-CascadeDCse2, with a pUC-l : Cascade molar ratio 
of 1 : 0.5 up to a 1 : 128 F) Gel-shift as in (E) with R44-CascadeDCse2 containing a non-targeting 
(R44) crRNA. G) KD determination of J3-CascadeDCse2 DNA binding using a y = x/(a+x) fit with y = 
fraction bound plasmid, x = free Cascade concentration and a = KD. H) Specific binding of R44-Cas-
cadeDCse2 to the protospacer monitored by BsmI footprinting at a pUC-l : CascadeDCse2 molar 
ratio of 32:1. Lane 1 contains only pUC-l. Lane 2 contain pUC-l mixed with CascadeDCse2. Lane 3 
contains pUC-l mixed with CascadeDCse2 and subsequent BsmI addition. Lane 4 contains pUC-l 
mixed with BsmI. Lin indicates linear plasmid. OC indicates plasmids with a relaxed open circular 
topology. I) Specific binding of J3-CascadeDCse2 to the protospacer monitored as in (H).
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contacts (4). Based on the cryo-EM structure, such interactions probably take 
place in the non-seed area of the target DNA (394). To understand the role of the 
Cse2 subunit in more detail, we made a subcomplex of Cascade lacking only the 
Cse2 subunit. This subcomplex has the same apparent stoichiometry as the entire 
Cascade, as estimated by SDS-PAGE (Fig. 1D). Interestingly, J3-CascadeDCse2 is 
able to bind the pUC-l target plasmid (Fig. 1E), albeit with an almost 10-fold lower 
affinity (KD = 119 ± 24 nM) than J3-Cascade (KD = 13 ± 1.4 nM) (Fig. 1G and ref 
(393)). In addition, R44-CascadeDCse2 is also able to interact nonspecifically with 
negatively supercoiled plasmid DNA (Fig. 1F) with roughly the same affinity (203 
± 36 nM) as Cascade (429 ± 152 nM), indicating that the nonspecific interaction 
is not affected by the absence of Cse2 and hence may be primarily mediated by 
the Cse1 subunit. The lowered specific binding affinity of CascadeDCse2 strongly 
suggests that Cse2 plays an important role during R-loop formation. The previ-
ously described basic patches on the Cse2 surface (4), together with the position of 
Cse2 near the non-seed region of the crRNA (394), make it tempting to speculate 
that Cse2 plays a role in either stabilizing the base pairing between the crRNA and 
the target DNA strand in the non-seed region, or in stabilizing or positioning the 
displaced DNA strand, or in both. As reported before, nearly half of the energy for 
strand separation is derived from the negatively supercoiled topology of the target 
DNA (393). The other half of the energy may be derived from the base pairing 
between crRNA and the target DNA and from stabilizing interactions of Cascade 
Figure 2 Cascade is 
bound specifically at 
the position of the 
protospacer. 
Scanning force microscopy 
images of pUC-λ (linear- 
ized by digestion with 
NdeI) with J3-Cascade 
containing a targeting 
(J3) crRNA. pUC-λ was 
mixed with J3-Cascade at 
a pUC-λ:Cascade ratio of 
1:2. Each image shows a 
750 × 750 nm surface area. 
White dots along the DNA 
correspond to Cascade.
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components with the R-loop, such as Cse2-mediated stabilization of the displaced 
strand or the non-seed base pairing region. The BsmI site, which is located within 
the J3 protospacer (393), is, as expected, not protected by R44-CascadeDCse2 
after binding to pUC-l (Fig. 1H). Intriguingly, and in contrast to J3-Cascade (393), 
J3-CascadeDCse2 also does not protect the BsmI site (Fig. 1I). This further suggests 
that Cse2 plays an important role in stabilization of the R-loop structure.
After binding of Cascade to negatively supercoiled targets, Cascade is predomi-
nantly located at the apex of a supercoiled loop, as demonstrated by scanning 
force microscopy (393). 
This indicates that Cascade 
introduces strong bending 
or possibly wrapping of 
the target DNA. To analyse 
this in more detail, J3-Cas-
cade binding to pUC-l was 
followed by the addition of 
a probe complementary to 
the displaced strand, which 
serves to stabilize the R-loop 
(as described before in (393)). 
Unlike the previous study in 
which we investigated the 
structure of Cascade bound 
to supercoiled plasmid DNA 
using scanning force micros-
copy, we now linearized 
these complexes using NdeI 
(which cleaves ~400 bp 
upstream of the protospacer) 
before visualization by scan-
ning force microscopy. The 
linearization of the Cascade-
bound plasmid DNA facili-
tates reliable measurements 
of the length of the DNA 
and the angles in the DNA 
at the site where Cascade is 
bound, providing insight in 
the degree of bending and/
or wrapping by Cascade.
Figure 3 Cascade bound specifically at the position 
of the protospacer bends DNA. 
A) End-to-end distributions (normalized to DNA contour 
length) of bare DNA molecules (white) and J3-Cascade-
DNA complexes (gray). The reduced end-to-end distance for 
Cascade-DNA complexes indicates DNA bending. B) Bending 
angle distributions of bare DNA molecules (white) and J3-
Cascade-DNA complexes (gray). The broad distribution of 
bending angles suggests enhanced DNA flexibility at the posi-
tion of the bound Cascade.
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A total number of 136 Cascade-DNA complexes and 185 bare DNA molecules were 
imaged (Fig. 2). In the Cascade-DNA complexes Cascade was consistently bound 
at the same position: 123 ± 9 nm (or 367  ± 27 bp) from one of the DNA extremities, 
indicating specific binding (the centre of the protospacer is at a distance of 403 bp 
(or 134 nm) from the extremity). Extensive wrapping of DNA around Cascade would 
reduce the contour length of Cascade-DNA complexes compared to that of bare 
DNA molecules. Similar measurements have previously revealed DNA wrapping 
by E. coli RNA polymerase and UvrB proteins (78; 377). We measured the contour 
length of both bare DNA molecules (960 ± 24 nm) and Cascade-DNA complexes 
(957 ± 26 nm). As these values are not significantly different, these experiments 
yield no direct evidence for extensive wrapping of DNA around Cascade. Subse-
quently, we investigated the bending at the position of the bound Cascade using 
two complementary approaches. First, we used an approach that relies on measu-
ring changes in distance between two defined points on a DNA molecule (usually 
the two extremities) (76). This distance (generally referred to as the end-to-end 
distance, EED) is a measure of DNA bending. As the linear DNA molecules used in 
these studies are relatively long (about 3 kb), we adapted this approach to measure 
the distance between the extremity closest to the bound Cascade and a second 
point on the other DNA arm at the same distance from the bound protein. The EED 
distribution of Cascade-DNA complexes is distinctly different from that of bare 
DNA molecules: it is shifted towards shorter distances, indicating that Cascade 
bends DNA (Fig. 3A). Next, we directly measured the Cascade-induced bend and 
compared the bending angle distribution of Cascade-DNA complexes with that 
of bare DNA (Fig. 3B). As expected, the bare DNA has a bending angle distribu-
tion centered around an angle of zero degrees. The bending angle distribution of 
Cascade–DNA complexes deviates in width and in position from the distribution 
found for bare DNA. It exhibits no preferential angle and the broad distribution of 
bending angles found suggests that the flexibility of Cascade-DNA complexes is 
significantly higher than that of bare double stranded DNA. Similar observations 
have been reported for HU and HMG-box proteins, which bend DNA and enhance 
its flexibility (371; 412). We attribute the enhanced flexibility in the Cascade-DNA 
complexes to helix unwinding or DNA melting at the DNA ‘entry/exit’ points into 
Cascade. This explanation is in agreement with a nuclease P1 footprint on Cascade-
bound double stranded target DNA, which shows that ~5 nucleotides located at 
the 3’ end of the PAM are highly sensitive to cleavage by this single stranded DNA 
specific endonuclease (191).
Altogether, the data presented here corroborate, in the context of negatively super-
coiled DNA, that Cse1 is required for nonspecific binding activity of Cascade, in 
line with its recently described role in PAM recognition (310). In addition, Cse2 
appears to be important for R-loop stabilization, possibly by interacting with the 
displaced DNA strand of the double stranded target, or by interacting with the 
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non-seed region of the crRNA-DNA heteroduplex, or both. Finally, we show that 
Cascade induces flexibility in the DNA target, most likely due to unwinding of the 
double stranded DNA adjacent to the base pairing region. This enhanced flexi-
bility explains why plasmid-bound Cascade is predominantly found at the apex of 
a supercoiled loop (393), since it facilitates the strong bending of the DNA at this 
position.
exPerimenTal ProCedures
Strains and plasmids used for protein production and purification
E. coli BL21 (DE3) strains were used throughout the study. J3-Cascade, R44-Cascade, 
J3-CascadeDCse1 and R44-CascadeDCse1 complexes were expressed as described in 
(191), and purified as described in (393). J3-CascadeDCse2 and R44-CascadeDCse2 
were expressed from the previously described pWUR408, pWUR403, pWUR555 
and pWUR547 or pWUR408, pWUR403, pWUR555 and pWUR630, respectively 
(191; 393). The CascadeDCse2 subcomplexes were purified as described in (393).
Electrophoretic Mobility Shift Assay
Purified Cascade (sub)complexes were mixed with pUC-l in a buffer containing 20 
mM HEPES pH 7.5, 75 mM NaCl, 1 mM DTT, 2 mM EDTA, and incubated at 37°C 
for 15 minutes, as described in (393). Samples containing Cascade-plasmid DNA 
complexes were run overnight at 10 mA on a 0.8 % TAE Agarose gel and post-stained 
with SybR safe (Invitrogen) 1:10000 dilution in TAE for 30 minutes. Cleavage with 
BsmI (Fermentas) was performed in the HEPES reaction buffer supplemented with 
5 mM MgCl2. 
Scanning Force Microscopy
Purified J3-Cascade was mixed with pUC-l (at a ratio of 7:1, 250 nM Cascade, 35 
nM DNA) in a buffer containing 20 mM HEPES pH 7.5, 75 mM NaCl, 0.2 mM DTT, 
12 mM MgCl2 and incubated at 37°C for 20 minutes. Subsequently, primer BG3141 
(5’-GCTCAATTTTGACAGCCCACATGGCATTCCACTTATCACTGGCATCCT-
TCCA-3’, which is complementary to the displaced strand in the R-loop) was 
added to the mixture to stabilize Cascade binding to the plasmid DNA, followed 
by incubation at 37°C for 10 minutes. Next, to linearize the plasmid DNA at the 
NdeI site located 385 bp upstream of the protospacer, 1 Unit NdeI (Fermentas) 
was added to the mixture, followed by incubation at 37°C for 40 minutes. For AFM 
sample preparation, the incubation mixture was diluted 10x in double distilled 
water and MgCl2 was added at a final concentration of 1.2 mM. Deposition of the 
protein-DNA complexes and imaging was carried out as described before (77). 
To measure bending of the DNA, the angle distribution of DNA molecules was 
measured using Image SXM software, as described previously (76; 371). Further-
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more, we adapted a previously described approach (76) that relies on measuring 
changes in distance between the two extremities of a DNA molecule, known as the 
end-to-end distance (EED), which is a measure of DNA bending. We adapted this 
approach by measuring the distance between the extremity closest to the bound 
Cascade and a second point on the other DNA arm at the same distance from the 
bound protein.
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absTraCT 
Discriminating self and non-self is a universal requirement of immune systems. Prokaryotic CRISPR-Cas immune systems are centered around genomic CRISPR loci into which invader DNA fragments are incorpo-
rated between host-derived repeats. All three types of CRISPR-Cas systems 
utilize processed transcripts (crRNA) of integrated sequences (spacers) to guide 
CRISPR-associated (Cas) proteins to degrade complementary nucleic acids. crRNAs 
consist of a single spacer sequence flanked by repeat-derived nucleotides, termed 
the 5’- and 3’-handles. To avoid autoimmunity, it is essential to exclusively target 
sequences (protospacers) in invading DNA and not in genomic CRISPR loci. Type 
III-A systems recognize “self” by sensing base pairing between the 5’-handle and 
spacer-flanking CRISPR repeat sequences. In Type I-E systems the Cse1 subunit 
of Cascade ribonucleoprotein complex interacts with conserved protospacer- 
flanking sequences, termed PAMs, and mediates nonself target recognition. It 
is unknown, however, whether base pairing between the 5’- and 3’-handles and 
protospacer flanking sequences also plays a role. By altering base pairing potential 
between crRNA repeats and protospacer flanking sequences, we demonstrate that 
Type I-E systems discriminate self from non-self through a base pairing-inde-
pendent mechanism that relies strictly on PAM sequence identity. This mechanism 
is fundamentally different from that employed by Type III-A systems, and has 
important implications for phage escape routes by point mutagenesis. We propose 
the exclusive targeting of PAM-flanked protospacers to be termed a target versus 
non-target discrimination mechanism.
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inTroduCTion
There are several prokaryotic defense systems that confer innate immunity against invading mobile genetic elements, such as receptor masking, blocking of DNA injection, restriction/modification (R-M) and abortive 
infection (reviewed in (36; 202; 392)). In addition, half of the bacteria, and most 
of the archaea, contain CRISPR-Cas (Clustered Regularly Interspaced Short Palin-
dromic Repeats/CRISPR associated) systems, unique in being the only adaptive 
line of prokaryotic defense (reviewed in (34; 36; 173; 192; 202; 236; 301; 349; 392; 
395)). CRISPR-Cas systems provide adaptive immunity by incorporating invader 
DNA sequences into CRISPR loci on the host chromosome (28; 79; 343; 405). 
The 30-40 nt invader-derived DNA sequences are separated by host-derived 
repeat sequences that are typically around the same size. Adjacent to a CRISPR 
locus, a set of cas genes can often be found that encodes the protein machinery 
essential for CRISPR-immunity. The cas genes occur in characteristic combina-
tions that can serve as a classification criterion of CRISPR-Cas systems into three 
major types (231). The CRISPR locus is transcribed into a long precursor CRISPR 
RNA (pre-crRNA). In Type I and Type III systems the pre-crRNA is processed by 
Cas6-like endoribonucleases to generate small crRNA molecules with the size of a 
spacer-repeat unit (49; 60; 157; 191; 296) that in some CRISPR-Cas subtypes undergo 
a second maturation/processing step (149; 156). In Type II CRISPR-Cas systems the 
pre-crRNA is processed by RNase III (90). The processed crRNA molecules then 
remain bound to one or more Cas proteins to guide recognition and cleavage of 
complementary nucleic acid sequences, known as protospacers (126; 150; 151; 188; 
191; 215; 291; 393; 396; 413).
With the exception of Type III-B CRISPR-Cas systems, which cleave RNA (150; 151; 
413), all other characterized CRISPR-Cas systems appear to target DNA (124; 188; 
234; 235; 393) and hence require a mechanism to avoid aberrant cleavage of genomic 
DNA, i.e. a mechanism to discriminate the genomic “self” DNA of a CRISPR cassette 
from the invader “non-self” DNA. The absence of such a discrimination should 
lead to a suicidal autoimmune response, as self genome targeting is lethal (104; 
333). In R-M systems this problem is solved by modification of the genomic DNA 
and cleavage of unmodified invader DNA only (reviewed in (392)). For CRISPR-Cas 
systems on the other hand, the mechanism(s) of self versus non-self discrimina-
tion is only partly understood.
For the Type III-A system of Staphylococcus epidermidis autoimmunity is prevented 
through a mechanism that relies on sensing base pairing between the 5’-handle 
(the repeat-derived sequence at the 5’-end of the crRNA) and the corresponding 
portion of CRISPR repeat (237). The Type III-A CRISPR-Cas system consists of 9 
cas genes (cas1, cas2, cas10, csm2, csm3, csm4, csm5, csm6, cas6) and a CRISPR 
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with type-8 repeats (201). After a primary processing step of the pre-crRNA, the 
resulting crRNAs are further matured through ruler-based cleavage from the 3’ 
end, yielding 43 and 37 nt crRNA species (156). These mature crRNA species are 
likely to guide one or more Cas proteins (possibly a Csm-complex) to target DNA 
(235), presumably through base pairing between the crRNA spacer sequence and 
the complementary protospacer sequence. However, CRISPR-interference is inhi-
bited when, in addition to base pairing over the spacer sequence, the 5’-handle 
also base pairs with the protospacer-flanking sequence of the target DNA (237). 
In this manner, self-targeting of the CRISPR locus is avoided, since self-targeting 
leads to full base pairing of the 5’-handle of the crRNA with the CRISPR repeat 
sequence. In particular, the presence or absence of base pairing at three positions 
downstream of the protospacer (positions -2, -3, and -4 relative to the 3’-end of the 
protospacer) is decisive in discriminating self from non-self (237). The molecular 
details of how base pairing at these positions downstream of the protospacer is 
sensed, and whether it involves Cas proteins, is currently unknown.
Intriguingly, Type I systems contain di- or tri-nucleotide conserved motifs (proto-
spacer adjacent motifs (PAM)) downstream of the protospacer, opposite of the 
5’-handle (115; 146; 253) (Fig 1A). In the Type I-E CRISPR-Cas system the PAM 
sequence is recognized by ribonucleoprotein complex Cascade during target DNA 
binding (315; 393). The Type I-E system of Escherichia coli K12 consists of 8 cas 
genes (cas3, cse1, cse2, cas7, cas5, cas6e, cas1, cas2) and two CRISPR loci with 
type-2 repeats (201). Ribonucleoprotein complex Cascade is composed of a 61 nt 
crRNA, and five different Cas proteins in an uneven stoichiometry: Cse11Cse22Cas76- 
Cas51Cas6e1 (49; 191). The Cse1 subunit has recently been shown to be specifically 
involved in PAM binding (310). Structural analyses of Cascade show that the crRNA 
spans the entire ribonucleoprotein complex, with the Cas6e subunit interacting 
with the stem-loop which forms the 3’- handle of the crRNA (131; 309), while the 
5’-handle is in close proximity of the Cse1, Cas5 and Cas7 subunits (394).
It has previously been shown that Cascade efficiently binds target DNA through 
an R-loop formed by the 32 nt spacer sequence of the crRNA and the protospacer 
sequence (191) (Fig 1A), but only if any one of four allowed PAM sequences is present 
(315; 393). Moreover, complete base pairing over the seed region, which is located 
immediately adjacent to the PAM (positions 1-5 and 7-8 of the protospacer), is an 
absolute requirement for efficient R-loop formation (315).
Interestingly, the seed-flanking last nucleotide of the repeat, which is opposite to 
the first nucleotide of the PAM during R-loop formation (e.g. corresponding to the 
-1 position immediately adjacent to the seed region), has recently been shown to 
be invader-derived during spacer acquisition rather than originating from repeat 
duplication (79; 136; 343). Hence, this nucleotide of the crRNA repeat invariably 
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has the potential to base pair with the -1 position of the PAM of the protospacer 
from which it was derived, and might be involved R-loop formation. In contrast, 
the -2 and -3 positions of the PAM lack base pairing potential with the 5’-handle 
of the crRNA (Fig. 2A). While Cascade can interact through its Cse1 subunit with 
the PAM sequence (310; 315; 393), it is unknown whether base pairing between the 
3’- and/or 5’-handles and protospacer flanking sequences plays a role in self versus 
non-self discrimination.
 
In this study, we demonstrate that discrimination of self from non-self by Type 
I-E CRISPR-Cas systems occurs through a mechanism that is independent of base 
pairing between the spacer-flanking repeats and protospacer-flanking sequences. 
Hence, the principal mechanism by which Type I-E systems discriminate self from 
non-self appears to be solely Cse1-mediated and as such is fundamentally different 
from the differential base pairing mechanism employed by Type III-A systems. 
While the mechanism employed by Type III-A is best described as being based 
on self-recognition (self versus non-self), the mechanism of Type I-E systems is 
instead based on target-recognition (target versus non-target).
resulTs
Self versus non-self discrimination by the Type III-A CRISPR-Cas system of S. 
epidermidis has been shown to rely on a differential base pairing mechanism (237). 
As a result of this mechanism, CRISPR-interference is specifically inhibited when 
protospacer sequences are flanked by CRISPR repeat sequences. To test whether 
this mechanism also applies to the Type I-E CRISPR-Cas system of E. coli K12, 
CRISPR-interference was tested against targets containing protospacers flanked by 
CRISPR repeat sequences. The previously described g8 CRISPR (315), which targets 
the gene VIII (g8) of phage M13, was used as a model system to analyze the effects of 
potential base pairing between the 3’- and 5’-handles of the crRNA and the proto-
spacer flanking sequences on CRISPR interference in vivo and Cascade DNA binding 
in vitro. For these analyses, the g8 protospacer was cloned into plasmid pUC19 
to allow for mutagenesis of protospacer-flanking sequences without disrupting 
coding sequences. Wild-type g8 crRNA expressing E. coli show in vivo resistance 
against transformation by plasmid pWUR690 (transformation efficiency approxi-
mately 10-3) in which the g8 protospacer is flanked by a CAT PAM (indicated as 
the sequence on the target DNA strand, from 5’-3’), but are susceptible to plasmid 
transformation by plasmid pWUR687 in which the g8 protospacer is flanked by 
CRISPR repeat sequences (Fig. 1B). However, the plasmid resistant phenotype can 
be restored by introducing a CAT PAM in the CRISPR repeat sequence flanking 
the protospacer (pWUR688), which alters the base pairing potential only at the 
-2 and -3 positions (Fig. 1B). In contrast, pWUR689, which carries the g8 proto-
spacer flanked by a CGG sequence that gives rise to base pairing exclusively at posi-
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tions -1, -2 and -3 (i.e. the positions corresponding to the PAM), escapes CRISPR- 
interference from wild-type g8 crRNA expressing E. coli (Fig. 1B).
Electrophoretic Mobility Shift Assays using purified g8 crRNA-loaded Cascade 
demonstrate high affinity binding to dsDNA containing the g8 protospacer flanked 
by the CAT PAM (Fig. 1B). In contrast, dsDNA containing the g8 protospacer either 
flanked by CRISPR repeat sequences or flanked by a CGG sequence is bound with 
low affinity by g8 crRNA-loaded Cascade (Fig. 1B). This indicates that target versus 
Figure 1 Base pairing between protospacer flanking regions and crRNA repeats 
does not affect CRISPR-interference 
A) Model of the R-loop formed by Cascade during dsDNA binding. B) Cells expressing wt g8-Cas-
cade and Cas3 are resistant to plasmids containing the CAT PAM adjacent to the g8 protospacer 
(white bars, transformation efficiency 1.8 ± 0.5 x 10-3 for plasmid pWUR690 and 3.1 ± 0.6 x 10-3 for 
plasmid pWUR688), but are susceptible to plasmid transformation when the g8 protospacer is 
flanked by a CGG PAM, which is fully complementary to the 5’-handle (black bars, transformation 
efficiency 1.1 ± 0.3 for plasmid pWUR687 and 1.2 ± 0.2 for plasmid pWUR689). The histogram shows 
the in vitro binding affinity of purified wt g8-Cascade for dsDNA containing the g8 protospacer 
flanked by sequences with a varying base pairing potential, as shown on the right. Asterisks indicate 
that the KD value is >>1000 nM and the error bars represent the standard deviation of the mean.
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non-target discrimination occurs at the level of Cascade affinity for dsDNA target 
sequences, which is in agreement with the recent finding that the Cse1 subunit of 
Cascade binds PAM sequences (310).
We next investigated the possibility if base pairing between three nucleotides 
from the 5’-handle of the crRNA and the PAM could be involved in discrimi-
nating self from non-self DNA. Previously (393), four PAM sequences (CAT, CTT, 
CCT and CTC, indicated as the sequence on the target DNA strand, from 5’-3’), 
have been reported to confer immunity on wild-type g8 crRNA expressing E. 
coli against phage M13 infection in vivo (efficiency of plaquing, e.o.p.<10-4), and 
to give rise to high affinity DNA binding by g8 crRNA-bound Cascade in vitro 
(Fig. 2B and Fig. S2A; please note that PAM sequences are shown in the 3’ to 5’ 
direction to visualize base pairing with the 5’-handle).  The last nucleotide of the 
5’-handle of the crRNA (the -1 position) invariably has the potential to base pair 
with the PAM (343), while the -2 and -3 positions lack such base pairing poten-
tial (Fig. 2A). The resulting configuration in the R-loop structure (a potential 
base pair at -1 and lack of potential base-pairing at -2 and -3) is distinct from 
the fully base-paired configuration that forms during the recognition of CRISPR 
DNA and can, in principle, form the basis of self versus non-self discrimination.
To analyze whether base pairing at position -1 is required for CRISPR interference 
a mutant CRISPR was constructed, yielding a g8 crRNA that lacks base pairing 
potential with the PAM at this position. This CRISPR, denoted g8G-1T carries a 
G-to-T substitution at position -1, within the repeat sequence. SDS-PAGE ana- 
lysis of Cascade complexes containing either mutant or wt crRNA shows that these 
complexes have the same apparent stoichiometry, thereby confirming the inte-
grity of the complex (Fig. S4A). In addition, isolation of crRNA from these protein 
complexes shows that crRNA biogenesis is unaffected by the introduced mutations 
(Fig. S4B). Interestingly, despite the absence of base pairing at the seed-flanking 
position -1, cells expressing mutant crRNA interfered with development of phages 
containing all four functional PAM sequences and high affinity binding by Cascade 
to targets containing the g8 protospacer and the mutant functional PAMs was 
observed (Fig. 2C and Fig. S2B). However, as previously observed for the wt g8- 
crRNA-Cascade complex (393), a CGT PAM variant neither confers resistance 
in vivo (e.o.p.=1) nor gives rise to high affinity DNA binding in vitro with targets 
containing this PAM mutant (Fig. 2BC, and Fig. S2A). This PAM mutant potentially 
yields an additional base pair with the -2 position of the 5’-handle (Fig. 2BC).
To further analyze the role of base pairing at position -2 in CRISPR-immunity, a 
mutant CRISPR was designed that yields an additional base pair at the -2 posi-
tion when binding a DNA target containing a CTT PAM, which is proficient for 
interference and most frequently observed upon spacer acquisition in E. coli (79; 
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Figure 2 Base pairing at the -1 position is not required for CRISPR-interference 
A) Model of the R-loop formed by Cascade during dsDNA binding. The nucleotide adjacent to the 
spacer sequence (the -1 position) has the potential to base pair with the first nucleotide of the PAM 
in the target strand of the DNA. B) Cells expressing wt g8-Cascade and Cas3 are resistant to M13 
phage containing the CAT, CTT, CCT or CTC PAMs adjacent to the M13 protospacer (black font/
white bars, e.o.p.<10-4), but not when containing the CGT PAM (red font/black bars, e.o.p.=1). Note 
that in the figure the PAMs are oriented in 3’ to 5’ direction to display base pairing potential with the 
last three nucleotides of the crRNA repeat. The in vitro binding affinity of purified wt g8-Cascade 
for dsDNA containing the g8 protospacer and each of the respective PAM mutants is shown in the 
adjacent histogram. C) Assays as in (B) using cells expressing the g8G-1T CRISPR, Cascade and Cas3, 
show that cells are resistant to M13 phage containing the CAT, CTT, CCT or CTC PAMs adjacent to 
the g8 protospacer (black font/white bars), but not when containing the CGT PAM (red font/black 
bars). The in vitro binding affinity of purified wt g8G-1T-Cascade for dsDNA containing the g8 proto-
spacer and each of the respective PAM mutants is shown in the adjacent histogram. In (B) and (C) 
error bars represent the standard deviation of the mean.
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343; 405). This CRISPR, denoted g8C-2A, carries a C-to-A substitution at position 
-2 in the CRISPR repeat sequence. While crRNA biogenesis is unaffected, this 
mutation does appear to have a slight effect on complex formation, as the bands 
corresponding to Cse1 and Cse2 have modestly lower and higher intensities on an 
SDS-PAGE, respectively (Fig. S4). Intriguingly, although an additional base pair 
can only be formed in complexes with DNA targets containing the CTT and CTC 
PAM (5’ - 3’), in vivo resistance is lost against phages containing a PAM sequence 
other than the preferred CTT PAM, where a partial resistant phenotype (e.o.p.~10-2) 
is observed (Fig. 3A). This correlates with an intermediate affinity of g8C-2A-Cas-
cade for CTT PAM containing DNA targets (Fig. 3A and Fig. S3A), indicating that 
binding affinities primarily determine the differentiation between a target and a 
non-target. The KD of g8
C-2A-Cascade for a DNA target containing the CTT PAM is 
60 ± 12 nM. Although the affinity of 100 ± 11 nM of g8C-2A-Cascade for a DNA target 
containing the CAT PAM is only ~2-fold higher, the phage resistant phenotype is 
entirely lost. This shows that over a gradual decrease of Cascade target binding 
affinities, from ~5 to ~25 nM for wt g8-Cascade to ~60 and ~100 nM for g8C-2A-Cas-
cade, CRISPR-based immunity is also gradually lost.
To probe the importance of base pairing at the -3 position, an additional CRISPR 
mutant was designed, denoted g8C-3G, which carries a C to G mutation at the -3 posi-
tion in the CRISPR repeat. Again, complex formation and crRNA biogenesis are unaf-
fected (Fig. S4). Although the potential for base pairing with most PAM sequences 
remains the same, a dramatic decrease in both resistance against M13 phage in 
Figure 3 Cascade complex formation and crRNA biogenesis is not affected by  
CRISPR repeat mutagenesis 
A) Coomassie stained SDS-PAGE of the wt and mutant g8-Cascade complexes shows that all com-
plexes are formed with a correct stoichiometry. B) Nucleic acids bound to each of the g8-Cascade 
complexes shows that intact crRNA is present in all complexes.
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vivo and DNA binding by g8C-3G-Cascade in vitro is observed (Fig. 3B and Fig. S3B). 
The combined results of the three CRISPR mutants indicate that the repeat 
sequence itself rather than its base pairing potential affects PAM recognition. In 
order to have a more complete and fully unbiased analysis of the effects of adding 
Figure 4 Base pairing at the -2 and -3 positions does not interfere with CRISPR- 
immunity
A) Cells expressing g8C-2A-Cascade and Cas3 are resistant to M13 phage containing the CTT, PAM 
adjacent to the g8 protospacer (black font/white bars), but not when containing the CTT, CCT, CTC 
or CGT PAM (red font/black bars). Note that in the figure the PAMs are oriented in 3’ to 5’direction 
to display base pairing potential with the last three nucleotides of the crRNA repeat. The in vitro 
binding affinity of purified g8C-2A-Cascade for dsDNA containing the g8 protospacer and each of the 
respective PAM mutants is shown in the adjacent histogram. B) Assays as in (A) using cells expres- 
sing the g8C-3G CRISPR, Cascade and Cas3, show that cells are not resistant to M13 phage containing 
the CAT, CTT, CCT, CTC or CGT PAMs adjacent to the g8 protospacer (red font/black bars). The in 
vitro binding affinity of purified g8C-3G-Cascade for dsDNA containing the M13 protospacer and each 
of the respective PAM mutants is shown in the adjacent histogram. Asterisks indicate that the KD 
value is >>1000 nM and the error bars represent the standard deviation of the mean.
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or removing base pairing potential at positions -1, -2 and -3, M13 phages with 26 
different PAM sequences adjacent to the g8 protospacer were constructed. All 
phages were viable as judged by their ability to infect host bacteria lacking the 
M13-targeting CRISPR (data not shown). The phages were tested for their ability 
to infect cells expressing each of the 21 different g8 crRNAs with mutated repeat 
sequences at positions -1, -2 and -3. The results, summarized in Fig. 4A, show that 
for all CRISPR repeat mutants tested, only a small subset of CRISPR repeat mutants 
conferred full phage resistance, and only in conjuction with the four previously 
validated PAM sequences. Resistance appeared to be irrespective of crRNA-PAM 
base pairing patterns, and rather showed to be constrained by a limited number 
of allowed nucleotides at the -1, -2 and -3 positions of the 5’-handle, and a fixed 
number of PAM sequences. An exception to this rule is the CTT PAM, which is 
bound with the highest affinity by Cascade. Presumably this high affinity binding 
can compensate for the negative effects on DNA binding caused by mutations at 
the -2 position of the 5’-handle, leading to a partially phage resistant phenotype. 
These data convincingly demonstrate that the specificity of PAM recognition is 
unaffected by its potential to base pair with the 5’-handle, in line with previously 
reported Cse1-mediated PAM recognition (310). In addition, these data exclude the 
possibility that the Type I-E system makes use of a differential base pairing mecha-
nism to inhibit self-targeting. Although some combinations of 5’-handle mutants 
and allowed PAMs that potentially yield full base pairing at all three positions do 
not provide phage resistance in vivo, this appears to be base pairing independent 
(Fig. S5). For example, the g8C-3A, C-2T CRISPR does not provide resistance against M13 
phage with a CAT PAM (Fig. 4B). However, the same CRISPR also does not protect 
against M13 phage with a CTC PAM, which potentially gives rise to base pairing at 
the -1 position only (Fig. 4C). Similar observations are made when combining the 
g8C-3A, C-2A CRISPR with M13 phage with a CTT PAM or with M13 phage with a CTC 
PAM (Fig. 4D and E). Hence, although 5’-handle/allowed PAM combinations that 
potentially yield full base pairing (Fig. 4B and D) or other base pairing patterns 
that deviate from the wt 5’-handle/allowed PAM combinations (Fig. S5), correlate 
with a lack of phage resistance, this phenotype cannot be rescued by substituting 
the PAM with another allowed PAM sequence, even when this yields a non-devi-
ating base pairing pattern (Fig. 4C and E and Fig. S5). This indicates that the repeat 
sequence itself rather than the potential to base pair is affecting CRISPR-inter- 
ference in these instances. The most likely explanation for the fact that some repeat 
mutants are not tolerated is that the Cascade subunits involved in binding the 
5’-handle exhibit a level of sequence specificity.
To exclude the possibility that the specificity of PAM recognition by g8-Cascade 
variants depends on the expression levels of CRISPR-Cas components, the same 
analyses were performed with an engineered M13 targeting E. coli strain with cas 
genes fused to inducible promoters (12). When repeat mutations were introduced 
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Figure 5 Synonymous mutations of the crRNA and the PAM do not affect self ver-
sus non-self discrimination. 
A) Infectivity of a library of M13 phage containing PAM mutants adjacent to the g8 protospacer was 
tested against cells expressing Cascade, Cas3 and g8 CRISPR containing mutations at the -1, -2 and 
-3 nucleotides of the CRISPR repeats. PAM mutations are shown on the left, with the PAM sequen- 
ces indicated in the 3’ to 5’ direction. CRISPR repeat mutations at positions -1, -2 and -3 are indi-
cated on the top in the 5’ to 3’ direction. Base pairing potential between the PAM positions and the 
repeat is indicated using numbers (0-7) that correspond to a base pairing pattern that is shown 
in the panel on the right. A 0 signifies no base pairing, a 1 signifies base pairing at the -3 position, 
a 2 signifies base pairing at the -2 position, etc. Black circles with white digits indicate resistance 
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into the genomic CRISPR cassette in this strain, identical results were obtained 
(Fig. S6), showing that the data described here are expression level independent. 
disCussion
CRISPR-Cas systems are the only prokaryotic adaptive immune systems described 
to date. Although initially thought of as a single system, nowadays their vast 
diversity, both structurally and mechanistically, is well-appreciated. CRISPR-Cas 
systems have been classified into three major types, which can be further sub- 
divided into 10 subtypes (231). The main differences between the (sub)types are the 
mechanism of crRNA processing and maturation (49; 59; 60; 90; 149; 156; 191; 396), 
the presence or absence of multi-subunit ribonucleoprotein complexes (49; 151; 215; 
396), the mechanism of nucleic acid degradation (124; 151; 393; 413) and the nature 
of the target (e.g. RNA versus DNA)(124; 151; 188; 235; 393; 413). Here, we add to this 
expanding list of fundamental differences the mechanism of self versus non-self 
Figure 6 Mutatagenesis 
of CRISPR repeat po-
sitions -2 and -3 affects 
CRISPR-interference. 
A selection of the data shown 
in Figure 5 is shown, lacking 
the repeat/non-allowed PAM 
combinations. The repeat/ 
allowed PAM combinations 
are highlighted that would 
give rise to a base pairing 
pattern corresponding to that 
observed for the resistant 
phenotype, but that do not 
give rise to CRISPR-inter-
ference. This suggests that 
in these cases the repeat 
sequence interferes with  
CRISPR immunity rather 
than that a correlation exists 
with base pairing potential.
against phage infection (e.o.p.<10-4), grey circles indicate partial resistance (e.o.p.~10-2) and black 
digits without circle indicate susceptibility to phage infection (e.o.p.=1), as determined by phage 
spot assays. B) Combination of g8C-3AC-2T CRISPR and M13 phage with CAT PAM, gives rise to full 
base pairing and a lack of resistance (red font). C) Combination of g8C-3AC-2T CRISPR and M13 phage 
with CTC PAM,  gives rise to only base pairing at the -1 position and yields a lack of resistance (red 
font). D) Combination of g8C-3AC-2A CRISPR and M13 phage with CTT PAM gives rise to full base 
pairing and a lack of resistance (red font). E) Combination of g8C-3AC-2A CRISPR and M13 phage with 
CTC PAM gives rise to only two potential base pairs at the -1 and -2 positions and yields a lack of 
resistance (red font). Note in (A – E) PAMs are oriented in 3’ to 5’direction to display base pairing 
potential with the last three nucleotides of the crRNA repeat.
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discrimination. Type I and Type II systems require a PAM for specific target recog-
nition (39; 124; 174; 188; 253; 315; 393), albeit at different sides of the protospacer, 
while Type III systems appear to lack a requirement for PAM (237). 
For Type III-A systems it has been shown that differentiation between self DNA 
and non-self DNA relies on sensing differential complementarity between the 
5’-handle of the crRNA and the protospacer-flanking sequence (Fig. 5A) (237). This 
discrimination mechanism is based on specific recognition of self DNA, and is 
therefore well described by the term self versus non-self discrimination. On the 
other hand, here we demonstrate that a Type I-E system from E. coli lacks an 
intrinsic property to specifically recognize self DNA based on base pairing poten-
tial. Rather, Cascade bound to cognate crRNA specifically recognizes target DNA 
through Cse1-mediated recognition of a PAM sequence (Fig. 5B)(310). This mecha-
nism is therefore more appropriately referred to as “target versus non-target” 
discrimination. Given the absence of PAM sequences in the CRISPR array, self 
DNA automatically falls into the non-target category and is not subject to inter-
ference. It is tempting to speculate that target vs. non-target discrimination is a 
universal property of PAM-sensing CRISPR-Cas systems of Type I and II, and that 
these systems lack a self vs. non-self discrimination mechanism. 
Initially, PAM sequences in Type I-E systems have been proposed to act in 
recruiting Cascade to potential target sites, after which the seed sequence could 
serve as a nucleation point for progressive R-loop formation from the PAM-proxi- 
mal to the PAM-distal end of the protospacer (315). In this model, PAM sequences 
would increase the efficiency of the target recognition mechanism by limiting the 
number of possible target sites scanned before a “correct” target is located. More 
recently, Cse1 structures have been solved (261; 310) and it was shown that the Cse1 
subunit of Cascade specifically binds PAM sequences through a conserved loop 
structure (310). It was proposed that this loop may destabilize the double stranded 
DNA duplex to allow strand invasion by the crRNA (310). Hence, PAM sequences 
could play a role at different stages of the target DNA binding process: both during 
scanning of DNA for potential target sequences and during the initial strand inva-
sion process preceding the R-loop formation. Furthermore, PAM sequences are 
also recognized by Cas1 and/or Cas2, during selection of pre-spacers for subse-
quent spacer acquisition (405). The CRISPR-adaptation and CRISPR-interference 
machineries have co-evolved PAM selectivities, as the preference for the CTT PAM 
is observed both during Cas1/Cas2-dependent spacer integration (405) and during 
target DNA binding by Cascade (393).
Surprisingly, while the -1 position (the last nucleotide of the CRISPR repeat) 
has been shown to be invader-derived and hence invariably has the potential to 
base pair with cognate DNA (79; 136; 343), this base pairing is not essential for 
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7CRISPR-interference. In contrast, the immediately adjacent seed sequence needs 
to be fully base paired (315). The absence of a base pairing requirement for the -1 
position might suggest that this position is not available for base pairing due to 
structural constraints. Since the pairing potential of the -1 position of the 5’-handle 
apparently does not affect the efficiency of CRISPR interference, the most likely 
function of this invader-derived nucleotide is to properly orient the new spacer 
during CRISPR spacer integration.
In contrast to the tolerance of the -1 position to substitutions, the -2 position of the 
repeat requires the presence of a cytosine for efficient CRISPR-interference (Fig. 4). 
When this position is mutated to an adenosine, a partially resistant phenotype 
Figure 7 Model of self versus non-self discrimination by Type III-A systems and 
target versus non-target discrimination by Type I-E systems. 
A) Model of the mechanism employed by Type III-A systems. Type III-A systems presumably target 
DNA through R-loop formation. The crRNA (here depicted as the 37 nt species) could be part of a 
ribonucleoprotein complex consisting of Cas proteins and a single crRNA (Csm complex). R-loop 
formation and subsequent interference is inhibited when base pairing occurs between the -2, -3 and 
-4 positions of the repeat sequence at the 5’ end of the crRNA and the sequence flanking the 3’ end 
of the protospacer. How this base pairing is monitored is currently unknown, but it might involve 
a Cas protein. B) Model of target versus non-target discrimination by Type I-E systems. Type I-E 
systems target DNA through R-loop formation. The 61 nt crRNA is part of the Cascade ribonucleo-
protein complex. R-loop formation and subsequent Cas3-mediated cleavage of the target DNA are 
activated when a PAM is present at the -1, -2 and -3 positions, in the sequence flanking the 3’ end of 
the protospacer. The presence of a PAM is monitored through the Cse1 subunit.
150
Chapter 7 Cascade Avoids Autoimmunity by Discriminating Targets from Non-targets
is observed during phage infection with the best PAM only. Substitution of the 
-2 position to a guanidine or uracil renders the CRISPR-interference pathway 
nonfunctional. Interestingly, the reduced level of phage resistance conferred by the 
g8C-2A CRISPR is accompanied by an apparent structural distortion of the Cascade 
complex. While most subunits are present in the same apparent stoichiometry in 
the mutant g8C-2A-Cascade as in the wildtype complex, the Cse1 subunit is under- 
represented. This might suggest that Cse1 interacts with the -2 position of the 
repeat and that interaction with this base is important for efficient incorporation 
of Cse1 into the complex. An interaction of Cse1 with the -2 position of the 5’ handle 
of the crRNA is also consistent with Cse1 being in close vicinity of the 5’-handle in 
the structure of the Cascade complex (394). The decreased affinity for target DNA 
of this class of mutants fits well with reduced levels of phage resistance, given the 
important role that Cse1 has in non-specific nucleic acid binding (191; 390) and 
PAM recognition (310). Like the -2 position, the -3 position requires a cytosine for 
CRISPR-mediated phage resistance to be manifested. However, complex formation 
is unaffected in g8C-3G-Cascade (Fig. S4A). The -3, -2 and -1 positions are among the 
best conserved bases of the repeat sequence. While weblogo representations of 
type 2 repeats the -1 and -3 positions display some degree of variation, the -2 posi-
tion appears to be invariable (201). For the -1 position the high level of conservation 
is primarily caused by the fact that this base is PAM-derived during spacer acquisi-
tion (79; 136; 343). The conservation of the -2 and -3 positions might be due to their 
involvement in Cse1 binding or caused by structural constraints within the complex.
The distinct mechanisms of self versus non-self discrimination and target versus 
non-target recognition have implications for the ability of phages to escape CRISPR- 
interference. Type III-A systems always target sequences containing a complemen-
tary protospacer sequence, except when three well-defined positions of the crRNA 
repeat base pair. On the other hand, Type I-E systems only target DNA when a 
tri-nucleotide PAM sequence is present adjacent to the complementary target 
sequence. Hence, phages are much more restricted in their escape-mutagenesis 
strategies when facing a Type III-A system as compared to Type I-E systems. While 
previous studies have demonstrated that phages primarily escape I-E CRISPR-Cas 
systems by acquiring point mutations in the PAM or the seed region, phages 
infecting bacteria/archaea that carry Type III-A systems would typically need at 
least three mutations in the protospacer-flanking sequence to escape CRISPR- 
interference. Because of the low frequency of simultaneous occurrence of multiple 
mutations, one can expect that generation of escape phenotype through point 
mutations in seed region-like sequences of the protospacer, if these exist, would 
be a more common pathway. Apart from this escape route through selection of 
random mutants, phages may also have developed more advanced escape mecha-
nisms, such as specific CRISPR-Cas inhibitors. These exciting possibilities will 
undoubtedly be addressed in future research efforts.
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exPerimenTal ProCedures
Bacterial strains, Gene cloning, Plasmids and Vectors
E. coli BL21 (DE3) strains were used for Cascade purification. Novablue (DE3) cells 
supplemented with CRISPR plasmid and plasmids expressing cas genes and engi-
neered K12 strains with cas genes fused to inducible promoters were used for phage 
sensitivity tests and transformation assays. A description of the plasmids and the 
strains used in this study can be found in the Supplementary Information (Table 
S1).
Protein expression and purification
Wildtype M13-Cascade was expressed and purified as described before (393), from 
pWUR408, pWUR514 and pWUR615 (Table S1). g8G-1T-Cascade, g8C-2A-Cascade, 
g8C-3G-Cascade, were expressed from pWUR408, pWUR514 and either pWUR680, 
pWUR682, or pWUR684, respectively (Table S1). pWUR680, pWUR682, and 
pWUR684 were generated by subcloning a synthetic CRISPR (Table S3, Geneart) 
into pACYC using EcoNI and Acc65I restriction sites.
Gel electrophoresis
Purified Cascade was separated on a 12 % SDS-PAGE as described before (191), and 
stained using Coomassie Blue overnight, followed by destaining in Millipore water. 
Nucleic acids were isolated from purified Cascade complexes using an extraction 
with phenol:chloroform:isoamylalcohol (25:24:1) equilibrated at pH 8.0 (Fluka) 
and separated on a 6M urea 15% acrylamide gel, as described in (191), followed by 
staining with SybR safe (Invitrogen) in a 1:10000 dilution in TAE for 30 minutes. Elec-
trophoretic Mobility Shift Assays were performed as in (393), using the PAGE-pu-
rified oligonucleotides listed in Table S2, which were annealed and 5’-labeled with 
γ-32P ATP (PerkinElmer) using T4 polynucleotide kinase (Fermentas). Determining 
the KD of the Cascade target DNA interaction was performed as described in (315). 
Briefly, the signals of unbound and bound probe were quantified using Quantity 
One software (Bio-Rad). The fraction of bound probe was plotted against the total 
Cascade concentration, and the data fitted by nonlinear regression analysis to the 
following equation: Fraction bound probe = [Cascade]total / (Kd + [Cascade]total).
Phage M13 mutagenesis
Mutations of PAM sequence preceding the g8 protospacer were introduced into 
the M13 phage genome by QuickChange Site-Directed Mutagenesis Kit (Strata-
gene) as described previously ((315)).
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CRISPR repeat mutagenesis
Repeat mutant library was generated by QuickChange Site-Directed Muta- 
genesis Kit (Stratagene) according to manufactur’s protocol. The g8 CRISPR 
cassette plasmid targeting the M13 phage gene 8 (pWUR477-g8, described in (315)) 
was used as template. Mutations were introduced at positions -3, -2, or -1 of the 
repeat preceding the g8 spacer.
Phage infection studies
Cells sensitivity to wildtype and mutant M13 phages was determined by a spot test 
method as described (315) or using standard plaquing assay. Efficiency of plaquing 
was calculated as a ratio of the plaque number formed on a lawn of tested cells to 
the number of plaques on sensitive (non-targeting) cell lawn.
Transformation assay
K12 strains with cas genes fused to inducible promoters were transformed with 10 
ng of plasmid DNA by electroporation. Transformation efficiency was determined 
as colony forming units ratio for transformants of targeting strain (BW40119) to 
that of nontargeting strain (BW40114) (Table S1).
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absTraCT 
Most prokaryotes contain CRISPR-Cas immune systems that provide protection against mobile genetic elements. We have focused on the ability of CRISPR-Cas to block plasmid conjugation, and analysed the 
position of target sequences (protospacers) on conjugative plasmids. The analysis 
reveals that protospacers are non-uniformly distributed over plasmid regions in a 
pattern that is determined by the plasmid’s mobilization type (MOB). While MOBP 
plasmids are most frequently targeted in the region entering the recipient cell last 
(lagging region), MOBF plasmids are mostly targeted in the region entering the 
recipient cell first (leading region). To explain this protospacer distribution bias, 
we propose two mutually non-exclusive hypotheses: (1) spacers are acquired more 
frequently from either the leading or lagging region depending on the MOB type (2) 
CRISPR-interference is more efficient when spacers target these preferred regions. 
To test the latter hypothesis we analysed Type I-E CRISPR-interference against 
MOBF prototype plasmid F in Escherichia coli. Our results show that plasmid conju-
gation is effectively inhibited, but the level of immunity is not affected by targeting 
the plasmid in the leading or lagging region. Moreover, CRISPR-immunity levels 
do not depend on whether the incoming single stranded plasmid DNA, or the DNA 
strand synthesized in the recipient is targeted. Our findings indicate that single 
stranded DNA may not be a target for Type I-E CRISPR-Cas systems, and suggest 
that the protospacer distribution bias might be due to spacer acquisition pre- 
ferences.
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inTroduCTion
Bacterial and archaeal genomes have been shaped to a considerable extent by events of horizontal gene transfer (HGT)(266);(83). The three main routes of HGT are transformation (DNA uptake from the environment), trans-
duction (virus or phage mediated DNA transfer) and conjugation (plasmid transfer 
through mating between self-transmissible plasmid containing donor cells and 
plasmid free recipient cells)(350). Whether or not the invasion provides a fitness 
gain to the host depends on the nature of the incoming DNA (249; 326) and on 
the genetic background of the host (74; 82; 169; 178). In addition, the impact of a 
particular HGT event may depend on environmental parameters (134; 284; 289; 
326), such as the presence or absence of antibiotics, toxic metal ions and nutrients. 
Upon a change in environment, previously beneficial DNA may no longer provide 
a selective advantage, and instead can reduce host fitness (24). In addition to DNA 
uptake mechanisms, bacteria therefore require systems that either block the entry 
of alien DNA or can remove such DNA from the cell. 
CRISPR-Cas (Clustered Regularly Interspaced Short Palindromic Repeats/ 
CRISPR-associated) is a widespread prokaryotic adaptive and heritable immune 
system that specifically degrades non-self DNA from cells (142). Three main types of 
CRISPR-Cas systems are currently recognized (231), and these show many striking 
mechanistic and structural dissimilarities (reviewed in refs (392; 395)). A universal 
property of CRISPR-Cas systems is that they make use of a genomic CRISPR locus 
for integration of short sequences derived from invader genomes. The invader 
sequences (spacers) in a CRISPR array are typically 30 nt each and are separated 
from each other by host-derived repeating sequences of approximately the same 
size. The acquisition of new spacer sequences during the CRISPR-adaptation stage 
provides resistance against genetic elements containing cognate sequences (28; 79; 
343; 405). During the expression and interference stages, the CRISPR is transcribed 
into precursor CRISPR RNA, which is subsequently cleaved in the repeat sequences 
by a Cas endoribonuclease in Type I and Type III systems, and by RNaseIII in Type 
II systems (49; 60; 90; 296). The resulting processed crRNA is further trimmed 
from the 3’ or 5’ end in some cases (90; 149; 156), to yield mature crRNA species. 
Cas proteins utilize mature crRNAs to bind and cleave nucleic acids containing a 
complementary sequence (150; 151; 188; 191; 215; 393; 396; 413).
CRISPR systems appear to be active against all forms of invading DNA. A high 
number of studies have demonstrated that CRISPR systems can provide adaptive 
immunity against phage infections under laboratory conditions (28; 49; 93; 104; 124; 
174; 234; 293; 391). In addition, CRISPR-Cas systems can mediate plasmid curing 
and resistance against plasmid transformation (124; 235; 287; 315; 343; 393). A recent 
paper indicates that CRISPR systems can be active against conjugative transposons 
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(219), and two studies reported on CRISPR-mediated resistance against conjuga-
tive plasmids (108; 235). In agreement with this, analyses of the CRISPR content 
of bacteria from environmental samples recovered spacer sequences that match a 
variety of known viral and plasmid sequences (13; 39; 96; 250; 294; 360; 387), or that 
can even be used for identifying new mobile genetic elements (327).
Whereas CRISPR-mediated protection against virulent phages provides a clear 
selective advantage to the host cell, the outcome of targeting conjugative plasmids 
is expected to be crucially dependent on environmental parameters and accessory 
genes encoded by the plasmid. Excess baggage theory predicts that when a plasmid 
does not encode proteins that provide a selective advantage, the presence of the 
plasmid results in a fitness cost for the host (24). A number of experimental studies 
have indeed reported a fitness cost for the host associated with plasmid carriage 
(43; 74; 81; 134; 165; 178; 243). However, some studies have reported examples where 
plasmid carriage by a bacterial strain in the absence of selective pressure on plasmid 
maintenance does not incur a fitness cost to the host, or can even provide a fitness 
gain under laboratory growth conditions (107; 178; 403). It appears likely, however, 
that a host’s fitness cost or benefit for carrying a plasmid is strongly dependent 
on the environmental conditions (e.g. nutrient availability, temperature, presence 
of other mobile DNA elements, etc.). For example, a number of phages use pili 
encoded by conjugative plasmids as receptors for adsorption to the host cell (e.g. 
refs. (185; 195)). In contrast, certain plasmid-encoded toxin-antitoxin loci provide 
both plasmid stability and phage-resistance phenotypes, and are maintained in 
either the presence or absence of viruses (112). Hence, depending on the condi-
tions, plasmid loss can provide a fitness gain to the host cell. Plasmid fitness on 
the other hand is determined by their ability to spread both vertically (dependent 
on copy number (358), stable partitioning (par) genes (129) and multimer resolu-
tion systems (102)) and horizontally (dependent on conjugation mobility genes 
and plasmid size [transduction]) to new hosts. Furthermore, many plasmids carry 
genes encoding addiction systems (128; 370) to avoid segregational loss (reviewed 
in ref. (402)).
Here, we elaborate on the role of CRISPR-Cas systems in targeting conjugative 
plasmids. By analyzing all spacers that show complementarity towards plasmids 
containing an origin of transfer (oriT, the site that allows for plasmid transfer via 
conjugation), we demonstrate that protospacers are distributed non-randomly over 
these conjugative plasmids. While MOBP plasmids are most frequently targeted 
in the lagging region (the plasmid region entering the recipient cell last), MOBF 
plasmids are mostly targeted in the leading region (the plasmid region entering the 
recipient cell first). Next, we performed an in-depth analysis of spacers targeting 
conjugative plasmids belonging to the MOBF family, which is one of the best 
studied conjugative plasmid families. By studying the CRISPR-mediated targeting 
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of conjugative plasmid F by Escherichia coli, we experimentally show that the 
level of CRISPR interference appears to be independent of the target location on 
the plasmid (leading region versus lagging region). In addition, CRISPR-immu-
nity levels are similar for recipient cells targeting the incoming single stranded 
plasmid DNA, as for recipient cells targeting the DNA strand that is newly synthe-
sized in the recipient. Our findings indicate that single stranded DNA may not be 
a target for Type-I-E CRISPR-Cas systems. Furthermore, these data suggest that 
either spacers are derived more frequently from the leading region of MOBF plas-
mids during CRISPR adaptation (possibly due to interrupted mating) or that, for 
unknown reasons, cells targeting the leading region have a higher Darwinian fitness 
as compared to cells targeting the lagging region of MOBF conjugative plasmids.
resulTs
CRISPR systems are biased towards targeting specific regions of conju-
gative plasmids 
Conjugative plasmid transfer is a multistep process (reviewed in (122; 207)) that 
requires an oriT and a set of transfer proteins encoded by the transfer region of 
the plasmid. Contact between a plasmid-encoded pilus of a donor cell and the cell 
surface of a recipient cell leads to a mating signal, pilus retraction and conjuga-
tive pore formation (101). Next, an oriT relaxosome complex is formed that causes 
nicking of one strand of the oriT. The relaxosome interacts via the coupling protein 
with the Type IV secretion system (218). Starting with the 5’ end (leading region), 
the nicked strand of the plasmid DNA is then transferred from the donor to the 
recipient cell. After the leading region enters the recipient cell first, conjugation 
generally proceeds until the entire plasmid is transferred. Mating is completed 
when the plasmid DNA in the recipient cell is re-circularized and the complemen-
tary DNA strand is synthesized.
The well conserved directionality of conjugative plasmid transfer may have implica-
tions for target selection/recognition during CRISPR adaptation and interference, 
since the timing of DNA entry is different for sequences within the leading region, 
which enter the cell first, than for sequences within the lagging region, which enter 
the recipient cell last. To investigate this, we used an in silico approach to check for 
a correlation between the location of protospacers (leading versus lagging regions) 
and the frequency they are being acquired as a spacer by a CRISPR system. Slightly 
more than 70,000 spacers sequences (of which roughly 65,000 were unique) were 
obtained from the CRISPRdb (142) and were locally blasted against 3,167 plasmid 
sequences taken from Genbank. After removing duplicate spacers, self-targeting 
spacers (e.g. when a CRISPR-locus is located on a megaplasmid), as well as spacers 
having multiple hits on the same target plasmid, we found that 30% of this subset 
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Figure 1. Spacers from CRISPRdb targeting conjugative plasmids. 
A) Conjugative plasmids, of which the oriT site and the relaxase gene could be identified, were 
screened for homology with spacers from the CRISPRdb. After establishing the leading and lagging 
regions of the plasmid, by taking into account the location of the relaxase relative to the oriT site, 
the distance of each spacer hit from the oriT site is expressed as a percentage of the total plasmid 
size. These values are depicted as open circles on the plasmid map (left). The red line indicates 
the protospacer density at the respective position. The protospacer distribution is also shown in a 
histogram (right). To this end, the plasmid is divided into 10% segments (i.e. plasmid fragments 
corresponding to 10% of the plasmid size). When equally distributed, each 10% segment would car-
ry 10% of all protospacers. The actual percentages of protospacers present in each 10% segment are 
indicated by the blue bars. B) A similar analysis as in (A) was performed, but using only the MOBF 
family of conjugative plasmids, and using the relaxase gene start position to calculate distances of 
the spacer hits.
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of spacers in the database match known plasmid sequences. Only protospacers 
from plasmid sequences containing an annotated oriT-feature (2.3% of all plas-
mids in the database) were selected for further analysis. To establish the direc-
tion of conjugation (and thereby identifying the leading and lagging regions), the 
oriT-containing plasmids were screened for the presence of relaxase genes, which 
are usually located in the lagging regions of the plasmid, in close proximity of the 
oriT (84; 325). Although the relaxase genes are not located at a fixed distance from 
the oriT, relaxase genes can be used as a marker gene for allocating lagging regions 
of a plasmid. 
This analysis revealed that 375 unique spacers target 39 different conjugative plas-
mids, yielding a total number of 506 protospacer sequences (Table 1), indicating 
that many spacers match multiple protospacers located on different, possibly 
related, plasmids. From this dataset, the shortest distance from each protospacer to 
the oriT was calculated and expressed as a percentage of the total plasmid size (Fig. 
1A). Since the oriT marks the boundary between leading and lagging regions of the 
plasmid, distance-scores smaller than 50% are indicative of spacers targeting the 
leading regions, while distance-scores larger than 50% represent spacers targeting 
the lagging regions.
To analyse whether the distribution of protospacers on these plasmids was random, 
we performed a statistical analysis using the Kolmogorov-Smirnov test. This test 
revealed a statistically significant difference between the observed protospacer 
distribution and a uniform protospacer distribution (P=0.044). The majority of 
spacers were found to target the lagging regions of these conjugative plasmids (Fig. 
1A). Apart from this, we also observed a slight bias towards protospacer occurrence 
in the leading region at distances between 10 and 20% away from the oriT. More-
over, a significant clustering of protospacers (P<0.05) was observed for 8 out of 
36 plasmids, as determined by comparisons of the circular distributions of proto-
spacers per plasmid to uniform distributions using Kuiper’s tests. If no clustering 
per plasmid would occur at all, the expected number of significant clustering (at 
P≤0.05) would be 0.05*36=1.8. In that case the probability to find 8 or more would 
be 0.00005. These analyses show that protospacers display significant clustering, 
and that they are slightly more often located within the lagging regions of conju-
gative plasmids.
The protospacer distribution bias is MOB family-dependent
Conjugative plasmids can be grouped into 6 different MOB families, based on the 
six different families of relaxase genes (119; 123; 325). It is envisaged that differ-
ences exist between the different MOB family plasmids with respect to the molec-
ular mechanism and kinetics of plasmid transfer. The observed bias towards 
targeting of the lagging region of conjugative plasmids may therefore be different 
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for different MOB families. To investigate this, the data shown in Fig. 1A were re- 
analysed for each MOB family independently (Fig. S1). While two families were not 
represented in this dataset due to the lack of annotated oriT (MOBH and MOBC), 
the results show that the targeting of lagging regions is most evident in the MOBP 
family (n=351). The MOBF family (n=42) however, shows a clear bias for targeting 
the leading regions.
To extend this analysis to conjugative plasmids lacking an annotated oriT, a comple-
mentary approach was carried out using annotated relaxase genes (325). This ana- 
lysis is warranted by the fact that relaxase genes are located in the lagging region of 
conjugative plasmids (84). The MOBF family is a well-characterized family of conju-
gative plasmids (123) that is well-suited for this approach due to two important 
characteristics. Firstly, the relaxase genes are well annotated (contrary to oriTs), 
allowing many members of this family to be included in our analysis. Secondly, 
the direction of transcription of the relaxase gene is (in the vast majority of cases) 
oriented away from the oriT (84), which can therefore be exploited as a marker to 
determine the directionality of the oriT, and hence the transition between leading 
and lagging regions can be predicted. 
Table 1 Specifications from the bioinformatics analysis of spacers targeting conjugative 
plasmids.
Database
Total spacersa 72431
     - unique 65574
Total plasmidsb 3167
     - annotated oriT and relaxase 48
     - annotated relaxase 127
Conjugative plasmids with annotated oriT and relaxase (Fig. 1A)
BLAST hits 506
Unique spacers 375
Unique plasmids 39
Conjugative MOBF plasmids with annotated relaxase (Fig. 1B)
BLAST hits 1213
Unique spacers 815
Unique plasmids hits 70
aCRISPRdb (http://crispr.u-psud.fr/crispr/)
bGenbank plasmid database (ftp://ftp.ncbi.nlm.nih.gov/genomes/Plasmids/)
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In this way, 127 different MOBF-plasmids with known relaxase gene orientations 
were obtained, and these were used for screening the spacer BLAST-hits database. 
This revealed a total number of 1213 protospacers on 70 different MOBF plasmids, 
resulting from 815 unique spacers (Fig. 1B, Table 1). Since the exact position of 
the oriT site could not be determined, the distance-scores were calculated as the 
shortest distance from each protospacer to the start of the relaxase gene.
Checking for overall distribution of spacer hits over the MOBF plasmids (analyzing 
the position relative to the relaxase gene) through the Kolmogorov-Smirnov test, 
showed a significant deviation from the uniform distribution (P=0.0025). Proto-
spacers are most frequently located approximately ~40% of the plasmid size away 
from the relaxase gene (Fig. 1B). Although the oriT is not taken into account in this 
analysis, based on the previous analysis of MOBF plasmids containing an annotated 
oriT (Fig. S1) it is likely that this region corresponds to the leading region of the 
plasmid. In addition, significant clustering (P<0.05) of protospacers was observed 
for 17 out of 68 plasmids, as determined by comparisons of the circular distribu-
tions of spacer hits per plasmid to uniform distributions using Kuiper’s tests. The 
frequency of plasmids that show statistically significant clustering (17 out of 68) is 
substantially more than expected by chance (P<0.00001). 
CRISPR targeting of conjugative plasmid F predominantly occurs with-
in the leading region
To experimentally investigate the functional importance of the enriched targeting 
of MOBF conjugative plasmids within the leading region, we selected plasmid F 
as an exemplary case. The approximately 100 kb conjugative plasmid F (Fig. 2A) 
was discovered over 60 years ago as a sex factor in E. coli K12 (208), and has been 
well-studied over the past decades. It encodes the CcdAB toxin/anti-toxin system 
(encoded roughly at position 46.5k of plasmid F) to prevent plasmid loss: the stable 
CcdB toxin targets the E. coli gyrase in the absence of the short-lived CcdA anti-
toxin (which therefore is absent in plasmid-cured cells) (reviewed in (71)). Plasmid 
F belongs to the MOBF1 subfamily of conjugative plasmids, which includes many 
members belonging to the IncF, IncN, IncW and IncP9 incompatability groups 
(123). Most plasmids belonging to the MOBF1 subfamily are hosted by Gamma- 
Proteobacteria (123).
The large size of plasmid F, together with the existence of F-specific phages, 
indicate that, depending on the conditions, plasmid F can be a fitness cost to 
the host. In accordance with this, in silico analysis reveals that CRISPRdb (142) 
contains 17 spacers that match the plasmid F sequence (e-value < 0.05) (Fig. 2D). 
Of these spacers, 8 are found in CRISPR loci of E. coli strains ED1, LF82, UM146 
and O83:H1 NRG857C, whereas the other 9 spacers are found in CRISPR loci of 
the following Gamma-Proteobacteria: Klebsiella variicola At-22, Klebsiella oxytoca 
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E718, Pectobacterium carotovorum PC1 (a.k.a. Erwinia carotovora) (all belonging 
to the Enterobacteriacaea) and Cellvibrio japonicus Ueda107, and in CRISPR loci 
of Firmicutes (Caldicellulosiruptor bescii DSM 6725, Caldicellulosiruptor lactoace-
ticus 6A), Ignavibacteria (Ignavibacterium album JCM16511) and Archaea (Ther-
mococcus onnurineus NA1 and Desulfurococcus kamchatkensis 1221n). In accor-
dance with its classification in the MOBF subfamily, most spacers (12 out of 17) were 
found in species belonging to the class of Gamma-Proteobacteria. F-like plasmids 
have a narrow host range, which is restricted to enteric bacteria (e.g. Escherichia, 
Klebsiella and Erwinia spp) (259; 415). The observation that non-enteric species 
contain spacers that give a significant BLAST hit with plasmid F may arise from the 
possibility that these strains host related plasmids, or, alternatively, these strains 
may have experienced invasion by plasmid F, despite the fact that they cannot host 
this plasmid, as described before (23; 86). In agreement with the previous analysis, 
the majority (9 out of 17) of the spacers target plasmid F sequences close to the 
oriT (Fig. 2A and 2B), within the leading region. The majority of protospacers is 
located approximately 40% upstream of the relaxase gene traI (Fig. 2C), similar 
to the general trend that was observed for the entire MOBF family (Fig. 1B). This 
further substantiates the finding that MOBF family conjugative plasmids are mainly 
targeted within the leading region. 
The Type I-E CRISPR-Cas system of E. coli K12 provides immunity 
against conjugative plasmid F
Next, we analysed whether the E. coli K12 Type I-E CRISPR system provides protec-
tion against conjugative invasion by plasmid F. The Type I-E system consists of 
8 cas genes (cas3, cse1, cse2, cas7, cas5, cas6e, cas1 and cas2) and CRISPRs with 
type-2 repeats (Fig. 3A) (201). Expression of the cse1 to cas2 operon is repressed 
by H-NS (297) and can be activated by LeuO (391), or by the BaeSR two-compo-
nent pathway (27; 287). To test for resistance against conjugation, we made use 
of the plasmid F-derived pOX38-Tc, which corresponds to the largest HindIII 
fragment of plasmid F, and contains a tetracycline resistance marker (Fig. 3B). 
Two synthetic CRISPRs were used to test for resistance against plasmid invasion. 
Figure 2. Spacers from CRISPRdb targeting plasmid F 
A) Map of plasmid F indicating the size of the plasmid and the location of the origin of transfer 
(oriT), the relaxase gene, the leading region (which enters the recipient cell first) and the transfer 
region (which encodes the genes essential for plasmid transfer). Asterisks indicate the approximate 
positions of the protospacers listed in (D). B) Similar analysis as presented in Fig. 1A, where the 
distance of each spacer hit on plasmid F from the oriT or C) from the relaxase gene is calculated and 
expressed as a percentage of the total plasmid size. D) Alignments of spacer sequences (“Query”, top 
sequences) and the corresponding plasmid F sequences (“Sbjct“, bottom sequences). The species, 
CRISPR and spacer are indicated above each alignment, following the nomenclature used by the 
CRISPRdb. The numbers adjacent to the alignment indicate the position of the spacer and proto-
spacer sequence, respectively.
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Figure 3 A synthetic anti-pOX CRISPR provides resistance against conjugational 
plasmid transfer. 
A) The Type I-E CRISPR-Cas system of E. coli contains 8 cas genes and a downstream CRISPR with 
type 2 repeats. Promoter elements (pcas3, anti-pcas, pcas and pCRISPR) are indicated by arrows. B) A plas-
mid map of the F-plasmid with all HindIII sites. The origin of transfer (oriT) is indicated by a black 
triangle, the leading and transfer regions of the plasmid are indicated with arrows. The plasmid F 
derived pOX38-Tc corresponds to the largest HindIII fragment of plasmid F, and contains a tetracy-
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CRISPR-J4 contains 4 identical spacers that target a sequence of phage Lambda, 
and serves as a negative control (Fig. 3C). CRISPR-F contains 5 different spacers 
that target the pOX38-Tc plasmid. Four of the spacers are randomly distributed 
over the plasmid backbone, whereas a fifth spacer targets the tetracycline resis-
tance gene (Fig. 3B and 3D).
Wild type E. coli K12 (recipient), transformed with plasmids containing either 
CRISPR-J4 or CRISPR-F, shows conjugation efficiencies of ~5 x 10-4 transcon-
jugants/donor with MC4100/pOX38-Tc as donor (Fig. 3E). The lack of 
CRISPR-dependent resistance to plasmid conjugation in E. coli K12 is in agree-
ment with the previously reported silencing of cas gene expression in this strain by 
H-NS (297; 391). When E. coli K12Dhns transformed with CRISPR-F served as a re- 
cipient strain, a ~50-fold CRISPR-dependent reduction in conjugation efficiency 
was observed as compared to the same strain transformed with CRISPR-J4 (Fig. 3E). 
Conjugation efficiencies in the K12Dhns strains (~2 x 10-5 transconjugants/donor) 
appear to be ~100 fold lower than in the wild type cells, which is likely due to growth 
inhibition caused by hns deletion (29).
When the same conjugation experiments were performed using E. coli BL21(DE3) 
transformed with plasmids encoding cas genes and CRISPR as a recipient strain 
(and MC4100/pOX38-Tc as donor), high level CRISPR-interference was observed 
(104-fold reduced conjugation efficiency compared to recipient cells carrying a 
non-targeting CRISPR) when cas gene and CRISPR expression were not induced. 
Conjugation was entirely abrogated when expression of cas genes and CRISPR was 
induced with IPTG (Fig. 3F). This demonstrates that E. coli K12 and BL21(DE3) 
strains are efficiently protected against conjugative invasion by plasmid pOX38-Tc.
cline resistance marker. The positions of the protospacers targeted by the synthetic anti-pOX CRIS-
PR indicated in (D) are indicated by colored boxes and labeled with the name of the spacer that 
targets the site (i.e. sp1-5). C) Schematic representation of the non-targeting CRISPR J4, which con-
tains 4 identical spacer sequences targeting the J gene of phage Lambda. D) Schematic representa-
tion of the targeting CRISPR-F, which contains 5 different spacer sequences targeting sequences of 
pOX38-Tc. The positions of the target sequences are indicated in (B) by colored boxes and labeled 
with the name of the spacer that targets the site. E) Conjugation efficiencies using E. coli MC4100 
+ pOX38-Tc as a donor strain and E. coli K12 or E. coli K12Dhns transformed with a plasmid carrying 
either CRISPR-J4 or CRISPR-F as recipient strains. F) Conjugation efficiencies using donor strain 
as in (E) and either induced or uninduced E. coli BL21 (DE3) transformed with either CRISPR-J4 or 
CRISPR-F as recipient strains. Conjugation efficiencies are expressed as transconjugants/donor.
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Figure 4. Interference levels of CRISPRs targeting leading regions as compared to 
CRISPRs targeting non-leading regions. 
A and B) Synthetic CRISPR constructs targeting plasmid F are shown together with the coordinates 
of the corresponding protospacer on plasmid F. Four CRISPRs contain a spacer at the second posi-
tion in the array that targets the leading region of plasmid F (IE1, IE2, SE1, SE2) and four additional 
CRISPRs target the lagging region of plasmid F (IL1, IL2, SL1, SL2). Of these CRISPRs, four target 
the incoming strand of plasmid F (IE1, IE2, IL1, IL2) and four CRISPRs target the synthesized strand 
of plasmid F (SE1, SE2, SL1, SL2). C) Efficiency of conjugation (#transconjugants/#donor) from E. 
coli MC4100 donor cells carrying pOX38-Tc to E. coli K12Dhns transformed with any of the CRISPRs 
shown in (A). D) Efficiency of conjugation (#transconjugants/#donor) from E. coli MC4100 donor 
cells carrying pOX38-Tc to E. coli K12Dhns transformed with any of the CRISPRs shown in (B). 
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Resistance levels conferred by Type I-E CRISPR-Cas is independent of 
the DNA strand and the region of plasmid F that is being targeted
The experimental system of CRISPR-mediated resistance in E. coli K12Dhns against 
plasmid pOX38-Tc that is described above allows for testing hypotheses that may 
explain the observed bias towards preferential targeting of leading sequences of 
MOBF conjugative plasmids under conditions that do not make use of overexpres-
sion of CRISPR and cas genes. A possible reason for the observed bias could be 
that cells containing spacers targeting the leading region of a MOBF conjugative 
plasmid are more resistant to conjugation than cells targeting the lagging region. 
To investigate this, 4 synthetic CRISPRs were designed, 2 of which contain a single 
spacer that target the leading region of pOX38-Tc, while the other 2 CRISPRs 
target the lagging region of pOX38-Tc (Fig. 4A). All 4 CRISPRs target the incoming 
strand of pOX38-Tc. The CRISPRs targeting the leading sequence were named 
CRISPR-F-IE1, CRISPR-F-IE2 (Incoming Early 1 and 2 [i.e. targeting the leading 
region of the incoming strand]). The CRISPRs targeting the lagging region were 
named CRISPR-F-IL1, CRISPR-F-IL2 (Incoming Late 1 and 2) (Fig. 4A).
Conjugation efficiencies (transconjugants/donor) of pOX38-Tc from MC4100 donor 
cells to E. coli K12Dhns transformed with any of these 4 synthetic CRISPRs are shown 
in Figure 4C. Some spacer sequences are more effective in protecting against plasmid 
transfer than other spacers: CRISPR-F-IE1, CRISPR-F-IL1 provide high levels of 
resistance (~100-fold reduction in conjugation efficiencies), whereas CRISPR-F-IE2 
provides a lower level of resistance (15-fold reduction in conjugation efficiencies). 
Interestingly, the level of immunity conferred by the CRISPR-F variants appears to 
be independent of the plasmid target region (i.e. leading versus lagging regions). 
Since no differences in immunity levels were found, the observed protospacer distri-
bution bias is unlikely to be due to differences at the level of CRISPR-interference.
During plasmid conjugation, single stranded plasmid DNA is transferred by a 
Type IV secretion system from the donor to the recipient cell, and synthesis of the 
complementary DNA strand is generally believed to occur after re-circularization 
of the conjugative plasmid in the recipient cell (144). At present it is unknown 
whether Type-I-E CRISPR-Cas systems target single stranded DNA. To test whether 
differences exist in CRISPR immunity levels that are associated with the DNA 
strand that is being targeted, 4 additional synthetic CRISPRs were constructed 
that target the synthesized strand of pOX38-Tc. Of these 4 CRISPRs, 2 target the 
leading region and 2 target the lagging region of pOX38-Tc (Fig. 4B). These CRISPRs 
were named CRISPR-F-SE1 and CRISPR-F-SE2 (Synthesized Early 1 and 2) and 
CRISPR-F-SL1 and CRISPR-F-SL2 (Synthesized Late 1 and 2) (Fig. 4B). 
CRISPR immunity levels appear to be independent of the plasmid strand that is 
being targeted, as determined by measuring the conjugation efficiencies (transcon-
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jugants/donor) of pOX38-Tc from MC4100 donor cells to E. coli K12Dhns carrying 
the CRISPR-F variants (Fig. 4D). Again, some variation exists in the levels of immu-
nity. Since the AT-content of the spacers and the PAM sequences flanking the proto-
spacers are identical in all cases, this suggests that additional factors play a role in 
determining the level of interference conferred by a spacer sequence. Altogether, 
it seems that the level of resistance is independent of whether the leading or the 
lagging region is being targeted by a CRISPR spacer and whether the incoming or 
synthesized strand is being targeted. These data indicate that single stranded DNA 
may not be a target for Type I-E CRISPR-Cas systems, and suggest that the proto-
spacer distribution bias might be due to spacer acquisition preferences.
disCussion
CRISPR/Cas systems are highly versatile immune systems that can block invading 
DNA to provide immunity against phage infections, prevent transfer of conjuga-
tive plasmids or transposons, and can remove resident DNA such as plasmids. The 
spacer content of CRISPRs in natural populations appears to be highly dynamic, 
with frequent spacer acquisition and spacer loss (13; 96; 146; 219; 295; 360; 387; 
389; 399). The adaptive properties of CRISPR-Cas make them uniquely capable of 
modulating the mobilome of a species (219). Indeed, these systems are well suited 
to remove a given DNA element, such as a conjugative plasmid, when such an 
element is associated with a fitness cost. If environmental conditions change such 
that the DNA element provides a selective advantage, natural selection will favor 
clones that have lost or mutated the corresponding spacer sequence.
In this study we have analysed the role of CRISPR-Cas in providing resistance 
against conjugative plasmids. Screening for spacers matching conjugative plasmid 
sequences revealed that their cognate target sequences are not randomly dispersed 
along the plasmid DNA sequence. Instead, our analysis showed that spacers pre- 
ferentially target the lagging region, while a smaller trend for targeting the leading 
region could also be observed (Fig. 1A). The different conjugative plasmids included 
in this analysis were selected on the basis of an annotated oriT site, which might 
not be representative for the whole population of conjugative plasmids. Indeed, 
the dataset was enriched for three particular classes of conjugative plasmids: MOBP 
(n = 351, 69%), MOBF (n = 42, 8%) and MOBQ (n= 33, 6.5%) (Fig. S1). Interestingly, 
MOBP-class plasmids were found to be mainly targeted in the lagging regions, 
while MOBF-class plasmids are more often targeted in the leading regions. The 
rationale for this is currently unclear.
Since the total number of MOBF plasmids containing an annotated oriT was rather 
low (n=42), we conducted a complementary approach by screening all known MOBF 
plasmids for the presence of a relaxase gene and using its start position to calculate 
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relative distances to the target sequences. The orientation of plasmid transfer was 
established by the direction of transcription of the relaxase gene that is pointing 
away from the oriT (84). In agreement with the first analysis, this approach demon-
strated that spacer sequences targeting MOBF family conjugative plasmids are 
significantly enriched for sequences that likely correspond to the leading region of 
these plasmids (Fig. 1B). The results clearly demonstrate that CRISPR-Cas-targeted 
regions on conjugative plasmids are not randomly dispersed, which is reinforced 
by the finding that protospacers on the same plasmid are significantly clustered. 
It should be kept in mind that we did not determine whether the protospacers found 
by BLAST searches would still support CRISPR interference, as our analysis lacks the 
ability to take into account biologically important features for the various CRISPR/
Cas types such as the presence of a PAM (39; 174; 253) and seed region of the proto-
spacer (315; 396). In addition to the protospacer distribution analysis presented here, 
it would also be interesting to investigate whether a bias exists for the strand of the 
conjugative plasmid that is being targeted. Unfortunately, the direction of trans- 
cription of most CRISPR arrays listed in the CRISPRdb is unknown, hence making it 
impossible to determine which strand of the conjugative plasmid is being targeted. 
Nevertheless, the distribution of protospacers on conjugative plasmids, even when 
these protospacers no longer support CRISPR interference due to escape mutations, 
provides a valuable insight into host defense strategies against conjugative plasmids.
Using plasmid F as an exemplary case, we have investigated the biological basis 
for the biased protospacer distribution. We propose two explanations that are not 
mutually exclusive. The first explanation would be a bias occurring at the level 
of CRISPR adaptation. This hypothesis suggests that sequences from the leading 
region of MOBF plasmids are preferentially selected for integration as a novel 
spacer into a CRISPR array. Such an effect could for example be caused by inter-
rupted mating events (i.e. the process where a mating pair is disrupted during 
conjugational plasmid transfer), which leads to partial transfer of the conjugative 
plasmid DNA. Hence, only DNA entering the recipient cell first (corresponding 
to the leading region) would be transferred and subsequently be available for a 
spacer integration event in the recipient cell. Since the incoming DNA is single 
stranded during plasmid conjugation, this model would have implications for the 
mechanism of spacer acquisition (i.e. single stranded pre-spacers would need to 
be substrates for spacer acquisition) (113; 343; 392). We have aimed to examine this 
hypothesis by following spacer integration under laboratory conditions in response 
to plasmid F, using both E. coli K12Dhns cells and E. coli K12Dcse1 cells as recipients. 
Whereas spacer acquisition into the Dhns strain would be subject to selection both 
at the level of CRISPR adaptation and at the level of CRISPR interference, spacer 
acquisition into the Dcse1 would be subject to selection at the level of CRISPR adap-
tation only (this strain displays high level expression of the cas genes downstream 
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of the integrated kanamycin resistance cassette (293)). Hence, differences between 
newly acquired spacers by these two strains with respect to the regions that are 
being targeted would provide insight into the biological basis causing the biased 
targeting of the leading region of MOBF plasmids. However, despite numerous 
attempts, spacer acquisition in response to conjugative plasmid transfer could not 
be observed (data not shown). This observation contrasts with previously described 
spacer acquisition during non-mobile plasmid curing by E. coli K12Dhns (343).
An alternative explanation for the biased targeting of the leading region of MOBF 
conjugative plasmids would be that this leads to more efficient CRISPR-interfe- 
rence as compared to targeting other regions of the conjugative plasmid. However, 
using synthetic CRISPRs targeting either the leading or the lagging region of 
plasmid F, we found no evidence for differences in resistance levels. In addition, we 
did not observe differences in the effectiveness of CRISPR arrays targeting either 
the incoming strand directly or the synthesized strand, which might suggest that 
CRISPR interference takes place on the double stranded protospacer target.
One factor that could influence both CRISPR-adaptation and interference is local 
DNA topology (390; 393), which can be influenced by DNA structuring proteins, 
such as H-NS (75; 77; 282; 357). This could cause increased exposure of defined 
regions of the plasmids to the integration and interference machineries. These 
regions may for example be linked to transcriptionally active or inactive regions 
and may be conserved within MOB plasmid families. 
In addition to the analyses presented here, it will be interesting to perform compe-
tition experiments between strains carrying different CRISPR-F variants, in order 
to obtain insight into Darwinian fitness associated with resistance and possible 
differences between strains due to the plasmid region that is being targeted. One 
possibility that we consider is that MOBF plasmid-encoded addiction systems may 
cause toxic effects when the plasmid is targeted in the lagging region, while this 
toxic effect is avoided by targeting of the leading region, since the plasmid will 
be degraded earlier during conjugation. Such effects may not influence resistance 
levels but could affect Darwinian fitness of the host.
This study has demonstrated that the E. coli CRISPR-Cas system effectively protects 
against conjugative plasmid transfer. Furthermore we have shown that a biased 
protospacer distribution exists on conjugative plasmids, which is MOB-family 
dependent. Whereas some MOB families are mainly targeted within the leading 
regions (e.g. MOBF), others are targeted more frequently within the lagging regions 
(e.g. MOBP). Future research is required to explore the biological factors that cause 
this biased protospacer distribution. The hypotheses that are proposed in this 
study aim to provide a framework for this exciting field of research.
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exPerimenTal ProCedures
Strains, Gene cloning, Plasmids and Vectors
E. coli K12, E. coli K12Dhns and E. coli BL21 (DE3) strains were used throughout the 
study as recipient strains. MC4100 transformed with pOX38-Tc (15)was used as a 
donor strain. Plasmids pWUR400 and pWUR397, which encode the Cascade genes 
and cas3, have been described previously (49; 191), and pWUR692, which encodes 
CRISPR-F, or pWUR691, which encodes CRISPR-J4  were used to express the cas 
genes and CRISPR in BL21(DE3). Synthetic CRISPRs were expressed in E. coli 
K12Dhns by introducing the following plasmids: pWUR692 (CRISPR-F), pWUR691 
(CRISPR J4), pWUR693 (CRISPR-F-IE1) pWUR694 (CRISPR-F-IE2) pWUR695 
(CRISPR-F-IL1) pWUR696 (CRISPR-F-IL2) pWUR697 (CRISPR-F-SE1) pWUR698 
(CRISPR-F-SE2) pWUR699 (CRISPR-F-SL1) pWUR700 (CRISPR-F-SE2). CRISPR 
encoding plasmids were generated by subcloning synthetic CRISPRs (GeneArt) in 
pACYC-duet vectors using the NcoI and KpnI sites. A full description of the plas-
mids used in this study is provided in Supplemental Table 1.
Bioinformatics analyses
Spacer sequences (taken from the CRISPRdb website (http://crispr.u-psud.fr/
crispr/)) and plasmid sequences (taken from the Genbank FTP site (ftp://ftp.ncbi.
nlm.nih.gov/genomes/Plasmids/)) were collected at 26 September 2012. Conju-
gative plasmids sequences were extracted from the initial plasmid database by 
screening them for the oriT feature key or by screening for annotated relaxase genes 
(123). In some cases, identification of the relaxase gene was performed by manual 
inspection of the plasmid’s feature table. BLAST (version.2.27) was used to screen 
for spacers hits in a locally generated BLAST database that was constructed using 
the above-mentioned plasmids. The BLAST settings included a word-size of 7, with 
an expectation value threshold of 0.1. The cost to open and extend a gap were set at 
5 and 2 respectively, with a +1 reward for nucleotide matches, and a -1 penalty for 
nucleotide mismatches. Results were imported in Excel for further processing and 
to calculate the distances.
Statistical analysis
For statistical analysis we used the R program, version 2.14.2, especially the 
R-package circular (223). To test for possible clustering of spacer hits within the 
plasmids, the Kolmogorov-Smirnov test was applied, which compares the distribu-
tion of spacer hits over the plasmids (relative to oriT in one analysis, and relative 
to the relaxase gene for the other analysis, as indicated in the text) to the uniform 
distribution. For this analysis, the spacer position within a plasmid was speci-
fied as a percentage of plasmid size, with small percentages indicating positions 
close to the reference site (oriT / relaxase) in the direction of the leading region 
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of the plasmid . A percentage of 50% indicates a position on the plasmid opposite 
the reference site and a percentage close to 100% indicates a position close to the 
reference site, in the lagging region of the plasmid.
To test for clustering of spacers within individual plasmids, we chose a circular 
approach, so that e.g. spacers on positions 1% and 99%, far apart on the linear 
scale, were close together on the circular scale. Testing for uniformity of the 
circular distribution of spacers per plasmid was done applying Kuiper’s test. To 
test whether the number of plasmids with significant clustering was higher than 
expected by chance, we performed a binomial test.
Conjugation experiments
Conjugation experiments were performed by diluting an overnight culture of the 
donor strain MC4100 carrying pOX38-Tc 1:50 into fresh LB supplemented with 
tetracycline (10 mg/ml) and by diluting an overnight recipient strain 1:50 into LB 
supplemented with the appropriate antibiotics. When donor and recipient cells 
reached an OD600 of 0.6 they were transferred into fresh LB lacking antibiotics: 
0.25 ml donor cells and 1 ml recipient cells were added to 5 ml LB. Conjugation was 
allowed for 4 hours at 37°C without shaking. For the experiments where BL21(DE3) 
served as a recipient strain, 1 mM IPTG was added to the medium during conju-
gation. Next, cells were plated on LB containing 1.5% agar and appropriate anti-
biotics (i.e. tetracycline (10 mg/ml) for plating MC4100 + pOX38-Tc donor cells; 
kanamycin (50 mg/ml) and chloramphenicol (34 mg/ml) for plating recipient Dhns 
strains carrying CRISPR-encoding pACYC-duet plasmids; kanamycin, strepto-
mycin (50 mg/ml) and chloramphenicol for plating recipient BL21 (DE3) strains 
carrying CRISPR-encoding pACYC-duet plasmids, Cascade-encoding pCDF1-b 
and Cas3-encoding pRSF1b; both tetracycline and chloramphenicol to plate 
transconjugants). Colony counting allows for calculation of conjugation efficien-
cies (expressed as #transconjugants/#donor cells).
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summary
This thesis is about the regulation and molecular mechanism of the Type I-E CRISPR-Cas system of Escherichia coli. This recently discoved adaptive immune system of prokaryotes against invading DNA relies on small RNA 
molecules that guide the defense. As is described in Chapter 1, small non-coding 
RNA molecules are well known to be important in bacteria for regulating gene 
expression and enzyme activity. However, until recently, it was unknown that small 
RNAs are also involved in prokaryotic defense against mobile genetic elements. As 
outlined in Chapter 2, prokaryotes contain a number of defense mechanisms, some 
of which, such as restriction/modification, superinfection exclusion and receptor 
masking, have been well-studied over the past decades. Other systems, such as 
abortive infection and CRISPR-Cas, have been discovered much more recently. 
Chapter 2 provides an overview of the molecular mechanisms of these systems, 
and provides a detailed description of the three types of CRISPR-Cas, with an 
emphasis on the Type I-E system. Despite the high level immunity conferred by the 
E. coli K12 Type I-E CRISPR-Cas system when recombinantly (over)expressed in E. 
coli BL21-derived strains, this system appears to be repressed by H-NS (heat-stable 
nucleoid structuring protein) in the wildtype K12 strain under laboratory growth 
conditions. In Chapter 3 it is described how this repression can be relieved by 
LeuO, a LysR-type transcriptional activator, which often functions as an H-NS 
antagonist. It is demonstrated that H-NS and LeuO can bind the cas gene promoter 
upstream of cse1, and that LeuO blocks cooperative spreading of H-NS over this 
region of the DNA. Since H-NS is well known to bind AT-rich DNA, a model is 
suggested in which invasion by AT-rich DNA leads to sequestration of H-NS, 
which in turn leads to de-repressed transcription of the LeuO and Cascade-en-
coding genes. In Chapter 4 the stoichiometry of Cascade (Cse11Cse22Cas76Cas51- 
Cas6e1crRNA1), its low resolution Electron Microscopy structure and its DNA 
binding activity are described. It is shown that the crRNA guides Cascade to bind 
dsDNA targets ATP-independently through R-loop formation. Furthermore, the 
mature crRNA molecules were analyzed using ESI-MS, which demonstrated that 
the crRNAs retained by Cascade are 61 nt in length, corresponding to the length 
of a single spacer and a single repeat, and that they contain a 5’ hydroxyl and a 2’, 
3’ cyclic phosphate group. In Chapter 5 it is demonstrated that Cascade utilizes 
energy stored in negative supercoiling of target DNA, which facilitates R-loop 
formation between the crRNA and protospacer sequences located on large, bio- 
logically relevant dsDNA elements, such as plasmids. Efficient Cascade-mediated 
R-loop formation also requires the presence of either one of four different Proto-
spacer Adjacent Motifs (PAMs). Atomic Force Microscopy analysis of the resulting 
Cascade-DNA complexes reveals that Cascade is mostly located at the apex of a 
supercoiled loop when bound to a negatively supercoiled plasmid. Next, Cas3 is 
recruited to the Cascade-DNA complex via the Cse1 subunit. Cas3 nicks the target 
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DNA in a magnesium-dependent reaction, and degrades the target DNA by 3’ to 5’ 
exonucleolytic cleavage in a magnesium and ATP-dependent manner. In Chapter 
6, Cascade-mediated bending of DNA is analyzed in more detail. It is shown that 
Cascade induces flexibility rather than bending of the target DNA at the site of the 
R-loop, explaining why Cascade is mainly found at the apex of supercoiled loops of 
negatively supercoiled plasmids. Furthermore, in this chapter it is demonstrated 
that Cascade requires Cse1 for nonspecific binding to negative supercoiled DNA 
and Cse2 for specific binding to negative supercoiled DNA. Chapter 7 deals with 
the issue of distinguishing invader DNA from self DNA. It is shown that, unlike 
Type III-A CRISPR-Cas systems, Cascade does not utilize a mechanism that relies 
on differential base pairing between crRNA and either protospacer-flanking DNA 
(non-self) or the CRISPR repeats (self). Instead, Cascade specifically recognizes 
targets based on the presence of a PAM sequence adjacent to the target sequence, 
through Cse1-mediated PAM recognition. Finally, in Chapter 8 CRISPR-mediated 
resistance against conjugative plasmids is analyzed in detail. Using in silico analysis, 
it is demonstrated that protospacers on MOBP conjugative plasmids are mostly 
located within the lagging regions of these plasmids (corresponding to plasmid 
regions that enter the recipient cell during the late stage of conjugational plasmid 
transfer), whereas protospacers on MOBF conjugative plasmids are mostly located 
within the leading region (entering the recipient during early stages of transfer). 
Using conjugative plasmid F it is shown that resistance levels conferred by spacers 
are independent of the plasmid region (leading vs. lagging) that is being targeted. 
Hence, understanding the biological basis of the biased protospacer distribution 
on conjugative plasmids requires future studies.
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ongoing researCh
The Type-I-E CRISPR-Cas system present in E. coli is arguably the best studied prokaryotic adaptive immune system. A number of mechanistic insights into the functioning of this system are described in this thesis. A key 
player of Type-I-E CRISPR-defense is ribonucleoprotein complex Cascade. It is well 
appreciated that Cascade functions as a surveillance complex during CRISPR-in-
terference. It binds invader double stranded DNA containing a sequence comple-
mentary to the crRNA through R-loop formation, as is described in Chapter 4. 
However, it is less well-understood what steps precede R-loop formation and what 
the roles of the individual Cascade components are in establishing the R-loop 
structure. These topics are the main focus of ongoing research, and some results 
of these studies are presented below. As the experiments described here are still in 
progress, they should be treated as preliminary results.
Figure 1. UV crosslinking of crRNA 
and target DNA to Cascade. 
A) SDS-PAGE analysis of Cascade before 
and after crosslinking. Lane 1 (M) contains a 
protein marker. Lane 2 (C) contains Cascade 
before crosslinking and serves as a control. 
Lane 3 contains Cascade after crosslink-
ing using 1200 mJ/cm at 254 nm. Lane 4 
contains Cascade after crosslinking using 
6000 mJ/cm at 254 nm. B) Experiment as in 
(A) with Cascade before crosslinking (lane 
1) and Cascade after crosslinking using 6000 
mJ/cm at 254 nm (UV), before and after sub-
sequent RNase T1 treatment (lane 2 and 3). 
C) Experiment as in (A). Lane 1 corresponds 
to Lane 4 of Fig. 1A, containing Cascade after 
crosslinking using 6000 mJ/cm at 254 nm. 
Lane 2 contains Cascade bound to single 
stranded target DNA complementary to 
the crRNA after crosslinking using 6000 
mJ/cm at 254 nm. D) Experiment as in (C) 
with Cascade before crosslinking (lane 1) 
and Cascade after crosslinking using 6000 
mJ/cm at 254 nm (UV) in the absence of 
DNA (lane 2), and in the presence of ssDNA 
(complementary to the crRNA) before and 
after subsequent DNase I treatment (lane 3 
and 4). Asterisks indicate extra bands that 
appear upon crosslinking.
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Mass Spectrometry approach to map Cascade nucleic acid interactions
Recently a cryo-EM structure of Cascade has been presented with a resolution of 8 
Å (394). This structure has revealed the positions of all individual subunits within 
the seahorse-shaped complex and shows that the crRNA spans the entire complex. 
Cas6e, which is located at the nose of the seahorse, binds the stem-loop forming 
3’-handle of the crRNA. The crRNA runs over the Cas7 subunits, which form the 
core of the complex. The 5’-handle of the crRNA appears to be bound either by Cse1, 
Cas7 or Cas5. However, the current resolution of the available Cascade structures 
is insufficient to determine how the 5’-handle is bound to the complex. To obtain 
further insight into the Cascade-crRNA interactions, UV-crosslinking studies at 254 
nm followed by SDS-PAGE and mass spectrometry (MS) analysis were performed. 
This approach enables the direct identification of protein nucleic acid interactions 
(199; 332), reviewed in (302). Upon crosslinking with increasing intensities of UV 
at 254 nm, additional bands are observed on SDS-PAGE, while the intensity of the 
Cas5 band decreases (Fig. 1A). Addition of RNase T1 results in disappearance of a 
band on the SDS PAGE consistent with an RNA-protein crosslink (Fig. 1B). In gel 
trypsin digestion of the corresponding band followed by Mass Spectrometry ana- 
lysis revealed the identity of the crRNA crosslinked protein as Cas5. Interestingly, 
when Cascade was UV crosslinked in the presence of target DNA, a number of high 
molecular weight bands appeared on the SDS-PAGE (Fig. 1C). In addition, these 
bands were not present upon the addition of DNase I consistent with the forma-
tion of DNA-protein crosslinks (Fig. 1D). In gel trypsin digestion of these bands, 
followed by Mass Spectrometry analysis revealed the presence of Cse1, Cse2, Cas7 
and Cas5. These results indicate that all Cascade subunits except Cas6e participate 
in Cascade-mediated DNA binding through direct protein-DNA interactions. 
Non-specific DNA scanning mechanism
To specifically locate protospacer sequences among very large numbers of other 
sequences Cascade requires a mechanism to efficiently scan DNA molecules. The 
mechanism of scanning is unknown, but is expected to be crucially dependent on 
the nonspecific DNA binding activity of the complex. Several scanning mecha-
nisms utilized by other DNA binding proteins have been described in literature 
(reviewed in (137)). These include (1) sliding mechanisms, where proteins move 
along one or both strands of the DNA by 1D diffusion, (2) hopping mechanisms, 
where proteins dissociate from and re-associate with the DNA with intermittent 
3D diffusion, (3) intersegmental transfers, where proteins move from one stretch of 
DNA directly to another stretch that is closeby in 3D space, and (4) active transloca-
tion, where a motor protein drives directional movement over the DNA in a process 
coupled to nucleoside triphosphate hydrolysis (Fig 2A). Studying the mecha-
nism of DNA scanning prior to formation of specific protein-DNA complexes has 
proved technically highly challenging. Using ensemble experiments, insights have 
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been obtained into the scanning mechanisms utilized by some DNA interacting 
proteins. For example, EcoRV appears to scan DNA by using both 1D and 3D diffu-
sion as part of its target search mechanism, corresponding to a mixture of sliding 
over small distances and hopping over larger distances, which allows sampling of 
new DNA sequences (139; 140). Intersegmental transfer requires two DNA binding 
domains within a protein or protein complex, as well as looping of the DNA. Such 
DNA looping has been observed in a co-crystal structure of SfiI nuclease bound 
Figure 2 Cascade scans DNA through a 3D diffusion mechanism. 
A) Several scanning mechanisms have been proposed for sequence specific DNA binding proteins: 
sliding (1D diffusion over the DNA), hopping (3D diffusion involving dissociation from and re-asso-
ciation to the DNA), intersegmental transfer (direct transfer from one area of the DNA to another 
area) and active translocation (directional movement over the DNA driven by a motor enzyme). 
Figure adapted from (137). B) Plasmid map of pUC3xJ3, which contains 3 identical protospacers (ab-
breviated as PS1-3), that are flanked by BamHI sites. Digestion with BamHI yields protospacer-con-
taining DNA fragments of 150, 250 and 350 bp. C) Gel shift of pUC3xJ3 with J3-Cascade, followed 
by BamHI cleavage. Each of the protospacer-containg fragments (150, 250, 350 bp) is indicated. The 
Cascade-bound form of these DNA fragments does not enter the gel and hence is not visible; Cas-
cade DNA binding to a protospacer-containing DNA fragment thus leads to a reduced intensity of 
the corresponding band. D) Fraction protospacer bound as a function of the Cascade concentration, 
and fitted with y = x/(KD+x).
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to DNA (87), which has been interpreted as being suggestive of intersegmental 
transfer as a scanning mechanism for this enzyme (152). Recent advances in Total 
Internal Reflection Fluorescence (TIRF) Microscopy have allowed for more detailed 
analysis of facilitated diffusion of DNA binding proteins at the single molecule 
level. One such single molecule study on two distinct DNA repair complexes has 
demonstrated that one of these complexes utilizes a hopping mechanism, whereas 
the other utilizes a sliding mechanism (138). The mechanism of DNA scanning 
by these complexes has implications for their ability to traverse obstacles, such 
as nucleosomes. In the case of active translocation of the RecBCD complex, such 
obstacles are simply being pushed over the DNA in the direction of RecBCD move-
ment until the obstacles fall off the DNA (114). As Cas ribonucleoprotein complexes 
do not utilize ATP or other chemical energy sources, active translocation as a scan-
ning mechanism can be ruled out. In the light of the recent interest of using Cas 
ribonucleoprotein complexes for genome editing (48; 58; 188), it will be relevant 
to study DNA scanning behavior of Cascade and other Cas complexes in order to 
understand and predict the effects of protein obstacles, which are very abundant 
in the highly organized eukaryotic genome, on Cascade DNA scanning efficiencies.
To obtain some initial insights into the scanning mechanism employed by Cascade, 
gel shift assays were conducted with a newly designed plasmid, denoted pUC3xJ3, 
which contains three identical target sites (Fig. 2B). By analyzing the binding 
behavior of Cascade to each of the three protospacers on the plasmid it can be 
inferred whether Cascade scans DNA by 1D diffusion (sliding mechanism) or by 
3D diffusion (hopping or intersegmental transfer mechanism). In case of Cascade 
scanning through 1D diffusion, the protospacer in the middle (protospacer 2; ps2) 
is expected to be less frequently bound by Cascade than the outer protospacers (ps1 
and ps3) due to the larger size of the non-target DNA flanking ps1 and ps3, which 
serves as an initial non-specific binding site for Cascade. BamHI digestion of the 
pUC3xJ3 plasmid yields 4 products of ~2.6 kb, 350 bp, 250 bp and 150 bp, corre-
sponding to the plasmid backbone, and ps1, ps2 and ps3-containing fragments, 
respectively (Fig 2B). The protospacer-containing DNA fragments can be sepa-
rated on an 8% acrylamide gel (Fig 2C, lane 1), while the fragment corresponding 
to the plasmid backbone does not enter the gel (data not shown). Cascade binding 
to each of the three protospacers was addressed by incubating Cascade for 30 
minutes with pUC3xJ3 at 37°C, followed by 15 minutes incubation in the presence 
of an excess of single stranded DNA complementary to the crRNA spacer sequence 
to neutralize unbound Cascade. Next, the plasmid was digested with BamHI and 
separated on an acrylamide gel. At increasing Cascade concentrations, the intensi-
ties of the bands corresponding to the unbound digestion products decrease, due 
to Cascade binding (Fig. 2C). The Cascade-bound products are not visible on gel, 
as they cannot enter the gel due to the large size of the protein-DNA complex. 
Quantification of the band intensities demonstrates that each of the three proto-
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spacer-containing DNA fragments is bound with roughly the same efficiency, i.e. 
Cascade affinities are similar for each of the three protospacers (KD(PS1) = 108 ± 23 
nM, KD(PS2) = 114 ± 20 nM, KD(PS3) = 82 ± 15 nM). Although future experiments 
are required to obtain a more detailed insight into the mechanism of scanning 
employed by Cascade, this experiment suggests that Cascade utilizes a 3D diffusion 
(i.e. hopping or intersegmental transfer) mechanism rather than a 1D diffusion (i.e. 
sliding) mechanism over the distances by which the protospacers are separated. 
PAM dependence of non-specific Cascade-DNA interactions 
At present it is unclear whether non-specific DNA interactions of Cascade are 
entirely DNA sequence independent, or whether some degree of sequence 
Figure 3 Cascade non-specific binding is enhanced by PAM sequences and by other 
single stranded tetranucleotide sequences. 
A) Electrophoretic Mobility Shift Assay of J3-Cascade and a non-target dsDNA containing 24 PAM 
sequences. From left to right, the lanes contain J3-Cascade concentrations of 9 mM, 4.6 mM, 2.5 
mM, 1.2 mM, 0.6 mM, 0.25 mM, 0.12 mM, 0.06 mM, 0.025 mM and 0 mM. B) Gel shift as in (A) 
with a non-target DNA containing 1 PAM C) Gel shift as in (A) with a non-target DNA lacking 
PAM sequences D) Gel shift as in (A) with a non-target DNA containing 1 PAM  with immediately 
adjacent an 8 bp bubble. E) Gel shift with a substrate as in (D) but lacking a PAM sequence. F) Gel 
shift as in (A) with a non-target DNA containing 1 PAM within a 4 bp bubble. G) Gel shift with a 
substrate as in (F) but lacking a PAM sequence.  
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specificity exists. Non-specific (re-)association of Cascade with DNA during the 
target scanning mechanism might well be dependent on Cse1-mediated interactions 
with PAM sequences on the target DNA (310; 315). To analyze the PAM dependence 
of nonspecific binding of Cascade to dsDNA, Electrophoretic Mobility Shift Assays 
were performed using 68 bp non-target dsDNA with a variable PAM content (see 
Table 1). Interestingly, non-target dsDNA containing 24 PAM sequences (as identi-
fied in Chapter 5 [Figure 3]) is bound by J3-Cascade with a higher affinity (KD = 373 
nM ± 133 nM) than non-target dsDNA containing only 1 PAM sequence (KD = 882 
nM ± 146 nM) or non-target dsDNA lacking PAM sequences (KD = 1018 nM ± 229 
nM) with identical AT-contents (Fig. 3ABC; the sequences of the oligos are listed in 
Table 1). These data indicate that PAM sequences play an important role in mediating 
Figure 4 Cascade specific binding is enhanced by bubbles and non-specific binding 
is possibly enhanced by single stranded CTGG or GGTC tetranucleotide sequences. 
A) Electrophoretic Mobility Shift Assays of J3-Cascade and R44-Cascade with dsDNA containing the 
J3 protospacer sequence. From left to right, the lanes contain J3-Cascade concentrations of 0.6 mM, 
0.25 mM, 0.12 mM, 0.06 mM, 0.025 mM, 0.012 mM, 0.006 mM, 0.0025 mM, 0 mM. B) Gel shift as in 
(A) with a dsDNA containing an 8 bp bubble over the 8 nt of the seed region of the J3 protospacer  
C) Gel shift as in (A) with a dsDNA containing an 8 bp bubble over PAM distal 8 nt of the proto-
spacer, corresponding to the non-seed region D) Gel shift as in (A) with a dsDNA containing a 16 
bp bubble over PAM distal 16 nt of the protospacer, corresponding to the non-seed region. E-H) Gel 
shifts as in (A-D) with J3- and R44-CascadeDCse1 complexes. 
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non-specific binding of Cascade. The multiple shifted bands likely correspond to 
higher order J3-Cascade-DNA complexes (i.e. dsDNA with more than one J3-Cas-
cade bound). The observation that dsDNA without PAM sequences are also bound 
at high J3-Cascade concentrations is indicative of a PAM-independent non-specific 
dsDNA binding mechanism. This could mean that Cascade contains, in addition to 
the PAM interacting loop of Cse1, an additional DNA binding subunit/domain that 
is involved in non-specific DNA interaction. However, at present it cannot be ruled 
out that allowed PAMs other than those described in Chapter 5 exist, and that 
the observed non-specific binding is mediated through Cse1-PAM interactions. 
Since PAM sequences are recognized in only one strand of the dsDNA (Chapter 5 
and (269)), gel shift assays were performed using non-target dsDNA containing 
single stranded DNA regions adjacent to a single PAM (Fig. 3D) or at the same posi-
tion in a dsDNA lacking a PAM (Fig. 3E). Whereas the presence of a bubble adja-
cent to the PAM appears to have some effect on J3-Cascade non-specific binding 
affinities (KD = 493 nM ± 135 nM for the PAM containing DNA and KD = 727 nM ± 
136 nM for the DNA lacking a PAM), the presence of a bubble at the same position 
as the PAM causes an even more significant improvement of non-specific binding 
affinity (KD = 394 nM ± 152 nM; Fig. 3F). Unexpectedly, a 4 bp bubble at the same 
position in a substrate lacking a PAM leads to a markedly improved non-specific 
DNA binding affinity (KD = 107 nM ± 36 nM; Fig. 3G), exceeding the non-specific 
binding affinity of J3-Cascade for the other dsDNA substrates. In this PAM-lacking 
substrate, the sequences of the two DNA strands in the bubble are 5’-CTGG-3’ 
and 5’-GGTC-3’. Apart from the bubble, this non-target DNA is identical to the 
substrate used in Figure 3C. To rule out that some base pairing between the crRNA 
spacer sequence and the non-target DNA influences the affinities of nonspecific 
binding, the same gel shift assays should be performed with Cascade loaded with 
another crRNA. 
To further study the effects of bubbles in a dsDNA substrate, both on specific and 
on non-specific binding, gel shift assays were performed with an additional set of 
dsDNA substrates. These substrates contain the J3 protospacer sequence flanked by 
an ATG PAM sequence and are listed in Table 2. The substrates include (1) a dsDNA 
substrates with an 8 bp bubble in the seed sequence of the protospacer, (2) a dsDNA 
substrates with an 8 bp bubble in the non-seed sequence, (3) a dsDNA substrate 
with a 18 bp bubble in the non-seed sequence, and (4) a fully dsDNA, which serves 
as a control. Specific binding to these substrates is analyzed using J3-Cascade, 
while non-specific binding is analyzed using R44-Cascade. As expected, J3-Cascade 
binds the fully complementary dsDNA with high affinity (KD = 67 nM ± 17 nM), 
whereas R44-Cascade binds the same dsDNA non-specifically with a much lower 
affinity (KD = 1.0 ± 0.8 mM) (Fig. 4A). Specific binding by J3-Cascade is markedly 
improved when the dsDNA contains an 8 bp bubble in the seed sequence (KD = 12.2 
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nM ± 5.5 nM). Interestingly, R44-Cascade also binds this substrate non-specifically 
with high affinity (KD = 42.5 ± 18.5 nM) (Fig. 4B). Intruigingly, the bubble in this 
dsDNA substrate also contains the 5’-CTGG-3’ and 5’-GGTC-3’ sequence, which 
in the experiments described before appeared to be bound non-specifically with 
high affinity by J3-Cascade (Fig. 3G). This further suggests that either the single 
stranded CTGG or GGTC sequence may serve as a Cascade binding site. Although 
the presence of a bubble at the PAM-distal end of the protospacer leads to enhanced 
specific binding by J3-Cascade (KD = 23.5 ± 9.8 nM for the 8 bp bubble containing 
substrate and KD = 26 ± 11 nM for the 18 bp bubble containing substrate), non- 
specific binding by R44-Cascade remains similar to a fully complementary dsDNA 
target (KD = 1.1 ± 0.8 mM for the 8 bp bubble containing substrate and KD = 465 ± 
98 nM for the 16 bp bubble containing substrate) (Fig. 4C and 4D). The targets 
containing a PAM-distal bubble do not contain single stranded 5’-CTGG-3’ and 
5’-GGTC-3’ sequences, which further supports the hypothesis that these sequences 
potentially serve as non-specific binding sites for Cascade. Whereas dsDNA binding 
by CascadeDCse1 complexes is hardly detectable (KD >> 1 mM), the presence of a 
bubble partially restores dsDNA binding activity (Fig. 4E-H), in particular when 
the bubble is present within the seed region (Fig. 4F), suggesting that Cse1 plays a 
role in facilitating or stabilizing dsDNA melting in this region of the target DNA. 
Figure 5: J3-Cascade interacting with target ssDNA
A) J3-Cascade was rapidly mixed with increasing concentrations of 3’-fluorescently labeled target 
ssDNA (68 nt) and the change of fluorescence emission was monitored and analyzed according to a 
first-order reaction involving three phases of interaction. The solid lines correspond to a triple expo-
nential regression of the kinetic traces. The final concentrations were 0.16 mM J3-Cascade and la- 
beled ssDNA 0.03 mM (blue), 0.13 mM (light blue), 0.25 mM (green), 0.30 mM (orange), 0.38 mM (red) 
and 0.50 mM (pink) in 20 mM HEPES/NaOH, 75 mM NaCl, 2 mM EDTA, 1 mM TCEP, pH = 7.5 at T 
= 296 K. B) For the interaction of J3-Cascade and ssDNA three phases could be resolved. The fastest 
observed rate constant (filled circles) was linear dependent on the ssDNA-concentration according 
to a bimolecular reaction, yielding kon = 180 mM-1 s-1 and k
off
 = 5 s-1. Two subsequent intramolecular 
reactions displayed observed rate constants of 1.5 s-1 (open squares) and 0.01 s-1 (filled diamonds).
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Figure 6: J3-Cascade interacting with target dsDNA. 
A) Increasing concentrations of J3-Cascade were mixed with fluorescently labeled target dsDNA 
(68 bp; 3’-fluorescently labeled at the target strand) and the change of fluorescence emission was 
monitored and analyzed according to a first-order reaction. The final concentrations were 0.01 mM 
target dsDNA (68 bp) and 0.018 µM (red), 0.036 mM (orange), 0.10 mM (yellow), 0.24 mM (green) 
and 0.60 mM (blue) J3-Cascade respectively in 20 mM HEPES/NaOH, 75 mM NaCl, 16 mM MgCl2, 1 
mM TCEP, pH = 7.5 at T = 310 K. B) According to a bimolecular reaction, the observed rate constant 
of the change of the fluorescence emission was linear dependent on the concentration of J3-Cas-
cade, yielding kon = 0.02 mM-1 s-1 and k
off
 = 0.0006 s-1 for the interaction of J3-Cascade and the target 
dsDNA.
Kinetics of Cascade binding to DNA
Although the gel-shift analyses described here and elsewhere in this thesis provide 
insights into the affinities of Cascade for ssDNA and dsDNA substrates, they do 
not provide any information on the kinetics of these interactions. To investigate 
the kinetics and thermodynamics of J3-Cascade interacting with target DNA, 
experiments were performed using fluorescently labeled oligonucleotides as a 
spectroscopic probe. Cascade-DNA complex formation was accompanied by a 
change of the fluorescence intensity of the labeled target DNA and could be moni-
tored in a time-dependent manner. From the observation of a phased quenching 
pattern, it is concluded that J3-Cascade most likely interacts with target ssDNA 
(68 nt) via intermediates (Fig. 5). Three phases could be resolved and thus the 
kinetic traces were analyzed by a triple-exponential first-order equation, yielding 
three rate constants. As expected for a second-order reaction, the fastest observed 
rate constant was linearly dependent on the concentration of the labeled ssDNA 
and accordingly corresponds to the initial, bimolecular interaction with kon = 180 
µM-1 s-1 and k
off
 = 5 s-1 under the chosen experimental conditions (20 mM HEPES/
NaOH, 75 mM NaCl, 2 mM EDTA, 1 mM TCEP, pH = 7.5, T = 296 K). The two 
slower observed phases (k2’ = 1.5 s
-1, k3’ = 0.01 s
-1) were shown to be independent of 
the ssDNA-concentration, thus are likely to represent some subsequent intramole- 
cular reactions like conformational transitions and / or positioning reactions.
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However, J3-Cascade interacting with double-stranded (68 bp) fluorescently 
labeled target DNA displayed a different behavior (Fig. 6). Firstly, this interac-
tion was demonstrated to be highly dependent on the magnesium concentration 
(Fig. 7). Furthermore, contrary to the interaction with the fluorescently labeled 
single-stranded target DNA, the interaction with the double-stranded target DNA 
resulted in an increase of the fluorescence intensity (Fig. 6). Compared to the asso-
ciation of ssDNA, this interaction with the dsDNA was very slow with kon = 0.02 
µM-1 s-1 and k
off
 = 0.0006 s-1 even at saturating concentrations of magnesium.
Interestingly, the kinetically different rate constants for association and disso- 
ciation of target ssDNA and dsDNA, respectively, yield similar KD-values for both 
single stranded and double stranded DNA (KD = koff/kon; KD (ssDNA) = 0.03 mM; KD 
(dsDNA) = 0.03 mM). In terms of half-time for complex dissociation, the complex 
of J3-Cascade and dsDNA is significantly more stable compared to the complex of 
J3-Cascade and ssDNA (t1/2 = ln2/koff; t1/2 (dsDNA) = 1155 s; t1/2 (ssDNA) = 0.1 s). This 
slow dissociation of J3-Cascade from native-like dsDNA-targets might facilitate the 
recruitment of additional factors such as Cas3.
Figure 7: The interaction of J3-Cascade and target dsDNA is dependent on Magne-
sium. 
A) The effect of Magnesium on the interaction of 0.6 mM J3-Cascade and 0.01 mM fluorescently la- 
beled target dsDNA (68 bp; 3’-fluorescently labeled at the target strand) at T = 310 K was recorded 
via the time-dependent change of the fluorescence emission. The assay buffer (20 mM HEPES/
NaOH, 75 mM NaCl, 1 mM TCEP, pH = 7.5) was supplemented with 0.5 mM MgCl2 (red), 1 mM 
MgCl2 (orange), 2 mM MgCl2 (yellow), 4 mM MgCl2 (light green), 8 mM MgCl2 (dark green), 13 
mM MgCl2 (light blue) and 16 mM MgCl2 (dark blue), respectively and the kinetics analyzed ac-
cording to first-order reactions. B) The fastest observed rate constant of the interaction of J3-Cas-
cade and the target dsDNA displayed a hyperbolic dependency on the Magnesium-concentration, 
thus yielding an apparent dissociation constant of KD’ (Mg
2+) = 2 mM.
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Single molecule measurements of Cascade-mediated R-loop formation
Recently, it was proposed that the Cse1 subunit of Cascade is playing a role in desta- 
bilizing the target dsDNA, to allow for strand invasion of the crRNA (310). To 
monitor unzipping of the dsDNA at the single molecule level, we designed experi-
ments in which FRET between fluorescently labelled nucleotides in the target and 
non-target strand of a dsDNA was measured using TIRF Microscopy. The efficiency 
of FRET is strongly dependent on the distance between the donor and acceptor 
fluorophores. In the absence of Cascade, high FRET levels (FRET efficiency = ~0.8) 
are being detected, as expected (see Fig. 8B (left) for a single molecule trace and 
8C (left) for FRET distribution within the population of dsDNA molecules). When 
Cascade is added to this dsDNA substrate, the FRET efficiency is reduced (FRET 
efficiency = ~0.65)(Fig. 8B (right) and 8C (right)), due to R-loop formation, which 
causes an increase in distance between the donor and acceptor fluorophores (Fig. 
8A). FRET efficiency levels of 0 are due to acceptor or donor photobleaching. Using 
a variety of labeled dsDNA constructs, this approach may provide highly detailed 
information on the kinetics and directionality of dsDNA unzipping during Cascade 
mediated R-loop formation.
ConClusions
Future experiments using both ensemble and single molecule experiments (i.e. 
EMSA, fluorescence spectroscopy using a stopped-flow setup and single molecule 
FRET using TIRF microscopy) will reveal fundamental insights into the mechanism 
and kinetics of Cascade-mediated DNA scanning and into the precise molecu- 
lar details of R-loop formation, such as directionality and kinetics of strand 
displacement. These topics comprise an as yet unexplored area of research that 
will contribute to a full molecular understanding of the mode of action of this 
intriguing immune system. 
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Figure 8: Single Molecule FRET experiments visualize Cascade R-loop formation. 
A) Cartoon illustrating a double-stranded DNA labeled with donor (green star) and acceptor (red 
star) dyes before (left) and after (right) the binding of Cascade (grey oval). The crRNA of Cascade 
is shown in red (repeat sequence) and purple (spacer sequence) (right). B) Donor fluorescence 
(green), acceptor fluorescence (red) and FRET (blue) traces of the target DNA alone (left) and the 
DNA in the presence of Cascade (right). A single-step decrease in donor or acceptor fluorescence 
intensity (ID and IA, respectively) to the background level indicates a photobleaching event.  FRET 
is calculated as: FRET = IA/(IA+ID). After bleaching of the donor dye the FRET is set to zero. C) The 
FRET distribution of DNA molecules in the absence (left) and presence (right) of Cascade. The 
FRET value for each molecule was derived as its average FRET over two seconds.
192
Chapter 9 Summary, Ongoing Research and General Discussion
Table 1. Primer sequences used in Fig. 3
BG3766 GCCTTCCTCCTTACCTTCTCCCTTTTCTTCAGAAGGAGG-
GAAGGCAAGAGAGATAAGGAGAATTATGT
24 PAM - sense
BG3767 ACATAATTCTCCTTATCTCTCTTGCCTTCCCTCCTTCTGAA-
GAAAAGGGAGAAGGTAAGGAGGAAGGC
24 PAM – anti sense
BG3768 GGCAACGTCGAATCCAAGACGGTATTGTTCAGATCGTGG-
GTTGCCAACAGTGAATTGGTCAATATTGT
One PAM - sense
BG3769 ACAATATTGACCAATTCACTGTTGGCAACCCACGATCTGAA-
CAATACCGTCTTGGATTCGACGTTGCC
One PAM – anti 
sense
BG3770 GGCAACGTCGAATCCCAGACGGTATTGTTCAGATCGTGG-
GTTGCCAACAGTGAATTGGTCAATATTGT
No PAM - sense
BG3771 ACAATATTGACCAATTCACTGTTGGCAACCCACGATCTGAA-
CAATACCGTCTGGGATTCGACGTTGCC
No PAM – anti sense
BG3772 GGCAACGTCGAATCCAAGACGGTAAAGTTCAGATCGTGG-
GTTGCCAACAGTGAATTGGTCAATATTGT
One PAM + bubble 
– sense
BG3773 ACAATATTGACCAATTCACTGTTGGCAACCCACGATCTGAA-
CAAATGGCACTTGGATTCGACGTTGCC
One PAM + bubble 
– anti sense
BG3774 GGCAACGTCGAATCCCAGACGGTAAAGTTCAGATCGTGG-
GTTGCCAACAGTGAATTGGTCAATATTGT
No PAM + bubble - 
sense
BG3775 ACAATATTGACCAATTCACTGTTGGCAACCCACGATCTGAA-
CAAATGGCACTGGGATTCGACGTTGCC
No PAM + bubble 
– anti sense
BG3776 GGCAACGTCGAATCGTTCACGGTATTGTTCAGATCGTGG-
GTTGCCAACAGTGAATTGGTCAATATTGT
One PAM + 
PAM-bubble - sense
BG3784 GGCAACGTCGAATCGGTCACGGTATTGTTCAGATCGTGG-
GTTGCCAACAGTGAATTGGTCAATATTGT
No PAM + 
PAM-bubble - sense
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Table 2. Primer sequences used in Fig. 4
BG3625 CCTGGATCCAGGAGTGTGGAAGGATGCCAGTGATAAGT-
GGAATGCCATGTGGGCTGTCAAAATTGAGCAGACCAAA-
GACGGCA
No mismatch: Fw
BG3626 TGCCGTCTTTGGTCTGCTCAATTTTGACAGCCCACATGG-
CATTCCACTTATCACTGGCATCCTTCCACACTCCTGGATC-
CAGG
No mismatch: Rv
BG3627 CCTGGATCCAGGAGTGTGGAAGGATGGGTCACTAAAGT-
GGAATGCCATGTGGGCTGTCAAAATTGAGCAGACCAAA-
GACGGCA
Bubble in Seed, 8bp: 
Fw
BG3628 TGCCGTCTTTGGTCTGCTCAATTTTGACAGCCCACATGG-
CATTCCACTTATCACTGGCATCCTTCCACACTCCTGGATC-
CAGG
Bubble in Seed, 8bp: 
Rv
BG3629 CCTGGATCCAGGAGTGTGGAAGGATGCCAGTGATAAGT-
GGAATGCCATGTCCCGACAGAAAATTGAGCAGACCAAA-
GACGGCA
Bubble 3’ in proto-
spacer, 8bp: Fw
BG3630 TGCCGTCTTTGGTCTGCTCAATTTTGACAGCCCACATGG-
CATTCCACTTATCACTGGCATCCTTCCACACTCCTGGATC-
CAGG
Bubble 3’ in proto-
spacer, 8bp: Rv
BG3631 CCTGGATCCAGGAGTGTGGAAGGATGCCAGTGATAAGT-
GGTTACGGTACACCCGACAGAAAATTGAGCAGACCAAA-
GACGGCA
Bubble 3’in proto-
spacer, 18bp: Fw
BG3632 TGCCGTCTTTGGTCTGCTCAATTTTGACAGCCCACATGG-
CATTCCACTTATCACTGGCATCCTTCCACACTCCTGGATC-
CAGG
Bubble 3’in proto-
spacer, 18bp: Rv
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general disCussion
Since Barrangou and co-workers provided the first experimental evidence that CRISPR-Cas systems provide adaptive immunity in prokaryotes (28), researchers have endeavored to understand the mechanistic basis of this fasci-
nating immune system. As different research groups were using different model 
organisms to study the mechanism of CRISPR defense, it soon became clear that 
CRISPR immune systems are highly diverse at the mechanistic level. As outlined 
in Chapter 2, CRISPR-Cas systems are nowadays grouped into three main types 
that can be further subdivided into at least ten subtypes (231). Although different 
(sub)types may share certain mechanistic features, they also display striking dis- 
similarities in key steps of the CRISPR-based resistance pathway. One should 
therefore be cautious to extrapolate insights gained in one subtype to other 
subtypes. For example, while in Type I-E systems PAM recognition takes place 
in the base pairing strand (Chapter 5), in Type II-A systems the PAM recognition 
takes place in the non-base paired strand (188). Another example is that in Type 
I-E systems, Cascade-mediated R-loop formation requires a negatively supercoiled 
topology of the target DNA (Chapter 5), while in Type II-A systems this requirement 
is lacking (188). Other striking differences, which have been touched upon in 
Chapters 2, 5 and 7, are the mechanism of pre-crRNA maturation, ribonucleo- 
protein complex formation, the mechanism of self versus non-self discrimination 
and the nature of the target nucleic acids (DNA or RNA). Mechanistic details thus 
need to be resolved for each subtype independently. As this thesis deals with the 
Type I-E system, our current knowledge of this system, and in particular the gaps 
in our current knowledge, will be summarized below. Each of the different stages 
of CRISPR-based immunity (adaptation, expression, interference) as defined by 
van der Oost et al. (366) will be discussed here, as are the implications of CRISPR 
systems for microbial evolution and the practical use of CRISPRs to gain insight 
into viral and microbial diversity in natural ecosystems.
CRISPR Adaptation
The adaptation stage of Type I-E CRISPR defense has been highly challenging to 
study under laboratory conditions. A breakthrough has been accomplished only 
recently, when three groups almost simultaneously reported on CRISPR adaptation 
in E. coli (79; 343; 405). Several important insights into the mechanism of adap-
tation followed from these studies. Firstly, it appears that Cas1 and Cas2 are both 
essential and, apart from potentially involved host factors, sufficient for CRISPR 
adaptation (405). This is in agreement with the previous observation that cas1 and 
cas2 are the only cas genes that are universally conserved in all CRISPR-Cas types 
(230; 231), and that they are not required for the other two stages of CRISPR immu-
nity: CRISPR expression and CRISPR interference (49). Another important finding 
that came from these studies is that the last nucleotide of the repeat sequence 
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is derived from the invader sequence from which a spacer is obtained (79; 343). 
This nucleotide corresponds with the PAM nucleotide immediately adjacent to 
the protospacer sequence. As pointed out by Swarts et al. (343) and was later re- 
emphasized by Qimron and colleagues (136), this implies that only part of the 
repeat (i.e. the entire repeat excluding the last nucleotide) is duplicated during the 
spacer integration process. A third important observation that was made in these 
studies is that the presence of a spacer sequence enhances the integration of addi-
tional spacers, all of which target the same DNA strand of the invader that is also 
targeted by the initial spacer sequence (79; 343). This so-called priming mecha-
nism is readily observed when the invader contains escape mutations from the first 
spacer, possibly due to enhanced selection for bacterial clones containing addi-
tional newly acquired spacers (79). The observation that newly acquired spacers 
target the same strand as the initial spacer is highly suggestive of a positive feed-
back mechanism between the interference and adaptation machinery.
Although these studies provide some first insights into the mechanism of spacer 
acquisition, a detailed molecular understanding is still lacking. As outlined in 
Chapter 2, the characterized biochemical activities of Cas1 (endonuclease activity 
on dsDNA (397)) and Cas2 (endoribonuclease activity on U-rich regions of ssRNA 
(32)) provide so far only limited insight into this process. Makarova and colleagues 
have suggested that Cas2 may be part of a toxin/anti-toxin system, with Cas2 acting 
as a toxin and Cas1 acting as an anti-toxin (228). The function of Cas2 would be to 
slow down viral proliferation by cleaving RNA (mRNA and/or ribosomal RNA) to 
buy time for CRISPR-adaptation or, if that fails, to induce cell death. The viability of 
an E. coli K12Dcas1 strain argues against this hypothesis. It was recently shown that 
Cas2 from the Bacillus halodurans Type I-C system has metal dependent endonu-
clease activity on dsDNA (267), and it therefore seems more likely that Cas2 plays a 
direct role in catalyzing certain steps of the spacer integration pathway. To dissect 
the molecular basis of CRISPR adaptation, biochemical studies are required where 
the combined activities of Cas1 and Cas2 on biologically relevant DNA substrates 
(e.g., a CRISPR locus and/or pre-spacer sequences) are determined. It would be 
interesting to analyze whether Cas1 and/or Cas2 display high affinity binding to the 
leader sequence of a CRISPR array, which could explain the polarized spacer acqui-
sition at the leader end. Furthermore, cleavage assays using a synthetic CRISPR 
as a substrate could provide insight into the mechanism of repeat opening during 
spacer acquisition. As discussed in Chapter 2, the mechanism may be analogous to 
the mechanism employed by HIV integrase (109), but in the absence of biochemical 
evidence, this is mere speculation. Moreover, at this stage, it is unknown whether 
the pre-spacers are single stranded or double stranded. The strand specific priming 
process might indicate that pre-spacers can be single stranded. It will be important 
to answer these questions in order to obtain some fundamental insights into the 
mechanism of spacer acquisition.
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CRISPR Expression
The Expression stage can be divided into two sub-stages: regulation of cas gene and 
CRISPR expression, and ribonucleoprotein complex formation, which includes 
pre-crRNA maturation.
Cas gene and CRISPR expression
In contrast to CRISPR systems in other species, such as the Type II systems of S. 
thermophilus (28) and of S. pyogenes (90), and the Type III system S. epidermidis 
(235), the Type I-E CRISPR-Cas system of E. coli K12 has been shown to be tightly 
regulated and to be nearly completely shut-off under laboratory growth condi-
tions. While in some species phage infection can serve as a trigger for increased 
cas gene expression (3; 406), this appears to be not or insufficiently the case for 
CRISPR-based resistance in E. coli (391). Expression from the CRISPR 2.1 and 
CRISPR 2.3 promoters, which are located in the AT-rich leader regions flanking the 
arrays (293; 297), is constitutive, although expression can be modulated by regula-
tory proteins that bind the leader sequences (297). The roughly 70 bp upstream of 
the first repeat of the CRISPR 2.1 and 2.3 arrays show extensive sequence identity 
(293) and this region contains both the s70-dependent RNA polymerase promoter 
with an extended -10 characteristic (297) as well as all DNA elements required for 
spacer integration (405). Expression of the cse1-cas2 operon on the other hand, is 
completely repressed under laboratory conditions (297). Several factors have been 
identified that are involved in regulation of E. coli cas gene expression, such as 
the transcriptional repressor H-NS (297), and the transcriptional activators LeuO 
(Chapter 3) and BaeS (27; 287), which is part of the BaeSR two-component system 
that is involved in sensing membrane stress.
Although these key regulators have been identified over the past years, it remains 
unclear which factors trigger cas gene expression under natural conditions. 
Sequence analysis of Type I-E and I-F CRISPR loci from the E. coli reference collec-
tion and available E. coli genomes shows some diversity in spacer content, which 
indicates spacer acquisition under natural consitions (96). However, additional 
analysis of 290 E. coli strains indicates that in nature spacer acquisition is rare, 
but if spacer acquisition occurs, turnover appears to be radical, which leads to a 
completely different spacer content (353). In line with this, spacer acquisition using 
wildtype E. coli K12 has never been observed under laboratory conditions (unpub-
lished data and (96)).
Ribonucleoprotein complex formation
CRISPR RNA maturation
It has been shown that the cas6e gene encodes an endoribonuclease that cleaves 
pre-crRNA (CRISPR transcripts) (49), yielding mature 61 nt crRNA molecules 
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with a 5’ hydroxyl and a 2’-3’-cyclic phosphate (Chapter 4). Structural analysis of 
Cas6e bound to crRNA repeat sequences has revealed the protein-RNA interac-
tions involved in binding of the 3’-handle of the crRNA by Cas6e and has allowed 
for proposing the catalytic mechanism of pre-crRNA cleavage by Cas6e (131; 309). 
Detailed structural analyses have also been performed for the Type I-F system, 
where cleavage is carried out by Cas6f (157; 158; 334). These studies, together 
with the structural and biochemical characterization of Cas6 from the Type III-B 
system of P. furiosus (59; 60; 382) has provided detailed insights into the mole-
cular mechanism of pre-crRNA processing. The high affinity and specific binding 
of some Cas6-like proteins to stem-loop structures of CRISPR repeats (334) could 
potentially be utilized for RNA purification purposes (i.e. an RNA of interest could 
be fused to a CRISPR repeat sequence and purified using a Cas6 mutant lacking 
cleavage activity). Recently a method has recently been developed to utilize Cas6f 
as a tool to modulate recombinant gene expression by introducing Cas6f cleavage 
sites into genetic elements. The cleavage sites within the genetic element can be 
chosen such that Cas6f-mediated transcript cleavage yields a minimal mRNA 
containing the coding sequence of interest flanked by standardized sequences 
(including the ribosome binding site), which minimizes structural intra-transcript 
interactions that cause variations in translation levels (298). In particular, transla-
tion of multigene operons was much less variable when Cas6f cleavage sites were 
encoded between the genes in an operon (298).
Cascade assembly and structure
Cascade is a ribonucleoprotein complex that consists of 11 protein subunits and a 
single crRNA molecule (Cse11Cse22Cas76Cas51Cas6e1crRNA1) (Chapter 4). Despite 
considerable advances in our understanding of Cascade structure and function 
(49; 191; 315; 393; 394), several key questions remain unanswered. Firstly, it is 
unknown how Cascade subunits assemble into a stable complex. Given the central 
positioning of the crRNA in the complex (394), it appears likely that the processing 
of the pre-crRNA comprises a first step in complex assembly. This is in line with 
the observation that homogeneous Cascade complexes are not being formed in the 
absence of CRISPR transcripts (unpublished data). Studying complex assembly in 
vitro requires purified Cascade subunits, which is hampered by the insolublility of 
Cse2 and Cas5. If these solubility issues can be resolved, complex assembly could 
be studied using a fluorescence microscopy approach using fluorescently labelled 
Cascade subunits, where Förster Resonance Energy Transfer (FRET) between 
fluorophores can be utilized as a read-out for complex formation. 
Over the last few years, the precise function of many Cascade subunits has been 
(partially) revealed. Recent studies demonstrated that the Cse1 subunit is impor-
tant for non-specific binding (Chapters 4 and 6) and for PAM recognition (310). The 
Cse2 subunit on the other hand, was shown to be important for specific binding 
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(Chapter 6), in line with its position in the complex close to the spacer sequence 
of the crRNA (394), and the observed crosslinking of this subunit in the presence 
of DNA (see “Ongoing research”). The Cas7 subunit has a structural role in the 
complex (191), is involved in binding the crRNA spacer region (394), and disrupts 
the B-type helix formed between the crRNA and the target nucleic acids, giving rise 
to helical segments (394). Based on the Cascade cryo-EM structure (394) and the 
UV-crosslinking experiments (see “Ongoing research”), the Cas5 subunit appears 
to interact with the 5’-handle of the crRNA. The Cas6e subunit has been shown to 
be essential for crRNA biogenesis (49) and to bind the 3’-handle of the crRNA (131; 
309). The crRNA itself is essential both for complex formation, as overproduction 
of Cascade proteins in the absence of CRISPR expression does not yield homoge-
neous complexes (data not shown), and for guiding invader DNA binding through 
base pairing. 
Interference
The interference stage of Type I-E CRISPR immunity has been studied in consi- 
derable detail in E. coli. This stage can be subdivided into two substages: Cascade-me-
diated target DNA binding and Cas3-mediated cleavage of Cascade-bound DNA. 
Cascade mediated DNA binding 
The ribonucleoprotein complex Cascade plays a key role in the CRISPR-inter- 
ference pathway by binding complementary DNA sequences within large dsDNA 
elements, such as plasmids, and subsequently recruiting the effector protein 
Cas3 (Chapter 5). Cascade-mediated DNA scanning and R-loop formation occurs 
without a requirement for ATP or other chemical energy sources. It has become 
clear that Cascade-DNA interactions are constrained both by the DNA topology 
(Chapter 5 and 6), and by the presence of a Protospacer Adjacent Motif (PAM), 
which is required for efficient binding of target DNA (Chapter 5) and for target 
versus non-target discrimination (Chapter 7). Cascade-DNA complexes in the 
R-loop conformation have been shown to cause increased flexibility in the dsDNA 
at the protospacer (Chapter 6). In agreement with this, Cascade complexes are often 
found at the apex of a supercoiled loop of a target plasmid (Chapter 5). Although 
Cascade-mediated R-loop formation has been studied in considerable detail 
(see Chapters 4 to 6), several key questions remain. It is for example unknown 
how Cascade efficiently locates a target sequence among very large numbers of 
non-target sequences. This DNA-scanning process is expected to rely on nonspe-
cific Cascade-DNA interactions, which may be PAM-dependent. When Cascade 
locates a target sequence, an R-loop structure is formed. The molecular details 
of strand displacement and kinetics of Cascade-DNA interactions in general and 
protospacer unzipping in particular have so far not been studied. These topics are 
the focus of ongoing research that aims at understanding the mechanism of Cascade 
scanning and R-loop formation in molecular detail (see “Ongoing research”). 
199
Chapter 9 Summary, Ongoing Research and General Discussion
9
DNA cleavage
Upon Cascade-mediated R-loop formation, Cascade and the target DNA undergo 
conformational changes, and Cas3 is recruited. The final step in CRISPR-inter-
ference is the cleavage of invader DNA by Cas3 (Chapter 5). Cas3 proteins from 
several organisms have been biochemically characterized, which demonstrated 
that the HD domain of Cas3 has endonuclease activity on single stranded DNA (33; 
260; 323) and exonuclease activity on single stranded DNA in the 3’ to 5’ direction 
(33). The SF2 helicase domain of Cas3 was shown to unwind dsDNA and DNA/
RNA heteroduplexes in the 3’ to 5’ direction (323). Both activities are essential for 
CRISPR interference in vivo, and for target DNA degradation in vitro (Chapter 5). 
The combined activities of Cascade and Cas3 lead to specific degradation of proto-
spacer-containing plasmids in a magnesium- and ATP-dependent reaction. In the 
absence of ATP, the target DNA is nicked but not degraded. A key question that 
has not been addressed is where the initial nicking takes place. Given the above-
mentioned biochemical activities of Cas3, it seems likely that the initial cleavage 
takes place in a single stranded stretch of DNA, such as the displaced strand in the 
R-loop formed by Cascade (33; 191).
Another unresolved issue is the priming phenomenon, where the presence of a 
spacer sequence, even if it contains a mismatch with the protospacer and does not 
provide in vivo resistance, leads to enhanced spacer acquisition (79; 343). It appears 
likely that this process is caused by (low-level) DNA degradation by Cascade and 
Cas3, thereby supplying substrates to the integration machinery that are utilized 
as pre-spacers. Physical interactions between the CRISPR-adaptation and inter-
ference machinery may also play a role in this. Cas1 has been shown to bind the 
Cascade subunits Cas7 and Cas6e (21). In Type I-F systems, Cas3 is fused to Cas2, 
which also suggests an interplay between CRISPR adaptation and interference 
(discussed in (366)). It will be highly interesting to resolve the biochemical basis 
of priming, and to explore any physical interactions between the interference and 
adaptation machinery that are involved in this process.
Inhibitors of CRISPR-Cas
Recently, a number of proteins encoded by Pseudomonas aeruginosa infecting 
phages have been discovered that inhibit Type I-F CRISPR-Cas systems (40). 
The inhibitors that are described are small proteins that are highly diverse at 
the amino acid level. While expression of some inhibitors resulted in lowered 
CRISPR-mediated resistance levels, others completely blocked CRISPR immunity. 
In the absence of biochemical data on these CRISPR inhibitors, the well investi-
gated suppressors of RNAi encoded by most plant viruses (reviewed in (53; 379)) 
could provide some hints towards potential mechanisms. It has been shown that 
many RNAi suppressors act by preventing RISC assembly, through sequestration 
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of long dsRNA or siRNA (62; 203; 247; 321; 374), or through binding the Argo-
naute protein (18). In addition, inhibition of Argonaute cleavage activity by plant 
virus encoded RNAi suppressors has been described (414). Suppressors can also 
act at the level of gene expression, as is shown by the indirect inhibition of RNAi 
through virus induced expression of a miRNA that inhibits argonaute1 transla-
tion (373). Many RNAi suppressors show very low sequence similarity, yet act in 
mechanistically similar ways (i.e. most RNAi suppressors identified to date bind 
siRNA or dsRNA), suggesting convergent evolution of these suppressors. Despite 
the fact that the majority of suppressors identified to date appears to act through 
binding RNA, the examples described above show that suppressors in principle 
can act at all stages of the RNAi pathway. In analogy, CRISPR inhibitors may inter-
fere with pre-crRNA processing, with complex formation, with crRNA loading on 
the complex (this is particularly relevant for systems where crRNAs are loaded on 
pre-existing protein complexes, which is likely the case for the Type III-B CMR 
complex (60; 151); (413)), with nucleic acid cleavage activity or with induction of the 
CRISPR-Cas system. Interestingly, a phage-encoded H-NS has been described that 
could be involved in mediating silencing of CRISPR systems upon infection of the 
host cell (324). Whether E. coli phages also contain CRISPR inhibitors is unknown. 
A screening method where phage P1 and T7 libraries DNA libraries were intro-
duced into E. coli BL21 (DE3) cells carrying the anti-pOX38 CRISPR (described 
in Chapter 8), followed by conjugation with a pOX38 carrying donor strain, did 
not reveal any phage-encoded inhibitors of CRISPR immunity against conjugative 
plasmid transfer (data not shown). This might also be related to the previously 
described repression of the CRISPR-Cas system of wildtype E. coli K12 (297). In E. 
coli strains isolated from natural samples, extremely low rates of spacer acquisition 
are observed (353). Encoding CRISPR inhibitors may therefore provide only little 
selective advantage for E. coli phages. CRISPR inhibitors are expected to be more 
widespread in phages that infect species that have a very active CRISPR-Cas system. 
For the inhibitors found in P. aeruginosa phages, and for other inhibitors that will 
be identified in future research efforts, it will be highly interesting to analyze the 
molecular mechanism of CRISPR suppression and to analyze their implications for 
bacteria-phage coevolutionary dynamics.
Ecological Significance of CRISPR-Cas
Bacteriophages are considered a driving force in the evolution of microbial commu-
nities and may be a main factor in generating microbial diversity (307). Clearly, 
phage resistance mechanisms play a central role in phage/bacterial and archaeal 
host interactions, and as such have a direct effect on co-evolutionary dynamics 
and implications for microbial diversity. CRISPR-Cas systems might be especially 
important in shaping microbial evolution, as they are very widespread (present in 
48% and 86% of all sequenced bacterial and archaeal genomes, respectively), and 
CRISPR immunity is expected to be accompanied by relatively low costs for the 
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host. However, at present fitness costs of CRISPR-Cas systems for the host have not 
been determined, nor has the role of CRISPR-Cas in co-evolution between phage 
and bacterial or archaeal hosts been experimentally quantified. It has become 
evident that phages can escape CRISPR-interference through point mutations in 
the protospacer (93; 315). A recent study showed that upon escape through point 
mutagenesis, hosts rapidly acquire new spacers by a so-called priming mechanism 
(79). Although several models have been described that attempt to predict how 
CRISPR-Cas systems influence co-evolutionary dynamics (66; 147; 159; 211; 387; 
388), these models provide only limited insights in the absence of experimental 
validation. 
The mechanism of CRISPR-based resistance against phage infection through 
incorporation of phage-derived sequence tags offers a unique opportunity to study 
bacteria-phage co-evolution in natural environments. A number of studies have 
already taken advantage of this, either by using a metagenomics approach or by 
analyzing single clones, to reveal microbial diversity within and between popula-
tions (73; 96; 161-163; 219; 300; 360). These studies reveal a general trend of higher 
diversity at the leader end of CRISPR-loci as compared to the trailer end of the 
array, presumably due to the general mechanism of spacer acquisition occurring 
at the leader proximal end of the array. An exception to this was reported recently 
for a Sulfolobus solfataricus CRISPR array, where internal spacer acquisition was 
observed (108). The high variability in spacer content suggests rapid evolution 
of CRISPR loci, a property that makes CRISPRs very suitable for a strain typing 
technique known as spoligotyping (see for example (69; 73; 141; 254; 376; 411)), or 
for tracking transmission of pathogens, as was done for Yersinia pestis (causing 
plague) and Erwinia amylovora (causing fire blight) (73; 300) and has recently been 
developed for enterohemorrhagic E. coli (EHEC) (89). By designing experiments in 
which the CRISPR spacer content in a bacterial population is analyzed over time, 
insights into evolutionary dynamics of CRISPR-Cas under natural conditions can 
be obtained, as was carried out in a study on streptococcal species present in the 
saliva of human subjects (295). 
Besides providing insights into microbial diversity and evolution under ecologi-
cally relevant conditions, CRISPR sequences can also be utilized to obtain infor-
mation on viral diversity and their spatial distribution. Such analyses on Sulfolobus 
islandicus CRISPR sequences (163) and CRISPR sequences from the Global Ocean 
Sampling metagenome (329) indicates spatial structuring of viruses in these cases 
(i.e. spacers more frequently match sequences from viruses present at the same site 
than viruses isolated elsewhere). Other viruses may be more globally dispersed, as 
spacers from different strains of the same species isolated from distinct sites some-
times target the same virus, as was shown for Synechococcus strains from cyano-
bacterial mats (161) and for Candidatus in sludge bioreactors (200). 
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Finally, the spacer sequences can also be utilized to identify new host-virus rela-
tionships (or more broadly, mobile genetic element (MGE) – host relationships) 
(12): the presence of a spacer matching a particular mobile genetic element can be 
considered strongly suggestive of a previous invasion by this element (i.e. the 
spacer-containing bacterium may serve as a host for this MGE). In one study, 
CRISPR spacer sequences have been utilized in a microarray to detect (new) 
viruses containing a complementary sequence and to monitor their abundance 
over time (327). In addition, CRISPRs can be used to directly obtain information 
on viral genomes present in a particular ecosystem. CRISPR spacer sequences 
from a metagenomics dataset from acidophilic microbial biofilms in an acid-mine 
drainage system could be assembled into contigs, yielding complete or partially 
complete viral genomes (13). These examples illustrate how the unique feature of 
genetically encoded adaptive immunity by CRISPR-Cas systems can be exploited 
to identify new viruses, to increase our insight into virus-hosts interactions, and to 
monitor genetic variation both of viruses and of microbial populations.
Concluding Remarks 
Insight into the mechanism of CRISPR-based adaptive immunity in bacteria and 
archaea has increased tremendously over the past few years. Several key questions 
concerning the mechanism of this intruiging defense mechanism remain, but will 
undoubtly be addressed within the next years. New avenues of scientific research 
are opened with the discovery of phage-encoded inhibitors. A biochemical and 
mechanistic analysis of these inhibitors will shed further light on the ongoing 
arms race between viruses and bacteria. In addition, many researchers, facilitated 
by our greatly improved biochemical understanding of the system, have become 
interested in utilizing CRISPR-Cas as a tool to protect production organisms 
against phage, or to perform genome engineering in microbes or genome editing 
in eukaryotes. Finally, the discovery of CRISPR-Cas provides a powerful tool to 
address biodiversity in natural ecosystems, and allows to monitor phage-bacteria 
co-evolution in their natural habitat. Although several models have attempted to 
describe the mode of co-evolution, experimental studies are required to validate 
these models, and to gain insight into the effect of CRISPR systems on evolution 
and diversity of prokaryotes.
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nederlandse samenvaTTing
Al het leven op aarde kan worden onderverdeeld in drie domeinen: eukaryoten, 
bacteriën en archaea. Dit proefschrift gaat over een afweersysteem dat uitslui-
tend voorkomt in bacteriën en archaea: het zogenaamde CRISPR-Cas systeem. 
Dit systeem is nog maar vrij recentelijk ontdekt. Om de werking en functie te 
begrijpen hebben we de afgelopen jaren onderzoek gedaan aan een darmbacterie, 
Escherichia coli, die uitgerust is met dit systeem.
Zoals alle organismen hebben ook bacteriën en archaea bij tijd en wijle last van 
virusinfecties, waarbij energie en bouwstoffen van de bacterie gebruikt worden 
voor de productie van nieuwe virusdeeltjes. Om zichzelf te beschermen zijn veel 
bacteriën uitgerust met één of meerdere afweersystemen. Sommige van deze 
afweersystemen zijn al meer dan een halve eeuw geleden ontdekt, terwijl andere 
pas zeer recentelijk aan het licht zijn gekomen. In 2006 werd op basis van een bioin-
formatische analyse door een onderzoeksgroep uit de Verenigde Staten voorspeld 
dat bacteriën en archaea een immuunsysteem hebben wat kleine RNA moleculen 
gebruikt om virussen op te sporen: het CRISPR-Cas systeem. De ontdekking van 
dit nieuwe systeem heeft een paar jaar geleden voor veel sensatie gezorgd onder 
(micro)biologen; niet alleen bleek dit systeem zeer specifiek te zijn voor indivi-
duele virussen, het kan daarnaast zichzelf ook aanpassen aan nieuwe virussen door 
het “onthouden” van de DNA volgorde van de desbetreffende virussen.
Dit “geheugen” van bacteriën werkt door stukjes DNA van virussen op te slaan 
op het bacteriële genoom, in de zogenaamde “CRISPR”, een soort zwarte lijst van 
virussen. Deze geheugen-modules worden overgeschreven in RNA, wat vervolgens 
door gespecialiseerde eiwitten als sleutelcode gebruikt wordt om virussen op te 
sporen.
Hoofdstuk 1 van dit proefschrift is een overzichtsartikel waarin beschreven wordt 
dat kleine RNA moleculen in bacteriën allerlei belangrijke functies hebben, zoals 
het aan- en uitzetten van genen en enzymen. Maar tot voor kort was onbekend dat 
RNA ook belangrijk was om bacteriën te beschermen tegen virusinfecties.
In hoofdstuk 2 wordt een overzicht gegeven van de bacteriële (en archeale) immuun- 
systemen die tot dusver bekend zijn. Er wordt in dit hoofdstuk ook beschreven wat 
we nu weten met betrekking tot hoe het CRISPR-Cas systeem werkt, en wat het 
belang is van dit systeem.
Het derde hoofdstuk gaat over het aan- en uitschakelen van CRISPR-Cas in E. 
coli. Normaal gesproken staat het CRISPR-Cas systeem in E. coli uit, vermoedelijk 
om te voorkomen dat er energie verspild wordt. Het was al bekend dat één eiwit 
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(genaamd H-NS) er voor zorgt dat CRISPR-Cas uit staat. Wij hebben ontdekt dat 
een ander eiwit (genaamd LeuO) het CRISPR-Cas systeem juist kan aanzetten. 
Onder normale omstandigheden staat het systeem uit omdat er meer H-NS 
aanwezig is dan LeuO. Het zou goed kunnen dat onder specifieke omstandigheden 
(bijvoorbeeld tijdens een virusinfectie) LeuO de overhand krijgt, en dat dan het 
CRISPR-Cas systeem wordt aangezet.
Het vierde hoofdstuk gaat over de hoofdrolspeler tijdens het opsporingsproces van 
virus DNA. In 2008 is een eiwitcomplex in Wageningen ontdekt dat de naam Cascade 
heeft gekregen (CRISPR-associated complex for antiviral defense). In Hoofdstuk 
4 staan proeven beschreven die laten zien dat het eiwitcomplex Cascade tijdens 
de immuunreactie de functie van surveillant heeft: Cascade gebruikt het CRISPR 
RNA om virus DNA te herkennen. Verder wordt in dit hoofdstuk beschreven 
hoe met behulp van electronenmicroscopie Cascade in beeld is gebracht, 
zodat we een idee hebben gekregen hoe het eiwitcomplex Cascade eruit ziet.
Om daadwerkelijk immuun te zijn tegen een virus heeft de bacterie ook nog een 
ander eiwit, genaamd Cas3, nodig. Het mechanisme van het uitschakelen van een 
virus door Cascade en Cas3 verloopt in een aantal stappen, die beschreven worden 
in Hoofdstuk 5. Cascade gebruikt het CRISPR RNA om voortdurend te zoeken naar 
virus DNA. Tijdens dit controle-proces moeten de strengen van potentieel vijandig 
DNA uit elkaar gehaald worden. De hiertoe benodigde energie wordt uit het DNA 
zelf gehaald; omdat het meeste DNA van zichzelf al in een hoge-energie toestand 
is (het is letterlijk opgewonden), kan Cascade daar handig gebruik van maken. 
Zodra Cascade een stukje DNA herkent dat afkomstig is van een virus, verandert 
zowel het eiwitcomplex als het DNA van vorm en wordt Cas3 erbij gehaald. Na 
binding aan Cascade breekt Cas3 het vijandige DNA af.
In Hoofdstuk 6 wordt in meer detail gekeken naar hoe Cascade de structuur van 
DNA verandert. Net als in Hoofdstuk 5 wordt dit geanalyseerd met behulp van de 
Atomic Force Microscope. De plaatjes die hiermee van Cascade-DNA complexen 
zijn gemaakt laten zien dat de flexibiliteit van het DNA toeneemt. Dit komt waar-
schijnlijk doordat Cascade lokaal de DNA strengen uit elkaar haalt, waardoor het 
DNA minder rigide wordt. Verder wordt in dit hoofdstuk het belang van 2 eiwit 
componenten van Cascade onderzocht met betrekking tot het specififiek en het 
niet-specifiek binden van DNA.
Hoofdstuk 7 gaat over autoimmuniteit, en het vermijden hiervan, door het 
CRISPR-Cas systeem. Alle immuunsystemen hebben mechanismen nodig die 
voorkomen dat de gastheer zelf wordt aangevallen. In het geval van CRISPR-Cas is 
dit extra belangrijk, omdat de stukjes virus DNA die specifiek herkend worden ook 
liggen opgeslagen in de CRISPR op het DNA van de gastheer. Dit is een intrinsieke 
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eigenschap van het CRISPR-Cas systeem, wat op deze manier stukjes virus DNA 
“onthoudt”. Voor het CRISPR-Cas systeem van de pathogene bacterie Staphylo-
coccus epidermidis was beschreven dat de activiteit van dit immuunsysteem speci-
fiek geremd wordt als het eigen DNA wordt herkend. De proeven die in Hoofdstuk 
7 beschreven staan laten zien dat het CRISPR-Cas systeem van E. coli juist specifiek 
geactiveerd wordt als virus DNA herkend wordt. Dit laat zien dat er belangrijke 
verschillen zijn tussen varianten van dit immuunsysteem.
Dat het CRISPR-Cas systeem niet alleen maar actief is tegen virussen wordt 
beschreven in Hoofdstuk 8. CRISPR-Cas systemen beschermen ook tegen zoge-
naamde “conjugatieve plasmides”. Dit zijn DNA elementen die veel minder agressief 
zijn dan virussen, en die een belangrijke rol spelen in de verspreiding van antibio- 
ticum resistentie. Soms leveren deze conjugatieve plasmiden een voordeel op voor 
de bacterie, bijvoorbeeld als er antibiotica aanwezig zijn, en soms leveren ze een 
nadeel op, en dan is het beter om immuun te zijn tegen zo’n plasmide. Veel bacte-
riën hebben inderdaad geheugenmodules in de CRISPR die specifiek gericht zijn 
tegen conjugatieve plasmides. Een bioinformatische analyse laat zien dat bepaalde 
stukjes van die plasmides veel vaker aangevallen worden dan andere stukken. De 
reden hiervoor is nog niet bekend; het zou kunnen dat die stukjes vaker onthouden 
worden, of het zou ook kunnen dat die stukjes beter aangevallen kunnen worden.
Hoofdstuk 9 is een algemene discussie over CRISPR-Cas. Er wordt onder andere 
samengevat wat we nog niet weten over dit fascinerende systeem. Daarnaast wordt 
aandacht besteed aan het belang van het CRISPR-Cas systeem voor biodiversiteit, 
en op welke manier de interactie tussen bacteriën en virussen hierdoor beïnvloed 
wordt. Het in detail begrijpen van het mechanisme van het CRISPR immuunsys-
teem is een belangrijke eerste stap op weg naar mogelijke toepassingen. Hierbij 
kan gedacht worden aan het beschermen van nuttige bacteriën tegen ongewenste 
virusinfecties, bijvoorbeeld industriële stammen in een productieproces van voe- 
dingsmiddelen zoals yoghurt of kaas. Een andere mogelijke toepassing beoogt 
precies het omgekeerde, namelijk het ondermijnen van het CRISPR systeem 
van ziekmakende bacteriën voor therapeutische doeleinden zodat virussen 
kunnen worden ingezet tegen de ziekteverwekker, ten gunste van de patiënt.
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dankwoord
De afgelopen 4 jaar heb ik gewerkt aan het tot stand brengen van dit proefschrift. 
Ik heb deze periode beleefd als een fascinerend traject wat weliswaar veel doorzet-
tingsvermogen vergt, maar wat ook enorm veel voldoening heeft gegeven (vooral 
in dit stadium waarin de laatste letters op papier gezet worden!). Echter, zonder 
de onmisbare hulp en steun van een aantal collega’s, vrienden en familie zou dit 
proefschrift nooit tot stand zijn gekomen.
In de eerste plaats wil ik John bedanken voor de geweldige manier waarop hij mij als 
promovendus begeleid en gestimuleerd heeft en voor de kansen die hij me geboden 
heeft om me te ontwikkelen. De manier waarop jij, John, je groep leidt is wat mij 
betreft een voorbeeld voor iedereen. In het bijzonder waardeer ik de vrijheid en 
het vertrouwen wat je me gegeven hebt om mijn promotieonderzoek richting te 
geven, en de mogelijkheden die jij me gegeven hebt om op verschillende interna-
tionale congressen ons werk te presenteren. Naast het werk heb ik ook bijzonder 
goede herinneringen aan onze mooie schaatstocht die we samen met Marcel en 
Stan onder barre omstandigheden over de Oostvaardersplassen gemaakt hebben - 
dat is zeker voor herhaling vatbaar!
Stan, als mijn dagelijkse begeleider ken je mij als onderzoeker beter dan wie ook. Je 
beschikt niet alleen over grote intellectuele kwaliteiten, maar bent ook erg sociaal, 
rustig en weloverwogen- eigenschappen die erg goed van pas zijn gekomen bij het 
afremmen van mijn “Action Man”-gedrag! Al klinkt het voor de hand liggend, toch 
heb ik vooral van jou geleerd hoe belangrijk het is veel en rustig na te denken en, 
naast labwerk, onderzoek achter de computer te doen. Ook heb je me geleerd vanaf 
het begin van een project na te denken over het verhaal van een potentieel manu-
script - een heel doeltreffende methode om te focussen op relevante vraagstukken. 
De afgelopen jaren waren dankzij jou een succes - ik ben nog steeds blij dat je in 
2008 bij mij in Bologna bent langsgeweest waar we voor het eerst de mogelijkheid 
besproken hebben om in Wageningen AIO te worden. Naast jouw professionele 
onderricht, heb je me ook geleerd werk en ontspanning tijdens een werkdag af 
te wisselen, zodat ik over de jaren behoorlijk bedreven ben geraakt in “kantoor-
voetbal” (voorlopig nog geen olympisch nummer, ben ik bang), een beetje heb 
leren tafeltennissen (en toch nog wel eens een paar games heb weten te pakken) 
en mooie schaatstochten met jou heb gemaakt. Toen ik je in de avonden wat leerde 
schaken mocht je iedere zet die verkeerd uitpakte terugzetten, zodat je er aan het 
eind van de avond meestal met de winst vandoor ging!
Ook wil ik op deze plaats graag Willem de Vos bedanken voor de begeleiding en het 
verzekeren van een optimale infrastructuur in het lab om goed onderzoek te doen. 
Willem, je hebt mij van een afstand begeleid, maar de discussies die we gevoerd 
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hebben waren altijd erg uitdagend. Ik heb groot respect voor de manier waarop je 
het Laboratorium voor Microbiologie weet vorm te geven en iedereen binnen de 
leerstoelgroep enthousiast weet te maken voor onderzoek.
Het promotieonderzoek van Matthijs Jore vormt de basis voor het onderzoek 
beschreven in dit proefschift. Matthijs, heel erg bedankt voor de samenwerking. 
Je hebt enorm veel werk verzet tijdens je promotieonderzoek waar ik nadrukke-
lijk van heb kunnen profiteren. Hopelijk verloopt je onderzoek in Oxford net zo 
succesvol als je onderzoek hier in Wageningen! Ook bedankt voor de gezelligheid, 
de competitie in kantoorvoetbal (al zijn sommige blauwe plekken op mijn schenen 
blijvend), en voor het delen van muziek (met name Calexico!!). We zien elkaar 
weer in Engeland!
Magnus, during your post-doc in Wageningen you showed a tremendous drive in 
your work and proved to be a great colleague. I particularly remember the fantastic 
dinners you organized (engraved in my memory)! No-one I know can match 
your cooking skills, nor your pleasure of eating!! Our hike in Yosemite after the 
CRISPR-meeting in Berkeley was also memorable - we should try to make such a 
combined trip again in the future!
Daan, het is bijzonder leuk dat je het “bacterial-defense-team” bent komen ver- 
sterken. Je gedrevenheid en scherpzinnigheid zullen vast en zeker tot mooie publi-
caties gaan leiden. Onze reis naar het Keystone congres in Vancouver was reuze 
gezellig: al geef ik toe dat ik in het begin niet wilde gaan (omdat er op natuurijs 
geschaatst kon worden) werd dit ruimschoots gecompenseerd door onze onver-
getelijke vogelkijktrip (20 sneeuwuilen en 2 velduilen!) en het skiën op Grouse 
Mountain, een paar km buiten de stad.
Raymond, ook jij bent van enorme toegevoegde waarde voor het CRISPR-team. 
Je kennis is erg complementair aan die van de rest van het team: jij weet erg veel 
van vanalles en nog wat, terwijl de rest van het team goed op de hoogte is van het 
CRISPR-onderzoek. Nee, dat is maar een flauw grapje hoor! Jouw bioinformatische 
analyse (hoofdstuk 8) was mij noch iemand anders binnen onze groep gelukt. Je 
vele publicaties in korte tijd weerspiegelen je betrokkenheid en enthousiasme voor 
onderzoek. Bovenal ben je gewoon een enorm sociale en aardige vent! 
Het is leuk, Tim, dat jij na een afstudeervak onder mijn begeleiding nu promovendus 
bij ons in de groep bent geworden! Tijdens je afstudeervak sprong je eruit vanwege 
je talent als onderzoeker. Veel succes toegewenst tijdens je promotieonderzoek!
246
Appendices Dankwoord
Vincent, bedankt voor de goede samenwerking aan de plasmid-capture approach 
voor SPR. Ik ben blij dat er een mooi manuscript uit dit project is voortgekomen!
Ik wil ook graag mijn (voormalige) kantoorgenoten bedanken voor de gezelligheid 
die er altijd was. Naast Stan, Matthijs, Magnus, Daan en Tim waren dat Fabian, Bart 
en Slavtscho. Fabian, succes in Londen met je werk aan RNA polymerase! Als ik 
weer eens langskom kunnen we nog een keer een Arsenal wedstrijd gaan bijwonen! 
Bart, jij ook bedankt voor de goede sfeer. Zodra je gaat promoveren hoor ik het 
graag! Slav, good luck with your new job in Germany, and thanks for all the cookies 
I stole!
Peter, you also joined our office for 6 months. It was really great having you here in 
Wageningen. You have a great expertise on phage-, plasmid- and microbiology. It 
was also really nice that you joined the 7-hills run, although from your perspective 
you may have wondered where the hills were.
In 2012 and 2013, I organized together with Mauricio and Elleke the Microbiology 
Seminar Series. Thanks to both of you for organizing this - we managed to main-
tain an attractive programme as witnessed by the fact that the seminar room is 
usually full.
John, Stan en Mali, samen hebben we in 2010 het CRISPR congres in Wageningen 
georganiseerd. Ik ben er nog steeds trots op hoe dit gelopen is; bedankt dat jullie 
me hierbij betrokken hebben. Ook wil ik hierbij Daan, Paul, Christel en Kaiyi 
bedanken voor hun logistieke hulp tijdens het congres.
I would also like to thank Bram, Martin, Mauricio, Teun, Jing, and Jimmy for their 
role in organizing the Ph.D. trip to China and Japan in 2011. With a complete lack of 
modesty I can claim that this was the best Ph.D. trip ever!! And organizing it with 
you guys was a great experience. I especially appreciate that no-one was refusing to 
get dirty hands. ;)
Thomas, Bram, Mark, Martin, I sincerely hope that we can maintain our yearly 
RISK battle! Usually the battle started weeks before the actual game, with people 
trying to bribe (Thomas), intimidate (Bram) or soften up (Martin and Mark) other 
participants - I thoroughly enjoyed this initial phase of our RISK games! Playing the 
Diplomacy boardgame with Tom, Mauricio, Daan, Fieke and Detmer to conquer 
Europe (or actually failing to do so) was also great fun!
Another great activity, initially organized by Matthijs, later by Tom, is the partici-
pation of a lab team in the Veluweloop. Matthijs and Tom, thanks for organizing. 
Thomas, Bram, Noora, Nora, Matthijs, Mauricio, Elleke, Tom, Rienk, Sebastiaan, 
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Fons, Vincent, Daan, Marjet thanks for joining. These estafette races were really 
great, and I learned (the hard way) that running without training is not a good idea! 
Bram, Thomas, Mauricio, Servé, Peter, Stefan, Tjalke and Hessel, I also enjoyed a 
lot our participation in the 7-hills run; thanks!
Ik wil graag de volgende AIO collega’s van de BacGen groep bedanken voor de gezel-
lige afgelopen 4 jaar: Marcel, bedankt voor de mooie schaatstocht over de Oost-
vaardersplassen en het vogelen met John en Stan, ook in de Oostvaardersplassen! 
Jammer dat ik die baardman gemist heb... Gelukkig hebben we een mooie spiegel 
thuis ;) Mark L., Mark M. (je was een waardige kantoorvoetbal-opponent), John R., 
Teunke, Melvin, Sjoerd, Elleke, Tom, Amos, Marco, Sinan, Sjon, Bram, Slav, Tijn, 
Rie, Pierpaolo, Raymond, Tessa, Daan, Nico, Bas, allemaal erg veel dank voor de 
goede sfeer in de groep! 
Ook het ondersteunend personeel Wim, Anja, Nees, Carolien en Jannie: Hartelijk 
dank voor jullie inspanningen!
During my Ph.D. I had the pleasure to work with a great number of very talented 
students. Without the experimental contributions of Luc, Sarah, Marieke, 
Kaiyi, Christel, Paul, Tim, Benedikt, Shi Pey, Søren, Camilla and Chong this thesis 
would have been a whole lot thinner. I am proud that your contributions have lead 
to many co-authorships, and I am very glad to see that nearly all of you started a 
Ph.D. yourselves. I wish you all the best in your scientific careers!
I’d also like to express my appreciation to Martin and Mauricio for being my para- 
nymphs. Thanks for your help in organizing everything that comes with a Ph.D. 
defense. It’s great to have you guys on my side during the defense! 
Our lab has been collaborating a lot with other research groups all over the world. 
As part of these collaborations, I spent time in the laboratory of Jennifer Doudna, 
who I would like to thank for her hospitality and the great time I had. A special 
thanks goes to Blake Wiedenheft, whose friendliness and hospitality are amazing. 
Blake, it was great working with you. Also, many thanks for taking the time to teach 
me the basics of protein crystallography. I still wonder why a brilliant guy like you 
lost so many of the chess games we played near the iHouse; I’m sure something 
down there must have distracted you from the game... ;) Kaihong, thanks for your 
friendliness! Rachel, it was very nice meeting you and having a pint in the pub!
Another lab that I visited and where I experienced great hospitality is that of Mark 
Dickman in Sheffield, UK. Mark, thanks a lot, both for teaching me Mass Spec-
trometry and for showing me the best pubs in town. Also thanks to Sak, Dan and 
Steve for their help and hospitality!
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Bram Snijders, jij ook bedankt voor de samenwerking! Het is ons altijd enorm goed 
bevallen projecten met jou samen te doen.
Many thanks to our collaborators in Düsseldorf: Ümit, Rolf, Reinhild, Melina and 
Zihni. Rolf, during the poster session of the small RNA conference in Berlin you 
told Stan and me about H-NS being a regulator of the CRISPR-Cas system in E. 
coli. Sharing this information with us initiated a collaboration that is still ongoing, 
and which I have appreciated a lot. You, Ümit and your labmembers are extremely 
knowledgeable, modest and generous. We were very happy to publish with you a 
follow-up story on CRISPR-Cas regulation in your favorite journal, and very much 
appreciated your input on the Cascade structure/function manuscript! Thanks for 
involving me in writing the chapter on CRISPR regulation! 
I would also like to thank Thomas Stratmann and Karin Schnetz from the Univer-
sity of Cologne and Gerhart Wagner, Nadja Heidrich and Amanda Raine from the 
University of Uppsala for their contribution to the CRISPR-Cas regulation story. 
By being open towards each other we found out that we trying to answer the same 
questions, and by collaborating rather than competing with each other we could 
quickly build a very nice story out of our combined data. I really appreciate this 
collaborative effort.
Esther, Arjan en Albert, de geavanceerde Mass Spectrometry technieken die 
jullie beheersen hebben tot een mooie publicaties geleid. Hartelijk dank voor jullie 
inspanningen! Jelle en Egbert, hartelijk dank voor de prettige samenwerking aan 
Electronen Microscopie op Cascade. 
Dankzij jouw berekeningen, Renko, begrijpen we waar Cascade de energie vandaan 
haalt om negatief gesupercoiled dsDNA te smelten. Voor iemand met jouw achter-
grond was dat misschien voor de hand liggend, voor ons was het een eye-opener. 
Bedankt voor de plezierige samenwerking!
Remus, dankzij jouw expertise op het gebied van AFM zijn we veel te weten gekomen 
over de structuur veranderingen die Cascade induceert in het target DNA. Bedankt 
voor jouw bijdrages alsmede die van Sander!
Katya and Konstantin, we have been working together many times over the last few 
years, and I always found it a very pleasurable experience. It’s amazing how much 
work you can get done. I appreciate how you handled our back-to-back publica-
tions in Molecular Microbiology in 2010. Kirill, thanks to your contributions to the 
work that we did in collaboration with Konstantin’s lab! 
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Gerrit, hartelijk dank voor de statistische analyse voor hoofdstuk 8. Het was erg 
prettig met je samen te werken, en het is leuk te zien hoe verschillend een onder- 
zoeker uit een andere discipline tegen een vraagstuk aankijkt. De input die je 
gegeven hebt was zeer waardevol! 
Fernando, it was great that you were willing to help us with the analysis shown in 
Chapter 8. I always find it very stimulating when different expertises are combined 
in a single study. Your knowledge of conjugative plasmids was essential for our 
bioinformatics analysis; thanks a lot!
Tim and Chirlmin, the single molecule studies we are doing with you are really 
exciting!! I am confident that these studies are going to turn into a very nice paper. 
It’s great to be working with such experts in the field! 
Stefan, we met on a conference in Frankfurt in 2011 and decided to start a colla- 
boration. Your kinetics studies provided new insights into Cascade-mediated DNA 
binding. I would like to thank you and your supervisor, Ralph, for your efforts. 
Good luck with your postdoc in Grenoble!
Naast alle mensen die op een professionele manier betrokken waren bij het tot stand 
komen van dit proefschift wil ik ook de mensen bedanken die mij op persoonlijk vlak 
gesteund hebben. In de eerste plaats bedank ik mijn ouders, Heit en Mem, en mijn 
broers en zus en mijn talrijke neefjes en nichtjes, Hessel & Jeannette - Eelke, Sybrich, 
Marije, Watse -, Hanneke & Remco - Johannes, Marijke, Eelke -, en Tjalke & Imke - 
Jildou, Sytse -, voor hun interesse in mijn onderzoek van de afgelopen jaren. Heit 
en Mem, ik waardeer erg dat mijn onderzoek jullie ook bezighoudt! Mem, ik kijk 
uit naar het eerste exemplaar van “Edze Ballontsje”! En bedankt dat we 2 weken 
bij jullie thuis konden werken, waar onder andere dit dankwoord is geschreven! 
Hessel, leuk dat we samen hardlopen; dat moeten we zeker blijven doen! Hanneke, 
als je ons komt opzoeken in Engeland kun je Johannes als tolk meenemen - zijn 
Engels is voortreffelijk! Tjalke, je bent hard bezig met je eigen proefschrift, en hebt 
nu al een mooie baan in het bedrijfsleven! Succes met je promotie!! 
Ook de familie van Stineke wil ik graag bedanken: Maarten en Kees, jullie willen 
altijd tot in detail weten wat ik qua onderzoek precies aan het doen ben - ik sta er 
iedere keer versteld van hoe goed jullie mijn technische verhalen kunnen volgen! 
Titia, jij maakt de meest fantastische tekeningen, waarvan er één de voorkant van 
dit proefschrift siert. Heel erg bedankt daarvoor! Succes met je bedrijfje, en ik 
hoop dat je er weldra genoeg mee verdient om alle reizen te maken waar je ooit 
van gedroomd hebt (en dat zijn er nogal wat). Leo en Nellie, jullie ook erg bedankt 
voor jullie interesse. Ik denk dat onze emigratie naar Engeland jullie er niet van zal 
weerhouden bij ons langs te gaan.
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Nelleke, bedankt voor het helpen schrijven van de press-release!! En voor de ingang 
die jij had bij NRC. Zonder jou was het waarschijnlijk niet gelukt de interesse van 
NRC te wekken. Ook de andere 6V-ers: bedankt voor alle gezelligheid de afgelopen 
jaren. Karin, succes met je promotie! Els, succes in Brazilië!
Ook Job & Dina, bedankt voor de gezelligheid; we moeten ons nodig weer eens 
laten insneeuwen om een weekend lang non-stop spelletjes te spelen en sneeuw-
ballen te gooien! Ard & Thijs, het is altijd enorm gezellig met jullie af te spreken 
en culturele uitstapjes te maken! Moeten we blijven doen! Michele & Eleonora, 
thanks for the great time, before I started my Ph.D., in Bologna. I hope you are still 
enjoying Cambridge!
Ik wil ook graag de collega’s van Stineke, bij het Laboratorium voor Virologie, 
bedanken voor de gezelligheid. Stefan, er gaat niks boven stellingen bedenken met 
een glas whiskey er bij! Paulus, de vogelreis naar de Pyreneeën was echt fantastisch! 
Vooral die ochtend dat we leeuweriken gingen kijken was onvergetelijk! Corinne 
& Simon, Jelke, Mia, Dryas, bedankt voor de gezelligheid tijdens een avondje bier 
drinken! Vera, veel succes met je projecten bij Virologie! Het is een fascinerende 
onderzoekslijn waar jij en Stien aan werken!
En dan het beste paard van stal: Stien, het is bijzonder om gelijktijdig door een 
promotie-traject te gaan. Het lag al vroeg vast waar ons promotieonderzoek over 
zou gaan: immers, op de lagere school gaf jij al een spreekbeurt over vlinders en ik 
over bacteriën; jij werkt tegenwoordig aan het gedrag van geïnfecteerde rupsen van 
een nachtmot en ik doe onderzoek aan een bacterieel immuunsysteem! Nu, 20 jaar 
later, weten we allebei precies hoe het is om na een dag hard werken gefrustreerd 
thuis te komen omdat een experiment mislukt is, of juist blij te zijn omdat er een 
doorbraak was (dit is helaas altijd zeldzamer). Een uitstekende remedie voor een 
teleurstellende dag is “de stoel”, waar het “slachtoffer” in de keuken op gaat zitten 
om z’n hart te luchten, terwijl de ander ondertussen in de pan staat te roeren. Zo 
hebben we de afgelopen jaren heel wat uurtjes gesproken over immuunsystemen 
van bacteriën en over klimmende rupsen! Als we straks in Engeland gaan wonen 
moeten we “de stoel” in ieder geval niet vergeten mee te verhuizen... Ik kijk er naar 
uit om met jou aan het volgende avontuur, in Engeland, te beginnen!
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overview of ComPleTed Training aCTiviTies
Discipline specific activities
Meetings:
• Annual Meeting NWO study group Protein Research, Nucleic Acids and Lipids & 
Membranes. 2012. Veldhoven, the Netherlands.* 
• Retreat staff members from Goethe University (Frankfurt). Löwenstein, Germany.*
• SMBE meeting. 2012. Dublin, Ireland.
• KeyStone Meeting “Gene Silencing by Small RNAs”. 2012. Vancouver, Canada.** 
• RNA-UK. 2012. Windermere, United Kingdom.*
• ALW meeting Molecular Genetics. 2011. Lunteren, the Netherlands. 
• International Symposium “Molecular Life Sciences 2011”. 2011. Frankfurt am Main, 
Germany.*
• Mosbacher Kolloquium, Mosbach, 2011 Germany. 
• Annual Meeting NWO study group Protein Research, Nucleic Acids and Lipids & 
Membranes. 2010. Veldhoven, the Netherlands.** 
• CRISPR meeting, Mechanisms and Applications. 2010. Wageningen, 
the Netherlands. 
• ALW-meeting Molecular Genetics. 2010. Lunteren, the Netherlands.*
• NEB meeting. 2010. Bremen, Germany.* 
• RNAi spring school. 2010. Wageningen, the Netherlands.*
• CRISPR meeting, Mechanisms and Ecology. 2009. Berkeley, USA. 
• Regulatory RNA in prokaryotes. 2010. Berlin, Germany. 
• Scientific Spring Meeting NVMM & NVvM. 2009. Papendal, the Netherlands. 
*Oral Presentation
**Poster Presentation
Courses:
• Guest Scientist – Hands on course Protein Crystallography. 2009. University of Cali-
fornia, Berkeley, USA.
• Guest Scientist – Hands on course Mass Spectrometry. 2012. University of Sheffield, 
Sheffield, United Kingdom.
General courses:
• VLAG PhD Week. 2009. Maastricht, the Netherlands.
• Communication with the media and the general public. 
• Techniques for Writing and Presenting Scientific Papers. 
• Philosophy and Ethics of Food Science and Technology. 
• Competence assessment.
Optionals:
• Radiation course, Wageningen University.
• Preparing PhD Research Proposal.
• Ph.D. study trip 2011 to China and Japan. 
• Bacterial Genetics Group Meetings (weekly).
• Laboratory of Microbiology PhD/PostDoc Meetings (biweekly).
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